import"../chunks/disclose-version.Bg9kRutz.js";import{aU as sc,i as Yr,A as lc,h as uc,aG as cc,c as Ge,p as Ke,o as Ve,v as ba,t as y,f as me,s,n as Be,b as v,k as c,m as se,l as L,a as A,x as Pe,d as We,z as V,e as n,r as t,aB as pe,g as m,y as De,w as ki,aS as Ne,ay as dc,aK as $t,$ as mc}from"../chunks/custom-element.DQtPqtwV.js";import{h as $}from"../chunks/html.Dn7-qKOW.js";import{D as pc,a as hc}from"../chunks/Dialog.CrNQWnop.js";import{i as qe}from"../chunks/lifecycle.By80OOUV.js";import{p as J}from"../chunks/props.DpOBpuVa.js";import{p as $r}from"../chunks/stores.B0uQfzi0.js";import{m as mr}from"../chunks/meta.store.Q6Z8Tcx4.js";import{i as P}from"../chunks/if.BrBjDjp-.js";import{b as sn,a as ln,d as ta,C as vc,c as fa,g as Aa,q as ci,w as ua,D as di,l as mi,E as qr}from"../chunks/firebase.ByBy7bFy.js";import{a as B,r as pr}from"../chunks/attributes.DQACxfmV.js";import{t as Ee}from"../chunks/class.DzKL41hs.js";import{b as Xr}from"../chunks/this.32Ewebps.js";import{g as Qr}from"../chunks/entry.DpD4jmoC.js";import{a as gc}from"../chunks/alert-wrapper.DmUxTNf7.js";import{e as He,i as xe}from"../chunks/each.CBDd4fNw.js";import{o as Da,a as jc}from"../chunks/index-client.cakr4NJt.js";import{s as ra,a as $e}from"../chunks/store.iOtDhSer.js";import{l as ea}from"../chunks/language.CzC4Du2W.js";import{a as es}from"../chunks/css.osYD52Gu.js";import{l as kc,b as fi}from"../chunks/select.CRhj634H.js";import{C as qt}from"../chunks/config.const.D0DIsJfW.js";import"../chunks/Product.CxCdmiuc.js";import"../chunks/image-gallery.wc.CZZbQSui.js";import{t as Oa,a as hr,s as li}from"../chunks/index.DUavQ0dq.js";import"../chunks/Resources.B7BMq9sO.js";import{d as fc}from"../chunks/index.BMbXZGcN.js";function vr(o,e,a=e){var i=sc();kc(o,"input",()=>{var r=gr(o)?jr(o.value):o.value;a(r),i&&r!==(r=e())&&(o.value=r??"")}),Yr(()=>{var r=e();if(lc&&o.defaultValue!==o.value){a(o.value);return}gr(o)&&r===jr(o.value)||o.type==="date"&&!r&&!o.value||r!==o.value&&(o.value=r??"")})}function gr(o){var e=o.type;return e==="number"||e==="range"}function jr(o){return o===""?null:+o}function bc(o,e,a=e){var i=()=>{r=!0,clearTimeout(l),l=setTimeout(d,100),a(window.scrollY)};addEventListener("scroll",i,{passive:!0});var r=!1,l,d=()=>{r=!1},u=!0;Yr(()=>{var p=e();u?u=!1:!r&&p!=null&&(r=!0,clearTimeout(l),scrollTo(window.scrollX,p),l=setTimeout(d,100))}),uc(i),cc(()=>{removeEventListener("scroll",i)})}const yc=(o,e)=>{const a=Array.isArray(e)?e:[e];return o.classList.add(...a),{destroy(){o.classList.remove(...a)}}};function kr(o){return`<style>${o}</style>`}var zc=y("<p>Select a popup to see content.</p>"),Sc=y('<button class="button" type="button"> </button> <!>',1);function Mc(o,e){Ke(e,!1);let a=J(e,"popup",12),i=J(e,"label",12,"Open"),r=se(!1),l=se();Ve(()=>(c(r),pe(a()),kr),()=>{c(r)&&a()&&Promise.all([sn(ln(ta,"landing-page-popups",a(),"content","html")),sn(ln(ta,"landing-page-popups",a(),"content","css"))]).then(j=>L(l,j[0].data().content+kr(j[1].data().content))).catch(console.error)}),ba(),qe();var d=Sc(),u=me(d),p=n(u);t(u);var h=s(u,2);return pc(h,{get showing(){return c(r)},set showing(j){L(r,j)},children:(j,S)=>{var G=Be(),z=me(G);P(z,()=>c(l),M=>{var k=Be(),g=me(k);$(g,()=>c(l)),v(M,k)},M=>{var k=zc();v(M,k)}),v(j,G)},$$slots:{default:!0},$$legacy:!0}),A(()=>m(p,i())),Pe("click",u,()=>L(r,!0)),v(o,d),We({get popup(){return a()},set popup(j){a(j),V()},get label(){return i()},set label(j){i(j),V()}})}customElements.define("pb-popup",Ge(Mc,{popup:{},label:{}},[],[],!1));class Ra extends Error{}class wc extends Ra{constructor(e){super(`Invalid DateTime: ${e.toMessage()}`)}}class Ac extends Ra{constructor(e){super(`Invalid Interval: ${e.toMessage()}`)}}class Gc extends Ra{constructor(e){super(`Invalid Duration: ${e.toMessage()}`)}}class Ua extends Ra{}class as extends Ra{constructor(e){super(`Invalid unit ${e}`)}}class Ze extends Ra{}class Ca extends Ra{constructor(){super("Zone is an abstract class")}}const N="numeric",ja="short",na="long",Pi={year:N,month:N,day:N},is={year:N,month:ja,day:N},Dc={year:N,month:ja,day:N,weekday:ja},os={year:N,month:na,day:N},ts={year:N,month:na,day:N,weekday:na},ns={hour:N,minute:N},rs={hour:N,minute:N,second:N},ss={hour:N,minute:N,second:N,timeZoneName:ja},ls={hour:N,minute:N,second:N,timeZoneName:na},us={hour:N,minute:N,hourCycle:"h23"},cs={hour:N,minute:N,second:N,hourCycle:"h23"},ds={hour:N,minute:N,second:N,hourCycle:"h23",timeZoneName:ja},ms={hour:N,minute:N,second:N,hourCycle:"h23",timeZoneName:na},ps={year:N,month:N,day:N,hour:N,minute:N},hs={year:N,month:N,day:N,hour:N,minute:N,second:N},vs={year:N,month:ja,day:N,hour:N,minute:N},gs={year:N,month:ja,day:N,hour:N,minute:N,second:N},Ic={year:N,month:ja,day:N,weekday:ja,hour:N,minute:N},js={year:N,month:na,day:N,hour:N,minute:N,timeZoneName:ja},ks={year:N,month:na,day:N,hour:N,minute:N,second:N,timeZoneName:ja},fs={year:N,month:na,day:N,weekday:na,hour:N,minute:N,timeZoneName:na},bs={year:N,month:na,day:N,weekday:na,hour:N,minute:N,second:N,timeZoneName:na};class hi{get type(){throw new Ca}get name(){throw new Ca}get ianaName(){return this.name}get isUniversal(){throw new Ca}offsetName(e,a){throw new Ca}formatOffset(e,a){throw new Ca}offset(e){throw new Ca}equals(e){throw new Ca}get isValid(){throw new Ca}}let Xt=null;class Li extends hi{static get instance(){return Xt===null&&(Xt=new Li),Xt}get type(){return"system"}get name(){return new Intl.DateTimeFormat().resolvedOptions().timeZone}get isUniversal(){return!1}offsetName(e,{format:a,locale:i}){return Is(e,a,i)}formatOffset(e,a){return ui(this.offset(e),a)}offset(e){return-new Date(e).getTimezoneOffset()}equals(e){return e.type==="system"}get isValid(){return!0}}let Ai={};function Pc(o){return Ai[o]||(Ai[o]=new Intl.DateTimeFormat("en-US",{hour12:!1,timeZone:o,year:"numeric",month:"2-digit",day:"2-digit",hour:"2-digit",minute:"2-digit",second:"2-digit",era:"short"})),Ai[o]}const Cc={year:0,month:1,day:2,era:3,hour:4,minute:5,second:6};function Tc(o,e){const a=o.format(e).replace(/\u200E/g,""),i=/(\d+)\/(\d+)\/(\d+) (AD|BC),? (\d+):(\d+):(\d+)/.exec(a),[,r,l,d,u,p,h,j]=i;return[d,r,l,u,p,h,j]}function Nc(o,e){const a=o.formatToParts(e),i=[];for(let r=0;r<a.length;r++){const{type:l,value:d}=a[r],u=Cc[l];l==="era"?i[u]=d:re(u)||(i[u]=parseInt(d,10))}return i}let bi={};class Ga extends hi{static create(e){return bi[e]||(bi[e]=new Ga(e)),bi[e]}static resetCache(){bi={},Ai={}}static isValidSpecifier(e){return this.isValidZone(e)}static isValidZone(e){if(!e)return!1;try{return new Intl.DateTimeFormat("en-US",{timeZone:e}).format(),!0}catch{return!1}}constructor(e){super(),this.zoneName=e,this.valid=Ga.isValidZone(e)}get type(){return"iana"}get name(){return this.zoneName}get isUniversal(){return!1}offsetName(e,{format:a,locale:i}){return Is(e,a,i,this.name)}formatOffset(e,a){return ui(this.offset(e),a)}offset(e){const a=new Date(e);if(isNaN(a))return NaN;const i=Pc(this.name);let[r,l,d,u,p,h,j]=i.formatToParts?Nc(i,a):Tc(i,a);u==="BC"&&(r=-Math.abs(r)+1);const G=Ei({year:r,month:l,day:d,hour:p===24?0:p,minute:h,second:j,millisecond:0});let z=+a;const M=z%1e3;return z-=M>=0?M:1e3+M,(G-z)/(60*1e3)}equals(e){return e.type==="iana"&&e.name===this.name}get isValid(){return this.valid}}let fr={};function Lc(o,e={}){const a=JSON.stringify([o,e]);let i=fr[a];return i||(i=new Intl.ListFormat(o,e),fr[a]=i),i}let un={};function cn(o,e={}){const a=JSON.stringify([o,e]);let i=un[a];return i||(i=new Intl.DateTimeFormat(o,e),un[a]=i),i}let dn={};function _c(o,e={}){const a=JSON.stringify([o,e]);let i=dn[a];return i||(i=new Intl.NumberFormat(o,e),dn[a]=i),i}let mn={};function Ec(o,e={}){const{base:a,...i}=e,r=JSON.stringify([o,i]);let l=mn[r];return l||(l=new Intl.RelativeTimeFormat(o,e),mn[r]=l),l}let ri=null;function Hc(){return ri||(ri=new Intl.DateTimeFormat().resolvedOptions().locale,ri)}let br={};function xc(o){let e=br[o];if(!e){const a=new Intl.Locale(o);e="getWeekInfo"in a?a.getWeekInfo():a.weekInfo,br[o]=e}return e}function Oc(o){const e=o.indexOf("-x-");e!==-1&&(o=o.substring(0,e));const a=o.indexOf("-u-");if(a===-1)return[o];{let i,r;try{i=cn(o).resolvedOptions(),r=o}catch{const p=o.substring(0,a);i=cn(p).resolvedOptions(),r=p}const{numberingSystem:l,calendar:d}=i;return[r,l,d]}}function Rc(o,e,a){return(a||e)&&(o.includes("-u-")||(o+="-u"),a&&(o+=`-ca-${a}`),e&&(o+=`-nu-${e}`)),o}function Fc(o){const e=[];for(let a=1;a<=12;a++){const i=ne.utc(2009,a,1);e.push(o(i))}return e}function Bc(o){const e=[];for(let a=1;a<=7;a++){const i=ne.utc(2016,11,13+a);e.push(o(i))}return e}function yi(o,e,a,i){const r=o.listingMode();return r==="error"?null:r==="en"?a(e):i(e)}function Vc(o){return o.numberingSystem&&o.numberingSystem!=="latn"?!1:o.numberingSystem==="latn"||!o.locale||o.locale.startsWith("en")||new Intl.DateTimeFormat(o.intl).resolvedOptions().numberingSystem==="latn"}class Jc{constructor(e,a,i){this.padTo=i.padTo||0,this.floor=i.floor||!1;const{padTo:r,floor:l,...d}=i;if(!a||Object.keys(d).length>0){const u={useGrouping:!1,...i};i.padTo>0&&(u.minimumIntegerDigits=i.padTo),this.inf=_c(e,u)}}format(e){if(this.inf){const a=this.floor?Math.floor(e):e;return this.inf.format(a)}else{const a=this.floor?Math.floor(e):fn(e,3);return Re(a,this.padTo)}}}class Kc{constructor(e,a,i){this.opts=i,this.originalZone=void 0;let r;if(this.opts.timeZone)this.dt=e;else if(e.zone.type==="fixed"){const d=-1*(e.offset/60),u=d>=0?`Etc/GMT+${d}`:`Etc/GMT${d}`;e.offset!==0&&Ga.create(u).valid?(r=u,this.dt=e):(r="UTC",this.dt=e.offset===0?e:e.setZone("UTC").plus({minutes:e.offset}),this.originalZone=e.zone)}else e.zone.type==="system"?this.dt=e:e.zone.type==="iana"?(this.dt=e,r=e.zone.name):(r="UTC",this.dt=e.setZone("UTC").plus({minutes:e.offset}),this.originalZone=e.zone);const l={...this.opts};l.timeZone=l.timeZone||r,this.dtf=cn(a,l)}format(){return this.originalZone?this.formatToParts().map(({value:e})=>e).join(""):this.dtf.format(this.dt.toJSDate())}formatToParts(){const e=this.dtf.formatToParts(this.dt.toJSDate());return this.originalZone?e.map(a=>{if(a.type==="timeZoneName"){const i=this.originalZone.offsetName(this.dt.ts,{locale:this.dt.locale,format:this.opts.timeZoneName});return{...a,value:i}}else return a}):e}resolvedOptions(){return this.dtf.resolvedOptions()}}class Wc{constructor(e,a,i){this.opts={style:"long",...i},!a&&Gs()&&(this.rtf=Ec(e,i))}format(e,a){return this.rtf?this.rtf.format(e,a):vd(a,e,this.opts.numeric,this.opts.style!=="long")}formatToParts(e,a){return this.rtf?this.rtf.formatToParts(e,a):[]}}const Zc={firstDay:1,minimalDays:4,weekend:[6,7]};class be{static fromOpts(e){return be.create(e.locale,e.numberingSystem,e.outputCalendar,e.weekSettings,e.defaultToEN)}static create(e,a,i,r,l=!1){const d=e||_e.defaultLocale,u=d||(l?"en-US":Hc()),p=a||_e.defaultNumberingSystem,h=i||_e.defaultOutputCalendar,j=pn(r)||_e.defaultWeekSettings;return new be(u,p,h,j,d)}static resetCache(){ri=null,un={},dn={},mn={}}static fromObject({locale:e,numberingSystem:a,outputCalendar:i,weekSettings:r}={}){return be.create(e,a,i,r)}constructor(e,a,i,r,l){const[d,u,p]=Oc(e);this.locale=d,this.numberingSystem=a||u||null,this.outputCalendar=i||p||null,this.weekSettings=r,this.intl=Rc(this.locale,this.numberingSystem,this.outputCalendar),this.weekdaysCache={format:{},standalone:{}},this.monthsCache={format:{},standalone:{}},this.meridiemCache=null,this.eraCache={},this.specifiedLocale=l,this.fastNumbersCached=null}get fastNumbers(){return this.fastNumbersCached==null&&(this.fastNumbersCached=Vc(this)),this.fastNumbersCached}listingMode(){const e=this.isEnglish(),a=(this.numberingSystem===null||this.numberingSystem==="latn")&&(this.outputCalendar===null||this.outputCalendar==="gregory");return e&&a?"en":"intl"}clone(e){return!e||Object.getOwnPropertyNames(e).length===0?this:be.create(e.locale||this.specifiedLocale,e.numberingSystem||this.numberingSystem,e.outputCalendar||this.outputCalendar,pn(e.weekSettings)||this.weekSettings,e.defaultToEN||!1)}redefaultToEN(e={}){return this.clone({...e,defaultToEN:!0})}redefaultToSystem(e={}){return this.clone({...e,defaultToEN:!1})}months(e,a=!1){return yi(this,e,Ts,()=>{const i=a?{month:e,day:"numeric"}:{month:e},r=a?"format":"standalone";return this.monthsCache[r][e]||(this.monthsCache[r][e]=Fc(l=>this.extract(l,i,"month"))),this.monthsCache[r][e]})}weekdays(e,a=!1){return yi(this,e,_s,()=>{const i=a?{weekday:e,year:"numeric",month:"long",day:"numeric"}:{weekday:e},r=a?"format":"standalone";return this.weekdaysCache[r][e]||(this.weekdaysCache[r][e]=Bc(l=>this.extract(l,i,"weekday"))),this.weekdaysCache[r][e]})}meridiems(){return yi(this,void 0,()=>Es,()=>{if(!this.meridiemCache){const e={hour:"numeric",hourCycle:"h12"};this.meridiemCache=[ne.utc(2016,11,13,9),ne.utc(2016,11,13,19)].map(a=>this.extract(a,e,"dayperiod"))}return this.meridiemCache})}eras(e){return yi(this,e,Hs,()=>{const a={era:e};return this.eraCache[e]||(this.eraCache[e]=[ne.utc(-40,1,1),ne.utc(2017,1,1)].map(i=>this.extract(i,a,"era"))),this.eraCache[e]})}extract(e,a,i){const r=this.dtFormatter(e,a),l=r.formatToParts(),d=l.find(u=>u.type.toLowerCase()===i);return d?d.value:null}numberFormatter(e={}){return new Jc(this.intl,e.forceSimple||this.fastNumbers,e)}dtFormatter(e,a={}){return new Kc(e,this.intl,a)}relFormatter(e={}){return new Wc(this.intl,this.isEnglish(),e)}listFormatter(e={}){return Lc(this.intl,e)}isEnglish(){return this.locale==="en"||this.locale.toLowerCase()==="en-us"||new Intl.DateTimeFormat(this.intl).resolvedOptions().locale.startsWith("en-us")}getWeekSettings(){return this.weekSettings?this.weekSettings:Ds()?xc(this.locale):Zc}getStartOfWeek(){return this.getWeekSettings().firstDay}getMinDaysInFirstWeek(){return this.getWeekSettings().minimalDays}getWeekendDays(){return this.getWeekSettings().weekend}equals(e){return this.locale===e.locale&&this.numberingSystem===e.numberingSystem&&this.outputCalendar===e.outputCalendar}toString(){return`Locale(${this.locale}, ${this.numberingSystem}, ${this.outputCalendar})`}}let Qt=null;class Ye extends hi{static get utcInstance(){return Qt===null&&(Qt=new Ye(0)),Qt}static instance(e){return e===0?Ye.utcInstance:new Ye(e)}static parseSpecifier(e){if(e){const a=e.match(/^utc(?:([+-]\d{1,2})(?::(\d{2}))?)?$/i);if(a)return new Ye(Hi(a[1],a[2]))}return null}constructor(e){super(),this.fixed=e}get type(){return"fixed"}get name(){return this.fixed===0?"UTC":`UTC${ui(this.fixed,"narrow")}`}get ianaName(){return this.fixed===0?"Etc/UTC":`Etc/GMT${ui(-this.fixed,"narrow")}`}offsetName(){return this.name}formatOffset(e,a){return ui(this.fixed,a)}get isUniversal(){return!0}offset(){return this.fixed}equals(e){return e.type==="fixed"&&e.fixed===this.fixed}get isValid(){return!0}}class Uc extends hi{constructor(e){super(),this.zoneName=e}get type(){return"invalid"}get name(){return this.zoneName}get isUniversal(){return!1}offsetName(){return null}formatOffset(){return""}offset(){return NaN}equals(){return!1}get isValid(){return!1}}function La(o,e){if(re(o)||o===null)return e;if(o instanceof hi)return o;if(ed(o)){const a=o.toLowerCase();return a==="default"?e:a==="local"||a==="system"?Li.instance:a==="utc"||a==="gmt"?Ye.utcInstance:Ye.parseSpecifier(a)||Ga.create(o)}else return _a(o)?Ye.instance(o):typeof o=="object"&&"offset"in o&&typeof o.offset=="function"?o:new Uc(o)}const vn={arab:"[٠-٩]",arabext:"[۰-۹]",bali:"[᭐-᭙]",beng:"[০-৯]",deva:"[०-९]",fullwide:"[０-９]",gujr:"[૦-૯]",hanidec:"[〇|一|二|三|四|五|六|七|八|九]",khmr:"[០-៩]",knda:"[೦-೯]",laoo:"[໐-໙]",limb:"[᥆-᥏]",mlym:"[൦-൯]",mong:"[᠐-᠙]",mymr:"[၀-၉]",orya:"[୦-୯]",tamldec:"[௦-௯]",telu:"[౦-౯]",thai:"[๐-๙]",tibt:"[༠-༩]",latn:"\\d"},yr={arab:[1632,1641],arabext:[1776,1785],bali:[6992,7001],beng:[2534,2543],deva:[2406,2415],fullwide:[65296,65303],gujr:[2790,2799],khmr:[6112,6121],knda:[3302,3311],laoo:[3792,3801],limb:[6470,6479],mlym:[3430,3439],mong:[6160,6169],mymr:[4160,4169],orya:[2918,2927],tamldec:[3046,3055],telu:[3174,3183],thai:[3664,3673],tibt:[3872,3881]},Yc=vn.hanidec.replace(/[\[|\]]/g,"").split("");function $c(o){let e=parseInt(o,10);if(isNaN(e)){e="";for(let a=0;a<o.length;a++){const i=o.charCodeAt(a);if(o[a].search(vn.hanidec)!==-1)e+=Yc.indexOf(o[a]);else for(const r in yr){const[l,d]=yr[r];i>=l&&i<=d&&(e+=i-l)}}return parseInt(e,10)}else return e}let Za={};function qc(){Za={}}function ha({numberingSystem:o},e=""){const a=o||"latn";return Za[a]||(Za[a]={}),Za[a][e]||(Za[a][e]=new RegExp(`${vn[a]}${e}`)),Za[a][e]}let zr=()=>Date.now(),Sr="system",Mr=null,wr=null,Ar=null,Gr=60,Dr,Ir=null;class _e{static get now(){return zr}static set now(e){zr=e}static set defaultZone(e){Sr=e}static get defaultZone(){return La(Sr,Li.instance)}static get defaultLocale(){return Mr}static set defaultLocale(e){Mr=e}static get defaultNumberingSystem(){return wr}static set defaultNumberingSystem(e){wr=e}static get defaultOutputCalendar(){return Ar}static set defaultOutputCalendar(e){Ar=e}static get defaultWeekSettings(){return Ir}static set defaultWeekSettings(e){Ir=pn(e)}static get twoDigitCutoffYear(){return Gr}static set twoDigitCutoffYear(e){Gr=e%100}static get throwOnInvalid(){return Dr}static set throwOnInvalid(e){Dr=e}static resetCaches(){be.resetCache(),Ga.resetCache(),ne.resetCache(),qc()}}class ga{constructor(e,a){this.reason=e,this.explanation=a}toMessage(){return this.explanation?`${this.reason}: ${this.explanation}`:this.reason}}const ys=[0,31,59,90,120,151,181,212,243,273,304,334],zs=[0,31,60,91,121,152,182,213,244,274,305,335];function ca(o,e){return new ga("unit out of range",`you specified ${e} (of type ${typeof e}) as a ${o}, which is invalid`)}function gn(o,e,a){const i=new Date(Date.UTC(o,e-1,a));o<100&&o>=0&&i.setUTCFullYear(i.getUTCFullYear()-1900);const r=i.getUTCDay();return r===0?7:r}function Ss(o,e,a){return a+(vi(o)?zs:ys)[e-1]}function Ms(o,e){const a=vi(o)?zs:ys,i=a.findIndex(l=>l<e),r=e-a[i];return{month:i+1,day:r}}function jn(o,e){return(o-e+7)%7+1}function Ci(o,e=4,a=1){const{year:i,month:r,day:l}=o,d=Ss(i,r,l),u=jn(gn(i,r,l),a);let p=Math.floor((d-u+14-e)/7),h;return p<1?(h=i-1,p=pi(h,e,a)):p>pi(i,e,a)?(h=i+1,p=1):h=i,{weekYear:h,weekNumber:p,weekday:u,...xi(o)}}function Pr(o,e=4,a=1){const{weekYear:i,weekNumber:r,weekday:l}=o,d=jn(gn(i,1,e),a),u=Ya(i);let p=r*7+l-d-7+e,h;p<1?(h=i-1,p+=Ya(h)):p>u?(h=i+1,p-=Ya(i)):h=i;const{month:j,day:S}=Ms(h,p);return{year:h,month:j,day:S,...xi(o)}}function en(o){const{year:e,month:a,day:i}=o,r=Ss(e,a,i);return{year:e,ordinal:r,...xi(o)}}function Cr(o){const{year:e,ordinal:a}=o,{month:i,day:r}=Ms(e,a);return{year:e,month:i,day:r,...xi(o)}}function Tr(o,e){if(!re(o.localWeekday)||!re(o.localWeekNumber)||!re(o.localWeekYear)){if(!re(o.weekday)||!re(o.weekNumber)||!re(o.weekYear))throw new Ua("Cannot mix locale-based week fields with ISO-based week fields");return re(o.localWeekday)||(o.weekday=o.localWeekday),re(o.localWeekNumber)||(o.weekNumber=o.localWeekNumber),re(o.localWeekYear)||(o.weekYear=o.localWeekYear),delete o.localWeekday,delete o.localWeekNumber,delete o.localWeekYear,{minDaysInFirstWeek:e.getMinDaysInFirstWeek(),startOfWeek:e.getStartOfWeek()}}else return{minDaysInFirstWeek:4,startOfWeek:1}}function Xc(o,e=4,a=1){const i=_i(o.weekYear),r=da(o.weekNumber,1,pi(o.weekYear,e,a)),l=da(o.weekday,1,7);return i?r?l?!1:ca("weekday",o.weekday):ca("week",o.weekNumber):ca("weekYear",o.weekYear)}function Qc(o){const e=_i(o.year),a=da(o.ordinal,1,Ya(o.year));return e?a?!1:ca("ordinal",o.ordinal):ca("year",o.year)}function ws(o){const e=_i(o.year),a=da(o.month,1,12),i=da(o.day,1,Ti(o.year,o.month));return e?a?i?!1:ca("day",o.day):ca("month",o.month):ca("year",o.year)}function As(o){const{hour:e,minute:a,second:i,millisecond:r}=o,l=da(e,0,23)||e===24&&a===0&&i===0&&r===0,d=da(a,0,59),u=da(i,0,59),p=da(r,0,999);return l?d?u?p?!1:ca("millisecond",r):ca("second",i):ca("minute",a):ca("hour",e)}function re(o){return typeof o>"u"}function _a(o){return typeof o=="number"}function _i(o){return typeof o=="number"&&o%1===0}function ed(o){return typeof o=="string"}function ad(o){return Object.prototype.toString.call(o)==="[object Date]"}function Gs(){try{return typeof Intl<"u"&&!!Intl.RelativeTimeFormat}catch{return!1}}function Ds(){try{return typeof Intl<"u"&&!!Intl.Locale&&("weekInfo"in Intl.Locale.prototype||"getWeekInfo"in Intl.Locale.prototype)}catch{return!1}}function id(o){return Array.isArray(o)?o:[o]}function Nr(o,e,a){if(o.length!==0)return o.reduce((i,r)=>{const l=[e(r),r];return i&&a(i[0],l[0])===i[0]?i:l},null)[1]}function od(o,e){return e.reduce((a,i)=>(a[i]=o[i],a),{})}function qa(o,e){return Object.prototype.hasOwnProperty.call(o,e)}function pn(o){if(o==null)return null;if(typeof o!="object")throw new Ze("Week settings must be an object");if(!da(o.firstDay,1,7)||!da(o.minimalDays,1,7)||!Array.isArray(o.weekend)||o.weekend.some(e=>!da(e,1,7)))throw new Ze("Invalid week settings");return{firstDay:o.firstDay,minimalDays:o.minimalDays,weekend:Array.from(o.weekend)}}function da(o,e,a){return _i(o)&&o>=e&&o<=a}function td(o,e){return o-e*Math.floor(o/e)}function Re(o,e=2){const a=o<0;let i;return a?i="-"+(""+-o).padStart(e,"0"):i=(""+o).padStart(e,"0"),i}function Na(o){if(!(re(o)||o===null||o===""))return parseInt(o,10)}function Ea(o){if(!(re(o)||o===null||o===""))return parseFloat(o)}function kn(o){if(!(re(o)||o===null||o==="")){const e=parseFloat("0."+o)*1e3;return Math.floor(e)}}function fn(o,e,a=!1){const i=10**e;return(a?Math.trunc:Math.round)(o*i)/i}function vi(o){return o%4===0&&(o%100!==0||o%400===0)}function Ya(o){return vi(o)?366:365}function Ti(o,e){const a=td(e-1,12)+1,i=o+(e-a)/12;return a===2?vi(i)?29:28:[31,null,31,30,31,30,31,31,30,31,30,31][a-1]}function Ei(o){let e=Date.UTC(o.year,o.month-1,o.day,o.hour,o.minute,o.second,o.millisecond);return o.year<100&&o.year>=0&&(e=new Date(e),e.setUTCFullYear(o.year,o.month-1,o.day)),+e}function Lr(o,e,a){return-jn(gn(o,1,e),a)+e-1}function pi(o,e=4,a=1){const i=Lr(o,e,a),r=Lr(o+1,e,a);return(Ya(o)-i+r)/7}function hn(o){return o>99?o:o>_e.twoDigitCutoffYear?1900+o:2e3+o}function Is(o,e,a,i=null){const r=new Date(o),l={hourCycle:"h23",year:"numeric",month:"2-digit",day:"2-digit",hour:"2-digit",minute:"2-digit"};i&&(l.timeZone=i);const d={timeZoneName:e,...l},u=new Intl.DateTimeFormat(a,d).formatToParts(r).find(p=>p.type.toLowerCase()==="timezonename");return u?u.value:null}function Hi(o,e){let a=parseInt(o,10);Number.isNaN(a)&&(a=0);const i=parseInt(e,10)||0,r=a<0||Object.is(a,-0)?-i:i;return a*60+r}function Ps(o){const e=Number(o);if(typeof o=="boolean"||o===""||Number.isNaN(e))throw new Ze(`Invalid unit value ${o}`);return e}function Ni(o,e){const a={};for(const i in o)if(qa(o,i)){const r=o[i];if(r==null)continue;a[e(i)]=Ps(r)}return a}function ui(o,e){const a=Math.trunc(Math.abs(o/60)),i=Math.trunc(Math.abs(o%60)),r=o>=0?"+":"-";switch(e){case"short":return`${r}${Re(a,2)}:${Re(i,2)}`;case"narrow":return`${r}${a}${i>0?`:${i}`:""}`;case"techie":return`${r}${Re(a,2)}${Re(i,2)}`;default:throw new RangeError(`Value format ${e} is out of range for property format`)}}function xi(o){return od(o,["hour","minute","second","millisecond"])}const nd=["January","February","March","April","May","June","July","August","September","October","November","December"],Cs=["Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],rd=["J","F","M","A","M","J","J","A","S","O","N","D"];function Ts(o){switch(o){case"narrow":return[...rd];case"short":return[...Cs];case"long":return[...nd];case"numeric":return["1","2","3","4","5","6","7","8","9","10","11","12"];case"2-digit":return["01","02","03","04","05","06","07","08","09","10","11","12"];default:return null}}const Ns=["Monday","Tuesday","Wednesday","Thursday","Friday","Saturday","Sunday"],Ls=["Mon","Tue","Wed","Thu","Fri","Sat","Sun"],sd=["M","T","W","T","F","S","S"];function _s(o){switch(o){case"narrow":return[...sd];case"short":return[...Ls];case"long":return[...Ns];case"numeric":return["1","2","3","4","5","6","7"];default:return null}}const Es=["AM","PM"],ld=["Before Christ","Anno Domini"],ud=["BC","AD"],cd=["B","A"];function Hs(o){switch(o){case"narrow":return[...cd];case"short":return[...ud];case"long":return[...ld];default:return null}}function dd(o){return Es[o.hour<12?0:1]}function md(o,e){return _s(e)[o.weekday-1]}function pd(o,e){return Ts(e)[o.month-1]}function hd(o,e){return Hs(e)[o.year<0?0:1]}function vd(o,e,a="always",i=!1){const r={years:["year","yr."],quarters:["quarter","qtr."],months:["month","mo."],weeks:["week","wk."],days:["day","day","days"],hours:["hour","hr."],minutes:["minute","min."],seconds:["second","sec."]},l=["hours","minutes","seconds"].indexOf(o)===-1;if(a==="auto"&&l){const S=o==="days";switch(e){case 1:return S?"tomorrow":`next ${r[o][0]}`;case-1:return S?"yesterday":`last ${r[o][0]}`;case 0:return S?"today":`this ${r[o][0]}`}}const d=Object.is(e,-0)||e<0,u=Math.abs(e),p=u===1,h=r[o],j=i?p?h[1]:h[2]||h[1]:p?r[o][0]:o;return d?`${u} ${j} ago`:`in ${u} ${j}`}function _r(o,e){let a="";for(const i of o)i.literal?a+=i.val:a+=e(i.val);return a}const gd={D:Pi,DD:is,DDD:os,DDDD:ts,t:ns,tt:rs,ttt:ss,tttt:ls,T:us,TT:cs,TTT:ds,TTTT:ms,f:ps,ff:vs,fff:js,ffff:fs,F:hs,FF:gs,FFF:ks,FFFF:bs};class Ue{static create(e,a={}){return new Ue(e,a)}static parseFormat(e){let a=null,i="",r=!1;const l=[];for(let d=0;d<e.length;d++){const u=e.charAt(d);u==="'"?(i.length>0&&l.push({literal:r||/^\s+$/.test(i),val:i}),a=null,i="",r=!r):r||u===a?i+=u:(i.length>0&&l.push({literal:/^\s+$/.test(i),val:i}),i=u,a=u)}return i.length>0&&l.push({literal:r||/^\s+$/.test(i),val:i}),l}static macroTokenToFormatOpts(e){return gd[e]}constructor(e,a){this.opts=a,this.loc=e,this.systemLoc=null}formatWithSystemDefault(e,a){return this.systemLoc===null&&(this.systemLoc=this.loc.redefaultToSystem()),this.systemLoc.dtFormatter(e,{...this.opts,...a}).format()}dtFormatter(e,a={}){return this.loc.dtFormatter(e,{...this.opts,...a})}formatDateTime(e,a){return this.dtFormatter(e,a).format()}formatDateTimeParts(e,a){return this.dtFormatter(e,a).formatToParts()}formatInterval(e,a){return this.dtFormatter(e.start,a).dtf.formatRange(e.start.toJSDate(),e.end.toJSDate())}resolvedOptions(e,a){return this.dtFormatter(e,a).resolvedOptions()}num(e,a=0){if(this.opts.forceSimple)return Re(e,a);const i={...this.opts};return a>0&&(i.padTo=a),this.loc.numberFormatter(i).format(e)}formatDateTimeFromString(e,a){const i=this.loc.listingMode()==="en",r=this.loc.outputCalendar&&this.loc.outputCalendar!=="gregory",l=(z,M)=>this.loc.extract(e,z,M),d=z=>e.isOffsetFixed&&e.offset===0&&z.allowZ?"Z":e.isValid?e.zone.formatOffset(e.ts,z.format):"",u=()=>i?dd(e):l({hour:"numeric",hourCycle:"h12"},"dayperiod"),p=(z,M)=>i?pd(e,z):l(M?{month:z}:{month:z,day:"numeric"},"month"),h=(z,M)=>i?md(e,z):l(M?{weekday:z}:{weekday:z,month:"long",day:"numeric"},"weekday"),j=z=>{const M=Ue.macroTokenToFormatOpts(z);return M?this.formatWithSystemDefault(e,M):z},S=z=>i?hd(e,z):l({era:z},"era"),G=z=>{switch(z){case"S":return this.num(e.millisecond);case"u":case"SSS":return this.num(e.millisecond,3);case"s":return this.num(e.second);case"ss":return this.num(e.second,2);case"uu":return this.num(Math.floor(e.millisecond/10),2);case"uuu":return this.num(Math.floor(e.millisecond/100));case"m":return this.num(e.minute);case"mm":return this.num(e.minute,2);case"h":return this.num(e.hour%12===0?12:e.hour%12);case"hh":return this.num(e.hour%12===0?12:e.hour%12,2);case"H":return this.num(e.hour);case"HH":return this.num(e.hour,2);case"Z":return d({format:"narrow",allowZ:this.opts.allowZ});case"ZZ":return d({format:"short",allowZ:this.opts.allowZ});case"ZZZ":return d({format:"techie",allowZ:this.opts.allowZ});case"ZZZZ":return e.zone.offsetName(e.ts,{format:"short",locale:this.loc.locale});case"ZZZZZ":return e.zone.offsetName(e.ts,{format:"long",locale:this.loc.locale});case"z":return e.zoneName;case"a":return u();case"d":return r?l({day:"numeric"},"day"):this.num(e.day);case"dd":return r?l({day:"2-digit"},"day"):this.num(e.day,2);case"c":return this.num(e.weekday);case"ccc":return h("short",!0);case"cccc":return h("long",!0);case"ccccc":return h("narrow",!0);case"E":return this.num(e.weekday);case"EEE":return h("short",!1);case"EEEE":return h("long",!1);case"EEEEE":return h("narrow",!1);case"L":return r?l({month:"numeric",day:"numeric"},"month"):this.num(e.month);case"LL":return r?l({month:"2-digit",day:"numeric"},"month"):this.num(e.month,2);case"LLL":return p("short",!0);case"LLLL":return p("long",!0);case"LLLLL":return p("narrow",!0);case"M":return r?l({month:"numeric"},"month"):this.num(e.month);case"MM":return r?l({month:"2-digit"},"month"):this.num(e.month,2);case"MMM":return p("short",!1);case"MMMM":return p("long",!1);case"MMMMM":return p("narrow",!1);case"y":return r?l({year:"numeric"},"year"):this.num(e.year);case"yy":return r?l({year:"2-digit"},"year"):this.num(e.year.toString().slice(-2),2);case"yyyy":return r?l({year:"numeric"},"year"):this.num(e.year,4);case"yyyyyy":return r?l({year:"numeric"},"year"):this.num(e.year,6);case"G":return S("short");case"GG":return S("long");case"GGGGG":return S("narrow");case"kk":return this.num(e.weekYear.toString().slice(-2),2);case"kkkk":return this.num(e.weekYear,4);case"W":return this.num(e.weekNumber);case"WW":return this.num(e.weekNumber,2);case"n":return this.num(e.localWeekNumber);case"nn":return this.num(e.localWeekNumber,2);case"ii":return this.num(e.localWeekYear.toString().slice(-2),2);case"iiii":return this.num(e.localWeekYear,4);case"o":return this.num(e.ordinal);case"ooo":return this.num(e.ordinal,3);case"q":return this.num(e.quarter);case"qq":return this.num(e.quarter,2);case"X":return this.num(Math.floor(e.ts/1e3));case"x":return this.num(e.ts);default:return j(z)}};return _r(Ue.parseFormat(a),G)}formatDurationFromString(e,a){const i=p=>{switch(p[0]){case"S":return"millisecond";case"s":return"second";case"m":return"minute";case"h":return"hour";case"d":return"day";case"w":return"week";case"M":return"month";case"y":return"year";default:return null}},r=p=>h=>{const j=i(h);return j?this.num(p.get(j),h.length):h},l=Ue.parseFormat(a),d=l.reduce((p,{literal:h,val:j})=>h?p:p.concat(j),[]),u=e.shiftTo(...d.map(i).filter(p=>p));return _r(l,r(u))}}const xs=/[A-Za-z_+-]{1,256}(?::?\/[A-Za-z0-9_+-]{1,256}(?:\/[A-Za-z0-9_+-]{1,256})?)?/;function Xa(...o){const e=o.reduce((a,i)=>a+i.source,"");return RegExp(`^${e}$`)}function Qa(...o){return e=>o.reduce(([a,i,r],l)=>{const[d,u,p]=l(e,r);return[{...a,...d},u||i,p]},[{},null,1]).slice(0,2)}function ei(o,...e){if(o==null)return[null,null];for(const[a,i]of e){const r=a.exec(o);if(r)return i(r)}return[null,null]}function Os(...o){return(e,a)=>{const i={};let r;for(r=0;r<o.length;r++)i[o[r]]=Na(e[a+r]);return[i,null,a+r]}}const Rs=/(?:(Z)|([+-]\d\d)(?::?(\d\d))?)/,jd=`(?:${Rs.source}?(?:\\[(${xs.source})\\])?)?`,bn=/(\d\d)(?::?(\d\d)(?::?(\d\d)(?:[.,](\d{1,30}))?)?)?/,Fs=RegExp(`${bn.source}${jd}`),yn=RegExp(`(?:T${Fs.source})?`),kd=/([+-]\d{6}|\d{4})(?:-?(\d\d)(?:-?(\d\d))?)?/,fd=/(\d{4})-?W(\d\d)(?:-?(\d))?/,bd=/(\d{4})-?(\d{3})/,yd=Os("weekYear","weekNumber","weekDay"),zd=Os("year","ordinal"),Sd=/(\d{4})-(\d\d)-(\d\d)/,Bs=RegExp(`${bn.source} ?(?:${Rs.source}|(${xs.source}))?`),Md=RegExp(`(?: ${Bs.source})?`);function $a(o,e,a){const i=o[e];return re(i)?a:Na(i)}function wd(o,e){return[{year:$a(o,e),month:$a(o,e+1,1),day:$a(o,e+2,1)},null,e+3]}function ai(o,e){return[{hours:$a(o,e,0),minutes:$a(o,e+1,0),seconds:$a(o,e+2,0),milliseconds:kn(o[e+3])},null,e+4]}function gi(o,e){const a=!o[e]&&!o[e+1],i=Hi(o[e+1],o[e+2]),r=a?null:Ye.instance(i);return[{},r,e+3]}function ji(o,e){const a=o[e]?Ga.create(o[e]):null;return[{},a,e+1]}const Ad=RegExp(`^T?${bn.source}$`),Gd=/^-?P(?:(?:(-?\d{1,20}(?:\.\d{1,20})?)Y)?(?:(-?\d{1,20}(?:\.\d{1,20})?)M)?(?:(-?\d{1,20}(?:\.\d{1,20})?)W)?(?:(-?\d{1,20}(?:\.\d{1,20})?)D)?(?:T(?:(-?\d{1,20}(?:\.\d{1,20})?)H)?(?:(-?\d{1,20}(?:\.\d{1,20})?)M)?(?:(-?\d{1,20})(?:[.,](-?\d{1,20}))?S)?)?)$/;function Dd(o){const[e,a,i,r,l,d,u,p,h]=o,j=e[0]==="-",S=p&&p[0]==="-",G=(z,M=!1)=>z!==void 0&&(M||z&&j)?-z:z;return[{years:G(Ea(a)),months:G(Ea(i)),weeks:G(Ea(r)),days:G(Ea(l)),hours:G(Ea(d)),minutes:G(Ea(u)),seconds:G(Ea(p),p==="-0"),milliseconds:G(kn(h),S)}]}const Id={GMT:0,EDT:-4*60,EST:-5*60,CDT:-5*60,CST:-6*60,MDT:-6*60,MST:-7*60,PDT:-7*60,PST:-8*60};function zn(o,e,a,i,r,l,d){const u={year:e.length===2?hn(Na(e)):Na(e),month:Cs.indexOf(a)+1,day:Na(i),hour:Na(r),minute:Na(l)};return d&&(u.second=Na(d)),o&&(u.weekday=o.length>3?Ns.indexOf(o)+1:Ls.indexOf(o)+1),u}const Pd=/^(?:(Mon|Tue|Wed|Thu|Fri|Sat|Sun),\s)?(\d{1,2})\s(Jan|Feb|Mar|Apr|May|Jun|Jul|Aug|Sep|Oct|Nov|Dec)\s(\d{2,4})\s(\d\d):(\d\d)(?::(\d\d))?\s(?:(UT|GMT|[ECMP][SD]T)|([Zz])|(?:([+-]\d\d)(\d\d)))$/;function Cd(o){const[,e,a,i,r,l,d,u,p,h,j,S]=o,G=zn(e,r,i,a,l,d,u);let z;return p?z=Id[p]:h?z=0:z=Hi(j,S),[G,new Ye(z)]}function Td(o){return o.replace(/\([^()]*\)|[\n\t]/g," ").replace(/(\s\s+)/g," ").trim()}const Nd=/^(Mon|Tue|Wed|Thu|Fri|Sat|Sun), (\d\d) (Jan|Feb|Mar|Apr|May|Jun|Jul|Aug|Sep|Oct|Nov|Dec) (\d{4}) (\d\d):(\d\d):(\d\d) GMT$/,Ld=/^(Monday|Tuesday|Wednesday|Thursday|Friday|Saturday|Sunday), (\d\d)-(Jan|Feb|Mar|Apr|May|Jun|Jul|Aug|Sep|Oct|Nov|Dec)-(\d\d) (\d\d):(\d\d):(\d\d) GMT$/,_d=/^(Mon|Tue|Wed|Thu|Fri|Sat|Sun) (Jan|Feb|Mar|Apr|May|Jun|Jul|Aug|Sep|Oct|Nov|Dec) ( \d|\d\d) (\d\d):(\d\d):(\d\d) (\d{4})$/;function Er(o){const[,e,a,i,r,l,d,u]=o;return[zn(e,r,i,a,l,d,u),Ye.utcInstance]}function Ed(o){const[,e,a,i,r,l,d,u]=o;return[zn(e,u,a,i,r,l,d),Ye.utcInstance]}const Hd=Xa(kd,yn),xd=Xa(fd,yn),Od=Xa(bd,yn),Rd=Xa(Fs),Vs=Qa(wd,ai,gi,ji),Fd=Qa(yd,ai,gi,ji),Bd=Qa(zd,ai,gi,ji),Vd=Qa(ai,gi,ji);function Jd(o){return ei(o,[Hd,Vs],[xd,Fd],[Od,Bd],[Rd,Vd])}function Kd(o){return ei(Td(o),[Pd,Cd])}function Wd(o){return ei(o,[Nd,Er],[Ld,Er],[_d,Ed])}function Zd(o){return ei(o,[Gd,Dd])}const Ud=Qa(ai);function Yd(o){return ei(o,[Ad,Ud])}const $d=Xa(Sd,Md),qd=Xa(Bs),Xd=Qa(ai,gi,ji);function Qd(o){return ei(o,[$d,Vs],[qd,Xd])}const Hr="Invalid Duration",Js={weeks:{days:7,hours:7*24,minutes:7*24*60,seconds:7*24*60*60,milliseconds:7*24*60*60*1e3},days:{hours:24,minutes:24*60,seconds:24*60*60,milliseconds:24*60*60*1e3},hours:{minutes:60,seconds:60*60,milliseconds:60*60*1e3},minutes:{seconds:60,milliseconds:60*1e3},seconds:{milliseconds:1e3}},em={years:{quarters:4,months:12,weeks:52,days:365,hours:365*24,minutes:365*24*60,seconds:365*24*60*60,milliseconds:365*24*60*60*1e3},quarters:{months:3,weeks:13,days:91,hours:91*24,minutes:91*24*60,seconds:91*24*60*60,milliseconds:91*24*60*60*1e3},months:{weeks:4,days:30,hours:30*24,minutes:30*24*60,seconds:30*24*60*60,milliseconds:30*24*60*60*1e3},...Js},la=146097/400,Ja=146097/4800,am={years:{quarters:4,months:12,weeks:la/7,days:la,hours:la*24,minutes:la*24*60,seconds:la*24*60*60,milliseconds:la*24*60*60*1e3},quarters:{months:3,weeks:la/28,days:la/4,hours:la*24/4,minutes:la*24*60/4,seconds:la*24*60*60/4,milliseconds:la*24*60*60*1e3/4},months:{weeks:Ja/7,days:Ja,hours:Ja*24,minutes:Ja*24*60,seconds:Ja*24*60*60,milliseconds:Ja*24*60*60*1e3},...Js},xa=["years","quarters","months","weeks","days","hours","minutes","seconds","milliseconds"],im=xa.slice(0).reverse();function Ta(o,e,a=!1){const i={values:a?e.values:{...o.values,...e.values||{}},loc:o.loc.clone(e.loc),conversionAccuracy:e.conversionAccuracy||o.conversionAccuracy,matrix:e.matrix||o.matrix};return new he(i)}function Ks(o,e){let a=e.milliseconds??0;for(const i of im.slice(1))e[i]&&(a+=e[i]*o[i].milliseconds);return a}function xr(o,e){const a=Ks(o,e)<0?-1:1;xa.reduceRight((i,r)=>{if(re(e[r]))return i;if(i){const l=e[i]*a,d=o[r][i],u=Math.floor(l/d);e[r]+=u*a,e[i]-=u*d*a}return r},null),xa.reduce((i,r)=>{if(re(e[r]))return i;if(i){const l=e[i]%1;e[i]-=l,e[r]+=l*o[i][r]}return r},null)}function om(o){const e={};for(const[a,i]of Object.entries(o))i!==0&&(e[a]=i);return e}class he{constructor(e){const a=e.conversionAccuracy==="longterm"||!1;let i=a?am:em;e.matrix&&(i=e.matrix),this.values=e.values,this.loc=e.loc||be.create(),this.conversionAccuracy=a?"longterm":"casual",this.invalid=e.invalid||null,this.matrix=i,this.isLuxonDuration=!0}static fromMillis(e,a){return he.fromObject({milliseconds:e},a)}static fromObject(e,a={}){if(e==null||typeof e!="object")throw new Ze(`Duration.fromObject: argument expected to be an object, got ${e===null?"null":typeof e}`);return new he({values:Ni(e,he.normalizeUnit),loc:be.fromObject(a),conversionAccuracy:a.conversionAccuracy,matrix:a.matrix})}static fromDurationLike(e){if(_a(e))return he.fromMillis(e);if(he.isDuration(e))return e;if(typeof e=="object")return he.fromObject(e);throw new Ze(`Unknown duration argument ${e} of type ${typeof e}`)}static fromISO(e,a){const[i]=Zd(e);return i?he.fromObject(i,a):he.invalid("unparsable",`the input "${e}" can't be parsed as ISO 8601`)}static fromISOTime(e,a){const[i]=Yd(e);return i?he.fromObject(i,a):he.invalid("unparsable",`the input "${e}" can't be parsed as ISO 8601`)}static invalid(e,a=null){if(!e)throw new Ze("need to specify a reason the Duration is invalid");const i=e instanceof ga?e:new ga(e,a);if(_e.throwOnInvalid)throw new Gc(i);return new he({invalid:i})}static normalizeUnit(e){const a={year:"years",years:"years",quarter:"quarters",quarters:"quarters",month:"months",months:"months",week:"weeks",weeks:"weeks",day:"days",days:"days",hour:"hours",hours:"hours",minute:"minutes",minutes:"minutes",second:"seconds",seconds:"seconds",millisecond:"milliseconds",milliseconds:"milliseconds"}[e&&e.toLowerCase()];if(!a)throw new as(e);return a}static isDuration(e){return e&&e.isLuxonDuration||!1}get locale(){return this.isValid?this.loc.locale:null}get numberingSystem(){return this.isValid?this.loc.numberingSystem:null}toFormat(e,a={}){const i={...a,floor:a.round!==!1&&a.floor!==!1};return this.isValid?Ue.create(this.loc,i).formatDurationFromString(this,e):Hr}toHuman(e={}){if(!this.isValid)return Hr;const a=xa.map(i=>{const r=this.values[i];return re(r)?null:this.loc.numberFormatter({style:"unit",unitDisplay:"long",...e,unit:i.slice(0,-1)}).format(r)}).filter(i=>i);return this.loc.listFormatter({type:"conjunction",style:e.listStyle||"narrow",...e}).format(a)}toObject(){return this.isValid?{...this.values}:{}}toISO(){if(!this.isValid)return null;let e="P";return this.years!==0&&(e+=this.years+"Y"),(this.months!==0||this.quarters!==0)&&(e+=this.months+this.quarters*3+"M"),this.weeks!==0&&(e+=this.weeks+"W"),this.days!==0&&(e+=this.days+"D"),(this.hours!==0||this.minutes!==0||this.seconds!==0||this.milliseconds!==0)&&(e+="T"),this.hours!==0&&(e+=this.hours+"H"),this.minutes!==0&&(e+=this.minutes+"M"),(this.seconds!==0||this.milliseconds!==0)&&(e+=fn(this.seconds+this.milliseconds/1e3,3)+"S"),e==="P"&&(e+="T0S"),e}toISOTime(e={}){if(!this.isValid)return null;const a=this.toMillis();return a<0||a>=864e5?null:(e={suppressMilliseconds:!1,suppressSeconds:!1,includePrefix:!1,format:"extended",...e,includeOffset:!1},ne.fromMillis(a,{zone:"UTC"}).toISOTime(e))}toJSON(){return this.toISO()}toString(){return this.toISO()}[Symbol.for("nodejs.util.inspect.custom")](){return this.isValid?`Duration { values: ${JSON.stringify(this.values)} }`:`Duration { Invalid, reason: ${this.invalidReason} }`}toMillis(){return this.isValid?Ks(this.matrix,this.values):NaN}valueOf(){return this.toMillis()}plus(e){if(!this.isValid)return this;const a=he.fromDurationLike(e),i={};for(const r of xa)(qa(a.values,r)||qa(this.values,r))&&(i[r]=a.get(r)+this.get(r));return Ta(this,{values:i},!0)}minus(e){if(!this.isValid)return this;const a=he.fromDurationLike(e);return this.plus(a.negate())}mapUnits(e){if(!this.isValid)return this;const a={};for(const i of Object.keys(this.values))a[i]=Ps(e(this.values[i],i));return Ta(this,{values:a},!0)}get(e){return this[he.normalizeUnit(e)]}set(e){if(!this.isValid)return this;const a={...this.values,...Ni(e,he.normalizeUnit)};return Ta(this,{values:a})}reconfigure({locale:e,numberingSystem:a,conversionAccuracy:i,matrix:r}={}){const d={loc:this.loc.clone({locale:e,numberingSystem:a}),matrix:r,conversionAccuracy:i};return Ta(this,d)}as(e){return this.isValid?this.shiftTo(e).get(e):NaN}normalize(){if(!this.isValid)return this;const e=this.toObject();return xr(this.matrix,e),Ta(this,{values:e},!0)}rescale(){if(!this.isValid)return this;const e=om(this.normalize().shiftToAll().toObject());return Ta(this,{values:e},!0)}shiftTo(...e){if(!this.isValid)return this;if(e.length===0)return this;e=e.map(d=>he.normalizeUnit(d));const a={},i={},r=this.toObject();let l;for(const d of xa)if(e.indexOf(d)>=0){l=d;let u=0;for(const h in i)u+=this.matrix[h][d]*i[h],i[h]=0;_a(r[d])&&(u+=r[d]);const p=Math.trunc(u);a[d]=p,i[d]=(u*1e3-p*1e3)/1e3}else _a(r[d])&&(i[d]=r[d]);for(const d in i)i[d]!==0&&(a[l]+=d===l?i[d]:i[d]/this.matrix[l][d]);return xr(this.matrix,a),Ta(this,{values:a},!0)}shiftToAll(){return this.isValid?this.shiftTo("years","months","weeks","days","hours","minutes","seconds","milliseconds"):this}negate(){if(!this.isValid)return this;const e={};for(const a of Object.keys(this.values))e[a]=this.values[a]===0?0:-this.values[a];return Ta(this,{values:e},!0)}get years(){return this.isValid?this.values.years||0:NaN}get quarters(){return this.isValid?this.values.quarters||0:NaN}get months(){return this.isValid?this.values.months||0:NaN}get weeks(){return this.isValid?this.values.weeks||0:NaN}get days(){return this.isValid?this.values.days||0:NaN}get hours(){return this.isValid?this.values.hours||0:NaN}get minutes(){return this.isValid?this.values.minutes||0:NaN}get seconds(){return this.isValid?this.values.seconds||0:NaN}get milliseconds(){return this.isValid?this.values.milliseconds||0:NaN}get isValid(){return this.invalid===null}get invalidReason(){return this.invalid?this.invalid.reason:null}get invalidExplanation(){return this.invalid?this.invalid.explanation:null}equals(e){if(!this.isValid||!e.isValid||!this.loc.equals(e.loc))return!1;function a(i,r){return i===void 0||i===0?r===void 0||r===0:i===r}for(const i of xa)if(!a(this.values[i],e.values[i]))return!1;return!0}}const Ka="Invalid Interval";function tm(o,e){return!o||!o.isValid?Le.invalid("missing or invalid start"):!e||!e.isValid?Le.invalid("missing or invalid end"):e<o?Le.invalid("end before start",`The end of an interval must be after its start, but you had start=${o.toISO()} and end=${e.toISO()}`):null}class Le{constructor(e){this.s=e.start,this.e=e.end,this.invalid=e.invalid||null,this.isLuxonInterval=!0}static invalid(e,a=null){if(!e)throw new Ze("need to specify a reason the Interval is invalid");const i=e instanceof ga?e:new ga(e,a);if(_e.throwOnInvalid)throw new Ac(i);return new Le({invalid:i})}static fromDateTimes(e,a){const i=ni(e),r=ni(a),l=tm(i,r);return l??new Le({start:i,end:r})}static after(e,a){const i=he.fromDurationLike(a),r=ni(e);return Le.fromDateTimes(r,r.plus(i))}static before(e,a){const i=he.fromDurationLike(a),r=ni(e);return Le.fromDateTimes(r.minus(i),r)}static fromISO(e,a){const[i,r]=(e||"").split("/",2);if(i&&r){let l,d;try{l=ne.fromISO(i,a),d=l.isValid}catch{d=!1}let u,p;try{u=ne.fromISO(r,a),p=u.isValid}catch{p=!1}if(d&&p)return Le.fromDateTimes(l,u);if(d){const h=he.fromISO(r,a);if(h.isValid)return Le.after(l,h)}else if(p){const h=he.fromISO(i,a);if(h.isValid)return Le.before(u,h)}}return Le.invalid("unparsable",`the input "${e}" can't be parsed as ISO 8601`)}static isInterval(e){return e&&e.isLuxonInterval||!1}get start(){return this.isValid?this.s:null}get end(){return this.isValid?this.e:null}get isValid(){return this.invalidReason===null}get invalidReason(){return this.invalid?this.invalid.reason:null}get invalidExplanation(){return this.invalid?this.invalid.explanation:null}length(e="milliseconds"){return this.isValid?this.toDuration(e).get(e):NaN}count(e="milliseconds",a){if(!this.isValid)return NaN;const i=this.start.startOf(e,a);let r;return a!=null&&a.useLocaleWeeks?r=this.end.reconfigure({locale:i.locale}):r=this.end,r=r.startOf(e,a),Math.floor(r.diff(i,e).get(e))+(r.valueOf()!==this.end.valueOf())}hasSame(e){return this.isValid?this.isEmpty()||this.e.minus(1).hasSame(this.s,e):!1}isEmpty(){return this.s.valueOf()===this.e.valueOf()}isAfter(e){return this.isValid?this.s>e:!1}isBefore(e){return this.isValid?this.e<=e:!1}contains(e){return this.isValid?this.s<=e&&this.e>e:!1}set({start:e,end:a}={}){return this.isValid?Le.fromDateTimes(e||this.s,a||this.e):this}splitAt(...e){if(!this.isValid)return[];const a=e.map(ni).filter(d=>this.contains(d)).sort((d,u)=>d.toMillis()-u.toMillis()),i=[];let{s:r}=this,l=0;for(;r<this.e;){const d=a[l]||this.e,u=+d>+this.e?this.e:d;i.push(Le.fromDateTimes(r,u)),r=u,l+=1}return i}splitBy(e){const a=he.fromDurationLike(e);if(!this.isValid||!a.isValid||a.as("milliseconds")===0)return[];let{s:i}=this,r=1,l;const d=[];for(;i<this.e;){const u=this.start.plus(a.mapUnits(p=>p*r));l=+u>+this.e?this.e:u,d.push(Le.fromDateTimes(i,l)),i=l,r+=1}return d}divideEqually(e){return this.isValid?this.splitBy(this.length()/e).slice(0,e):[]}overlaps(e){return this.e>e.s&&this.s<e.e}abutsStart(e){return this.isValid?+this.e==+e.s:!1}abutsEnd(e){return this.isValid?+e.e==+this.s:!1}engulfs(e){return this.isValid?this.s<=e.s&&this.e>=e.e:!1}equals(e){return!this.isValid||!e.isValid?!1:this.s.equals(e.s)&&this.e.equals(e.e)}intersection(e){if(!this.isValid)return this;const a=this.s>e.s?this.s:e.s,i=this.e<e.e?this.e:e.e;return a>=i?null:Le.fromDateTimes(a,i)}union(e){if(!this.isValid)return this;const a=this.s<e.s?this.s:e.s,i=this.e>e.e?this.e:e.e;return Le.fromDateTimes(a,i)}static merge(e){const[a,i]=e.sort((r,l)=>r.s-l.s).reduce(([r,l],d)=>l?l.overlaps(d)||l.abutsStart(d)?[r,l.union(d)]:[r.concat([l]),d]:[r,d],[[],null]);return i&&a.push(i),a}static xor(e){let a=null,i=0;const r=[],l=e.map(p=>[{time:p.s,type:"s"},{time:p.e,type:"e"}]),d=Array.prototype.concat(...l),u=d.sort((p,h)=>p.time-h.time);for(const p of u)i+=p.type==="s"?1:-1,i===1?a=p.time:(a&&+a!=+p.time&&r.push(Le.fromDateTimes(a,p.time)),a=null);return Le.merge(r)}difference(...e){return Le.xor([this].concat(e)).map(a=>this.intersection(a)).filter(a=>a&&!a.isEmpty())}toString(){return this.isValid?`[${this.s.toISO()} – ${this.e.toISO()})`:Ka}[Symbol.for("nodejs.util.inspect.custom")](){return this.isValid?`Interval { start: ${this.s.toISO()}, end: ${this.e.toISO()} }`:`Interval { Invalid, reason: ${this.invalidReason} }`}toLocaleString(e=Pi,a={}){return this.isValid?Ue.create(this.s.loc.clone(a),e).formatInterval(this):Ka}toISO(e){return this.isValid?`${this.s.toISO(e)}/${this.e.toISO(e)}`:Ka}toISODate(){return this.isValid?`${this.s.toISODate()}/${this.e.toISODate()}`:Ka}toISOTime(e){return this.isValid?`${this.s.toISOTime(e)}/${this.e.toISOTime(e)}`:Ka}toFormat(e,{separator:a=" – "}={}){return this.isValid?`${this.s.toFormat(e)}${a}${this.e.toFormat(e)}`:Ka}toDuration(e,a){return this.isValid?this.e.diff(this.s,e,a):he.invalid(this.invalidReason)}mapEndpoints(e){return Le.fromDateTimes(e(this.s),e(this.e))}}class zi{static hasDST(e=_e.defaultZone){const a=ne.now().setZone(e).set({month:12});return!e.isUniversal&&a.offset!==a.set({month:6}).offset}static isValidIANAZone(e){return Ga.isValidZone(e)}static normalizeZone(e){return La(e,_e.defaultZone)}static getStartOfWeek({locale:e=null,locObj:a=null}={}){return(a||be.create(e)).getStartOfWeek()}static getMinimumDaysInFirstWeek({locale:e=null,locObj:a=null}={}){return(a||be.create(e)).getMinDaysInFirstWeek()}static getWeekendWeekdays({locale:e=null,locObj:a=null}={}){return(a||be.create(e)).getWeekendDays().slice()}static months(e="long",{locale:a=null,numberingSystem:i=null,locObj:r=null,outputCalendar:l="gregory"}={}){return(r||be.create(a,i,l)).months(e)}static monthsFormat(e="long",{locale:a=null,numberingSystem:i=null,locObj:r=null,outputCalendar:l="gregory"}={}){return(r||be.create(a,i,l)).months(e,!0)}static weekdays(e="long",{locale:a=null,numberingSystem:i=null,locObj:r=null}={}){return(r||be.create(a,i,null)).weekdays(e)}static weekdaysFormat(e="long",{locale:a=null,numberingSystem:i=null,locObj:r=null}={}){return(r||be.create(a,i,null)).weekdays(e,!0)}static meridiems({locale:e=null}={}){return be.create(e).meridiems()}static eras(e="short",{locale:a=null}={}){return be.create(a,null,"gregory").eras(e)}static features(){return{relative:Gs(),localeWeek:Ds()}}}function Or(o,e){const a=r=>r.toUTC(0,{keepLocalTime:!0}).startOf("day").valueOf(),i=a(e)-a(o);return Math.floor(he.fromMillis(i).as("days"))}function nm(o,e,a){const i=[["years",(p,h)=>h.year-p.year],["quarters",(p,h)=>h.quarter-p.quarter+(h.year-p.year)*4],["months",(p,h)=>h.month-p.month+(h.year-p.year)*12],["weeks",(p,h)=>{const j=Or(p,h);return(j-j%7)/7}],["days",Or]],r={},l=o;let d,u;for(const[p,h]of i)a.indexOf(p)>=0&&(d=p,r[p]=h(o,e),u=l.plus(r),u>e?(r[p]--,o=l.plus(r),o>e&&(u=o,r[p]--,o=l.plus(r))):o=u);return[o,r,u,d]}function rm(o,e,a,i){let[r,l,d,u]=nm(o,e,a);const p=e-r,h=a.filter(S=>["hours","minutes","seconds","milliseconds"].indexOf(S)>=0);h.length===0&&(d<e&&(d=r.plus({[u]:1})),d!==r&&(l[u]=(l[u]||0)+p/(d-r)));const j=he.fromObject(l,i);return h.length>0?he.fromMillis(p,i).shiftTo(...h).plus(j):j}const sm="missing Intl.DateTimeFormat.formatToParts support";function ge(o,e=a=>a){return{regex:o,deser:([a])=>e($c(a))}}const lm=" ",Ws=`[ ${lm}]`,Zs=new RegExp(Ws,"g");function um(o){return o.replace(/\./g,"\\.?").replace(Zs,Ws)}function Rr(o){return o.replace(/\./g,"").replace(Zs," ").toLowerCase()}function va(o,e){return o===null?null:{regex:RegExp(o.map(um).join("|")),deser:([a])=>o.findIndex(i=>Rr(a)===Rr(i))+e}}function Fr(o,e){return{regex:o,deser:([,a,i])=>Hi(a,i),groups:e}}function Si(o){return{regex:o,deser:([e])=>e}}function cm(o){return o.replace(/[\-\[\]{}()*+?.,\\\^$|#\s]/g,"\\$&")}function dm(o,e){const a=ha(e),i=ha(e,"{2}"),r=ha(e,"{3}"),l=ha(e,"{4}"),d=ha(e,"{6}"),u=ha(e,"{1,2}"),p=ha(e,"{1,3}"),h=ha(e,"{1,6}"),j=ha(e,"{1,9}"),S=ha(e,"{2,4}"),G=ha(e,"{4,6}"),z=g=>({regex:RegExp(cm(g.val)),deser:([w])=>w,literal:!0}),k=(g=>{if(o.literal)return z(g);switch(g.val){case"G":return va(e.eras("short"),0);case"GG":return va(e.eras("long"),0);case"y":return ge(h);case"yy":return ge(S,hn);case"yyyy":return ge(l);case"yyyyy":return ge(G);case"yyyyyy":return ge(d);case"M":return ge(u);case"MM":return ge(i);case"MMM":return va(e.months("short",!0),1);case"MMMM":return va(e.months("long",!0),1);case"L":return ge(u);case"LL":return ge(i);case"LLL":return va(e.months("short",!1),1);case"LLLL":return va(e.months("long",!1),1);case"d":return ge(u);case"dd":return ge(i);case"o":return ge(p);case"ooo":return ge(r);case"HH":return ge(i);case"H":return ge(u);case"hh":return ge(i);case"h":return ge(u);case"mm":return ge(i);case"m":return ge(u);case"q":return ge(u);case"qq":return ge(i);case"s":return ge(u);case"ss":return ge(i);case"S":return ge(p);case"SSS":return ge(r);case"u":return Si(j);case"uu":return Si(u);case"uuu":return ge(a);case"a":return va(e.meridiems(),0);case"kkkk":return ge(l);case"kk":return ge(S,hn);case"W":return ge(u);case"WW":return ge(i);case"E":case"c":return ge(a);case"EEE":return va(e.weekdays("short",!1),1);case"EEEE":return va(e.weekdays("long",!1),1);case"ccc":return va(e.weekdays("short",!0),1);case"cccc":return va(e.weekdays("long",!0),1);case"Z":case"ZZ":return Fr(new RegExp(`([+-]${u.source})(?::(${i.source}))?`),2);case"ZZZ":return Fr(new RegExp(`([+-]${u.source})(${i.source})?`),2);case"z":return Si(/[a-z_+-/]{1,256}?/i);case" ":return Si(/[^\S\n\r]/);default:return z(g)}})(o)||{invalidReason:sm};return k.token=o,k}const mm={year:{"2-digit":"yy",numeric:"yyyyy"},month:{numeric:"M","2-digit":"MM",short:"MMM",long:"MMMM"},day:{numeric:"d","2-digit":"dd"},weekday:{short:"EEE",long:"EEEE"},dayperiod:"a",dayPeriod:"a",hour12:{numeric:"h","2-digit":"hh"},hour24:{numeric:"H","2-digit":"HH"},minute:{numeric:"m","2-digit":"mm"},second:{numeric:"s","2-digit":"ss"},timeZoneName:{long:"ZZZZZ",short:"ZZZ"}};function pm(o,e,a){const{type:i,value:r}=o;if(i==="literal"){const p=/^\s+$/.test(r);return{literal:!p,val:p?" ":r}}const l=e[i];let d=i;i==="hour"&&(e.hour12!=null?d=e.hour12?"hour12":"hour24":e.hourCycle!=null?e.hourCycle==="h11"||e.hourCycle==="h12"?d="hour12":d="hour24":d=a.hour12?"hour12":"hour24");let u=mm[d];if(typeof u=="object"&&(u=u[l]),u)return{literal:!1,val:u}}function hm(o){return[`^${o.map(a=>a.regex).reduce((a,i)=>`${a}(${i.source})`,"")}$`,o]}function vm(o,e,a){const i=o.match(e);if(i){const r={};let l=1;for(const d in a)if(qa(a,d)){const u=a[d],p=u.groups?u.groups+1:1;!u.literal&&u.token&&(r[u.token.val[0]]=u.deser(i.slice(l,l+p))),l+=p}return[i,r]}else return[i,{}]}function gm(o){const e=l=>{switch(l){case"S":return"millisecond";case"s":return"second";case"m":return"minute";case"h":case"H":return"hour";case"d":return"day";case"o":return"ordinal";case"L":case"M":return"month";case"y":return"year";case"E":case"c":return"weekday";case"W":return"weekNumber";case"k":return"weekYear";case"q":return"quarter";default:return null}};let a=null,i;return re(o.z)||(a=Ga.create(o.z)),re(o.Z)||(a||(a=new Ye(o.Z)),i=o.Z),re(o.q)||(o.M=(o.q-1)*3+1),re(o.h)||(o.h<12&&o.a===1?o.h+=12:o.h===12&&o.a===0&&(o.h=0)),o.G===0&&o.y&&(o.y=-o.y),re(o.u)||(o.S=kn(o.u)),[Object.keys(o).reduce((l,d)=>{const u=e(d);return u&&(l[u]=o[d]),l},{}),a,i]}let an=null;function jm(){return an||(an=ne.fromMillis(1555555555555)),an}function km(o,e){if(o.literal)return o;const a=Ue.macroTokenToFormatOpts(o.val),i=qs(a,e);return i==null||i.includes(void 0)?o:i}function Us(o,e){return Array.prototype.concat(...o.map(a=>km(a,e)))}class Ys{constructor(e,a){if(this.locale=e,this.format=a,this.tokens=Us(Ue.parseFormat(a),e),this.units=this.tokens.map(i=>dm(i,e)),this.disqualifyingUnit=this.units.find(i=>i.invalidReason),!this.disqualifyingUnit){const[i,r]=hm(this.units);this.regex=RegExp(i,"i"),this.handlers=r}}explainFromTokens(e){if(this.isValid){const[a,i]=vm(e,this.regex,this.handlers),[r,l,d]=i?gm(i):[null,null,void 0];if(qa(i,"a")&&qa(i,"H"))throw new Ua("Can't include meridiem when specifying 24-hour format");return{input:e,tokens:this.tokens,regex:this.regex,rawMatches:a,matches:i,result:r,zone:l,specificOffset:d}}else return{input:e,tokens:this.tokens,invalidReason:this.invalidReason}}get isValid(){return!this.disqualifyingUnit}get invalidReason(){return this.disqualifyingUnit?this.disqualifyingUnit.invalidReason:null}}function $s(o,e,a){return new Ys(o,a).explainFromTokens(e)}function fm(o,e,a){const{result:i,zone:r,specificOffset:l,invalidReason:d}=$s(o,e,a);return[i,r,l,d]}function qs(o,e){if(!o)return null;const i=Ue.create(e,o).dtFormatter(jm()),r=i.formatToParts(),l=i.resolvedOptions();return r.map(d=>pm(d,o,l))}const on="Invalid DateTime",bm=864e13;function si(o){return new ga("unsupported zone",`the zone "${o.name}" is not supported`)}function tn(o){return o.weekData===null&&(o.weekData=Ci(o.c)),o.weekData}function nn(o){return o.localWeekData===null&&(o.localWeekData=Ci(o.c,o.loc.getMinDaysInFirstWeek(),o.loc.getStartOfWeek())),o.localWeekData}function Ha(o,e){const a={ts:o.ts,zone:o.zone,c:o.c,o:o.o,loc:o.loc,invalid:o.invalid};return new ne({...a,...e,old:a})}function Xs(o,e,a){let i=o-e*60*1e3;const r=a.offset(i);if(e===r)return[i,e];i-=(r-e)*60*1e3;const l=a.offset(i);return r===l?[i,r]:[o-Math.min(r,l)*60*1e3,Math.max(r,l)]}function Mi(o,e){o+=e*60*1e3;const a=new Date(o);return{year:a.getUTCFullYear(),month:a.getUTCMonth()+1,day:a.getUTCDate(),hour:a.getUTCHours(),minute:a.getUTCMinutes(),second:a.getUTCSeconds(),millisecond:a.getUTCMilliseconds()}}function Gi(o,e,a){return Xs(Ei(o),e,a)}function Br(o,e){const a=o.o,i=o.c.year+Math.trunc(e.years),r=o.c.month+Math.trunc(e.months)+Math.trunc(e.quarters)*3,l={...o.c,year:i,month:r,day:Math.min(o.c.day,Ti(i,r))+Math.trunc(e.days)+Math.trunc(e.weeks)*7},d=he.fromObject({years:e.years-Math.trunc(e.years),quarters:e.quarters-Math.trunc(e.quarters),months:e.months-Math.trunc(e.months),weeks:e.weeks-Math.trunc(e.weeks),days:e.days-Math.trunc(e.days),hours:e.hours,minutes:e.minutes,seconds:e.seconds,milliseconds:e.milliseconds}).as("milliseconds"),u=Ei(l);let[p,h]=Xs(u,a,o.zone);return d!==0&&(p+=d,h=o.zone.offset(p)),{ts:p,o:h}}function Wa(o,e,a,i,r,l){const{setZone:d,zone:u}=a;if(o&&Object.keys(o).length!==0||e){const p=e||u,h=ne.fromObject(o,{...a,zone:p,specificOffset:l});return d?h:h.setZone(u)}else return ne.invalid(new ga("unparsable",`the input "${r}" can't be parsed as ${i}`))}function wi(o,e,a=!0){return o.isValid?Ue.create(be.create("en-US"),{allowZ:a,forceSimple:!0}).formatDateTimeFromString(o,e):null}function rn(o,e){const a=o.c.year>9999||o.c.year<0;let i="";return a&&o.c.year>=0&&(i+="+"),i+=Re(o.c.year,a?6:4),e?(i+="-",i+=Re(o.c.month),i+="-",i+=Re(o.c.day)):(i+=Re(o.c.month),i+=Re(o.c.day)),i}function Vr(o,e,a,i,r,l){let d=Re(o.c.hour);return e?(d+=":",d+=Re(o.c.minute),(o.c.millisecond!==0||o.c.second!==0||!a)&&(d+=":")):d+=Re(o.c.minute),(o.c.millisecond!==0||o.c.second!==0||!a)&&(d+=Re(o.c.second),(o.c.millisecond!==0||!i)&&(d+=".",d+=Re(o.c.millisecond,3))),r&&(o.isOffsetFixed&&o.offset===0&&!l?d+="Z":o.o<0?(d+="-",d+=Re(Math.trunc(-o.o/60)),d+=":",d+=Re(Math.trunc(-o.o%60))):(d+="+",d+=Re(Math.trunc(o.o/60)),d+=":",d+=Re(Math.trunc(o.o%60)))),l&&(d+="["+o.zone.ianaName+"]"),d}const Qs={month:1,day:1,hour:0,minute:0,second:0,millisecond:0},ym={weekNumber:1,weekday:1,hour:0,minute:0,second:0,millisecond:0},zm={ordinal:1,hour:0,minute:0,second:0,millisecond:0},el=["year","month","day","hour","minute","second","millisecond"],Sm=["weekYear","weekNumber","weekday","hour","minute","second","millisecond"],Mm=["year","ordinal","hour","minute","second","millisecond"];function wm(o){const e={year:"year",years:"year",month:"month",months:"month",day:"day",days:"day",hour:"hour",hours:"hour",minute:"minute",minutes:"minute",quarter:"quarter",quarters:"quarter",second:"second",seconds:"second",millisecond:"millisecond",milliseconds:"millisecond",weekday:"weekday",weekdays:"weekday",weeknumber:"weekNumber",weeksnumber:"weekNumber",weeknumbers:"weekNumber",weekyear:"weekYear",weekyears:"weekYear",ordinal:"ordinal"}[o.toLowerCase()];if(!e)throw new as(o);return e}function Jr(o){switch(o.toLowerCase()){case"localweekday":case"localweekdays":return"localWeekday";case"localweeknumber":case"localweeknumbers":return"localWeekNumber";case"localweekyear":case"localweekyears":return"localWeekYear";default:return wm(o)}}function Am(o){return Ii[o]||(Di===void 0&&(Di=_e.now()),Ii[o]=o.offset(Di)),Ii[o]}function Kr(o,e){const a=La(e.zone,_e.defaultZone);if(!a.isValid)return ne.invalid(si(a));const i=be.fromObject(e);let r,l;if(re(o.year))r=_e.now();else{for(const p of el)re(o[p])&&(o[p]=Qs[p]);const d=ws(o)||As(o);if(d)return ne.invalid(d);const u=Am(a);[r,l]=Gi(o,u,a)}return new ne({ts:r,zone:a,loc:i,o:l})}function Wr(o,e,a){const i=re(a.round)?!0:a.round,r=(d,u)=>(d=fn(d,i||a.calendary?0:2,!0),e.loc.clone(a).relFormatter(a).format(d,u)),l=d=>a.calendary?e.hasSame(o,d)?0:e.startOf(d).diff(o.startOf(d),d).get(d):e.diff(o,d).get(d);if(a.unit)return r(l(a.unit),a.unit);for(const d of a.units){const u=l(d);if(Math.abs(u)>=1)return r(u,d)}return r(o>e?-0:0,a.units[a.units.length-1])}function Zr(o){let e={},a;return o.length>0&&typeof o[o.length-1]=="object"?(e=o[o.length-1],a=Array.from(o).slice(0,o.length-1)):a=Array.from(o),[e,a]}let Di,Ii={};class ne{constructor(e){const a=e.zone||_e.defaultZone;let i=e.invalid||(Number.isNaN(e.ts)?new ga("invalid input"):null)||(a.isValid?null:si(a));this.ts=re(e.ts)?_e.now():e.ts;let r=null,l=null;if(!i)if(e.old&&e.old.ts===this.ts&&e.old.zone.equals(a))[r,l]=[e.old.c,e.old.o];else{const u=_a(e.o)&&!e.old?e.o:a.offset(this.ts);r=Mi(this.ts,u),i=Number.isNaN(r.year)?new ga("invalid input"):null,r=i?null:r,l=i?null:u}this._zone=a,this.loc=e.loc||be.create(),this.invalid=i,this.weekData=null,this.localWeekData=null,this.c=r,this.o=l,this.isLuxonDateTime=!0}static now(){return new ne({})}static local(){const[e,a]=Zr(arguments),[i,r,l,d,u,p,h]=a;return Kr({year:i,month:r,day:l,hour:d,minute:u,second:p,millisecond:h},e)}static utc(){const[e,a]=Zr(arguments),[i,r,l,d,u,p,h]=a;return e.zone=Ye.utcInstance,Kr({year:i,month:r,day:l,hour:d,minute:u,second:p,millisecond:h},e)}static fromJSDate(e,a={}){const i=ad(e)?e.valueOf():NaN;if(Number.isNaN(i))return ne.invalid("invalid input");const r=La(a.zone,_e.defaultZone);return r.isValid?new ne({ts:i,zone:r,loc:be.fromObject(a)}):ne.invalid(si(r))}static fromMillis(e,a={}){if(_a(e))return e<-864e13||e>bm?ne.invalid("Timestamp out of range"):new ne({ts:e,zone:La(a.zone,_e.defaultZone),loc:be.fromObject(a)});throw new Ze(`fromMillis requires a numerical input, but received a ${typeof e} with value ${e}`)}static fromSeconds(e,a={}){if(_a(e))return new ne({ts:e*1e3,zone:La(a.zone,_e.defaultZone),loc:be.fromObject(a)});throw new Ze("fromSeconds requires a numerical input")}static fromObject(e,a={}){e=e||{};const i=La(a.zone,_e.defaultZone);if(!i.isValid)return ne.invalid(si(i));const r=be.fromObject(a),l=Ni(e,Jr),{minDaysInFirstWeek:d,startOfWeek:u}=Tr(l,r),p=_e.now(),h=re(a.specificOffset)?i.offset(p):a.specificOffset,j=!re(l.ordinal),S=!re(l.year),G=!re(l.month)||!re(l.day),z=S||G,M=l.weekYear||l.weekNumber;if((z||j)&&M)throw new Ua("Can't mix weekYear/weekNumber units with year/month/day or ordinals");if(G&&j)throw new Ua("Can't mix ordinal dates with month/day");const k=M||l.weekday&&!z;let g,w,f=Mi(p,h);k?(g=Sm,w=ym,f=Ci(f,d,u)):j?(g=Mm,w=zm,f=en(f)):(g=el,w=Qs);let T=!1;for(const Q of g){const D=l[Q];re(D)?T?l[Q]=w[Q]:l[Q]=f[Q]:T=!0}const W=k?Xc(l,d,u):j?Qc(l):ws(l),X=W||As(l);if(X)return ne.invalid(X);const O=k?Pr(l,d,u):j?Cr(l):l,[E,R]=Gi(O,h,i),U=new ne({ts:E,zone:i,o:R,loc:r});return l.weekday&&z&&e.weekday!==U.weekday?ne.invalid("mismatched weekday",`you can't specify both a weekday of ${l.weekday} and a date of ${U.toISO()}`):U.isValid?U:ne.invalid(U.invalid)}static fromISO(e,a={}){const[i,r]=Jd(e);return Wa(i,r,a,"ISO 8601",e)}static fromRFC2822(e,a={}){const[i,r]=Kd(e);return Wa(i,r,a,"RFC 2822",e)}static fromHTTP(e,a={}){const[i,r]=Wd(e);return Wa(i,r,a,"HTTP",a)}static fromFormat(e,a,i={}){if(re(e)||re(a))throw new Ze("fromFormat requires an input string and a format");const{locale:r=null,numberingSystem:l=null}=i,d=be.fromOpts({locale:r,numberingSystem:l,defaultToEN:!0}),[u,p,h,j]=fm(d,e,a);return j?ne.invalid(j):Wa(u,p,i,`format ${a}`,e,h)}static fromString(e,a,i={}){return ne.fromFormat(e,a,i)}static fromSQL(e,a={}){const[i,r]=Qd(e);return Wa(i,r,a,"SQL",e)}static invalid(e,a=null){if(!e)throw new Ze("need to specify a reason the DateTime is invalid");const i=e instanceof ga?e:new ga(e,a);if(_e.throwOnInvalid)throw new wc(i);return new ne({invalid:i})}static isDateTime(e){return e&&e.isLuxonDateTime||!1}static parseFormatForOpts(e,a={}){const i=qs(e,be.fromObject(a));return i?i.map(r=>r?r.val:null).join(""):null}static expandFormat(e,a={}){return Us(Ue.parseFormat(e),be.fromObject(a)).map(r=>r.val).join("")}static resetCache(){Di=void 0,Ii={}}get(e){return this[e]}get isValid(){return this.invalid===null}get invalidReason(){return this.invalid?this.invalid.reason:null}get invalidExplanation(){return this.invalid?this.invalid.explanation:null}get locale(){return this.isValid?this.loc.locale:null}get numberingSystem(){return this.isValid?this.loc.numberingSystem:null}get outputCalendar(){return this.isValid?this.loc.outputCalendar:null}get zone(){return this._zone}get zoneName(){return this.isValid?this.zone.name:null}get year(){return this.isValid?this.c.year:NaN}get quarter(){return this.isValid?Math.ceil(this.c.month/3):NaN}get month(){return this.isValid?this.c.month:NaN}get day(){return this.isValid?this.c.day:NaN}get hour(){return this.isValid?this.c.hour:NaN}get minute(){return this.isValid?this.c.minute:NaN}get second(){return this.isValid?this.c.second:NaN}get millisecond(){return this.isValid?this.c.millisecond:NaN}get weekYear(){return this.isValid?tn(this).weekYear:NaN}get weekNumber(){return this.isValid?tn(this).weekNumber:NaN}get weekday(){return this.isValid?tn(this).weekday:NaN}get isWeekend(){return this.isValid&&this.loc.getWeekendDays().includes(this.weekday)}get localWeekday(){return this.isValid?nn(this).weekday:NaN}get localWeekNumber(){return this.isValid?nn(this).weekNumber:NaN}get localWeekYear(){return this.isValid?nn(this).weekYear:NaN}get ordinal(){return this.isValid?en(this.c).ordinal:NaN}get monthShort(){return this.isValid?zi.months("short",{locObj:this.loc})[this.month-1]:null}get monthLong(){return this.isValid?zi.months("long",{locObj:this.loc})[this.month-1]:null}get weekdayShort(){return this.isValid?zi.weekdays("short",{locObj:this.loc})[this.weekday-1]:null}get weekdayLong(){return this.isValid?zi.weekdays("long",{locObj:this.loc})[this.weekday-1]:null}get offset(){return this.isValid?+this.o:NaN}get offsetNameShort(){return this.isValid?this.zone.offsetName(this.ts,{format:"short",locale:this.locale}):null}get offsetNameLong(){return this.isValid?this.zone.offsetName(this.ts,{format:"long",locale:this.locale}):null}get isOffsetFixed(){return this.isValid?this.zone.isUniversal:null}get isInDST(){return this.isOffsetFixed?!1:this.offset>this.set({month:1,day:1}).offset||this.offset>this.set({month:5}).offset}getPossibleOffsets(){if(!this.isValid||this.isOffsetFixed)return[this];const e=864e5,a=6e4,i=Ei(this.c),r=this.zone.offset(i-e),l=this.zone.offset(i+e),d=this.zone.offset(i-r*a),u=this.zone.offset(i-l*a);if(d===u)return[this];const p=i-d*a,h=i-u*a,j=Mi(p,d),S=Mi(h,u);return j.hour===S.hour&&j.minute===S.minute&&j.second===S.second&&j.millisecond===S.millisecond?[Ha(this,{ts:p}),Ha(this,{ts:h})]:[this]}get isInLeapYear(){return vi(this.year)}get daysInMonth(){return Ti(this.year,this.month)}get daysInYear(){return this.isValid?Ya(this.year):NaN}get weeksInWeekYear(){return this.isValid?pi(this.weekYear):NaN}get weeksInLocalWeekYear(){return this.isValid?pi(this.localWeekYear,this.loc.getMinDaysInFirstWeek(),this.loc.getStartOfWeek()):NaN}resolvedLocaleOptions(e={}){const{locale:a,numberingSystem:i,calendar:r}=Ue.create(this.loc.clone(e),e).resolvedOptions(this);return{locale:a,numberingSystem:i,outputCalendar:r}}toUTC(e=0,a={}){return this.setZone(Ye.instance(e),a)}toLocal(){return this.setZone(_e.defaultZone)}setZone(e,{keepLocalTime:a=!1,keepCalendarTime:i=!1}={}){if(e=La(e,_e.defaultZone),e.equals(this.zone))return this;if(e.isValid){let r=this.ts;if(a||i){const l=e.offset(this.ts),d=this.toObject();[r]=Gi(d,l,e)}return Ha(this,{ts:r,zone:e})}else return ne.invalid(si(e))}reconfigure({locale:e,numberingSystem:a,outputCalendar:i}={}){const r=this.loc.clone({locale:e,numberingSystem:a,outputCalendar:i});return Ha(this,{loc:r})}setLocale(e){return this.reconfigure({locale:e})}set(e){if(!this.isValid)return this;const a=Ni(e,Jr),{minDaysInFirstWeek:i,startOfWeek:r}=Tr(a,this.loc),l=!re(a.weekYear)||!re(a.weekNumber)||!re(a.weekday),d=!re(a.ordinal),u=!re(a.year),p=!re(a.month)||!re(a.day),h=u||p,j=a.weekYear||a.weekNumber;if((h||d)&&j)throw new Ua("Can't mix weekYear/weekNumber units with year/month/day or ordinals");if(p&&d)throw new Ua("Can't mix ordinal dates with month/day");let S;l?S=Pr({...Ci(this.c,i,r),...a},i,r):re(a.ordinal)?(S={...this.toObject(),...a},re(a.day)&&(S.day=Math.min(Ti(S.year,S.month),S.day))):S=Cr({...en(this.c),...a});const[G,z]=Gi(S,this.o,this.zone);return Ha(this,{ts:G,o:z})}plus(e){if(!this.isValid)return this;const a=he.fromDurationLike(e);return Ha(this,Br(this,a))}minus(e){if(!this.isValid)return this;const a=he.fromDurationLike(e).negate();return Ha(this,Br(this,a))}startOf(e,{useLocaleWeeks:a=!1}={}){if(!this.isValid)return this;const i={},r=he.normalizeUnit(e);switch(r){case"years":i.month=1;case"quarters":case"months":i.day=1;case"weeks":case"days":i.hour=0;case"hours":i.minute=0;case"minutes":i.second=0;case"seconds":i.millisecond=0;break}if(r==="weeks")if(a){const l=this.loc.getStartOfWeek(),{weekday:d}=this;d<l&&(i.weekNumber=this.weekNumber-1),i.weekday=l}else i.weekday=1;if(r==="quarters"){const l=Math.ceil(this.month/3);i.month=(l-1)*3+1}return this.set(i)}endOf(e,a){return this.isValid?this.plus({[e]:1}).startOf(e,a).minus(1):this}toFormat(e,a={}){return this.isValid?Ue.create(this.loc.redefaultToEN(a)).formatDateTimeFromString(this,e):on}toLocaleString(e=Pi,a={}){return this.isValid?Ue.create(this.loc.clone(a),e).formatDateTime(this):on}toLocaleParts(e={}){return this.isValid?Ue.create(this.loc.clone(e),e).formatDateTimeParts(this):[]}toISO({format:e="extended",suppressSeconds:a=!1,suppressMilliseconds:i=!1,includeOffset:r=!0,extendedZone:l=!1}={}){if(!this.isValid)return null;const d=e==="extended";let u=rn(this,d);return u+="T",u+=Vr(this,d,a,i,r,l),u}toISODate({format:e="extended"}={}){return this.isValid?rn(this,e==="extended"):null}toISOWeekDate(){return wi(this,"kkkk-'W'WW-c")}toISOTime({suppressMilliseconds:e=!1,suppressSeconds:a=!1,includeOffset:i=!0,includePrefix:r=!1,extendedZone:l=!1,format:d="extended"}={}){return this.isValid?(r?"T":"")+Vr(this,d==="extended",a,e,i,l):null}toRFC2822(){return wi(this,"EEE, dd LLL yyyy HH:mm:ss ZZZ",!1)}toHTTP(){return wi(this.toUTC(),"EEE, dd LLL yyyy HH:mm:ss 'GMT'")}toSQLDate(){return this.isValid?rn(this,!0):null}toSQLTime({includeOffset:e=!0,includeZone:a=!1,includeOffsetSpace:i=!0}={}){let r="HH:mm:ss.SSS";return(a||e)&&(i&&(r+=" "),a?r+="z":e&&(r+="ZZ")),wi(this,r,!0)}toSQL(e={}){return this.isValid?`${this.toSQLDate()} ${this.toSQLTime(e)}`:null}toString(){return this.isValid?this.toISO():on}[Symbol.for("nodejs.util.inspect.custom")](){return this.isValid?`DateTime { ts: ${this.toISO()}, zone: ${this.zone.name}, locale: ${this.locale} }`:`DateTime { Invalid, reason: ${this.invalidReason} }`}valueOf(){return this.toMillis()}toMillis(){return this.isValid?this.ts:NaN}toSeconds(){return this.isValid?this.ts/1e3:NaN}toUnixInteger(){return this.isValid?Math.floor(this.ts/1e3):NaN}toJSON(){return this.toISO()}toBSON(){return this.toJSDate()}toObject(e={}){if(!this.isValid)return{};const a={...this.c};return e.includeConfig&&(a.outputCalendar=this.outputCalendar,a.numberingSystem=this.loc.numberingSystem,a.locale=this.loc.locale),a}toJSDate(){return new Date(this.isValid?this.ts:NaN)}diff(e,a="milliseconds",i={}){if(!this.isValid||!e.isValid)return he.invalid("created by diffing an invalid DateTime");const r={locale:this.locale,numberingSystem:this.numberingSystem,...i},l=id(a).map(he.normalizeUnit),d=e.valueOf()>this.valueOf(),u=d?this:e,p=d?e:this,h=rm(u,p,l,r);return d?h.negate():h}diffNow(e="milliseconds",a={}){return this.diff(ne.now(),e,a)}until(e){return this.isValid?Le.fromDateTimes(this,e):this}hasSame(e,a,i){if(!this.isValid)return!1;const r=e.valueOf(),l=this.setZone(e.zone,{keepLocalTime:!0});return l.startOf(a,i)<=r&&r<=l.endOf(a,i)}equals(e){return this.isValid&&e.isValid&&this.valueOf()===e.valueOf()&&this.zone.equals(e.zone)&&this.loc.equals(e.loc)}toRelative(e={}){if(!this.isValid)return null;const a=e.base||ne.fromObject({},{zone:this.zone}),i=e.padding?this<a?-e.padding:e.padding:0;let r=["years","months","days","hours","minutes","seconds"],l=e.unit;return Array.isArray(e.unit)&&(r=e.unit,l=void 0),Wr(a,this.plus(i),{...e,numeric:"always",units:r,unit:l})}toRelativeCalendar(e={}){return this.isValid?Wr(e.base||ne.fromObject({},{zone:this.zone}),this,{...e,numeric:"auto",units:["years","months","days"],calendary:!0}):null}static min(...e){if(!e.every(ne.isDateTime))throw new Ze("min requires all arguments be DateTimes");return Nr(e,a=>a.valueOf(),Math.min)}static max(...e){if(!e.every(ne.isDateTime))throw new Ze("max requires all arguments be DateTimes");return Nr(e,a=>a.valueOf(),Math.max)}static fromFormatExplain(e,a,i={}){const{locale:r=null,numberingSystem:l=null}=i,d=be.fromOpts({locale:r,numberingSystem:l,defaultToEN:!0});return $s(d,e,a)}static fromStringExplain(e,a,i={}){return ne.fromFormatExplain(e,a,i)}static buildFormatParser(e,a={}){const{locale:i=null,numberingSystem:r=null}=a,l=be.fromOpts({locale:i,numberingSystem:r,defaultToEN:!0});return new Ys(l,e)}static fromFormatParser(e,a,i={}){if(re(e)||re(a))throw new Ze("fromFormatParser requires an input string and a format parser");const{locale:r=null,numberingSystem:l=null}=i,d=be.fromOpts({locale:r,numberingSystem:l,defaultToEN:!0});if(!d.equals(a.locale))throw new Ze(`fromFormatParser called with a locale of ${d}, but the format parser was created for ${a.locale}`);const{result:u,zone:p,specificOffset:h,invalidReason:j}=a.explainFromTokens(e);return j?ne.invalid(j):Wa(u,p,i,`format ${a.format}`,e,h)}static get DATE_SHORT(){return Pi}static get DATE_MED(){return is}static get DATE_MED_WITH_WEEKDAY(){return Dc}static get DATE_FULL(){return os}static get DATE_HUGE(){return ts}static get TIME_SIMPLE(){return ns}static get TIME_WITH_SECONDS(){return rs}static get TIME_WITH_SHORT_OFFSET(){return ss}static get TIME_WITH_LONG_OFFSET(){return ls}static get TIME_24_SIMPLE(){return us}static get TIME_24_WITH_SECONDS(){return cs}static get TIME_24_WITH_SHORT_OFFSET(){return ds}static get TIME_24_WITH_LONG_OFFSET(){return ms}static get DATETIME_SHORT(){return ps}static get DATETIME_SHORT_WITH_SECONDS(){return hs}static get DATETIME_MED(){return vs}static get DATETIME_MED_WITH_SECONDS(){return gs}static get DATETIME_MED_WITH_WEEKDAY(){return Ic}static get DATETIME_FULL(){return js}static get DATETIME_FULL_WITH_SECONDS(){return ks}static get DATETIME_HUGE(){return fs}static get DATETIME_HUGE_WITH_SECONDS(){return bs}}function ni(o){if(ne.isDateTime(o))return o;if(o&&o.valueOf&&_a(o.valueOf()))return ne.fromJSDate(o);if(o&&typeof o=="object")return ne.fromObject(o);throw new Ze(`Unknown datetime argument: ${o}, of type ${typeof o}`)}var Gm=y('<button class="button" type="submit"> </button>');function Dm(o,e){Ke(e,!1);let a=J(e,"id",12,null),i=J(e,"label",12),r=J(e,"form",12),l=J(e,"redirect",12,""),d=J(e,"success",12),u=J(e,"error",12),p=se(),h=se(!1),j=se(!1);function S(){var k;L(h,!0);const M=(k=c(p))==null?void 0:k.closest("form");M.addEventListener("submit",async g=>{if(g.preventDefault(),c(j))return;L(j,!0);const w=new FormData(M),f=Object.fromEntries(w);await gc(vc(fa(ta,"forms",r(),"form-responses"),{createdOn:ne.now().toUTC().toISO(),...f}),d(),u()),l()&&(l().startsWith("http")?window.open(l(),"_self"):Qr(l())),M.reset(),L(j,!1)})}Ve(()=>(c(h),c(p)),()=>{!c(h)&&c(p)&&S()}),ba(),qe();var G=Gm();Xr(G,M=>L(p,M),()=>c(p));var z=n(G);return t(G),A(()=>{B(G,"id",a()),Ee(G,"loading",c(j)),m(z,i())}),v(o,G),We({get id(){return a()},set id(M){a(M),V()},get label(){return i()},set label(M){i(M),V()},get form(){return r()},set form(M){r(M),V()},get redirect(){return l()},set redirect(M){l(M),V()},get success(){return d()},set success(M){d(M),V()},get error(){return u()},set error(M){u(M),V()}})}customElements.define("pb-submit",Ge(Dm,{id:{},label:{},form:{},redirect:{},success:{},error:{}},[],[],!1));var Im=y('<button type="button" class="cat-btn"> </button>'),Pm=y('<button class="cat-btn" type="button"> </button> <!>',1),Cm=y('<div class="post-category-wrapper"><span class="news-category"> </span></div>'),Tm=y('<p class="post-date"> </p>'),Nm=y('<a class="post-card"><img class="news-img"> <div class="post-content-wrapper"><!> <div class="post-content"><h3 class="h3"> </h3> <!> <p class="p"> </p></div></div></a>'),Lm=y('<button type="button"> </button>'),_m=y('<div class="container categories-container"><!></div> <div class="container blog-container"></div> <!>',1);function Em(o,e){Ke(e,!1);const a=se(),i=se(),r=se();let l=J(e,"category",12,""),d=J(e,"author",12,""),u=J(e,"pagesize",12,"10"),p=J(e,"singlearticlelink",12),h=J(e,"showcategoryfilters",12),j=J(e,"collectionprefx",12),S=J(e,"loadmorelabel",12),G=J(e,"datelabel",12),z=J(e,"allcategorieslabel",12),M=se([]),k=se(null),g=se(!1),w=se({}),f=se({}),T=se();async function W(D,_,x,b){if(!Object.keys(b).length)return;L(g,!0),L(k,null);const{docs:I}=await Aa(ci(fa(ta,"blog-articles"+(j()||"")),...[_?ua("category","==",_):null,x?ua("author","==",x):null].filter(Boolean),ua("active","==",!0),di("publicationDate","desc"),mi(D+1)));I.length===D+1?L(k,I[I.length-1]):L(k,null),L(M,I.map(C=>C.data())),L(g,!1)}async function X(){const{docs:D}=await Aa(ci(fa(ta,"blog-articles"+(j()||"")),...[l()?ua("category","==",l()):null,d()?ua("author","==",d()):null].filter(Boolean),ua("active","==",!0),di("publicationDate","desc"),qr(c(k)),mi(c(r)+1)));D.length===c(r)+1?L(k,D[D.length-1]):L(k,null),L(M,[...c(M),...D.map(_=>_.data())])}Da(async()=>{const D=await Promise.all([Aa(fa(ta,"blog-categories"+(j()||""))),Aa(fa(ta,"blog-authors"+(j()||"")))]);L(T,D[0].docs.map(_=>{var x;return{name:((x=_.data())==null?void 0:x.name)||"",id:_.id}})),L(w,D[0].docs.reduce((_,x)=>(_[x.id]=x.data(),_),{})),L(f,D[1].docs.reduce((_,x)=>(_[x.id]=x.data(),_),{}))}),Ve(()=>pe(h()),()=>{L(a,h()==="Yes")}),Ve(()=>pe(p()),()=>{L(i,p())}),Ve(()=>pe(u()),()=>{L(r,parseInt(u(),10))}),Ve(()=>(c(r),pe(l()),pe(d()),c(f)),()=>{W(c(r),l(),d(),c(f))}),ba(),qe();var O=_m(),E=me(O),R=n(E);P(R,()=>c(a),D=>{var _=Pm(),x=me(_),b=n(x);t(x);var I=s(x,2);He(I,1,()=>c(T),xe,(C,H)=>{var Y=Im(),ie=n(Y);t(Y),A(()=>{Ee(Y,"active",l()===c(H).id),m(ie,c(H).name)}),Pe("click",Y,()=>{l(c(H).id),W(c(r),l(),d(),c(f))}),v(C,Y)}),A(()=>{Ee(x,"active",l()===""),m(b,z())}),Pe("click",x,()=>{l(""),W(c(r),l(),d(),c(f))}),v(D,_)}),t(E);var U=s(E,2);He(U,5,()=>c(M),xe,(D,_)=>{var x=Nm(),b=n(x),I=s(b,2),C=n(I);P(C,()=>c(_).category,ke=>{var oe=Cm(),le=n(oe),Oe=n(le);t(le),t(oe),A(()=>{var Fe;return m(Oe,((Fe=c(w)[c(_).category])==null?void 0:Fe.name)||"")}),v(ke,oe)});var H=s(C,2),Y=n(H),ie=n(Y);t(Y);var K=s(Y,2);P(K,()=>c(_).publicationDate,ke=>{var oe=Tm(),le=n(oe);A(()=>m(le,`${G()??""}: ${new Date(c(_).publicationDate).toLocaleDateString()??""}`)),t(oe),v(ke,oe)});var Z=s(K,2),F=n(Z);t(Z),t(H),t(I),t(x),A(()=>{B(x,"href",c(i)+"/"+c(_).url),B(b,"src",c(_).image),B(b,"alt",c(_).imageAlt||c(_).title),m(ie,c(_).title),m(F,c(_).description)}),v(D,x)}),t(U);var Q=s(U,2);return P(Q,()=>c(k),D=>{var _=Lm(),x=n(_);t(_),A(()=>{Ee(_,"loading",c(g)),m(x,S())}),Pe("click",_,X),v(D,_)}),v(o,O),We({get category(){return l()},set category(D){l(D),V()},get author(){return d()},set author(D){d(D),V()},get pagesize(){return u()},set pagesize(D){u(D),V()},get singlearticlelink(){return p()},set singlearticlelink(D){p(D),V()},get showcategoryfilters(){return h()},set showcategoryfilters(D){h(D),V()},get collectionprefx(){return j()},set collectionprefx(D){j(D),V()},get loadmorelabel(){return S()},set loadmorelabel(D){S(D),V()},get datelabel(){return G()},set datelabel(D){G(D),V()},get allcategorieslabel(){return z()},set allcategorieslabel(D){z(D),V()}})}customElements.define("pb-blog",Ge(Em,{category:{},author:{},pagesize:{},singlearticlelink:{},showcategoryfilters:{},collectionprefx:{},loadmorelabel:{},datelabel:{},allcategorieslabel:{}},[],[],!1));var Hm=y('<div class="gc-12"><iframe src="https://widgets.sociablekit.com/linkedin-profile-posts/iframe/25556751" class="social-feed" frameborder="0" width="100%"></iframe></div>'),xm=y("<button> </button>"),Om=y('<div class="gc-12 filters"><button> </button> <!></div>'),Rm=y('<div class="article-category"> </div>'),Fm=y('<a class="article gc-4"><div class="article-image"><img> <!></div> <span class="article-content"><h2 class="article-title"> </h2> <span class="article-description"> </span></span></a>'),Bm=y('<div class="gc-12"> </div>'),Vm=y('<div class="gc-12 flex justify-center"><button type="button" class="button-filled"> </button></div>'),Jm=y("<!> <!> <!>",1),Km=y('<div class="grid grid-large news"><div class="gc-12 filters"><button> </button> <button> </button></div> <!></div>');function Wm(o,e){Ke(e,!1);const a=ra(),i=()=>$e(ea,"$language",a),r=se(),l=se(),d=se();let u=J(e,"category",12,""),p=J(e,"author",12,""),h=J(e,"pagesize",12,"10"),j=J(e,"singlearticlelink",12),S=J(e,"showcategoryfilters",12),G=J(e,"collectionprefx",12),z=J(e,"loadmorelabel",12),M=J(e,"datelabel",12),k=se(!0),g=se([]),w=se(null),f=se(!1),T=se({}),W=se({}),X=se();async function O(I,C,H,Y){if(!Object.keys(Y).length)return;L(f,!0),L(w,null);const{docs:ie}=await Aa(ci(fa(ta,"blog-articles"+(G()||"")),...[C?ua("category","==",C):null,H?ua("author","==",H):null].filter(Boolean),ua("active","==",!0),di("publicationDate","desc"),mi(I+1)));ie.length===I+1?L(w,ie[ie.length-1]):L(w,null),L(g,ie.map(K=>K.data())),L(f,!1)}async function E(){const{docs:I}=await Aa(ci(fa(ta,"blog-articles"+(G()||"")),...[u()?ua("category","==",u()):null,p()?ua("author","==",p()):null].filter(Boolean),ua("active","==",!0),di("publicationDate","desc"),qr(c(w)),mi(c(d)+1)));I.length===c(d)+1?L(w,I[I.length-1]):L(w,null),L(g,[...c(g),...I.map(C=>C.data())])}Da(async()=>{const I=await Promise.all([Aa(fa(ta,"blog-categories"+(G()||""))),Aa(fa(ta,"blog-authors"+(G()||"")))]);L(X,I[0].docs.map(C=>{var H;return{name:((H=C.data())==null?void 0:H.name)||"",id:C.id}})),L(T,I[0].docs.reduce((C,H)=>(C[H.id]=H.data(),C),{})),L(W,I[1].docs.reduce((C,H)=>(C[H.id]=H.data(),C),{}))}),Ve(()=>pe(S()),()=>{L(r,S()==="Yes")}),Ve(()=>pe(j()),()=>{L(l,j())}),Ve(()=>pe(h()),()=>{L(d,parseInt(h(),10))}),Ve(()=>(c(d),pe(u()),pe(p()),c(W)),()=>{O(c(d),u(),p(),c(W))}),ba(),qe();var R=Km(),U=n(R),Q=n(U),D=n(Q);t(Q);var _=s(Q,2),x=n(_);t(_),t(U);var b=s(U,2);return P(b,()=>c(k),I=>{var C=Hm();v(I,C)},I=>{var C=Jm(),H=me(C);P(H,()=>c(r),K=>{var Z=Om(),F=n(Z),ke=n(F);t(F);var oe=s(F,2);He(oe,1,()=>c(X),xe,(le,Oe)=>{var Fe=xm(),aa=n(Fe);t(Fe),A(()=>{Ee(Fe,"active",u()===c(Oe).id),m(aa,c(Oe).name)}),Pe("click",Fe,()=>{u(c(Oe).id),O(c(d),u(),p(),c(W))}),v(le,Fe)}),t(Z),A(()=>{Ee(F,"active",u()===""),m(ke,i()==="en"?"All posts":"Sve novosti")}),Pe("click",F,()=>{u(""),O(c(d),u(),p(),c(W))}),v(K,Z)});var Y=s(H,2);P(Y,()=>c(g).length,K=>{var Z=Be(),F=me(Z);He(F,1,()=>c(g),xe,(ke,oe)=>{var le=Fm(),Oe=n(le),Fe=n(Oe),aa=s(Fe,2);P(aa,()=>c(oe).category,Me=>{var sa=Rm(),ye=n(sa);t(sa),A(()=>{var q;return m(ye,((q=c(T)[c(oe).category])==null?void 0:q.name)||"")}),v(Me,sa)}),t(Oe);var ma=s(Oe,2),Ce=n(ma),ve=n(Ce);t(Ce);var Je=s(Ce,2),Te=n(Je);t(Je),t(ma),t(le),A(()=>{B(le,"href","/posts/"+c(oe).url),B(Fe,"src",c(oe).image),B(Fe,"alt",c(oe).imageAlt||c(oe).title),m(ve,c(oe).title),m(Te,c(oe).description)}),v(ke,le)}),v(K,Z)},K=>{var Z=Bm(),F=n(Z);t(Z),A(()=>m(F,i()==="en"?"No posts for this category yet.":"Nema objava za ovu kategoriju.")),v(K,Z)});var ie=s(Y,2);P(ie,()=>c(w),K=>{var Z=Vm(),F=n(Z),ke=n(F);t(F),t(Z),A(()=>{Ee(F,"loading",c(f)),m(ke,z())}),Pe("click",F,E),v(K,Z)}),v(I,C)}),t(R),A(()=>{Ee(Q,"active",c(k)),m(D,`LinkedIn ${(i()==="en"?"Feed":"Objave")??""}`),Ee(_,"active",!c(k)),m(x,i()==="en"?"News":"Novosti")}),Pe("click",Q,()=>{L(k,!0)}),Pe("click",_,()=>{L(k,!1)}),v(o,R),We({get category(){return u()},set category(I){u(I),V()},get author(){return p()},set author(I){p(I),V()},get pagesize(){return h()},set pagesize(I){h(I),V()},get singlearticlelink(){return j()},set singlearticlelink(I){j(I),V()},get showcategoryfilters(){return S()},set showcategoryfilters(I){S(I),V()},get collectionprefx(){return G()},set collectionprefx(I){G(I),V()},get loadmorelabel(){return z()},set loadmorelabel(I){z(I),V()},get datelabel(){return M()},set datelabel(I){M(I),V()}})}customElements.define("pb-news",Ge(Wm,{category:{},author:{},pagesize:{},singlearticlelink:{},showcategoryfilters:{},collectionprefx:{},loadmorelabel:{},datelabel:{}},[],[],!1));var Zm=y('<svg width="18" height="18" viewBox="0 0 18 18" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M1.92871 16.071L16.0708 1.92891" stroke="#032130" stroke-width="3"></path><path d="M1.92871 1.92944L16.0708 16.0716" stroke="#032130" stroke-width="3"></path></svg>'),Um=y('<svg width="20" height="14" viewBox="0 0 20 14" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M0 2H20" stroke="white" stroke-width="3"></path><path d="M0 12H20" stroke="white" stroke-width="3"></path></svg>'),Ym=y("<li><a> </a></li>"),$m=y('<header><div><a href="/"><img class="logo" src="/brand/logo.svg" alt="genos logo"></a></div> <span>GENOS</span> <div><button class="mobile-menu-trigger" type="button"><svg class="bg-svg" width="56" height="62" viewBox="0 0 56 62" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M24 1.3094C26.4752 -0.119662 29.5248 -0.119661 32 1.3094L51.7128 12.6906C54.188 14.1197 55.7128 16.7607 55.7128 19.6188V42.3812C55.7128 45.2393 54.188 47.8803 51.7128 49.3094L32 60.6906C29.5248 62.1197 26.4752 62.1197 24 60.6906L4.28719 49.3094C1.81198 47.8803 0.287188 45.2393 0.287188 42.3812V19.6188C0.287188 16.7607 1.81198 14.1197 4.28719 12.6906L24 1.3094Z"></path></svg> <!></button></div></header> <div class="mobile-menu"><div class="mobile-menu-side" style="border-right-width: 1px"><div class="mobile-menu-side-text" style="transform: rotate(-180deg)">© 2022 — Genos Glyco</div></div> <nav><div class="links-menu"><ul class="links-social"><li><a href="mailto:info@genos.hr" style="text-decoration: underline">info@genos.hr</a></li> <li><a href="tel:+38516471181">+385 1 647 1181</a> <br> <a href="tel:+38516471182">+385 1 647 1182</a></li> <li><a href="https://maps.app.goo.gl/1bfL66FpdEin1hL16" target="_blank" rel="noreferrer noopener">Borongajska cesta 83h <br> 10000 Zagreb <br> Croatia</a></li></ul> <ul class="links-web"></ul></div> <a class="link-to-contact" href="/contact">Submit free request</a></nav> <div class="mobile-menu-side" style="border-left-width: 1px"><div class="mobile-menu-side-text"><a href="https://x.com/gglycoscience?lang=hr" target="_blank" rel="noreferrer noopener">Twitter</a> — <a href="https://www.linkedin.com/company/genos-ltd/posts/?feedView=all" target="_blank" rel="noreferrer noopener">LinkedIn</a></div></div></div>',1);function qm(o,e){Ke(e,!1);const a=se();let i=0,r=se(!0),l=J(e,"links",12),d=J(e,"labels",12),u=se(!1);function p(){const O=l().split(","),E=d().split(",");return O.map((R,U)=>({label:E[U],url:R}))}function h(){const O=window.scrollY;O>400&&O>i?L(r,!1):L(r,!0),i=O}Da(()=>(window.addEventListener("scroll",h),()=>{window.removeEventListener("scroll",h)})),Ve(()=>(pe(l()),pe(d())),()=>{L(a,l()&&d()?p():[])}),ba(),qe();var j=$m(),S=me(j),G=s(n(S),2),z=s(G,2),M=n(z),k=n(M),g=n(k);t(k);var w=s(k,2);P(w,()=>c(u),O=>{var E=Zm();v(O,E)},O=>{var E=Um();v(O,E)}),t(M),t(z),t(S);var f=s(S,2),T=s(n(f),2),W=n(T),X=s(n(W),2);return He(X,5,()=>c(a),xe,(O,E)=>{var R=Ym(),U=n(R),Q=n(U);t(U),t(R),A(()=>{B(U,"href",c(E).url),m(Q,c(E).label)}),v(O,R)}),t(X),t(W),De(2),t(T),De(2),t(f),A(()=>{Ee(S,"transparent-bg",c(u)),Ee(S,"inactive",!c(r)),Ee(G,"active",c(u)),B(g,"fill",c(u)?"#ffffff":"#032130"),Ee(f,"active",c(u))}),Pe("click",M,()=>L(u,!c(u))),v(o,j),We({get links(){return l()},set links(O){l(O),V()},get labels(){return d()},set labels(O){d(O),V()}})}customElements.define("pb-mobile-menu",Ge(qm,{links:{},labels:{}},[],[],!1));var Xm=y('<div class="news-card svelte-a5afwo"><div class="news-bg-img svelte-a5afwo"></div> <div class="card news-content svelte-a5afwo"><h3 class="h3 svelte-a5afwo"> </h3> <p class="p svelte-a5afwo"> </p> <div class="svelte-a5afwo"><a class="btn-pink"> </a></div></div></div>'),Qm=y('<div class="card container news-card-container svelte-a5afwo"></div>');const ep={hash:"svelte-a5afwo",code:`
  .news-card-container.svelte-a5afwo {
    gap: 20px;
    padding-top: 70px !important;
    justify-content: center;
    @media (max-width: 1100px) {
      gap: 20px;
    }
    @media (max-width: 900px) {
      flex-direction: column;
    }

    .news-card:where(.svelte-a5afwo) {
      max-width: 900px;
      border: 1px solid #000;
      border-radius: 6px;
      display: flex;
      max-height: 550px;
      flex-direction: column;
      .news-bg-img:where(.svelte-a5afwo) {
        height: 230px;
      }
      h3:where(.svelte-a5afwo) {
        color: var(--text-primary);
      }
    }
    .news-content:where(.svelte-a5afwo) {
      display: flex;
      padding: 20px;
      flex-direction: column;
      gap: 10px;
      h3:where(.svelte-a5afwo) {
        margin-top: 0;
        margin-bottom: 10px;
      }
      .p:where(.svelte-a5afwo) {
        font-size: 20px;
        line-height: 26px;
        overflow: hidden;
        text-overflow: ellipsis;
        display: -webkit-box;
        -webkit-line-clamp: 3;
        -webkit-box-orient: vertical;
      }
    }
    .news-content > div:where(.svelte-a5afwo) {
      display: flex;
      justify-content: flex-end;
    }
  }
`};function ap(o,e){Ke(e,!1),es(o,ep);let a=J(e,"collectionPrefx",12),i=J(e,"singlearticlelink",12),r=J(e,"linklabel",12),l=se([]);Da(async()=>{const{docs:u}=await Aa(ci(fa(ta,"blog-articles"+(a()||"")),di("publicationDate","desc"),mi(3)));L(l,u.map(p=>p.data()))}),qe();var d=Qm();return He(d,5,()=>c(l),xe,(u,p)=>{var h=Xm(),j=n(h),S=s(j,2),G=n(S),z=n(G);t(G);var M=s(G,2),k=n(M);t(M);var g=s(M,2),w=n(g),f=n(w);t(w),t(g),t(S),t(h),A(()=>{B(j,"style",`background-image: url(${c(p).image??""}); background-repeat: no-repeat;
      background-size: cover;
      background-position: center;`),m(z,c(p).title),m(k,c(p).description),B(w,"href",`${i()??""}/${c(p).url??""}`),m(f,r())}),v(u,h)}),t(d),v(o,d),We({get collectionPrefx(){return a()},set collectionPrefx(u){a(u),V()},get singlearticlelink(){return i()},set singlearticlelink(u){i(u),V()},get linklabel(){return r()},set linklabel(u){r(u),V()}})}customElements.define("pb-featured-blog-articles",Ge(ap,{collectionPrefx:{},singlearticlelink:{},linklabel:{}},[],[],!1));const ip=[{collection:"pages",titleKey:"title",urlKey:"url",prefix:"",keysToTrack:["id","title","lastUpdatedOn"],skipGenerateJsonFile:!0}],je=ip.reduce((o,{keysToTrack:e,collection:a})=>(o[a]=e.reduce((i,r)=>{let l=r[0],d=1;for(;i.hasOwnProperty(l);)l=r[0]+d,d++;return i[r]=l,i},{}),o),{});var op=y("<h4>Sort</h4> <select><option>Name</option><option>Price</option><option>Created On</option></select> <select><option>Ascending</option><option>Descending</option></select>",1),tp=y("<option> </option>"),np=y("<h4>Categories</h4> <select></select>",1),rp=y("<option> </option>"),sp=y("<h4>Tags</h4> <select></select>",1),lp=y('<input type="number" placeholder="Min price"> <input type="number" placeholder="Max price">',1),up=y('<input type="text" placeholder="Search">'),cp=y("<p>No products found</p>"),dp=y('<a class="product"><img> <h4> </h4> <p> </p></a>'),mp=y('<div class="products"><div class="filters"><!> <!> <!> <!> <!></div> <!> <!></div>');function pp(o,e){Ke(e,!1);let a=J(e,"limit",12),i=J(e,"property",12),r=J(e,"direction",12),l=J(e,"showSort",12),d=J(e,"showpricerangefilter",12),u=J(e,"showcategoriesfilter",12),p=J(e,"showtagsfilter",12),h=J(e,"showsearch",12),j=J(e,"initialcategories",12),S=J(e,"initialtags",12),G=J(e,"initialminprice",12),z=J(e,"initialmaxprice",12),M=se([]),k=se([]),g=se([]),w=se(""),f;Da(async()=>{await(async b=>(L(k,b[0]),L(g,b[1]),L(M,b[2])))(await Promise.all([fetch(qt.websiteUrl+"/data/tags.json").then(b=>b.json()).catch(()=>[]),fetch(qt.websiteUrl+"/data/categories.json").then(b=>b.json()).catch(()=>[]),fetch(qt.websiteUrl+"/data/products.json").then(b=>b.json()).catch(()=>[])]))});function T(b){L(M,c(M).reduce((I,C)=>{let H=!1;return b.initialcategories&&(H=b.initialcategories.includes(C[je.products.category])),H&&b.initialtags&&(H=C[je.products.tags].some(Y=>b.initialtags.includes(Y))),H&&(b.initialminprice||b.initialminprice===0)&&(H=C[je.products.price]>=b.initialminprice),H&&b.initialmaxprice&&(H=C[je.products.price]<=b.initialmaxprice),H&&b.search&&(H=C[je.products.name].toLowerCase().split(" ").includes(b.search.toLowerCase())),H&&(!b.limit||I.length<parseInt(b.limit,10))&&(I.push(C),b.direction&&b.property&&I.sort((Y,ie)=>b.direction==="asc"?Y[je.products[i()]]>ie[je.products[i()]]?1:-1:Y[je.products[i()]]<ie[je.products[i()]]?1:-1)),I},[]))}function W(b){clearTimeout(f),f=setTimeout(()=>{L(w,b.target.value)},300)}Ve(()=>(pe(j()),pe(S()),pe(G()),pe(z()),c(w),pe(a()),pe(r()),pe(i())),()=>{T({initialcategories:j(),initialtags:S(),initialminprice:G(),initialmaxprice:z(),search:c(w),limit:a(),direction:r(),property:i()})}),ba(),qe();var X=mp(),O=n(X),E=n(O);P(E,l,b=>{var I=op(),C=s(me(I),2);A(()=>{i(),ki(()=>{})});var H=n(C),Y={},ie=s(H),K={},Z=s(ie),F={};t(C);var ke=s(C,2);A(()=>{r(),ki(()=>{})});var oe=n(ke);oe.value=(oe.__value="asc")==null?"":"asc";var le=s(oe);le.value=(le.__value="desc")==null?"":"desc",t(ke),A(()=>{Y!==(Y=je.products.name)&&(H.value=(H.__value=je.products.name)==null?"":je.products.name),K!==(K=je.products.price)&&(ie.value=(ie.__value=je.products.price)==null?"":je.products.price),F!==(F=je.products.createdOn)&&(Z.value=(Z.__value=je.products.createdOn)==null?"":je.products.createdOn)}),fi(C,i),fi(ke,r),v(b,I)});var R=s(E,2);P(R,()=>u()&&c(g).length,b=>{var I=np(),C=s(me(I),2);A(()=>{j(),ki(()=>{c(g)})}),He(C,5,()=>c(g),xe,(H,Y)=>{var ie=tp(),K={},Z=n(ie);t(ie),A(()=>{K!==(K=c(Y)[je.categories.id])&&(ie.value=(ie.__value=c(Y)[je.categories.id])==null?"":c(Y)[je.categories.id]),m(Z,c(Y)[je.categories.name])}),v(H,ie)}),t(C),fi(C,j),v(b,I)});var U=s(R,2);P(U,()=>p()&&c(k).length,b=>{var I=sp(),C=s(me(I),2);A(()=>{S(),ki(()=>{c(k)})}),He(C,5,()=>c(k),xe,(H,Y)=>{var ie=rp(),K={},Z=n(ie);t(ie),A(()=>{K!==(K=c(Y)[je.tags.id])&&(ie.value=(ie.__value=c(Y)[je.tags.id])==null?"":c(Y)[je.tags.id]),m(Z,c(Y)[je.tags.name])}),v(H,ie)}),t(C),fi(C,S),v(b,I)});var Q=s(U,2);P(Q,d,b=>{var I=lp(),C=me(I);pr(C);var H=s(C,2);pr(H),vr(C,z),vr(H,G),v(b,I)});var D=s(Q,2);P(D,h,b=>{var I=up();Pe("input",I,C=>W(C)),v(b,I)}),t(O);var _=s(O,2);P(_,()=>c(M).length===0,b=>{var I=cp();v(b,I)});var x=s(_,2);return He(x,1,()=>c(M),xe,(b,I)=>{var C=dp(),H=n(C),Y=s(H,2),ie=n(Y);t(Y);var K=s(Y,2),Z=n(K);t(K),t(C),A(()=>{B(C,"href",`/product/${c(I)[je.products.id]}`),B(H,"src",c(I)[je.products.image]),B(H,"alt",c(I)[je.products.name]),m(ie,c(I)[je.products.name]),m(Z,c(I)[je.products.description])}),v(b,C)}),t(X),v(o,X),We({get limit(){return a()},set limit(b){a(b),V()},get property(){return i()},set property(b){i(b),V()},get direction(){return r()},set direction(b){r(b),V()},get showSort(){return l()},set showSort(b){l(b),V()},get showpricerangefilter(){return d()},set showpricerangefilter(b){d(b),V()},get showcategoriesfilter(){return u()},set showcategoriesfilter(b){u(b),V()},get showtagsfilter(){return p()},set showtagsfilter(b){p(b),V()},get showsearch(){return h()},set showsearch(b){h(b),V()},get initialcategories(){return j()},set initialcategories(b){j(b),V()},get initialtags(){return S()},set initialtags(b){S(b),V()},get initialminprice(){return G()},set initialminprice(b){G(b),V()},get initialmaxprice(){return z()},set initialmaxprice(b){z(b),V()}})}customElements.define("pb-products",Ge(pp,{limit:{},property:{},direction:{},showSort:{},showpricerangefilter:{},showcategoriesfilter:{},showtagsfilter:{},showsearch:{},initialcategories:{},initialtags:{},initialminprice:{},initialmaxprice:{}},[],[],!1));var hp=y('<div class="product"><img> <h4> </h4> <p> </p></div>');function vp(o,e){Ke(e,!1);let a=J(e,"id",12),i=se();Da(async()=>{const d=await sn(ln(ta,"products",a()));d.exists()&&L(i,d.data())}),qe();var r=Be(),l=me(r);return P(l,()=>c(i),d=>{var u=hp(),p=n(u),h=s(p,2),j=n(h);t(h);var S=s(h,2),G=n(S);t(S),t(u),A(()=>{B(p,"src",c(i).image),B(p,"alt",c(i).name),m(j,c(i).name),m(G,c(i).description)}),v(d,u)}),v(o,r),We({get id(){return a()},set id(d){a(d),V()}})}customElements.define("pb-product-card",Ge(vp,{id:{}},[],[],!1));var gp=y("<div></div>");function jp(o,e){Ke(e,!1);let a=J(e,"enablepagination",12),i=J(e,"sliderbar",12),r=J(e,"autoslide",12),l=J(e,"interval",12),d=J(e,"images",12),u=J(e,"columncount",12),p=J(e,"columncounttable",12),h=J(e,"columncountmobile",12),j=J(e,"enablegallery",12),S=J(e,"gapx",12),G=J(e,"gapy",12),z=se();Ve(()=>(c(z),pe(d()),pe(a()),pe(i()),pe(r()),pe(j()),pe(u()),pe(p()),pe(h()),pe(S()),pe(G()),pe(l())),()=>{var k;if(c(z)){const g=document.createElement("jp-image-gallery");g.images=(k=d())!=null&&k.length?d().split(",").map(w=>({src:w,alt:""})):[{}],g.enablePagination=a()!==void 0,g.sliderBar=i()!==void 0,g.autoSlide=r()!==void 0,g.enableGallery=j()!==void 0,u()&&(g.columnCount=+parseInt(u(),12)),p()&&(g.columnCountTable=+parseInt(p(),12)),h()&&(g.columnCountMobile=+parseInt(h(),12)),S()&&(g.gapX=+parseInt(S(),10)),G()&&(g.gapY=+parseInt(G(),10)),l()&&(g.interval=l()),c(z).appendChild(g)}}),ba(),qe();var M=gp();return Xr(M,k=>L(z,k),()=>c(z)),v(o,M),We({get enablepagination(){return a()},set enablepagination(k){a(k),V()},get sliderbar(){return i()},set sliderbar(k){i(k),V()},get autoslide(){return r()},set autoslide(k){r(k),V()},get interval(){return l()},set interval(k){l(k),V()},get images(){return d()},set images(k){d(k),V()},get columncount(){return u()},set columncount(k){u(k),V()},get columncounttable(){return p()},set columncounttable(k){p(k),V()},get columncountmobile(){return h()},set columncountmobile(k){h(k),V()},get enablegallery(){return j()},set enablegallery(k){j(k),V()},get gapx(){return S()},set gapx(k){S(k),V()},get gapy(){return G()},set gapy(k){G(k),V()}})}customElements.define("pb-image-gallery",Ge(jp,{enablepagination:{},sliderbar:{},autoslide:{},interval:{},images:{},columncount:{},columncounttable:{},columncountmobile:{},enablegallery:{},gapx:{},gapy:{}},[],[],!1));var kp=y("<a> </a>"),fp=y("<a> </a>"),bp=y('<button class="overlay"></button> <div class="menu"><!> <div class="filler"></div> <div class="socials"><a href="https://x.com/gglycoscience?lang=hr" target="_blank" rel="noreferrer noopener"><img src="/socials/x.svg" alt=""></a> <a href="https://www.linkedin.com/company/genos-ltd/posts/?feedView=all" target="_blank" rel="noreferrer noopener"><img src="/socials/linkedin.svg" alt=""></a></div></div>',1),yp=y('<header class="navigation"><nav><a><img class="logo" src="/brand/genos-logo-white.svg" alt="genos logo"></a> <div class="links"></div> <div class="flex gap-12"><button class="links-link mobile">Menu</button> <button class="flex gap-4 text-white"><span>EN</span> <span>HR</span></button></div></nav></header> <!>',1);function zp(o,e){Ke(e,!1);const a=ra(),i=()=>$e(ea,"$language",a),r=()=>$e($r,"$page",a);let l=0,d=se(!0),u=se(!1),p=[{hr:{label:"O nama",link:"/o-nama"},en:{label:"About",link:"/about"}},{hr:{label:"Projekti",link:"/projekti"},en:{label:"Projects",link:"/projects"}},{hr:{label:"Publikacije",link:"/publikacije"},en:{label:"Publications",link:"/publications"}},{hr:{label:"Usluge",link:"/usluge"},en:{label:"Services",link:"/services"}},{hr:{label:"Korisni linkovi",link:"/korisni-linkovi"},en:{label:"Resources",link:"/resources"}},{hr:{label:"Novosti",link:"/novosti"},en:{label:"News",link:"/news"}},{hr:{label:"Naš tim",link:"/tim"},en:{label:"Our team",link:"/team"}},{hr:{label:"Kontaktirajte nas",link:"/kontakt"},en:{label:"Contact us",link:"/contact"},alt:!0}];function h(){const E=window.scrollY;E>96&&E>l?L(d,!1):L(d,!0),l=E}function j(E){E.key==="Escape"&&L(u,!1)}function S(){ea.update(E=>{const R=E==="en"?"hr":"en";if(typeof window>"u")return R;localStorage.setItem("language",R);const U={"/":"/pocetna","/pocetna":"/","/about":"/o-nama","/o-nama":"/about","/projects":"/projekti","/projekti":"/projects","/publications":"/publikacije","/publikacije":"/publications","/services":"/usluge","/usluge":"/services","/resources":"/korisni-linkovi","/korisni-linkovi":"/resources","/news":"/novosti","/novosti":"/news","/team":"/tim","/tim":"/team","/contact":"/kontakt","/kontakt":"/contact","/glikomika":"/glycomics","/glycomics":"/glikomika","/epigenetika":"/epigenetics","/epigenetics":"/epigenetika","/dna-i-forenzika":"/dna-and-forensics","/dna-and-forensics":"/dna-i-forenzika"},Q=window.location.pathname,D=U[Q]||(R==="en"?"/":"/pocetna");return D!==Q&&Qr(D),R})}Da(()=>(window.addEventListener("scroll",h),window.addEventListener("keydown",j),()=>{window.removeEventListener("scroll",h),window.removeEventListener("keydown",j)})),qe();var G=yp(),z=me(G),M=n(z),k=n(M),g=s(k,2);He(g,5,()=>p,xe,(E,R)=>{var U=kp(),Q=n(U);t(U),A(()=>{B(U,"href",i()==="en"?c(R).en.link:c(R).hr.link),Ee(U,"contact",c(R).alt),m(Q,i()==="en"?c(R).en.label:c(R).hr.label)}),v(E,U)}),t(g);var w=s(g,2),f=n(w),T=s(f,2),W=n(T),X=s(W,2);t(T),t(w),t(M),t(z);var O=s(z,2);P(O,()=>c(u),E=>{var R=bp(),U=me(R),Q=s(U,2),D=n(Q);He(D,1,()=>p,xe,(_,x)=>{var b=fp(),I=n(b);t(b),A(()=>{B(b,"href",i()==="en"?c(x).en.link:c(x).hr.link),Ee(b,"contact",c(x).alt),Ee(b,"active",(i()==="en"?c(x).en.link:c(x).hr.link)===r().url.pathname),m(I,i()==="en"?c(x).en.label:c(x).hr.label)}),v(_,b)}),De(4),t(Q),Oa(3,U,()=>hr),Pe("click",U,()=>L(u,!1)),Oa(3,Q,()=>hr,()=>({y:-1e3})),v(E,R)}),A(()=>{Ee(z,"inactive",!c(d)),B(k,"href",i()==="en"?"/":"/pocetna"),Ee(W,"underline",i()==="en"),Ee(X,"underline",i()==="hr")}),Pe("click",f,()=>{L(u,!c(u))}),Pe("click",T,()=>{S()}),v(o,G),We()}customElements.define("pb-navigation",Ge(zp,{},[],[],!1));var Sp=y('<div class="grid grid-large"><div class="gc-12 leaders"><img src="/images/team.jpg" alt=""> <h2> </h2> <p style="max-width: 44ch"><!></p> <div><a class="button-filled-yellow"> </a></div></div></div>');function Mp(o){const e=ra(),a=()=>$e(ea,"$language",e);var i=Sp(),r=n(i),l=s(n(r),2),d=n(l);t(l);var u=s(l,2),p=n(u);$(p,()=>a()==="en"?"With almost two decades of research and innovation behind us, our team of world-renowned scientists conducted over 80% of all glycan analyses globally.<br><br>From advanced analytical solutions for complex samples to groundbreaking biomarker discovery, we lead the way in robust and sensitive glycan analysis.":"S gotovo dva desetljeća istraživanja i inovacija iza nas, naš tim svjetski priznatih znanstvenika proveo je više od 80% svih analiza glikana na globalnoj razini.<br><br>Od naprednih analitičkih rješenja za složene uzorke do revolucionarnog otkrivanja biomarkera, predvodimo u robusnoj i osjetljivoj analizi glikana."),t(u);var h=s(u,2),j=n(h),S=n(j);t(j),t(h),t(r),t(i),A(()=>{m(d,a()==="en"?"Global Leaders in Glycoscience":"Svjetski stručnjaci u glikoznanosti"),B(j,"href",`/${(a()==="en"?"team":"tim")??""}`),m(S,a()==="en"?"Our team":"Naš tim")}),v(o,i)}customElements.define("pb-leaders",Ge(Mp,{},[],[],!1));var wp=y('<a class="button-filled" href="/services#3.5.1.">Explore more</a>'),Ap=y('<a class="button-filled" href="/usluge#3.5.1.">Više o setu</a>'),Gp=y('<div class="grid grid-large gap-y-12 plug"><div class="gc-12"><div class="image-text"><div class="image"><img src="/images/hgp-card.jpg"></div> <div class="text"><h2><!></h2> <p class="text-p"><!></p> <div><a class="button-filled" href="https://human-glycome.org/" target="_blank"> </a></div></div></div></div> <div class="gc-12"><div class="image-text"><div class="image"><img src="/images/glycanage.jpg" alt="glycanage kit"></div> <div class="text"><h2> </h2> <p class="text-p"><!></p> <div><a class="button-filled" href="https://glycanage.com/" target="_blank"> </a></div></div></div></div> <div class="gc-12"><div class="image-text"><div class="image"><img src="/images/test-kit.jpg"></div> <div class="text"><h2> </h2> <p class="text-p"><!></p> <div class="flex"><!></div></div></div></div></div>');function Dp(o){const e=ra(),a=()=>$e(ea,"$language",e);var i=Gp(),r=n(i),l=n(r),d=n(l),u=n(d);t(d);var p=s(d,2),h=n(p),j=n(h);$(j,()=>a()==="en"?"The Human Glycome Project":"Projekt Humanog Glikoma"),t(h);var S=s(h,2),G=n(S);$(G,()=>a()==="en"?'An ambitious scientific initiative focused on mapping the entire human glycome, encompassing all glycans present in the human body.<br><br><a href="https://www.youtube.com/@HumanGlycomeProject" target="_blank">Watch the latest videos</a> on glycobiology research and innovations.':'Ambiciozna znanstvena inicijativa usmjerena na mapiranje cijelog ljudskog glikoma, koji obuhvaća sve glikane prisutne u ljudskom tijelu.<br><br><a href="https://www.youtube.com/@HumanGlycomeProject" target="_blank">Pogledajte najnovije</a> videozapise o istraživanjima i inovacijama u glikobiologiji.'),t(S);var z=s(S,2),M=n(z),k=n(M);t(M),t(z),t(p),t(l),t(r);var g=s(r,2),w=n(g),f=s(n(w),2),T=n(f),W=n(T);t(T);var X=s(T,2),O=n(X);$(O,()=>a()==="en"?"GlycanAge is a cutting-edge test that measures biological age by assessing chronic inflammation through glycans.<br><br>Genos has researched glycans as biomarkers over the past 18 years, and now serves as the central hub for GlycanAge blood sample analysis.":"GlycanAge je vrhunski test koji mjeri biološku dob procjenjujući kroničnu upalu putem glikana.<br><br>Genos je proučavao glikane kao biomarkere tijekom posljednjih 18 godina i sada služi kao središnje središte za analizu uzoraka krvi za GlycanAge."),t(X);var E=s(X,2),R=n(E),U=n(R);t(R),t(E),t(f),t(w),t(g);var Q=s(g,2),D=n(Q),_=n(D),x=n(_);t(_);var b=s(_,2),I=n(b),C=n(I);t(I);var H=s(I,2),Y=n(H);$(Y,()=>a()==="en"?"If, due to any reason, it is not convenient for you to visit our laboratory, you can also take the sample in the privacy of your home with the Sample Collection Kit for DNA Testing. The kit contains everything you need for quick, reliable, and painless sampling and for sending/delivering the samples to our laboratory.":"Ako vam iz bilo kojeg razloga ne odgovara dolazak u naš laboratorij, uzorak možete uzeti i u privatnosti vlastitog doma pomoću Seta za izuzimanje uzorka za DNA analizu. Set sadrži sve što vam je potrebno za brzo, pouzdano i bezbolno uzimanje uzoraka te njihovo slanje/dostavu u naš laboratorij."),t(H);var ie=s(H,2),K=n(ie);P(K,()=>a()==="en",Z=>{var F=wp();v(Z,F)},Z=>{var F=Ap();v(Z,F)}),t(ie),t(b),t(D),t(Q),t(i),A(()=>{B(u,"alt",`${(a()==="en"?"The Human Glycome Project":"Projekt Humanog Glikoma")??""} Logo`),m(k,a()==="en"?"Official website":"Službena stranica"),m(W,a()==="en"?"From Science to Product: GlycanAge":"Od znanosti do proizvoda: GlycanAge"),m(U,a()==="en"?"Official website":"Službena stranica"),B(x,"alt",a()==="en"?"DNA Sample Collection Kit":"Set za prikupljanje DNA uzorka"),m(C,a()==="en"?"DNA Testing Sample Collection Kit":"Set za izuzimanje uzoraka za analizu DNA")}),v(o,i)}customElements.define("pb-plug",Ge(Dp,{},[],[],!1));var Ip=y('<div class="grid spacer"><div class="gc-12 contact-section spacer"><div class="contact-section-left"><h2> </h2></div> <div class="contact-section-right"><div><span class="span-label">Email:</span> <div class="contact-links"><a href="mailto:info@genos.hr">info@genos.hr</a></div></div> <p class="text-3xl md:text-2xl mt-4"> </p> <div><span class="span-label"> </span> <div class="contact-links"><a href="tel:+38516471181">+385 1 647 1181</a> <a href="tel:+38516471182">+385 1 647 1182</a></div></div> <div><span class="span-label">Fax:</span> <div class="contact-links"><span>+385 1 647 1169</span></div></div> <p class="text-3xl md:text-2xl mt-4"> </p> <div><span class="span-label"> </span> <div class="contact-links"><a href="tel:+38512352660">+385 1 235 2660</a> <a href="tel:+38512352661">+385 1 235 2661</a></div></div> <div><span class="span-label"> </span> <div class="contact-links"><span> </span> <span> </span></div></div></div></div> <div class="gc-12 contact-section spacer"><div class="contact-section-left"><h2> </h2></div> <div class="contact-section-right"><div class="flex flex-col gap-2"><h3> </h3> <p>Borongajska cesta 83h, 10000 Zagreb</p></div> <iframe src="https://www.google.com/maps/embed?pb=!1m18!1m12!1m3!1d2781.043093962708!2d16.0378828529667!3d45.81039533126865!2m3!1f0!2f0!3f0!3m2!1i1024!2i768!4f13.1!3m3!1m2!1s0x47667878cfccc679%3A0xcd44853685675d18!2sBIOCentar!5e0!3m2!1sen!2shr!4v1746530710947!5m2!1sen!2shr" width="600" height="450" title="Genos in Zagreb" class="map-iframe" loading="lazy" referrerpolicy="no-referrer-when-downgrade"></iframe> <div class="flex flex-col gap-2 mt-14"><h3> </h3> <p>Drniška 9, 31000 Osijek</p> <p> <a href="tel:+38531218612">+385 31 218 612</a></p> <b> </b></div> <iframe src="https://www.google.com/maps/embed?pb=!1m14!1m8!1m3!1d391.6209008573307!2d18.70494826164722!3d45.54262289695526!3m2!1i1024!2i768!4f13.1!3m3!1m2!1s0x475ce6329d240dbd%3A0x3ba7ee8572ac6c1f!2sDrni%C5%A1ka%20ul.%209%2C%2031000%2C%20Osijek!5e0!3m2!1shr!2shr!4v1746531428409!5m2!1shr!2shr" width="600" height="450" title="Genos in Osijek" class="map-iframe" loading="lazy" referrerpolicy="no-referrer-when-downgrade"></iframe></div></div></div>');function Pp(o){const e=ra(),a=()=>$e(ea,"$language",e);var i=Ip(),r=n(i),l=n(r),d=n(l),u=n(d);t(d),t(l);var p=s(l,2),h=s(n(p),2),j=n(h);t(h);var S=s(h,2),G=n(S),z=n(G);t(G),De(2),t(S);var M=s(S,4),k=n(M);t(M);var g=s(M,2),w=n(g),f=n(w);t(w),De(2),t(g);var T=s(g,2),W=n(T),X=n(W);t(W);var O=s(W,2),E=n(O),R=n(E);t(E);var U=s(E,2),Q=n(U);t(U),t(O),t(T),t(p),t(r);var D=s(r,2),_=n(D),x=n(_),b=n(x);t(x),t(_);var I=s(_,2),C=n(I),H=n(C),Y=n(H);t(H),De(2),t(C);var ie=s(C,4),K=n(ie),Z=n(K);t(K);var F=s(K,4),ke=n(F);De(),t(F);var oe=s(F,2),le=n(oe);t(oe),t(ie),De(2),t(I),t(D),t(i),A(()=>{m(u,a()==="en"?"Contact info":"Kontakt informacije"),m(j,a()==="en"?"Glycomics and Glycoproteomics lab":"Laboratorij za glikomiku i glikoproteomiku"),m(z,a()==="en"?"Phone":"Telefon"),m(k,a()==="en"?"DNA & Forensics lab":"Laboratorij za DNA i forenziku"),m(f,a()==="en"?"Phone":"Telefon"),m(X,a()==="en"?"Working hours":"Radno vrijeme"),m(R,a()==="en"?"Monday - Friday, 9:00-15:30":"Ponedjeljak - petak, od 9:00 do 15:30"),m(Q,a()==="en"?"Closed on public holidays":"Tijekom državnih praznika i blagdana ne radimo"),m(b,a()==="en"?"Our locations":"Naše lokacije"),m(Y,a()==="en"?"Zagreb, Headquarters of the research laboratory":"Zagreb, Sjedište istraživačkog laboratorija"),m(Z,a()==="en"?"Osijek, Main headquarters and DNA laboratory office":"Osijek, Glavno sjedište i ured DNA laboratorija"),m(ke,`${(a()==="en"?"Telephone":"Telefon")??""}: `),m(le,a()==="en"?"Arrival by prior phone appointment":"Dolazak uz prethodnu najavu telefonom")}),v(o,i)}customElements.define("pb-contact",Ge(Pp,{},[],[],!1));var Cp=y('<div class="grid grid-small"><div class="gc-12"><h2><!></h2></div> <div class="gc-12 spacer"><div class="image-text"><div class="image"><img src="/images/glycomics-vertical.jpg" alt="glycanage kit"></div> <div class="text"><h2> </h2> <p class="text-p"><!></p></div></div></div> <div class="gc-12 spacer"><div class="image-text"><div class="image"><img src="/images/forensics-vertical.jpg" alt="glycanage kit"></div> <div class="text"><h2> </h2> <p class="text-p"><!></p></div></div></div> <div class="gc-12 spacer"><div class="image-text"><div class="image"><img src="/images/epigenetics-vertical.jpg" alt="glycanage kit"></div> <div class="text"><h2> </h2> <p class="text-p"><!></p></div></div></div></div>');function Tp(o){const e=ra(),a=()=>$e(ea,"$language",e);var i=Cp(),r=n(i),l=n(r),d=n(l);$(d,()=>a()==="en"?"We are the largest and most advanced laboratory dedicated to glycan analysis, <b>setting the standard</b> in high-throughput glycomics research. With the capacity for <b>over 50,000 glycan and glycoproteomic analyses</b> annually, our laboratory handles the majority of global glycan research.":"Mi smo najveći i najnapredniji laboratorij posvećen analizi glikana, <b>postavljajući standard</b> u istraživanju glikomike visokog kapaciteta. S kapacitetom za <b>više od 50.000 analiza glikana i glikoproteoma</b> godišnje, naš laboratorij provodi većinu svjetskih istraživanja glikana."),t(l),t(r);var u=s(r,2),p=n(u),h=s(n(p),2),j=n(h),S=n(j);t(j);var G=s(j,2),z=n(G);$(z,()=>a()==="en"?"Our journey began in 2008 with a pioneering study analyzing glycans from over 1,000 individuals on the Croatian island of Vis—one of the first large-scale glycomic studies at a time when high-throughput methods were still in development. This foundational work set the stage for Genos to become a global leader in glycomics.<br><br>Today, we perform over 50,000 glycan and glycoproteomic analyses annually, representing the majority of high-throughput glycan analysis worldwide. With a track record of over 300 scientific publications and 40 collaborative projects, our expertise extends across clinical research, pharmaceutical development, and biotech innovations.<br><br>Over the years, our team has grown to more than 50 employees, including 30 PhD scientists, making us one of the largest glycobiology research groups in the world. Beyond analytical services, we continuously develop and refine glycan analysis methods for diverse sample types, ensuring robust, scalable, and reproducible results. Our validated procedures for IgG and plasma glycan analysis have become routine in the field, reinforcing our role at the forefront of glycobiology.":"Naše putovanje započelo je 2008. godine pionirskim istraživanjem u kojem smo analizirali glikane više od 1.000 pojedinaca s hrvatskog otoka Visa — jednim od prvih velikih glikomskih istraživanja u vrijeme kada su metode visokog kapaciteta još bile u razvoju. Ovo temeljno istraživanje postavilo je temelje da Genos postane globalni predvodnik u glikomici.<br><br>Danas godišnje provodimo preko 50,000 analiza glikana i glikoproteoma, što predstavlja većinu visokoprotočnih analiza glikana u svijetu. S više od 300 znanstvenih publikacija i 40 suradničkih projekata iza sebe, naše se stručnosti protežu kroz klinička istraživanja, razvoj lijekova i biotehnološke inovacije.<br><br>Tijekom godina naš se tim proširio na više od 50 zaposlenika, uključujući 30 doktora znanosti, čime smo postali jedna od najvećih istraživačkih skupina u području glikobiologije u svijetu. Osim analitičkih usluga, kontinuirano razvijamo i unapređujemo metode analize glikana za razne vrste uzoraka, osiguravajući robusne, skalabilne i ponovljive rezultate. Naši validirani protokoli za analizu IgG i plazma glikana postali su standard u struci, dodatno učvršćujući našu vodeću ulogu u području glikobiologije."),t(G),t(h),t(p),t(u);var M=s(u,2),k=n(M),g=s(n(k),2),w=n(g),f=n(w);t(w);var T=s(w,2),W=n(T);$(W,()=>a()==="en"?"Alongside our work in glycomics, Genos has a rich history in DNA analysis. Founded in 2007, the Genos DNA & Forensic Laboratory was the first private DNA laboratory in the region and continues to be a leader in human and animal genetic testing in Croatia.<br><br>All DNA analyses are conducted in-house at our Zagreb laboratory using state-of-the-art equipment for precise and reliable results. Genos is part of the internationally certified GEDNAP (German DNA Profiling) quality control system, ensuring the highest standards in forensic DNA testing. As the first private lab in Croatia authorized for forensic DNA analysis, our experts have contributed to national identification efforts, including the post-war victim identification program.<br><br>Unlike companies that outsource testing, Genos performs all analyses internally, maintaining full control over quality and accuracy.":"Uz naš rad u glikomici, Genos ima bogatu povijest u analizi DNA. Osnovan 2007. godine, Genos DNA laboratorij bio je prvi privatni DNA laboratorij u regiji.<br><br>Sve DNA analize provodimo u našem laboratoriju u Zagrebu koristeći najsuvremeniju opremu za precizne i pouzdane rezultate. Genos je uključen u međunarodni certificirani sustav kontrole kvalitete GEDNAP (German DNA Profiling), čime se osiguravaju najviši standardi u forenzičkoj DNA analizi. Genos je bio prvi privatni laboratorij u Hrvatskoj koji je uvršten na popis pravnih osoba ovlaštenih za obavljanje poslova sudskog vještačenja za područje analize DNA, naši su stručnjaci bili i dio tima koji je radio na nacionalnom projektu identifikacija žrtava Domovinskog rata.<br><br>Za razliku od tvrtki koje testiranja prepuštaju vanjskim partnerima, Genos sve analize provodi u svom laboratoriju, zadržavajući potpunu kontrolu nad kvalitetom i točnošću analiza."),t(T),t(g),t(k),t(M);var X=s(M,2),O=n(X),E=s(n(O),2),R=n(E),U=n(R);t(R);var Q=s(R,2),D=n(Q);$(D,()=>a()==="en"?"Epigenetics Laboratory has been officially part of the Genos Research Laboratory since 2022 with the primary focus on unraveling the complex epigenetic regulation of protein glycosylation.<br><br>By repurposing CRISPR/Cas9 technology for epigenome editing, we specifically manipulate the expression of targeted genes, including various GWAS or EWAS hits, to disentangle the epigenetic regulatory network of protein glycosylation.<br><br>We have designed a modular CRISPR/dCas9-based Epi-Toolbox. This toolbox enables targeted gene regulation, manipulation of DNA methylation, various histone post-translational modifications, and genome editing. Furthermore, we also aim to understand the crosstalk between different epigenetic mechanisms in gene expression regulation, DNA methylation introduction, and maintenance.":"Epigenetski laboratorij je službeno postao dio Istraživačkog laboratorija Genos 2022. godine, s primarnim fokusom na razotkrivanje složene epigenetske regulacije glikozilacije proteina.<br><br>Prenamjenom CRISPR/Cas9 tehnologije za epigenomsko uređivanje, specifično manipuliramo ekspresijom ciljanih gena, uključujući razne GWAS ili EWAS nalaze, kako bismo rasvijetlili epigenetsku regulatornu mrežu glikozilacije proteina.<br><br>Dizajnirali smo modularni CRISPR/dCas9 bazirani Epi-Toolbox. Ova alatka omogućuje ciljanu regulaciju gena, manipulaciju metilacije DNA, razne posttranslacijske modifikacije histona te uređivanje genoma. Nadalje, cilj nam je razumjeti međudjelovanje različitih epigenetskih mehanizama u regulaciji genske ekspresije, uvođenju i održavanju metilacije DNA."),t(Q),t(E),t(O),t(X),t(i),A(()=>{m(S,a()==="en"?"Glycomics & Glycoproteomics":"Glikomika i Glikoproteomika"),m(f,a()==="en"?"DNA & Forensics":"DNA i Forenzika"),m(U,a()==="en"?"Epigenetics":"Epigenetika")}),v(o,i)}customElements.define("pb-about",Ge(Tp,{},[],[],!1));var Np=y('<div class="footer"><div class="grid grid-large"><div class="col-span-12 footer-top"><img src="/brand/genos-logo-white.svg" alt=""> <div class="footer-top-links"><a href="">Borongajska cesta 83h, 10000 Zagreb</a> <a href="">+385 1 647 1181</a> <a href="">+385 1 647 1182</a> <div>Fax: <a href="">+385 1 647 1169</a></div> <a href="">info@genos.hr</a></div></div> <div class="col-span-12 footer-bottom"><div class="footer-bottom-links"><div class="footer-bottom-links-container"><a href="">Privacy Policy</a> <a href="">Gender Equality Plan</a></div> <div class="footer-bottom-links-container"><div></div> <a href="https://jaspero.co/" target="_blank" rel="noreferrer noopener">By Jaspero</a></div></div></div></div></div>');function Lp(o,e){Ke(e,!1);const a=new Date().getFullYear();qe();var i=Np(),r=n(i),l=s(n(r),2),d=n(l),u=s(n(d),2),p=n(u);p.textContent=`© ${a??""} Genos Glyco`,De(2),t(u),t(d),t(l),t(r),t(i),v(o,i),We()}customElements.define("pb-footer",Ge(Lp,{},[],[],!1));var _p=y('<div class="price-list grid grid-large"><div class="col-span-12"><p>Our service price list is available <a class="underline" href="/pdfs/price-list.pdf" target="_blank">here</a>.</p> <p class="mt-4">Payments for analyses and services can be made in the following ways:</p> <p class="font-bold mt-4">One-time payment:</p> <ul><li>Cash</li> <li>General payment slip (bank transfer)</li> <li>Online/mobile banking</li> <li>Debit cards (Maestro and Visa)</li> <li>Credit cards (MasterCard, VISA, Premium VISA, Diners)</li></ul> <p class="font-bold mt-4">Installment payments:</p> <ul><li>Debit cards (Maestro and VISA from Zagrebačka banka and Privredna banka)</li> <li>Credit cards (MasterCard and VISA from Zagrebačka banka, VISA and Premium VISA from Privredna banka, and Diners card from Erste banka)</li></ul> <table class="mt-4"><thead><tr><th>Amount (€)</th><th>Number of installments</th></tr></thead><tbody><tr><td>66.00€ - 132.50€</td><td>2</td></tr><tr><td>Above 132.50€</td><td>6</td></tr></tbody></table> <p class="mt-12">Payments in cash and by card are only possible at the premises of Genos.</p> <p class="mt-4">Installment payments by debit cards are only possible if the user has this option arranged with their bank.</p></div></div>');function Ep(o){var e=_p();v(o,e)}customElements.define("pb-price-list",Ge(Ep,{},[],[],!1));var Hp=y('<div class="flex flex-col gap-y-1"><a class="sub-link"> </a> <a class="sub-link"> </a> <a class="sub-link"> </a> <a class="sub-link"> </a> <a class="sub-link"> </a> <a class="sub-link"> </a> <a class="sub-link"> </a> <a class="sub-link"> </a></div>'),xp=y('<div class="flex flex-col gap-y-1"><a class="sub-link"> </a> <a class="sub-link"> </a> <a class="sub-link"> </a></div>'),Op=y('<div class="flex flex-col gap-y-1"><a class="sub-link"> </a> <a class="sub-link"> </a> <a class="sub-link"> </a> <a class="sub-link"> </a> <a class="sub-link"> </a> <a class="sub-link"> </a> <a class="sub-link"> </a> <a class="sub-link"> </a> <a class="sub-link"> </a></div>'),Rp=y('Download: <a href="/pdfs/price-list.pdf" target="_blank" class="underline">Price List</a>',1),Fp=y('Preuzmi: <a href="/pdfs/cjenik.pdf" target="_blank" class="underline">Cjenik usluga</a>',1),Bp=y('<ul class="list-disc ml-6"><li>Three collectors for samples of buccal swabs</li> <li>Sample storage bag</li> <li>Gloves</li> <li>Instructions</li> <li>Order form</li> <li>Unbreakable protective envelope for sending samples to laboratory</li></ul>'),Vp=y('<ul class="list-disc ml-6"><li>Tri kolektora za uzorke brisa bukalne sluznice</li> <li>Vrećicu za pohranu uzorka</li> <li>Rukavice</li> <li>Upute</li> <li>Narudžbenicu</li> <li>Nepoderivu zaštitnu omotnicu za slanje uzoraka u laboratorij</li></ul>'),Jp=y('<a class="button-filled" href="/contact">Order a set for sampling</a>'),Kp=y('<a class="button-filled" href="/kontakt">Naruči set za uzorkovanje</a>'),Wp=y('<li>Psychological Center TESA, tel. <a class="underline" href="tel:+38514828888">+385 1 48 28 888</a> / <a class="underline" href="https://www.tesa.hr/">tesa.hr</a></li> <li>Society for Psychological Assistance, MODUS – Center for Children, Youth and Family, tel. <a class="underline" href="tel:+38514621554">+385 1 4621 554</a> / <a class="underline" href="https://dpp.hr/">dpp.hr</a></li>',1),Zp=y('<li>Psihološki centar TESA, tel. <a class="underline" href="tel:+38514828888">+385 1 48 28 888</a> / <a class="underline" href="https://www.tesa.hr/">tesa.hr</a></li> <li>Društvo za psihološku pomoć, MODUS – Centar za djecu, mlade i obitelj, tel. <a class="underline" href="tel:+38514621554">+385 1 4621 554</a> / <a class="underline" href="https://dpp.hr/">dpp.hr</a></li>',1),Up=y('<a href="/pdfs/genbird-en.pdf" target="_blank" class="underline">View intructions for the GENBird test (PDF)</a>'),Yp=y('<a href="/pdfs/genbird-hr.pdf" target="_blank" class="underline">Pogledaj uputstva za GENBird test (PDF)</a>'),$p=y('<div class="grid grid-small services"><div class="gc-12 mb-24"><h2> </h2></div> <div class="gc-xs-12 gc-3 sticky"><p> </p> <div class="sticky-items"><button class="flex text-left"> <img src="/icons/arrow_dropdown.svg" alt=""></button> <!> <button class="flex text-left"> <img src="/icons/arrow_dropdown.svg" alt=""></button> <!> <button class="flex text-left"> <img src="/icons/arrow_dropdown.svg" alt=""></button> <!></div></div> <div class="gc-9 gc-xs-12 services-container"><h3 id="1.0."> </h3> <img src="/illustrations/glycomics.jpg" alt="" class="w-full"> <div class="services-segment"><h4 id="1.1."> </h4> <div class="services-images-row"><div><img src="/images/uhplc.jpg" alt=""></div> <div><img src="/images/cge.jpg" alt=""></div> <div><img src="/images/ms.jpg" alt=""></div></div> <h5> </h5> <p> </p> <h5> </h5> <p> </p> <h5> </h5> <p> </p></div> <div class="services-segment"><h4 id="1.2."> </h4> <div class="services-images-row"><div><img src="/images/glycoprofiling/glycoprofiling-1.jpg" alt=""></div> <div><img src="/images/glycoprofiling/glycoprofiling-2.jpg" alt=""></div> <div><img src="/images/glycoprofiling/glycoprofiling-3.jpg" alt=""></div></div> <ul> <li class="ml-6"> </li></ul> <ul> <li class="ml-6"> </li></ul> <ul> <li class="ml-6"> </li></ul></div> <div class="services-segment"><h4 id="1.3."> </h4> <h5> </h5> <p> </p> <h5> </h5> <p> </p> <h5> </h5> <p> </p></div> <div class="services-segment dropdowns"><h4 id="1.4."> </h4> <p> </p> <label class="dropdown-container"><input class="dropdown-checkbox" type="checkbox"> <span class="dropdown-header"><span class="dropdown-arrow"><img src="/icons/arrow_dropdown.svg" alt=""></span> <span class="dropdown-label"> </span></span> <span class="dropdown-content"><img src="/images/glycoprofiling/analysis_of_total_human_serum.jpg" alt=""></span></label> <label class="dropdown-container"><input class="dropdown-checkbox" type="checkbox"> <span class="dropdown-header"><span class="dropdown-arrow"><img src="/icons/arrow_dropdown.svg" alt=""></span> <span class="dropdown-label"> </span></span> <span class="dropdown-content"><img src="/images/glycoprofiling/analysis_of_total_human_igg_n-glycans.jpg" alt=""></span></label> <label class="dropdown-container"><input class="dropdown-checkbox" type="checkbox"> <span class="dropdown-header"><span class="dropdown-arrow"><img src="/icons/arrow_dropdown.svg" alt=""></span> <span class="dropdown-label"> </span></span> <span class="dropdown-content"><img src="/images/glycoprofiling/analysis_of_total_human_iga_n-glycans.jpg" alt=""></span></label> <label class="dropdown-container"><input class="dropdown-checkbox" type="checkbox"> <span class="dropdown-header"><span class="dropdown-arrow"><img src="/icons/arrow_dropdown.svg" alt=""></span> <span class="dropdown-label"> </span></span> <span class="dropdown-content"><img src="/images/glycoprofiling/analysis_of_human_igg_n-glycopeptides.jpg" alt=""></span></label> <label class="dropdown-container"><input class="dropdown-checkbox" type="checkbox"> <span class="dropdown-header"><span class="dropdown-arrow"><img src="/icons/arrow_dropdown.svg" alt=""></span> <span class="dropdown-label"> </span></span> <span class="dropdown-content"><img src="/images/glycoprofiling/analysis_of_human_agp_n-glycopeptides.jpg" alt=""></span></label> <label class="dropdown-container"><input class="dropdown-checkbox" type="checkbox"> <span class="dropdown-header"><span class="dropdown-arrow"><img src="/icons/arrow_dropdown.svg" alt=""></span> <span class="dropdown-label"> </span></span> <span class="dropdown-content"><img src="/images/glycoprofiling/analysis_of_human_c3_n-glycopeptides.jpg" alt=""></span></label> <label class="dropdown-container"><input class="dropdown-checkbox" type="checkbox"> <span class="dropdown-header"><span class="dropdown-arrow"><img src="/icons/arrow_dropdown.svg" alt=""></span> <span class="dropdown-label"> </span></span> <span class="dropdown-content"><img src="/images/glycoprofiling/analysis_of_rodent_igg_n-glycopeptides.jpg" alt=""></span></label></div> <div class="services-segment"><h4 id="1.5."> </h4> <p> </p></div> <div class="services-segment"><h4 id="1.6."> </h4> <p> </p></div> <div class="services-segment"><h4 id="1.7."> </h4> <p><!></p></div> <hr> <div class="services-segment"><h3 id="2.0."> </h3> <img src="/illustrations/epigenetics.jpg" alt="" class="w-full"> <h4 id="2.1."> </h4> <ul><li> </li> <li> </li></ul> <h5> </h5> <ul><li> </li> <li> </li> <li> </li></ul> <h5> </h5> <ul><li> </li> <li> </li> <li> </li> <li> </li> <li> </li></ul></div> <div class="services-segment"><h4 id="2.2."> </h4> <ul><li> </li> <li> </li> <li> </li></ul></div> <hr> <div class="services-segment"><h3 id="3.0."> </h3> <img src="/illustrations/dna.jpg" alt="" class="w-full"> <h4 id="3.1."> </h4> <ul><li> </li> <li> </li></ul> <p><!></p> <h5> </h5> <p><!></p> <h5> </h5> <p><!></p> <h4 id="3.2."> </h4> <ul><li> </li> <li> </li> <li> </li></ul> <h5> </h5> <p><!></p> <ul><li> </li> <li> </li> <li> </li></ul> <h5> </h5> <p><!></p> <ul><li> </li> <li> </li></ul> <h5> </h5> <p> </p> <h4 id="3.3."> </h4> <p><!></p> <h4 id="3.4."> </h4> <ul><li> </li> <li> </li> <li> </li></ul> <h5> </h5> <p> </p> <ul><li> </li> <li> </li> <li> </li> <li> </li> <li> </li> <li> </li> <li> </li></ul> <p> </p> <h5> </h5> <p> </p> <h5> </h5> <p> </p> <ul><li> </li> <li> </li></ul> <p><!></p> <h4 id="3.5."> </h4> <p><!></p> <ul><li><!></li></ul> <h4 id="3.5.1."> </h4> <p><!></p> <!> <p><!></p> <!> <h4 id="3.6."> </h4> <p><!></p> <div><ul><!></ul></div> <h4 id="3.7."> </h4> <ul><li> </li></ul> <h5> </h5> <p> </p> <h5> </h5> <ul><li> </li> <li> </li> <li> </li> <li> </li> <li> </li></ul> <h5> </h5> <ul><li> </li> <li> </li> <li> </li> <li> </li> <li> </li></ul> <h5> </h5> <p> </p> <p> </p> <h5>GENBird test</h5> <p><!></p> <ul><li><!></li> <li><a href="/pdfs/genbird-order-form.pdf" target="_blank" class="underline"> </a></li> <li><a href="/pdfs/genbird-order-form-appendix.pdf" target="_blank" class="underline"> </a></li></ul></div></div></div>');function qp(o){const e=ra(),a=()=>$e(ea,"$language",e);let i=se(!1),r=se(!1),l=se(!1);var d=$p(),u=n(d),p=n(u),h=n(p);t(p),t(u);var j=s(u,2),S=n(j),G=n(S);t(S);var z=s(S,2),M=n(z),k=n(M),g=s(k);t(M);var w=s(M,2);P(w,()=>c(i),Ie=>{var de=Hp(),Xe=n(de),ii=n(Xe);t(Xe);var Qe=s(Xe,2),oi=n(Qe);t(Qe);var oa=s(Qe,2),ti=n(oa);t(oa);var za=s(oa,2),Jt=n(za);t(za);var Sa=s(za,2),Kt=n(Sa);t(Sa);var Ma=s(Sa,2),Wt=n(Ma);t(Ma);var wa=s(Ma,2),Zt=n(wa);t(wa);var Pa=s(wa,2),Ut=n(Pa);t(Pa),t(de),A(()=>{B(Xe,"href",a()==="en"?"/services#1.0.":"/usluge#1.0."),m(ii,`1. ${(a()==="en"?"Glycomics & Glycoproteomics":"Glikomika i glikoproteomika")??""}`),B(Qe,"href",a()==="en"?"/services#1.1.":"/usluge#1.1."),m(oi,`1.1. ${(a()==="en"?"Technologies":"Tehnologije")??""}`),B(oa,"href",a()==="en"?"/services#1.2.":"/usluge#1.2."),m(ti,`1.2. ${(a()==="en"?"Sample types":"Tipovi uzoraka")??""}`),B(za,"href",a()==="en"?"/services#1.3.":"/usluge#1.3."),m(Jt,`1.3. ${(a()==="en"?"Glycoprofiling":"Glikoprofiliranje")??""}`),B(Sa,"href",a()==="en"?"/services#1.4.":"/usluge#1.4."),m(Kt,`1.4. ${(a()==="en"?"High-throughput analyses":"Visokoprotočne analize")??""}`),B(Ma,"href",a()==="en"?"/services#1.5.":"/usluge#1.5."),m(Wt,`1.5. ${(a()==="en"?"Data analysis":"Analiza podataka")??""}`),B(wa,"href",a()==="en"?"/services#1.6.":"/usluge#1.6."),m(Zt,`1.6. ${(a()==="en"?"Study design":"Dizajn studije")??""}`),B(Pa,"href",a()==="en"?"/services#1.7.":"/usluge#1.7."),m(Ut,`1.7. ${(a()==="en"?"Joint research collaboration":"Zajednička znanstvena suradnja")??""}`)}),Oa(3,de,()=>li),v(Ie,de)});var f=s(w,2),T=n(f),W=s(T);t(f);var X=s(f,2);P(X,()=>c(r),Ie=>{var de=xp(),Xe=n(de),ii=n(Xe);t(Xe);var Qe=s(Xe,2),oi=n(Qe);t(Qe);var oa=s(Qe,2),ti=n(oa);t(oa),t(de),A(()=>{B(Xe,"href",a()==="en"?"/services#2.0.":"/usluge#2.0."),m(ii,`2. ${(a()==="en"?"Epigenetics":"Epigenetika")??""}`),B(Qe,"href",a()==="en"?"/services#2.1.":"/usluge#2.1."),m(oi,`2.1. ${(a()==="en"?"Technologies":"Tehnologije")??""}`),B(oa,"href",a()==="en"?"/services#2.2.":"/usluge#2.2."),m(ti,`2.2. ${(a()==="en"?"Services":"Usluge")??""}`)}),Oa(3,de,()=>li),v(Ie,de)});var O=s(X,2),E=n(O),R=s(E);t(O);var U=s(O,2);P(U,()=>c(l),Ie=>{var de=Op(),Xe=n(de),ii=n(Xe);t(Xe);var Qe=s(Xe,2),oi=n(Qe);t(Qe);var oa=s(Qe,2),ti=n(oa);t(oa);var za=s(oa,2),Jt=n(za);t(za);var Sa=s(za,2),Kt=n(Sa);t(Sa);var Ma=s(Sa,2),Wt=n(Ma);t(Ma);var wa=s(Ma,2),Zt=n(wa);t(wa);var Pa=s(wa,2),Ut=n(Pa);t(Pa);var Yt=s(Pa,2),rc=n(Yt);t(Yt),t(de),A(()=>{B(Xe,"href",a()==="en"?"/services#3.0.":"/usluge#3.0."),m(ii,`3. ${(a()==="en"?"DNA & Forensics":"DNA i Forenzika")??""}`),B(Qe,"href",a()==="en"?"/services#3.1.":"/usluge#3.1."),m(oi,`3.1. ${(a()==="en"?"Paternity testing":"Utvrđivanje očinstva")??""}`),B(oa,"href",a()==="en"?"/services#3.2.":"/usluge#3.2."),m(ti,`3.2. ${(a()==="en"?"Kinship testing":"Utvrđivanje srodstva")??""}`),B(za,"href",a()==="en"?"/services#3.3.":"/usluge#3.3."),m(Jt,`3.3. ${(a()==="en"?"Non-Invasive Prenatal Gender and Paternity Testing":"Neinvazivno prenatalno utvrđivanje spola djeteta i testiranje očinstva")??""}`),B(Sa,"href",a()==="en"?"/services#3.4.":"/usluge#3.4."),m(Kt,`3.4. ${(a()==="en"?"Other analyses":"Ostale analize")??""}`),B(Ma,"href",a()==="en"?"/services#3.5.":"/usluge#3.5."),m(Wt,`3.5. ${(a()==="en"?"Testing Procedure":"Postupak testiranja")??""}`),B(wa,"href",a()==="en"?"/services#3.5.1.":"/usluge#3.5.1."),m(Zt,`3.5.1. ${(a()==="en"?"Set for DNA sample collection and analysis":"Set za izuzimanje uzoraka za analizu DNA")??""}`),B(Pa,"href",a()==="en"?"/services#3.6.":"/usluge#3.6."),m(Ut,`3.6. ${(a()==="en"?"Data confidentiality":"Povjerljivost podataka")??""}`),B(Yt,"href",a()==="en"?"/services#3.7.":"/usluge#3.7."),m(rc,`3.7. ${(a()==="en"?"Avian Gender Determination via DNA Analysis":"Određivanje spola ptica DNA analizom")??""}`)}),Oa(3,de,()=>li),v(Ie,de)}),t(z),t(j);var Q=s(j,2),D=n(Q),_=n(D);t(D);var x=s(D,4),b=n(x),I=n(b);t(b);var C=s(b,4),H=n(C);t(C);var Y=s(C,2),ie=n(Y);t(Y);var K=s(Y,2),Z=n(K);t(K);var F=s(K,2),ke=n(F);t(F);var oe=s(F,2),le=n(oe);t(oe);var Oe=s(oe,2),Fe=n(Oe);t(Oe),t(x);var aa=s(x,2),ma=n(aa),Ce=n(ma);t(ma);var ve=s(ma,4),Je=n(ve),Te=s(Je),Me=n(Te);t(Te),t(ve);var sa=s(ve,2),ye=n(sa),q=s(ye),te=n(q);t(q),t(sa);var ze=s(sa,2),ce=n(ze),fe=s(ce),Fa=n(fe);t(fe),t(ze),t(aa);var Ba=s(aa,2),Va=n(Ba),Oi=n(Va);t(Va);var we=s(Va,2),ee=n(we);t(we);var ae=s(we,2),Ae=n(ae);t(ae);var ue=s(ae,2),Se=n(ue);t(ue);var ka=s(ue,2),ya=n(ka);t(ka);var ia=s(ka,2),pa=n(ia);t(ia);var Ia=s(ia,2),al=n(Ia);t(Ia),t(Ba);var Ri=s(Ba,2),Fi=n(Ri),il=n(Fi);t(Fi);var Bi=s(Fi,2),ol=n(Bi);t(Bi);var Vi=s(Bi,2),Sn=s(n(Vi),2),Mn=s(n(Sn),2),tl=n(Mn);t(Mn),t(Sn),De(2),t(Vi);var Ji=s(Vi,2),wn=s(n(Ji),2),An=s(n(wn),2),nl=n(An);t(An),t(wn),De(2),t(Ji);var Ki=s(Ji,2),Gn=s(n(Ki),2),Dn=s(n(Gn),2),rl=n(Dn);t(Dn),t(Gn),De(2),t(Ki);var Wi=s(Ki,2),In=s(n(Wi),2),Pn=s(n(In),2),sl=n(Pn);t(Pn),t(In),De(2),t(Wi);var Zi=s(Wi,2),Cn=s(n(Zi),2),Tn=s(n(Cn),2),ll=n(Tn);t(Tn),t(Cn),De(2),t(Zi);var Ui=s(Zi,2),Nn=s(n(Ui),2),Ln=s(n(Nn),2),ul=n(Ln);t(Ln),t(Nn),De(2),t(Ui);var _n=s(Ui,2),En=s(n(_n),2),Hn=s(n(En),2),cl=n(Hn);t(Hn),t(En),De(2),t(_n),t(Ri);var Yi=s(Ri,2),$i=n(Yi),dl=n($i);t($i);var xn=s($i,2),ml=n(xn);t(xn),t(Yi);var qi=s(Yi,2),Xi=n(qi),pl=n(Xi);t(Xi);var On=s(Xi,2),hl=n(On);t(On),t(qi);var Qi=s(qi,2),eo=n(Qi),vl=n(eo);t(eo);var Rn=s(eo,2),gl=n(Rn);$(gl,()=>a()==="en"?"Genos is an active research organization. On the basis of the recommendation of the National Science Council, the Ministry of Science, Education and Sports of the Republic of Croatia issued a permit that allowed Genos to formally register as a research organization in 2007. Genos has participated in six FP7 projects, five Horizon2020 projects and is currently active in eight Horizon Europe projects.<br><br>We are constantly in search of potential collaborative projects where we can contribute with our expertise in high-throughput glycomics and extensive experience of participation in large research consortia.":"Genos je aktivna istraživačka organizacija. Na temelju preporuke Nacionalnog vijeća za znanost, Ministarstvo znanosti, obrazovanja i sporta Republike Hrvatske izdalo je dozvolu kojom je Genos 2007. godine službeno registriran kao istraživačka organizacija. Genos je sudjelovao u šest FP7 projekata, pet Horizon2020 projekata i trenutno je aktivan u osam projekata programa Horizon Europe.<br><br>Stalno tražimo potencijalne suradničke projekte u kojima možemo doprinijeti svojim stručnim znanjem iz područja visokoprotočne glikomike i bogatim iskustvom sudjelovanja u velikim istraživačkim konzorcijima."),t(Rn),t(Qi);var ao=s(Qi,4),io=n(ao),jl=n(io);t(io);var oo=s(io,4),kl=n(oo);t(oo);var to=s(oo,2),no=n(to),fl=n(no);t(no);var Fn=s(no,2),bl=n(Fn);t(Fn),t(to);var ro=s(to,2),yl=n(ro);t(ro);var so=s(ro,2),lo=n(so),zl=n(lo);t(lo);var uo=s(lo,2),Sl=n(uo);t(uo);var Bn=s(uo,2),Ml=n(Bn);t(Bn),t(so);var co=s(so,2),wl=n(co);t(co);var Vn=s(co,2),mo=n(Vn),Al=n(mo);t(mo);var po=s(mo,2),Gl=n(po);t(po);var ho=s(po,2),Dl=n(ho);t(ho);var vo=s(ho,2),Il=n(vo);t(vo);var Jn=s(vo,2),Pl=n(Jn);t(Jn),t(Vn),t(ao);var go=s(ao,2),jo=n(go),Cl=n(jo);t(jo);var Kn=s(jo,2),ko=n(Kn),Tl=n(ko);t(ko);var fo=s(ko,2),Nl=n(fo);t(fo);var Wn=s(fo,2),Ll=n(Wn);t(Wn),t(Kn),t(go);var Zn=s(go,4),bo=n(Zn),_l=n(bo);t(bo);var yo=s(bo,4),El=n(yo);t(yo);var zo=s(yo,2),So=n(zo),Hl=n(So);t(So);var Un=s(So,2),xl=n(Un);t(Un),t(zo);var Mo=s(zo,2),Ol=n(Mo);$(Ol,()=>a()==="en"?`DNA analysis today plays a unique role in forensic science and is universally accepted in most legal systems. In forensic medicine, it has become an integral part of standard procedures in the investigation of various crimes, establishing identity, and conducting paternity testing. The use of DNA analysis is an indispensable method for identifying the remains of victims of natural disasters, terrorist attacks, civil and military traffic accidents, fires, explosions, and war casualties. The development of DNA extraction and analysis methods has enabled the successful detection of DNA profiles from various biological traces.<br><br>The results of DNA analysis are a fundamental form of evidence in numerous civil and criminal cases at municipal and county courts. Although DNA analysis can unequivocally determine the identity of a person or a biological trace, proper interpretation of laboratory results requires significant expertise and experience.<br><br>Genos d.o.o. was the first private laboratory in Croatia authorized to conduct forensic DNA analyses, and our clients recognize this accreditation as an added value that contributes to trust and reliability in our results.<br><br>Our team includes a permanent court expert with extensive experience in DNA analysis and collaborates with other court experts in Croatia. Our experts were part of the nat
`:"Analiza DNA danas ima jedinstvenu ulogu u forenzičkim znanostima i univerzalno je prihvaćena u većini pravnih sustava. U sudskoj medicini je postala sastavni dio standardnih postupaka u istragama raznih zločina, utvrđivanju identiteta te vještačenju roditeljstva. Primjena analize DNA je neizostavna metoda kod utvrđivanja identiteta posmrtnih ostataka žrtava prirodnih katastrofa, terorističkih napada, civilnih i vojnih prometnih nesreća, požara, eksplozija i žrtava rata. Razvojem metoda izdvajanja i analize DNA omogućeno je uspješno detektiranje DNA profila iz različitih bioloških tragova.<br><br>Rezultat analize DNA temeljni je dokaz u brojnim građanskim i kaznenim predmetima na općinskim i županijskim sudovima. Iako DNA analiza može nedvojbeno utvrditi identitet osobe ili biološkog traga, pravilna interpretacija laboratorijskih rezultata zahtijeva značajnu stručnost i iskustvo.<br><br>Genos d.o.o. bio je prvi privatni laboratorij u Hrvatskoj ovlašten za provedbu forenzičkih DNA analiza, a to priznanje naši klijenti prepoznaju kao dodatnu vrijednost koja doprinosi povjerenju u pouzdanost naših rezultata.<br><br>Naš tim uključuje stalnog sudskog vještaka s bogatim iskustvom u DNA analizama te surađuje i s drugim sudskim vještacima u Hrvatskoj. Naši su stručnjaci bili dio nacionalnog tima za identifikaciju žrtava Domovinskog rata pod okriljem Ministarstva obitelji, branitelja i međugeneracijske solidarnosti.<br><br>Za razliku od tvrtki koje testiranje DNA uzoraka povjeravaju vanjskim partnerima, sve analize provodimo u vlastitom laboratoriju u Zagrebu.<br><br>Novija znanstvena otkrića iz područja molekularne biologije omogućila su analizu DNA koja zadovoljava sve kriterije izuzetno pouzdane metode za testiranje spornog roditeljstva. Time je testiranje očinstva, odnosno majčinstva, postalo dostupnije široj javnosti."),t(Mo);var wo=s(Mo,2),Rl=n(wo);t(wo);var Ao=s(wo,2),Fl=n(Ao);$(Fl,()=>a()==="en"?"To determine paternity/maternity upon personal request, it is sufficient to compare the DNA profiles of one parent and the child. We analyze 18 or 24 STR markers (loci), which are recognized by international guidelines as sufficiently discriminatory, providing a probability of biological parenthood greater than 99.99%.<br><br>For greater accuracy in determining paternity, we recommend including the mother's sample in the analysis. When standard samples from the alleged father, child, and mother are analyzed, the mother's sample is tested at no additional cost.<br><br>After obtaining and comparing DNA profiles in paternity testing, mandatory alleles are identified to determine whether the alleged father carries the listed alleles. A mandatory allele is one inherited from the biological parent.<br><br>If the analysis result shows a mismatch in at least three mandatory alleles between the child and the alleged father, it can be concluded with certainty that the alleged father is not the biological father. In cases of mismatch in one or even two molecular markers, it may be assumed that mutations (which are relatively common) are present. In such cases, it is recommended to include the mother's sample in the analysis or test additional genetic markers.<br><br>If there is a need or the client requests testing of additional markers, Genos can, for an additional fee, perform analysis on a total of 24 markers.":`Za utvrđivanje očinstva/majčinstva na osobni zahtjev dovoljno je usporediti DNA profile jednog roditelja i djeteta. Analiziramo 18 ili 24 STR biljega (lokusa), koji su prema međunarodnim preporukama priznati kao dovoljno diskriminatorni tj. daju vjerojatnost biološkog roditeljstva veću od 99,99%.<br><br>Za veću točnost u utvrđivanju očinstva preporučujemo uključivanje uzorka majke u analizu. Kada se analiziraju standardni uzorci pretpostavljenog oca, djeteta i majke, uzorak majke se analizira bez dodatne naknade.<br><br>Nakon dobivanja i usporedbe DNA profila, u testiranju očinstva, identificiraju se obvezni aleli kako bi se utvrdilo nosi li pretpostavljeni otac navedene alele. Obvezni alel je onaj koji je naslijeđen od biološkog roditelja.<br><br>Pokaže li rezultat analize nepodudaranje u najmanje tri obvezna alela između djeteta i pretpostavljenog oca, sa sigurnošću se može isključiti da je pretpostavljeni otac biološki otac djeteta. U slučajevima nepodudaranja na jednom ili čak dva molekularna biljega, može se pretpostaviti da se radi o mutacijama (koje su relativno česte). U takvim slučajevima preporučuje se uključivanje uzorka majke u analizu ili testiranje dodatnih genetičkih biljega.<br><br>Ukoliko postoji potreba ili stranka izrazi želju za testiranjem dodatnih biljega, Genos je u mogućnosti, uz nadoplatu, napraviti analizu na ukupno 24 biljega.
`),t(Ao);var Go=s(Ao,2),Bl=n(Go);t(Go);var Do=s(Go,2),Vl=n(Do);$(Vl,()=>a()==="en"?"Establishing or disputing paternity/maternity for legal proceedings is carried out based on a Decision issued by the competent court, by comparing the genotypes of the mother, child, and alleged father. As a certified court expert, Genos d.o.o. also conducts paternity testing upon personal request, and the report and opinion of our authorized court expert are admissible as legal evidence. This helps avoid unnecessary costs of double testing (once for personal purposes and once for legal proceedings).<br><br>The probability values of paternity in court expert reports range from one in several million to one in several billion. The minimum threshold required to conclusively establish paternity in court is 99.999%.":"Utvrđivanje ili osporavanje očinstva/majčinstva za sudske postupke provodi se na temelju Rješenja nadležnog suda, usporedbom genotipova majke, djeteta i pretpostavljenog oca. Kao stalni sudski vještak, Genos d.o.o. provodi testiranje očinstva i na osobni zahtjev, a nalaz i mišljenje našeg ovlaštenog sudskog vještaka vrijedi kao dokaz na sudu. To pomaže u izbjegavanju nepotrebnih troškova dvostrukog testiranja (jednom za osobne potrebe, a jednom za sudske postupke).<br><br>Vrijednosti vjerojatnosti očinstva kod vještačenja za potrebe suda kreću se od jedan prema nekoliko milijuna, do jedan prema nekoliko milijardi. Minimalna granica koja je potrebna za nedvojbeno utvrđivanje očinstva na sudu je 99,999 %."),t(Do);var Io=s(Do,2),Jl=n(Io);t(Io);var Po=s(Io,2),Co=n(Po),Kl=n(Co);t(Co);var To=s(Co,2),Wl=n(To);t(To);var Yn=s(To,2),Zl=n(Yn);t(Yn),t(Po);var No=s(Po,2),Ul=n(No);t(No);var Lo=s(No,2),Yl=n(Lo);$(Yl,()=>a()==="en"?"Paternity testing through the male line is conducted by analyzing 23 STR markers on the Y chromosome. Since the sex chromosome is inherited unchanged, kinship is confirmed by a complete match of all the analyzed Y STR markers. Any changes that might occur are mutations, which are random nucleotide substitutions that happen spontaneously and very rarely.<br><br>The Y chromosome is inherited through the male line, passed directly from father to son. Therefore, all male relatives on the paternal side share the same markers on the Y chromosome, meaning they have an identical Y DNA profile. This method is useful in indirect paternity testing for male children when a male relative on the paternal side (brother, grandfather, uncle, or any male family member) can substitute for the deceased alleged father. It can also be applied for proving kinship between brothers, grandfather and grandson, uncle and nephew, etc. The test is also used in male identification cases when only paternal relatives are available.<br><br>Y chromosome testing is valuable in the following cases:":"Testiranje srodstva po muškoj liniji provodi se analizom 23 STR biljega na Y kromosomu. Budući da se spolni kromosom nasljeđuje nepromijenjen, srodstvo se potvrđuje potpunim podudaranjem svih analiziranih Y STR biljega. Promjene koje bi se eventualno mogle dogoditi su mutacije, koje predstavljaju nasumične zamjene nukleotida, koje se događaju spontano i vrlo rijetko.<br><br>Y kromosom se nasljeđuje po muškoj liniji, odnosno prenosi se izravno s oca na sina. Stoga svi muški srodnici s očeve strane dijele iste lokuse na Y kromosomu, što znači da imaju identičan Y DNA profil. Ova metoda je korisna i primjenjiva u neizravnom testiranju očinstva za mušku djecu kada muški srodnik s očeve strane (brat, djed, stric ili bilo koji član obitelji po muškoj liniji) može zamijeniti preminulog navodnog oca.<br><br>Također se može primijeniti za dokazivanje srodstva između braće, djeda i unuka, strica i nećaka itd. Primjenjuje se i u slučajevima identifikacije muške osobe kada su dostupni samo srodnici s očeve strane.<br><br>Testiranje po Y kromosomu je korisno u slučajevima:"),t(Lo);var _o=s(Lo,2),Eo=n(_o),$l=n(Eo);t(Eo);var Ho=s(Eo,2),ql=n(Ho);t(Ho);var $n=s(Ho,2),Xl=n($n);t($n),t(_o);var xo=s(_o,2),Ql=n(xo);t(xo);var Oo=s(xo,2),eu=n(Oo);$(eu,()=>a()==="en"?"Kinship testing for first-generation relationships between potential siblings and half-siblings is conducted by analyzing 24 STR markers. The test is used when the alleged father is unavailable for testing, and potential brothers or sisters, or half-siblings, want to confirm if they share the same father.<br><br>There are two types of tests:":"Testiranje srodstva za prve generacije odnosa između potencijalnih braće i sestara ili polubraće i polusestara provodi se analizom 24 STR biljega. Test se koristi kada pretpostavljeni otac nije dostupan za testiranje, a potencijalni braća i sestre, ili polubraća i polusestre, žele utvrditi da li imaju istog oca.<br><br>Postoje dva tipa testova:"),t(Oo);var Ro=s(Oo,2),Fo=n(Ro),au=n(Fo);t(Fo);var qn=s(Fo,2),iu=n(qn);t(qn),t(Ro);var Bo=s(Ro,2),ou=n(Bo);t(Bo);var Vo=s(Bo,2),tu=n(Vo);t(Vo);var Jo=s(Vo,2),nu=n(Jo);t(Jo);var Ko=s(Jo,2),ru=n(Ko);$(ru,()=>a()==="en"?"The sex of a baby is usually determined via ultrasound. However, in cases where this is not possible, prenatal gender determination can be performed through a DNA test.<br><br>This test analyzes free fetal DNA present in the mother’s blood by detecting Y STR markers. Since the Y chromosome is unique to males, the presence of a Y chromosome confirms that the fetus is male. If Y chromosome is not detected, the fetus is female.<br><br>Genos DNA Laboratory researchers, in collaboration with other scientific institutions, were among the first to publish findings on prenatal gender determination in the prestigious journal Prenatal Diagnosis in 2008.<br><br>Paternity testing before birth is only possible if the fetus is male. The fetal Y DNA profile is compared to the Y DNA profile of the alleged father to determine if they match.<br><br>However, prenatal paternity testing is not possible if the alleged fathers are close male relatives (e.g., brothers or father and son) since they share an identical Y chromosome. Due to this limitation, it is recommended to test all alleged fathers and confirm paternity with a standard DNA test after birth. This analysis can only determine whether the alleged father can be the biological father but cannot definitively confirm paternity—it can only exclude a man as the biological father.<br><br>Testing is available from the 18th week of pregnancy. An appointment must be scheduled in advance, and a pregant woman must bring her pregnancy record book. The test requires 9 ml of the mother’s venous blood and a buccal swab from the alleged father. The blood draw is completely safe for the fetus.":"Spol djeteta najčešće se određuje ultrazvukom. No, nerijetko se događa da to ipak nije moguće te se u takvim situacijama može primijeniti prenatalno utvrđivanje spola fetusa.<br><br>Radi se o analizi slobodne fetalne DNA prisutne u krvi majke detekcijom 23 Y STR biljega. Budući da je Y kromosom specifičan za muškarce, prisutnost Y kromosoma potvrđuje da je fetus muškog spola. Ako Y kromosom nije detektiran, fetus je ženskog spola.<br><br>Istraživači iz Genos DNA laboratorija, u suradnji s drugim znanstvenim institucijama, bili su među prvima koji su 2008. godine objavili rezultate istraživanja o prenatalnom određivanju spola u prestižnom časopisu Prenatal Diagnosis.<br><br>Testiranje očinstva prije rođenja moguće je samo ako je fetus muškog spola. Dobiveni Y DNA profil fetusa uspoređuje se s Y DNA profilom pretpostavljenog oca kako bi se utvrdilo podudaranje. Međutim, prenatalno testiranje očinstva nije moguće ako su pretpostavljeni očevi bliski muški rođaci (npr. braća ili otac i sin), jer dijele identičan Y kromosom. Zbog tog ograničenja preporučuje se testiranje svih pretpostavljenih očeva te naknadna potvrda očinstva standardnim DNA testom nakon rođenja. Ova analiza može isključiti muškarca kao biološkog oca, ali ne može s apsolutnom sigurnošću potvrditi očinstvo.<br><br>Testiranje je moguće od 18. tjedna trudnoće. Potrebno je prethodno dogovoriti termin, a trudnica na izuzimanje uzoraka mora donijeti trudničku knjižicu. Za analizu se uzima 9 ml venske krvi trudnice te bris sluznice usne šupljine potencijalnog oca. Uzimanje uzorka potpuno je sigurno za fetus."),t(Ko);var Wo=s(Ko,2),su=n(Wo);t(Wo);var Zo=s(Wo,2),Uo=n(Zo),lu=n(Uo);t(Uo);var Yo=s(Uo,2),uu=n(Yo);t(Yo);var Xn=s(Yo,2),cu=n(Xn);t(Xn),t(Zo);var $o=s(Zo,2),du=n($o);t($o);var qo=s($o,2),mu=n(qo);t(qo);var Xo=s(qo,2),Qo=n(Xo),pu=n(Qo);t(Qo);var et=s(Qo,2),hu=n(et);t(et);var at=s(et,2),vu=n(at);t(at);var it=s(at,2),gu=n(it);t(it);var ot=s(it,2),ju=n(ot);t(ot);var tt=s(ot,2),ku=n(tt);t(tt);var Qn=s(tt,2),fu=n(Qn);t(Qn),t(Xo);var nt=s(Xo,2),bu=n(nt);t(nt);var rt=s(nt,2),yu=n(rt);t(rt);var st=s(rt,2),zu=n(st);t(st);var lt=s(st,2),Su=n(lt);t(lt);var ut=s(lt,2),Mu=n(ut);t(ut);var ct=s(ut,2),dt=n(ct),wu=n(dt);t(dt);var er=s(dt,2),Au=n(er);t(er),t(ct);var mt=s(ct,2),Gu=n(mt);$(Gu,()=>a()==="en"?"Since some of these analyses are not available in Croatia, the isolated DNA sample is often sent abroad for testing.<br><br>For DNA isolation, a 3 mL whole blood sample is required in a vacutainer tube with EDTA anticoagulant (purple cap). The sample should ideally be delivered immediately after collection. If necessary, it can be stored at +4°C for a few hours or at -20°C for longer periods.":"Često se radi o analizama koje nisu dostupne u Hrvatskoj, zbog čega se izolat DNA šalje u inozemstvo.<br><br>Za izolaciju DNA je potrebno 3 mL pune krvi u vacutainer epruveti s antikoagulansom EDTA (ljubičasti čep). Uzorak bi trebao biti dostavljen odmah nakon uzimanja. Ako je potrebno, može se čuvati na +4°C nekoliko sati ili na -20°C dulje vrijeme."),t(mt);var pt=s(mt,2),Du=n(pt);t(pt);var ht=s(pt,2),Iu=n(ht);$(Iu,()=>a()==="en"?"In the DNA laboratory of Genos d.o.o., paternity/kinship testing through DNA analysis is conducted quickly and painlessly by collecting buccal swab samples (a swab of the inner cheek mucosa). Blood collection is not required.<br><br>Scheduling an appointment is mandatory before coming to the laboratory! Fasting before sample collection is not necessary.<br><br>Sample collection can be done at our laboratory in Zagreb (Borongajska cesta 83 H, 1st floor, BIOCenter building, within the Borongaj campus), or at our office in Osijek (Drniška 9).<br><br>For sample collection from minors, both parents/guardians must be present, or a written and notarized consent from the absent parent/guardian must be provided.<br><br>There is no age limit for paternity testing of a child.<br><br>If the test is being conducted for court purposes upon personal request, an appointment must be scheduled in advance. At the scheduled time, all parties must be present for sample collection. As a means of identification, valid ID cards or other valid photo IDs (including OIB) are required. For the child, a birth certificate and ID card (if available) must be presented. The child’s identity is confirmed by all parties involved through their signature on the order form.<br><br>If paternity testing is requested by the court, an authorized Genos representative may collect samples at the court during the hearing or at Genos premises based on a court decision.<br><br>You can also collect samples yourself in the privacy of your home using a DNA sample collection kit.<br><br>Results available as soon as possible!<br><br>For paternity/kinship testing upon personal request, the standard turnaround time for completing the analysis and delivering results is 7 working days from the date of payment and sample receipt in the lab.<br><br>The turnaround time for urgent analysis is 4 working days. Urgent analysis incurs an additional fee.<br><br>For court purposes, the turnaround time for completing the analysis and delivering the expert opinion is 10 working days.<br><br>The analysis results are delivered exclusively to the ordering party or the person specified on the signed order form. You will receive the results by email, mail, or in person—depending on your preference indicated on the order form. Only the status of the analysis can be provided over the phone, not the results!":"U DNA laboratoriju tvrtke Genos d.o.o., određivanje očinstva/rodbinskih odnosa putem DNA analize, provodi se brzo i bezbolno izuzimanjem uzoraka brisa bukalne sluznice (bris sluznice usne šupljine s unutarnje strane obraza). Izuzimanje krvi nije potrebno.<br><br>Za dolazak u laboratorij obavezno je dogovoriti termin dolaska! Prije izuzimanja uzorka nije potrebno biti natašte.<br><br>Izuzimanje uzoraka može se obaviti u našem laboratoriju u Zagrebu (Borongajska cesta 83 H, 1. kat, zgrada BIOCentra, unutar kampusa Borongaj), ili u našoj poslovnici u Osijeku (Drniška 9).<br><br>Za izuzimanje uzoraka maloljetne djece obavezna je nazočnost oba roditelja/skrbnika ili pisana i ovjerena suglasnost roditelja/skrbnika koji nije nazočan.<br><br>Ne postoji dobna granica djeteta za utvrđivanja očinstva.<br><br>Ukoliko se testiranje provodi na osobni zahtjev za sudske potrebe, prije dolaska je potrebno dogovoriti termin. U dogovorenom terminu sve stranke trebaju zajedno pristupiti izuzimanju uzoraka. Kao sredstvo identifikacije trebaju donijeti važeće osobne iskaznice ili neki drugi važeći dokument sa slikom (koji uključuje i OIB), a za dijete rodni list i osobnu iskaznicu (ukoliko ju posjeduje). Identitet djeteta potvrđuju sve stranke u postupku svojim potpisom na narudžbenici.<br><br>Ukoliko se testiranje očinstva provodi na zahtjev suda, ovlaštena osoba tvrtke Genos može izuzeti uzorke na sudu tijekom rasprave ili u prostorijama tvrtke Genos temeljem Rješenja suda.<br><br>Uzorke možete izuzeti i sami u privatnosti svog doma koristeći Set za izuzimanje uzoraka za analizu DNA.<br><br>Rezultati analize u najkraćem roku!<br><br>Za testiranje očinstva/srodstva na osobni zahtjev standardni rok za dovršetak analize i dostavu rezultata je 7 radnih dana od dana zaprimanja uplate i uzoraka u laboratorij.<br><br>Rok za slanje rezultata za hitnu analizu je 4 radna dana. Hitna analiza se dodatno naplaćuje.<br><br>Za potrebe suda, rok za dovršetak analize te slanje nalaza i mišljenja ovlaštenog sudskog vještaka je 10 radnih dana.<br><br>Rezultat analize dostavlja se isključivo naručitelju ili osobi koju je naručitelj naveo na potpisanoj narudžbenici. Rezultate ćete primiti e-mail-om, poštom ili osobno preuzeti ovisno o tome kako ste označili na narudžbenici. Telefonom je moguće dobiti isključivo informaciju o statusu analize, ali ne i rezultat analize!"),t(ht);var vt=s(ht,2),ar=n(vt),Pu=n(ar);P(Pu,()=>a()==="en",Ie=>{var de=Rp();De(),v(Ie,de)},Ie=>{var de=Fp();De(),v(Ie,de)}),t(ar),t(vt);var gt=s(vt,2),Cu=n(gt);t(gt);var jt=s(gt,2),Tu=n(jt);$(Tu,()=>a()==="en"?"The Sample Collection Kit is used for DNA analysis from a buccal swab sample.<br><br>Such samples can be collected easily and painlessly using the collectors from the kit, which are specially designed for this purpose.<br><br>The sterile protective tube is designed to safeguard the sample from environmental factors, reducing the overall risk of contamination and enabling safe transport of the sample to the laboratory.<br><br>If the sample is collected according to the instructions enclosed in the kit, it remains preserved in the collector for months.<br><br>All collectors, the completed order form, and proof of payment need to be enclosed in the pre-addressed protective envelope and then mailed or delivered to the laboratory.<br><br>Sample Collection Kit for DNA Testing contains:":"Set za izuzimanje uzorka koristi se za DNA analizu iz brisa bukalne sluznice.<br><br>Takvi se uzorci mogu jednostavno i bezbolno uzeti pomoću kolektora iz seta, koji su posebno dizajnirani za tu svrhu.<br><br>Sterilna zaštitna epruveta osigurava zaštitu uzorka od vanjskih utjecaja, smanjuje rizik od kontaminacije i omogućuje siguran transport uzorka do laboratorija.<br><br>Ako se uzorak uzme prema uputama priloženima u setu, ostaje stabilan u kolektoru mjesecima.<br><br>Svi kolektori, ispunjena narudžbenica i potvrda o uplati moraju se staviti u unaprijed adresiranu zaštitnu omotnicu te poslati poštom ili osobno dostaviti u laboratorij.<br><br>Set za izuzimanje uzorka za DNA analizu sadrži:"),t(jt);var ir=s(jt,2);P(ir,()=>a()==="en",Ie=>{var de=Bp();v(Ie,de)},Ie=>{var de=Vp();v(Ie,de)});var kt=s(ir,2),Nu=n(kt);$(Nu,()=>a()==="en"?"You can order the Sample Collection Kit by phone, e-mail or via our website and receive it at your home address. You can buy it in our laboratory and in pharmacies.":"Set za uzorkovanje možete naručiti telefonom, e-mailom ili putem naše web stranice i primit ćete ga na svoju kućnu adresu. Također ga možete kupiti u našem laboratoriju i u ljekarnama."),t(kt);var or=s(kt,2);P(or,()=>a()==="en",Ie=>{var de=Jp();v(Ie,de)},Ie=>{var de=Kp();v(Ie,de)});var ft=s(or,2),Lu=n(ft);t(ft);var bt=s(ft,2),_u=n(bt);$(_u,()=>a()==="en"?'All DNA test results are strictly confidential. Biological samples submitted for DNA analysis are destroyed after testing, and all digital records are deleted 5 years after results are issued. Within this period, a copy of the issued results can be requested only by the original client through a written request.<br><br>The Genos d.o.o. DNA laboratory uses cutting-edge DNA analysis methods to provide accurate answers to all inquiries. However, in some cases, results may not align with expectations, which can have emotional and social consequences. Genos d.o.o. is not authorized to provide psychological counselling and cannot offer direct support in such situations.<br><br>If DNA test results cause emotional distress such as dissatisfaction, anger, fear, sadness, or concern, we strongly recommend seeking professional support from one of the organizations listed below, a family doctor, or a psychologist at the relevant social services center.<br><br>Psychological Center TESA, tel. 01 48 28 888 / <a href="https://www.tesa.hr" target="_blank" class="underline">www.tesa.hr</a><br>Society for Psychological Help, MODUS – Center for Children, Youth, and Families, tel. 01 4621 554 / <a href="https://www.dpp.hr" target="_blank" class="underline">www.dpp.hr</a>':"Rezultati svakog provedenog testiranja su strogo povjerljivi i izdaju se isključivo Naručitelju analize. Biološki uzorci dostavljeni na DNA analizu uništavaju se nakon testiranja, a svi digitalni zapisi brišu se 5 godina nakon izdavanja rezultata.<br><br>U tom periodu može se zatražiti kopija izdanog rezultata, isključivo uz osobni pisani zahtjev Naručitelja analize.<br><br>DNA laboratorij tvrtke Genos d.o.o. primjenjuje najsuvremenije metode analize DNA kako bi utvrdio istinit odgovor na sva pitanja koja su nam postavljena. Nažalost, ponekad se rezultat ne podudara s očekivanjima naručitelja i/ili ostalih sudionika testiranja što može imati negativne emocionalne i socijalne posljedice. Genos d.o.o. nije ovlašten za usluge psihološkog savjetovanja i ne može pružiti izravnu pomoć u takvim situacijama.<br><br>Ukoliko rezultati provedene analize DNA kod vas izazovu negativne emocije poput nezadovoljstva, srdžbe, straha, tuge ili zabrinutosti preporučujemo da se svakako obratite stručnim osobama na jednoj od dolje navedenih adresa, obiteljskom liječniku ili psihologu u nadležnom centru za socijalnu skrb."),t(bt);var yt=s(bt,2),tr=n(yt),Eu=n(tr);P(Eu,()=>a()==="en",Ie=>{var de=Wp();De(2),v(Ie,de)},Ie=>{var de=Zp();De(2),v(Ie,de)}),t(tr),t(yt);var zt=s(yt,2),Hu=n(zt);t(zt);var St=s(zt,2),nr=n(St),xu=n(nr);t(nr),t(St);var Mt=s(St,2),Ou=n(Mt);t(Mt);var wt=s(Mt,2),Ru=n(wt);t(wt);var At=s(wt,2),Fu=n(At);t(At);var Gt=s(At,2),Dt=n(Gt),Bu=n(Dt);t(Dt);var It=s(Dt,2),Vu=n(It);t(It);var Pt=s(It,2),Ju=n(Pt);t(Pt);var Ct=s(Pt,2),Ku=n(Ct);t(Ct);var rr=s(Ct,2),Wu=n(rr);t(rr),t(Gt);var Tt=s(Gt,2),Zu=n(Tt);t(Tt);var Nt=s(Tt,2),Lt=n(Nt),Uu=n(Lt);t(Lt);var _t=s(Lt,2),Yu=n(_t);t(_t);var Et=s(_t,2),$u=n(Et);t(Et);var Ht=s(Et,2),qu=n(Ht);t(Ht);var sr=s(Ht,2),Xu=n(sr);t(sr),t(Nt);var xt=s(Nt,2),Qu=n(xt);t(xt);var Ot=s(xt,2),ec=n(Ot);t(Ot);var Rt=s(Ot,2),ac=n(Rt);t(Rt);var Ft=s(Rt,4),ic=n(Ft);$(ic,()=>a()==="en"?"The GENBird Test allows for simple and non-invasive DNA sample collection from birds using either feathers or blood. Clear instructions guide users through labeling, collecting, and sending the samples. Feathers must include the calamus (the base of the feather) as it contains DNA, while blood is collected with a sterile needle and applied to a card or tissue. Each sample is stored in a labeled paper envelope and sent to the lab with an order form. The test enables accurate genetic analysis while ensuring the bird’s wellbeing and sample quality.":"GENBird test omogućuje jednostavno i neinvazivno prikupljanje DNA uzoraka ptica putem pera ili krvi. Upute jasno opisuju kako označiti, prikupiti i poslati uzorke. Važno je da pero sadrži kalamus (osnovu pera) jer on nosi DNA, dok se krv uzima sterilnom iglom i nanosi na papir ili maramicu. Svaki uzorak sprema se u označenu papirnatu omotnicu i šalje u laboratorij zajedno s narudžbenicom. Test omogućuje točnu genetsku analizu uz brigu o zdravlju ptice i kvaliteti uzorka."),t(Ft);var lr=s(Ft,2),Bt=n(lr),oc=n(Bt);P(oc,()=>a()==="en",Ie=>{var de=Up();v(Ie,de)},Ie=>{var de=Yp();v(Ie,de)}),t(Bt);var Vt=s(Bt,2),ur=n(Vt),tc=n(ur);t(ur),t(Vt);var cr=s(Vt,2),dr=n(cr),nc=n(dr);t(dr),t(cr),t(lr),t(Zn),t(Q),t(d),A(()=>{m(h,a()==="en"?"Genos unites expertise in glycomics, glycoproteomics, epigenetics, and DNA analysis to deliver integrated, high-quality solutions for diverse research and commercial applications.":"Genos objedinjuje stručnost u glikomici, glikoproteomici, epigenetici i analizi DNA kako bi pružio integrirana, visokokvalitetna rješenja za raznolike istraživačke i komercijalne primjene."),m(G,a()==="en"?"Quick links:":"Izbornik:"),m(k,`${(a()==="en"?"Glycomics & glycoproteomics":"Glikomika i glikoproteomika")??""} `),Ee(g,"rotate-180",c(i)),m(T,`${(a()==="en"?"Epigenetics":"Epigenetika")??""} `),Ee(W,"rotate-180",c(r)),m(E,`${(a()==="en"?"DNA & Forensics":"DNA i Forenzika")??""} `),Ee(R,"rotate-180",c(l)),m(_,`1. ${(a()==="en"?"Glycomics & Glycoproteomics":"Glikomika i glikoproteomika")??""}`),m(I,`1.1. ${(a()==="en"?"Technologies":"Tehnologije")??""}`),m(H,a()==="en"?"UHPLC GLYCOPROFILING (1)":"UHPLC GLIKOPROFILIRANJE (1)"),m(ie,a()==="en"?"7 Waters UHPLC instruments with fluorescence detectors, HT glycoprofiling of up to 200 samples/day":"7 Waters UHPLC instrumenata s fluorescentnim detektorima, visokoprotočno glikoprofiliranje do 200 uzoraka dnevno"),m(Z,a()==="en"?"CGE GLYCOPROFILING (2)":"CGE GLIKOPROFILIRANJE (2)"),m(ke,a()==="en"?"2 Applied Biosystems 3500 DNA sequencers adapted for glycan analysis, HT glycoprofiling of up to 300 samples/day":"2 Applied Biosystems 3500 DNA sekvencera prilagođena za analizu glikana, visokoprotočno glikoprofiliranje do 300 uzoraka dnevno"),m(le,a()==="en"?"MS GLYCOPROFILING (3)":"MS GLIKOPROFILIRANJE (3)"),m(Fe,a()==="en"?"2 Bruker Compact Q-TOF coupled to Waters nanoUPLC systems, Orbitrap Exploris 240 coupled to Dionex UltiMate 3000 RSLCnano system, HT glycoprofiling of up to 100 samples/day":"2 Bruker Compact Q-TOF spojena s Waters nanoUPLC sustavima, Orbitrap Exploris 240 spojen na Dionex UltiMate 3000 RSLCnano sustav, visokoprotočno glikoprofiliranje do 100 uzoraka dnevno"),m(Ce,`1.2. ${(a()==="en"?"Sample types":"Vrste uzoraka")??""}`),m(Je,`${(a()==="en"?"Complex biological samples":"Složeni biološki uzorci")??""} `),m(Me,a()==="en"?"(e.g. human serum/plasma, cell lysates, tissues)":"(npr. ljudski serum/plazma, stanični lizati, tkiva)"),m(ye,`${(a()==="en"?"Purified glycoproteins":"Pročišćeni glikoproteini")??""} `),m(te,a()==="en"?"(e.g. human IgG, IgA, AGP, C3, transferrin, HDL, LDL, rodent IgG)":"(npr. ljudski IgG, IgA, AGP, C3, transferin, HDL, LDL, IgG glodavaca)"),m(ce,`${(a()==="en"?"Biopharmaceuticals":"Biofarmaceutici")??""} `),m(Fa,a()==="en"?"(e.g. mAb)":"(npr. monoklonska antitijela)"),m(Oi,`1.3. ${(a()==="en"?"Glycoprofiling":"Glikoprofiliranje")??""}`),m(ee,a()==="en"?"Released N-glycans":"Oslobođeni N-glikani"),m(Ae,a()==="en"?"N-glycans are released from glycoproteins by digestion with PNGaseF, fluorescently labelled, purified and analysed by hydrophilic interaction ultra-high-performance liquid chromatography with fluorescence detection (HILIC-UHPLC-FLD) or capillary gel electrophoresis with laser-induced fluorescence (CGE-LIF), which allows relative quantification of different glycan species. Assignment of N-glycan structures is based on HILIC retention time, accurate mass and fragmentation spectra obtained by coupling HILIC-UHPLC-FLD to mass spectrometry via electrospray ionization (ESI-MS/MS).":"N-glikani se oslobađaju iz glikoproteina digestijom s PNGaseF, fluorescentno se obilježavaju, pročišćavaju i analiziraju hidrofilnom interakcijskom ultra-visokoučinkovitom tekućinskom kromatografijom s fluorescentnom detekcijom (HILIC-UHPLC-FLD) ili kapilarnom gel elektroforezom s laserski induciranom fluorescencijom (CGE-LIF), što omogućuje relativnu kvantifikaciju različitih glikanskih vrsta. Identifikacija N-glikanskih struktura temelji se na HILIC retencijskom vremenu, točnoj masi i spektrima fragmentacije dobivenima spajanjem HILIC-UHPLC-FLD sustava s masenom spektrometrijom putem elektrospray ionizacije (ESI-MS/MS)."),m(Se,a()==="en"?"Site-specific glycosylation":"Specifična glikozilacija po mjestu"),m(ya,a()==="en"?"N-glycopeptides are obtained from glycoproteins by protease digestion, purified and analysed by C18 liquid chromatography coupled to mass spectrometry via electrospray ionization (C18-LC-ESI-MS/MS). Relative quantification of N-glycopeptides is obtained in a site-specific manner determined by the amino acid sequence of the glycoprotein. Assignment of N-glycopeptide structures is based on accurate mass and fragmentation spectra.":"N-glikopeptidi se dobivaju iz glikoproteina proteolitičkom digestijom, pročišćavaju se i analiziraju C18 tekućinskom kromatografijom spojenom s masenom spektrometrijom putem elektrospray ionizacije (C18-LC-ESI-MS/MS). Relativna kvantifikacija N-glikopeptida dobiva se na specifičan način određen aminokiselinskim slijedom glikoproteina. Dodjeljivanje struktura N-glikopeptida temelji se na točnoj masi i spektrima fragmentacije."),m(pa,a()==="en"?"Glycosylation site occupancy":"Zauzetost mjesta glikozilacije"),m(al,a()==="en"?"Site occupancy analysis is used to calculate the occupancy of potential N-glycosylation sites by measuring the proportion of N-glycosylated peptides in total peptides. The analysis is performed by releasing N-glycans with PNGaseF in the presence of 18O water followed by protease digestion, purification and C18-LC-ESI-MS/MS.":"Analiza zauzetosti mjesta koristi se za izračun udjela potencijalnih N-glikozilacijskih mjesta koji su stvarno glikozilirani, mjerenjem udjela N-glikoziliranih peptida u ukupnoj količini peptida. Analiza se provodi oslobađanjem N-glikana pomoću PNGaseF u prisutnosti vode obogaćene kisikom-18 (^18O), nakon čega slijede proteolitička digestija, pročišćavanje i C18-LC-ESI-MS/MS analiza."),m(il,`1.4. ${(a()==="en"?"High-Throughput analyses":"Visokoprotočne analize")??""}`),m(ol,a()==="en"?"Genos offers in-depth glycoprofiling for various sample types such as biopharmaceuticals and glycoproteins purified from complex samples. Sample preparation conditions and analysis parameters are optimised for a specific sample.":"Genos nudi detaljno glikoprofiliranje za različite vrste uzoraka kao što su biofarmaceutici i glikoproteini pročišćeni iz složenih uzoraka. Uvjeti pripreme uzorka i parametri analize optimizirani su za specifičan uzorak."),m(tl,a()==="en"?"Analysis of total human serum/plasma N-glycans":"Analiza ukupnih N-glikana humanog seruma/plazme"),m(nl,a()==="en"?"Analysis of total human IgG N-glycans":"Analiza ukupnih N-glikana humanog IgG"),m(rl,a()==="en"?"Analysis of total human IgA N-glycans":"Analiza ukupnih N-glikana humanog IgA"),m(sl,a()==="en"?"Analysis of subclass-specific human IgG N-glycopeptides":"Analiza podtip-specifičnih N-glikopeptida humanog IgG"),m(ll,a()==="en"?"Analysis of human AGP N-glycopeptides":"Analiza N-glikopeptida humanog AGP"),m(ul,a()==="en"?"Analysis of human C3 N-glycopeptides":"Analiza N-glikopeptida humanog C3"),m(cl,a()==="en"?"Analysis of subclass-specific rodent IgG N-glycopeptides":"Analiza podtip-specifičnih N-glikopeptida IgG glodavaca"),m(dl,`1.5. ${(a()==="en"?"Data analysis":"Analiza podataka")??""}`),m(ml,a()==="en"?"Data analysis is an important aspect of the workflow that we provide for our partners and collaborators. Since pure numbers, without thoughtful and meaningful explanation, are usually of little interest, Genos offers a wide range of statistical techniques from basic experimental methods of normalization or batch correction to standard topics like statistical inference or machine/statistical learning.":`Analiza podataka važan je aspekt radnog toka koji pružamo našim partnerima i suradnicima. Budući da su čisti brojevi, bez promišljenog i smislenog objašnjenja, obično od malog interesa, Genos nudi širok raspon statističkih tehnika, od osnovnih eksperimentalnih metoda normalizacije ili korekcije serija do standardnih tema kao što su statistički zaključci ili strojno/statističko učenje.
`),m(pl,`1.6. ${(a()==="en"?"Study design":"Dizajn studije")??""}`),m(hl,a()==="en"?"Genos offers consultancies in study design, under the full or partial control of the experiment, for different fields of biomedicine. The mixture of expertise from Genos employees (biologists, pharmacist, biotechnologists, chemists, chemical engineers and statisticians ) ensures the quality of the study design.":"Genos nudi konzultacije u dizajnu studija, uz potpuni ili djelomični nadzor nad eksperimentom, za različita područja biomedicine. Mješavina stručnosti zaposlenika Genosa (biologa, farmaceuta, kemičara, statističara i matematičara) jamči kvalitetu dizajna studije./statističko učenje."),m(vl,`1.7. ${(a()==="en"?"Cooperation and joint project development":"Suradnja i zajednički razvoj projekata")??""}`),m(jl,`2. ${(a()==="en"?"Epigenetics":"Epigenetika")??""}`),m(kl,`2.1. ${(a()==="en"?"Technologies":"Tehnologije")??""}`),m(fl,a()==="en"?"Epigenetics analyses":"Epigenetske analize"),m(bl,a()==="en"?"Cell culture":"Stanična kultura"),m(yl,a()==="en"?"Equipment for specific epigenetic analyses:":"Oprema za specifične epigenetske analize:"),m(zl,a()==="en"?"Epigenetics Pyrosequencers PyroMark Q24 Advanced (Qiagen) for DNA methylation analyses":"Pirosekvenceri PyroMark Q24 Advanced (Qiagen) za analize metilacije DNA"),m(Sl,a()==="en"?"A sonicator Sonopuls mini20 for cells distruption":"Sonikator Sonopuls mini20 za razgradnju stanica"),m(Ml,a()==="en"?"Bioruptor Plus sonication device for chromatin Fragmentation":"Uređaj za sonikaciju Bioruptor Plus za fragmentaciju kromatina"),m(wl,a()==="en"?"Equipment for cell culture work:":"Oprema za rad sa staničnim kulturama:"),m(Al,a()==="en"?"Two Panasonic CO2 incubators":"Dva CO2 inkubatora Panasonic"),m(Gl,a()==="en"?"Brunswick S41i CO2 Incubator Shaker":"CO2 inkubator s tresilicom Brunswick S41i"),m(Dl,a()==="en"?"Three class II safety cabinets":"Tri sigurnosna kabineta klase II"),m(Il,a()==="en"?"Nucleofector for electroporation of animal cells in culture":"Nucleofector za elektroporaciju životinjskih stanica u kulturi"),m(Pl,a()==="en"?"Laboratory BSL2+ for lentiviral production with equipment":"Laboratorij BSL2+ za proizvodnju lentivirusa s pripadajućom opremom"),m(Cl,`2.2. ${(a()==="en"?"Services":"Usluge")??""}`),m(Tl,a()==="en"?"Analysis of DNA methylation by pyrosequencing":"Analiza metilacije DNA pomoću pirosekvenciranja"),m(Nl,a()==="en"?"High-throughput gene expression analysis":"Visokoprotočna analiza genske ekspresije"),m(Ll,a()==="en"?"Custom purpose design and production of CRISPR/dCas9-based molecular tools":"Dizajn i proizvodnja molekularnih alata temeljenih na CRISPR/dCas9 tehnologiji za specifične namjene"),m(_l,`3. ${(a()==="en"?"DNA & Forensics":"DNA i Forenzika")??""}`),m(El,`3.1. ${(a()==="en"?"Paternity testing":"Utvrđivanje očinstva")??""}`),m(Hl,a()==="en"?"Personal Paternity Test – Analysis of 18 or 24 STR markers":"Test očinstva za osobne potrebe – Analiza 18 ili 24 STR biljega"),m(xl,a()==="en"?`Paternity test for court proceedings – Analysis of 24 STR markers
`:"Test očinstva za sudske postupke – Analiza 24 STR biljega"),m(Rl,a()==="en"?"Paternity/Maternity Testing for Personal Purposes":"Testiranje očinstva/majčinstva za osobne potrebe"),m(Bl,a()==="en"?"Paternity/Maternity Testing for Legal Proceedings":"Testiranje očinstva/majčinstva za sudske postupke"),m(Jl,`3.2. ${(a()==="en"?"Kinship testing":"Utvrđivanje srodstva")??""}`),m(Kl,a()==="en"?"Male Lineage Testing – Analysis of 23 STR markers on the Y chromosome":"Testiranje srodstva po muškoj liniji – Analiza 23 STR biljega na Y kromosomu"),m(Wl,a()==="en"?"Sibling and Half-Sibling Testing – Analysis of 24 STR markers":"Testiranje srodstva između braće/sestara te polubraće/polusestara– Analiza 24 STR biljega"),m(Zl,a()==="en"?"Grandparent-Grandchild Testing – Analysis of 24 STR markers":"Testiranje srodstva između djeda (bake) i unučadi – Analiza 24 STR biljega"),m(Ul,a()==="en"?"Patrilineality":"Testiranje srodstva po muškoj liniji"),m($l,a()==="en"?"When brothers want to confirm they share the same biological father":"Kada braća žele potvrditi da dijele istog biološkog oca"),m(ql,a()==="en"?"When adopted male children seek to find their biological father or other male relatives":"Kada posvojena muška djeca žele pronaći svog biološkog oca ili druge muške rođake"),m(Xl,a()==="en"?"When official proof of kinship is required between males, such as in legal disputes or immigration cases.":"Kada je potrebno službeno dokazivanje srodstva između muških osoba, kao što je u sudskim sporovima ili imigracijskim slučajevima."),m(Ql,a()==="en"?"Sibling and Half-Sibling Testing":"Testiranje srodstva između braće i sestara te polubraće i polusestara"),m(au,a()==="en"?"Full-Sibling Test – To confirm if two individuals share the same biological parents":"Test utvrđivanja srodstva između polubraće i polusestara – Za potvrdu da li dvoje pojedinaca dijele jednog biološkog roditelja."),m(iu,a()==="en"?"Half-Sibling Test – To confirm if two individuals share one biological parent.":"Test utvrđivanja srodstva između braće i sestara – Za potvrdu da li dvoje pojedinaca dijele iste biološke roditelje"),m(ou,a()==="en"?"Grandparent-Grandchild Testing":"Testiranje srodstva između djeda (bake) i unučadi"),m(tu,a()==="en"?"Grandparent-grandchild testing is performed by analyzing 24 STR markers and is conducted when the alleged father is unavailable for testing. The test confirms whether the child is biologically related to the grandparents, thus aiding in identifying the biological father. This test can also assist in confirming maternity.":"Testiranje srodstva između djeda/bake i unuka/unuke provodi se analizom 24 STR biljega i provodi se kada pretpostavljeni otac nije dostupan za testiranje. Testom se utvrđuje da li je dijete biološki povezano s djedom i bakom i time pomaže u identificiranju biološkog oca djeteta. Ovaj test također može pomoći u potvrđivanju majčinstva."),m(nu,`3.3.
        ${(a()==="en"?"Non-Invasive Prenatal Gender and Paternity Testing":"Neinvazivno prenatalno utvrđivanje spola djeteta i testiranje očinstva")??""}`),m(su,`3.4.
        ${(a()==="en"?"Other analyses":"Ostale analize")??""}`),m(lu,a()==="en"?"DNA Profiling – Analysis of 24 STR markers":"Utvrđivanje DNA profila – Analiza 24 STR biljega"),m(uu,a()==="en"?"Detection of Seminal Fluid Traces":"Utvrđivanje prisutnosti tragova sjemene tekućine"),m(cu,a()==="en"?"DNA Isolation":"Izolacija DNA"),m(du,a()==="en"?"DNA Profiling":"Utvrđivanje DNA profila"),m(mu,a()==="en"?"DNA profiling is often requested to verify an existing DNA profile, confirm the authenticity of previous test results, or supplement earlier paternity or kinship tests. A DNA profile serves as genetic identification and can be used in various cases, such as:":"Utvrđivanje DNA profila često se traži kako bi se provjerila vjerodostojnost postojećeg DNA profila, potvrdila autentičnost prethodnih rezultata testiranja ili dopunili raniji testovi očinstva ili srodstva. DNA profil služi kao genetička identifikacija i može se koristiti u različitim slučajevima, poput:"),m(pu,a()==="en"?"Establishing or disputing inheritance rights":"ostvarivanja ili osporavanja prava na nasljedstvo"),m(hu,a()==="en"?"Resolving cases of missing or abducted children":"rješavanja slučajeva nestale ili otete djece"),m(vu,a()==="en"?"Immigration disputes":"imigracijskih sporova"),m(gu,a()==="en"?"For individuals in high-risk professions":"za osobe u visokorizičnim profesijama"),m(ju,a()==="en"?"Insurance purposes":"za potrebe osiguranja"),m(ku,a()==="en"?"Identifying victims of natural disasters, accidents, or terrorist attacks":"identifikacije žrtava prirodnih katastrofa, nesreća ili terorističkih napada"),m(fu,a()==="en"?"Investigating potential sample mix-ups (e.g., verifying preserved tissue samples in cancer diagnoses or ensuring proper handling of reproductive cells in IVF procedures)":"istraga potencijalnih zamjena uzoraka (npr. provjera sačuvanih uzoraka tkiva u dijagnozama raka ili osiguranje pravilnog rukovanja reproduktivnim stanicama u IVF postupcima)"),m(bu,a()==="en"?"DNA profiling is performed by analyzing 24 STR loci.":"DNA profiliranje se izvodi analizom 24 STR lokusa."),m(yu,a()==="en"?"Detection of Semen Traces":"Utvrđivanje prisutnosti tragova sjemene tekućine"),m(zu,a()==="en"?"The presence of semen traces on various samples (e.g., clothing, bedding, towels, vaginal swabs) is determined using the RSID™-Semen test (Rapid Stain Identification of Human Semen; Independent Forensics, USA). This test detects the presence of human semenogelin protein via an immunochromatographic strip assay using two anti-semenogelin monoclonal antibodies.":"Prisutnost tragova sjemene tekućine na različitim uzorcima (npr. odjeća, posteljina, ručnici, vaginalni brisevi) utvrđuje se korištenjem RSID™-Semen testa (Rapid Stain Identification of Human Semen; Independent Forensics, SAD). Ovaj test detektira prisutnost humanog proteina semenogelina imunokromatografskom testnom trakom koristeći dva anti-semenogelin monoklonska protutijela."),m(Su,a()==="en"?"DNA Isolation":"Izolacija DNA"),m(Mu,a()==="en"?"DNA isolation is typically performed upon request when the DNA sample is needed for molecular diagnostic tests, which are essential for personalized medicine. These tests may include:":"Izolacija DNA obično se provodi na zahtjev stranke kojoj je uzorak DNA potreban za molekularno-dijagnostičke testove, koji su ključni za personaliziranu medicinu. Ovi testovi mogu uključivati:"),m(wu,a()==="en"?"Assessing genetic predisposition to certain diseases or disorders to enable early prevention and targeted treatment":"Procjenu genetičke predispozicije za određene bolesti ili poremećaje radi omogućavanja rane prevencije i ciljanog liječenja"),m(Au,a()==="en"?"Evaluating treatment outcomes to improve drug efficacy and reduce ineffective treatments (pharmacogenetics)":"Procjene ishoda liječenja za poboljšanje učinkovitosti lijekova i smanjenje neučinkovitih tretmana (farmakogenetika)"),m(Du,`3.5.
        ${(a()==="en"?"Testing Procedure":"Postupak testiranja")??""}`),m(Cu,`3.5.1.
        ${(a()==="en"?"Set for DNA sample collection and analysis":"Set za izuzimanje uzoraka za analizu DNA")??""}`),m(Lu,a()==="en"?"3.6. Data Confidentiality":"3.6. Povjerljivost podataka"),m(Hu,`3.7.
        ${(a()==="en"?"Avian Gender Determination via DNA Analysis":"Određivanje spola ptica putem DNA analize")??""}`),m(xu,a()==="en"?"Analysis of bird sex chromosomes to differentiate male and female birds":"Analiza spolnih kromosoma ptica za razlikovanje mužjaka i ženki ptica"),m(Ou,a()==="en"?"Avian Gender Determination":"Određivanje spola ptica"),m(Ru,a()==="en"?"The sex of many bird species cannot be determined based on physical appearance and characteristics. By using DNA analysis methods, it is possible to examine parts of the birds' sex chromosomes. This allows us to distinguish between male birds (ZZ) and female birds (ZW).":"Spol mnogih vrsta ptica ne može se odrediti na temelju fizičkog izgleda i karakteristika. Korištenjem metoda DNA analize moguće je ispitati fragmente spolnih kromosoma ptica. To nam omogućava razlikovanje mužjaka ptica (ZZ) i ženki ptica (ZW)."),m(Fu,a()==="en"?"Advantages of DNA Analysis":"Prednosti DNA analize"),m(Bu,a()==="en"?"The sex of a bird can be determined from feather or blood samples.":"Spol ptice može se odrediti iz uzoraka perja ili krvi."),m(Vu,a()==="en"?"The accuracy of DNA-based sex determination does not depend on the bird's age.":"Točnost određivanja spola na temelju DNA ne ovisi o dobi ptice."),m(Ju,a()==="en"?"The accuracy of DNA sex determination is very high (>99%).":"Točnost određivanja spola na temelju DNA je vrlo visoka (>99%)."),m(Ku,a()==="en"?"Knowing the bird's sex increases its value.":"Poznavanje spola ptice povećava njezinu vrijednost."),m(Wu,a()==="en"?"The analysis is conducted by experts with years of experience in DNA analysis.":"Analizu provode stručnjaci s dugogodišnjim iskustvom u DNA analizi."),m(Zu,a()==="en"?"Sample Collection":"Prikupljanje uzoraka"),m(Uu,a()==="en"?"3–5 freshly plucked feathers, preferably from the bird's chest (collect without touching the tip of the feather with your hands).":"3–5 svježe iščupanih pera, po mogućnosti sa prsa ptica (prikupljati bez dodirivanja vrha pera rukama)."),m(Yu,a()==="en"?"2–3 drops of blood on a card or tissue (sample collection cards for blood can be requested from the Genos DNA laboratory).":"2–3 kapi krvi na kartici ili maramici (kartice za prikupljanje krvi mogu se zatražiti od Genos DNA laboratorija)."),m($u,a()==="en"?"Each bird's sample should be placed in a separate envelope.":"Uzorke svake ptice treba staviti u zasebnu omotnicu."),m(qu,a()==="en"?"Samples can be sent by mail or delivered in person.":"Uzorke možete poslati poštom ili donijeti osobno."),m(Xu,a()==="en"?"When sending samples by mail, include an order form and proof of payment for the analysis.":"Prilikom slanja uzoraka poštom, priložite popunjenu i potpisanu narudžbenicu."),m(Qu,a()==="en"?"Results":"Rezultati"),m(ec,a()==="en"?"The average time for sex determination is 5–10 business days.":"Prosječno vrijeme za određivanje spola je 5–10 radnih dana."),m(ac,a()==="en"?"Results can be sent by mail or email.":"Rezultati mogu biti poslani poštom ili e-mailom."),m(tc,`${(a()==="en"?"Order form for the GENBird test":"Narudžbenica za GENBird test")??""} (PDF)`),m(nc,`${(a()==="en"?"Appendix to the order form for a larger number of samples":"Dodatak narudžbenici za veći broj uzoraka")??""} (PDF)`)}),Pe("click",M,()=>{L(i,!c(i)),L(r,!1),L(l,!1)}),Pe("click",f,()=>{L(i,!1),L(r,!c(r)),L(l,!1)}),Pe("click",O,()=>{L(i,!1),L(r,!1),L(l,!c(l))}),v(o,d)}customElements.define("pb-services",Ge(qp,{},[],[],!1));var Xp=y('<div class="grid grid-large gap-16 items-center spacer"><div class="gc-6 flex flex-col gap-4"><h2 class="h2 font-bold max-w-[24ch]">Global Leaders in High-Throughput Glycomics</h2> <p class="h4">With decades of research and innovation behind us, our team of world-renowned scientists conducts over 80% of all glycan analyses globally. <br><br> From pioneering discoveries to advancing clinical applications, we’re at the forefront of unlocking the power of glycans to transform health.</p> <div><a href="/team" class="button-outlined">Our team</a></div></div> <div class="gc-6"><img src="/images/team.jpg" alt="" class="rounded-lg"></div></div>');function Qp(o){var e=Xp();v(o,e)}customElements.define("pb-we-are",Ge(Qp,{},[],[],!1));var eh=y('<div class="grid grid-large sm:gap-y-6 gap-y-12 gap-x-2 spacer automated"><div class="gc-12"><h2> </h2></div> <div class="gc-3 gc-sm-6"><div class="data-number">300k+</div> <div class="data-label"> </div> <div class="progress-bar" style="background-color: #66AACC;"></div></div> <div class="gc-3 gc-sm-6"><div class="data-number">25k+</div> <div class="data-label"> </div> <div class="progress-bar" style="background-color: #FFDD33;"></div></div> <div class="gc-3 gc-sm-6"><div class="data-number">350+</div> <div class="data-label"> </div> <div class="progress-bar" style="background-color: #66CCCC;"></div></div> <div class="gc-3 gc-sm-6"><div class="data-number">40+</div> <div class="data-label"> </div> <div class="progress-bar" style="background-color: #FF9933;"></div></div></div>');function ah(o){const e=ra(),a=()=>$e(ea,"$language",e);var i=eh(),r=n(i),l=n(r),d=n(l);t(l),t(r);var u=s(r,2),p=s(n(u),2),h=n(p);t(p),De(2),t(u);var j=s(u,2),S=s(n(j),2),G=n(S);t(S),De(2),t(j);var z=s(j,2),M=s(n(z),2),k=n(M);t(M),De(2),t(z);var g=s(z,2),w=s(n(g),2),f=n(w);t(w),De(2),t(g),t(i),A(()=>{m(d,a()==="en"?"Simple and automated scientific solutions for your research or commercial needs.":"Jednostavna i automatizirana znanstvena rješenja za vaša istraživanja ili komercijalne potrebe."),m(h,a()==="en"?"Total samples analysed":"Dosad analiziranih uzoraka"),m(G,a()==="en"?"Samples analysed annually":"Uzoraka analizirano godišnje"),m(k,a()==="en"?"Scientific publications":"Znanstvene publikacije"),m(f,a()==="en"?"Collaboration projects":"Projekti suradnje")}),v(o,i)}customElements.define("pb-automated",Ge(ah,{},[],[],!1));var ih=y('<div class="grid grid-large collaboration"><div class="gc-12"><h2 class="centered" style="max-width: 28ch"> </h2> <picture><source srcset="/partners/projects-mobile.jpg" media="(max-width: 600px)"> <img src="/partners/projects.jpg" alt="projects" class="centered rounded"></picture></div> <div class="gc-12"><h2 class="centered" style="max-width: 42ch"> </h2> <picture><source srcset="/partners/universities-mobile.jpg" media="(max-width: 600px)"> <img src="/partners/universities.jpg" alt="sniversities" class="centered rounded"></picture></div></div>');function oh(o){const e=ra(),a=()=>$e(ea,"$language",e);var i=ih(),r=n(i),l=n(r),d=n(l);t(l),De(2),t(r);var u=s(r,2),p=n(u),h=n(p);t(p),De(2),t(u),t(i),A(()=>{m(d,a()==="en"?"We’ve actively contributed to over 40 scientific projects...":"Aktivno smo sudjelovali u više od 40 znanstvenih projekata..."),m(h,a()==="en"?"...and continue to collaborate with leading academic and research institutions worldwide":"...i nastavljamo surađivati s vodećim akademskim i istraživačkim institucijama diljem svijeta.")}),v(o,i)}customElements.define("pb-collaboration",Ge(oh,{},[],[],!1));var th=y('<div class="grid grid-large labs"><div class="gc-12"><h2 class="title"> </h2> <p class="subtitle"> </p></div> <div class="gc-12"><div class="image-text"><div class="image"><img src="/illustrations/glycomics.jpg" alt=""></div> <div class="text"><h2> </h2> <p class="text-p"> </p> <div><a class="button-filled"> </a></div></div></div></div> <div class="gc-12 spacer"><div class="image-text"><div class="image"><img src="/illustrations/epigenetics.jpg" alt=""></div> <div class="text"><h2> </h2> <p class="text-p"> </p> <div><a class="button-filled"> </a></div></div></div></div> <div class="gc-12 spacer"><div class="image-text"><div class="image"><img src="/illustrations/dna.jpg" alt=""></div> <div class="text"><h2> </h2> <p class="text-p"> </p> <div><a class="button-filled"> </a></div></div></div></div></div>');function nh(o){const e=ra(),a=()=>$e(ea,"$language",e);var i=th(),r=n(i),l=n(r),d=n(l);t(l);var u=s(l,2),p=n(u);t(u),t(r);var h=s(r,2),j=n(h),S=s(n(j),2),G=n(S),z=n(G);t(G);var M=s(G,2),k=n(M);t(M);var g=s(M,2),w=n(g),f=n(w);t(w),t(g),t(S),t(j),t(h);var T=s(h,2),W=n(T),X=s(n(W),2),O=n(X),E=n(O);t(O);var R=s(O,2),U=n(R);t(R);var Q=s(R,2),D=n(Q),_=n(D);t(D),t(Q),t(X),t(W),t(T);var x=s(T,2),b=n(x),I=s(n(b),2),C=n(I),H=n(C);t(C);var Y=s(C,2),ie=n(Y);t(Y);var K=s(Y,2),Z=n(K),F=n(Z);t(Z),t(K),t(I),t(b),t(x),t(i),A(()=>{m(d,a()==="en"?"Services provided by our laboratories":"Usluge koje pružaju naši laboratoriji."),m(p,a()==="en"?"Genos unites expertise in glycomics, glycoproteomics, epigenetics, and DNA analysis to deliver integrated, high-quality solutions for diverse research and commercial applications.":"Genos ujedinjuje stručnost u glikomici, glikoproteomici, epigenetici i DNA analizi kako bi pružio integrirana, visokokvalitetna rješenja za različite istraživačke i komercijalne primjene."),m(z,a()==="en"?"Glycomics & Glycoproteomics":"Glikomika i Glikoproteomika"),m(k,a()==="en"?"Reliable and accurate high-throughput glycan analysis and custom method development.":"Pouzdana i precizna visokoprotočna analiza glikana te razvoj prilagođenih metoda."),B(w,"href",`/${(a()==="en"?"services#1.0.":"usluge#1.0.")??""}`),m(f,a()==="en"?"Glycomic & Glycoproteomic services":"Usluge za Glikomiku i Glikoproteomiku"),m(E,a()==="en"?"Epigenetics":"Epigenetika"),m(U,a()==="en"?"DNA methylation analysis, gene expression profiling, and custom CRISPR/dCas9 tool design.":"Analiza metilacije DNA, profiliranje genske ekspresije i dizajn prilagođenih CRISPR/dCas9 alata."),B(D,"href",a()==="en"?"services#2.0.":"usluge#2.0."),m(_,a()==="en"?"Epigenetics services":"Usluge za epigenetiku"),m(H,a()==="en"?"DNA & Forensics":"DNA i Forenzika"),m(ie,a()==="en"?"Accurate and confidential DNA testing for paternity, kinship, and identity verification.":"Točno i povjerljivo DNA testiranje za utvrđivanje očinstva, srodstva i identiteta."),B(Z,"href",`/${(a()==="en"?"services#3.0.":"usluge#3.0.")??""}`),m(F,a()==="en"?"DNA & Forensics services":"Usluge za DNA i forenziku")}),v(o,i)}customElements.define("pb-labs",Ge(nh,{},[],[],!1));const Ur=[{group:"Founder, CEO, Head of Research Laboratory",members:[{name:"Prof. Gordan Lauc",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Founder, CEO, Head of Research Laboratory",hr:"Osnivač, izvršni direktor, voditelj istraživačkog laboratorija"},img:"lauc",descriptionEn:'Gordan Lauc is a Professor of Biochemistry and Molecular Biology at the University of Zagreb Faculty of Pharmacy and Biochemistry and the founder and CEO of Genos Ltd. <br><br> He is a respected figure in the fields of biochemistry, molecular biology, and glycoscience, with a significant impact on research, education, and international collaborations. <br><br> Dr. Lauc has contributed significantly to the field through his research, publishing over 100 papers in international journals and securing six international patents. <br><br> He is a frequent speaker at international conferences and has been invited as a visiting professor at institutions such as Johns Hopkins University. <br><br> In 2011, he was inducted into the Johns Hopkins Society of Scholars. <br><br> Dr. Lauc has taken on leadership roles, including chairing the "European Science Foundation Exploratory Workshop on Glycoscience," which led to the establishment of the "European Glycoscience Forum." <br><br> He played a key role in preparing the Croatian National Action Plan for increased investment in research and development in 2007. <br><br> Dr. Lauc served as a member of the National Science Council from 2009 to 2013 and held the position of President of the National Council for Natural Sciences. <br><br> Furthermore, Dr. Lauc has been elected as the President-elect of the International Glycoscience Organization and is a member of the Steering Committee of the European Glycoscience Forum. <br><br> In recognition of his contributions, he was appointed as Honorary Professor at the University of Edinburgh in 2012 and as Adjunct Professor at Edith Cowan University in Perth. <br><br> He completed his undergraduate studies in molecular biology at the University of Zagreb Faculty of Science in 1992, followed by a PhD in Biochemistry from the University of Zagreb in 1995. <br><br> Dr. Lauc gained further experience through postdoctoral training at the Institute for Medical Physics and Biophysics in Münster and Johns Hopkins University in Baltimore. <br><br> Since 1993, he has been employed at the Faculty of Pharmacy and Biochemistry in Zagreb. <br><br> During this time, Dr. Lauc also held part-time positions at the University of Osijek School of Medicine, where he founded a DNA laboratory for the identification of war victims. <br><br> Additionally, he served as Vice-Dean for Science from 2001 to 2005.',descriptionHr:"Gordan Lauc je profesor biokemije i molekularne biologije na Farmaceutsko-biokemijskom fakultetu Sveučilišta u Zagrebu te osnivač i direktor tvrtke Genos d.o.o.<br><br>Ugledna je osoba na poljima biokemije, molekularne biologije i glikoznanosti, s velikim utjecajem na istraživanje, obrazovanje i međunarodnu suradnju.<br><br>Dr. Lauc značajno je doprinio ovom području kroz svoja istraživanja, objavivši više od 100 radova u međunarodnim časopisima i osiguravši šest međunarodnih patenata.<br><br>Čest je govornik na međunarodnim konferencijama i gostujući profesor na institucijama poput Sveučilišta Johns Hopkins.<br><br>Godine 2011. primljen je u Johns Hopkins Society of Scholars.<br><br>Dr. Lauc preuzeo je vodeće uloge, uključujući predsjedanje „Exploratory Workshop on Glycoscience“ Europske zaklade za znanost, što je dovelo do osnivanja „Europskog foruma za glikoznanost“.<br><br>Igrao je ključnu ulogu u pripremi Hrvatskog nacionalnog akcijskog plana za povećanje ulaganja u istraživanje i razvoj 2007. godine.<br><br>Dr. Lauc bio je član Nacionalnog vijeća za znanost od 2009. do 2013. te predsjednik Nacionalnog vijeća za prirodne znanosti.<br><br>Također je izabran za predsjednika Međunarodne organizacije za glikoznanost i član je Upravnog odbora Europskog foruma za glikoznanost.<br><br>U znak priznanja za svoje doprinose, 2012. imenovan je počasnim profesorom na Sveučilištu u Edinburghu te izvanrednim profesorom na Sveučilištu Edith Cowan u Perthu.<br><br>Dodiplomski studij molekularne biologije završio je na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu 1992., a doktorat iz biokemije stekao je na Sveučilištu u Zagrebu 1995. godine.<br><br>Daljnje iskustvo stekao je kroz postdoktorsku izobrazbu na Institutu za medicinsku fiziku i biofiziku u Münsteru i na Sveučilištu Johns Hopkins u Baltimoreu.<br><br>Od 1993. zaposlen je na Farmaceutsko-biokemijskom fakultetu u Zagrebu.<br><br>Tijekom tog razdoblja, dr. Lauc je također radio na dijelu radnog vremena na Medicinskom fakultetu Sveučilišta u Osijeku, gdje je osnovao DNA laboratorij za identifikaciju žrtava rata.<br><br>Osim toga, obnašao je dužnost prodekana za znanost od 2001. do 2005. godine."}]},{group:"Vice Head of Research Laboratory",members:[{name:"Maja Pučić Baković",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Vice Head of Research Laboratory",hr:"Zamjenica voditelja istraživačkog laboratorija"},img:"bakovic",descriptionEn:"Maja Pučić Baković joined Genos Ltd. in 2008 as a researcher, and her exceptional contributions and leadership qualities led to her appointment as the Head of the Glycobiology laboratory in 2012. <br><br> In this role, she is responsible for coordinating and supervising lab activities and PhD students, managing project writing and reporting, implementing new procedures, and maintaining lab equipment and supplies. <br><br> In 2018, she assumed the position of Head of Glycoprofiling, where she focuses on method development, managing research within European and national funded projects and grants, and establishing collaborations with potential partners. <br><br> Maja completed her Master's degree in Molecular Biology at the University of Zagreb, Faculty of Science in 2008, and later obtained her PhD in Biochemistry and Molecular Biology from the same university in 2013. <br><br> During her doctoral training, Maja conducted research at renowned institutions such as the Proteomics Core of COBRE Center for Cancer Research and Development at Rhode Island Hospital in Providence, USA, the Biomolecular Mass Spectrometry Unit at the Leiden University Medical Center in Leiden, the Netherlands, and BIA Separations Ltd in Slovenia. <br><br> Her international collaborations and research excellence were recognized through prestigious awards, including the Collaborative Experimental Scholarship from FEBS in 2010, the Young Scientist Award for 2011 from the Croatian Society of Biochemistry and Molecular Biology, and the Best Publication Award for 2011 from the Croatian Immunological Society.",descriptionHr:"Maja Pučić Baković pridružila se tvrtki Genos d.o.o. 2008. godine kao istraživačica, a njezin izniman doprinos i liderske kvalitete doveli su do njezinog imenovanja voditeljicom Laboratorija za glikobiologiju 2012. godine.<br><br>U toj ulozi odgovorna je za koordinaciju i nadzor laboratorijskih aktivnosti i doktoranada, upravljanje pisanjem i izvještavanjem o projektima, implementaciju novih procedura te održavanje laboratorijske opreme i zaliha.<br><br>Godine 2018. preuzela je funkciju voditeljice Odjela za glikoprofiliranje, gdje se fokusira na razvoj metoda, upravljanje istraživanjima unutar europskih i nacionalnih projekata i grantova te uspostavljanje suradnje s potencijalnim partnerima.<br><br>Maja je završila diplomski studij molekularne biologije na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu 2008. godine, a potom stekla doktorat iz biokemije i molekularne biologije na istom sveučilištu 2013. godine.<br><br>Tijekom doktorske izobrazbe, Maja je provodila istraživanja u renomiranim institucijama kao što su Proteomski centar COBRE Centra za istraživanje i razvoj raka u Rhode Island Hospital u Providenceu, SAD, Jedinica za biomolekularnu masenu spektrometriju na Medicinskom centru Sveučilišta u Leidenu, Nizozemska, te BIA Separations d.o.o. u Sloveniji.<br><br>Njezina međunarodna suradnja i istraživačka izvrsnost prepoznati su kroz prestižne nagrade, uključujući Eksperimentalnu stipendiju za suradnju FEBS-a 2010. godine, Nagradu za mladog znanstvenika za 2011. godinu Hrvatskog društva za biokemiju i molekularnu biologiju te Nagradu za najbolju publikaciju za 2011. godinu Hrvatskog imunološkog društva."}]},{group:"Head of Glycomics",members:[{name:"Irena Trbojević Akmačić",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Head of Glycomics",hr:"Voditeljica glikomike"},img:"akmacic",descriptionEn:"Irena Trbojević Akmačić is an accomplished biochemist and analytical chemist, currently serving as the Head of Glycomics at Genos, where she provides scientific and strategic leadership across glycomics technologies, driving innovation and integration of high-throughput analytical platforms in research and commercial projects.<br><br>NIrena began her scientific journey during her graduate studies in chemistry at the Faculty of Science, University of Zagreb, volunteering at the Ruđer Bošković Institute, Laboratory for Molecular Genetics, working on recombinant protein expression, purification, and biochemical characterization; she earned her Master’s degree in chemistry with research on the cloning and isolation of elongation factor Tu from E. coli and its interactions with aminoacylated tRNA^Leu, and received her PhD in Biochemistry in 2015, focusing on the analysis of IgG glycosylation in inflammatory bowel disease; she further expanded her expertise at Johns Hopkins University, Baltimore, and the Max Planck Institute for Dynamics of Complex Technical Systems in Magdeburg, working on glycan analysis methods and MALDI-MS characterization of N-glycans.<br><br>Since joining Genos, Irena has held multiple leadership roles including Deputy Head, Acting Head, Head of the UHPLC Laboratory for Glycan Analysis, and Head of the Laboratory for High-throughput Glycomics, leading a multidisciplinary team on the development, optimization, and application of advanced glycomics workflows; in her current role as Head of Glycomics, she provides cross-platform strategic leadership aligning innovation with Genos’s scientific vision and global collaborations; she has mentored two PhD students and numerous junior researchers, authored/co-authored over 60 scientific publications and book chapters (Google Scholar H-index: 37, >4000 citations), actively contributed to national and EU-funded projects (FP7, H2020), and regularly participates in conferences, symposia, and expert trainings in glycoscience.",descriptionHr:"Irena Trbojević Akmačić je istaknuta biokemičarka i analitička kemičarka, trenutno na poziciji voditeljice glikomike u tvrtki Genos, gdje pruža znanstveno i strateško vodstvo u području glikomike, potičući inovacije i integraciju visokoprotočnih analitičkih platformi u istraživačke i komercijalne projekte.<br><br>Irena je svoj znanstveni put započela tijekom diplomskog studija kemije na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu, volontirajući u Institutu Ruđer Bošković, u Laboratoriju za molekularnu genetiku, gdje je radila na ekspresiji, pročišćavanju i biokemijskoj karakterizaciji rekombinantnih proteina; magistrirala je kemiju istraživanjem kloniranja i izolacije elongacijskog faktora Tu iz E. coli i njegovih interakcija s aminoaciliranim tRNA^Leu, a doktorat iz biokemije stekla je 2015. godine s fokusom na analizu glikozilacije IgG-a kod upalnih bolesti crijeva; dodatno je usavršavala svoje znanje na Sveučilištu Johns Hopkins u Baltimoreu i Institutu Max Planck za dinamiku složenih tehničkih sustava u Magdeburgu, radeći na metodama analize glikana i MALDI-MS karakterizaciji N-glikana.<br><br>Od dolaska u Genos, Irena je obnašala više rukovodećih funkcija, uključujući zamjenicu voditelja, vršiteljicu dužnosti voditeljice, voditeljicu UHPLC laboratorija za analizu glikana te voditeljicu Laboratorija za visokoprotočnu glikomiku, vodeći multidisciplinarni tim u razvoju, optimizaciji i primjeni naprednih glikomičkih metoda; u svojoj trenutnoj ulozi voditeljice glikomike pruža strateško vodstvo kroz različite platforme usklađujući inovacije s Genosovom znanstvenom vizijom i globalnim suradnjama; mentorirala je dvoje doktoranada i brojne mlađe istraživače, autorica je i koautorica više od 60 znanstvenih publikacija i poglavlja u knjigama (Google Scholar H-indeks: 37, >4000 citata), aktivno sudjeluje u nacionalnim i EU projektima (FP7, H2020) te redovito sudjeluje na konferencijama, simpozijima i stručnim usavršavanjima u području glikoznanosti."}]},{group:"Head of",members:[{name:"Tea Pribić",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Head of Glycomics UPLC Laboratory",hr:"Voditeljica UPLC laboratorija glikomike"},img:"pribic",descriptionEn:'Tea Pribić has been an integral part of the Glycoscience Research Laboratory at Genos Ltd in Zagreb, Croatia since 2018. <br><br> In July 2022, she assumed the role of Acting Head of the UPLC Laboratory at Genos, further demonstrating her leadership capabilities and commitment to advancing glycomics research. <br><br> Tea obtained her PhD degree in Biology at the Faculty of Science in 2023, which was focused on IgG glycosylation in COVID-19 disease. <br><br> Tea obtained her Master’s degree in Molecular Biology from the University of Zagreb in 2016. <br><br> She worked on her Master’s Thesis named "Effect of body mass index on in vitro fertilization outcomes in women" at Clinic for Gynecology and Obstetrics, University Hospital Center, Zagreb. <br><br> She volunteered at the Institute for Brain Research in Zagreb from August to November 2017, gaining valuable experience in the field of genetic engineering.',descriptionHr:"Tea Pribić je od 2018. godine sastavni dio Laboratorija za istraživanje glikoznanosti u tvrtki Genos d.o.o. u Zagrebu, Hrvatska.<br><br>U srpnju 2022. preuzela je funkciju vršiteljice dužnosti voditeljice UPLC laboratorija u Genosu, dodatno pokazujući svoje liderske sposobnosti i predanost napretku istraživanja u području glikomike.<br><br>Tea je doktorirala biologiju na Prirodoslovno-matematičkom fakultetu 2023. godine, a njezin doktorat bio je usmjeren na glikozilaciju IgG-a kod bolesti COVID-19.<br><br>Diplomski studij molekularne biologije završila je na Sveučilištu u Zagrebu 2016. godine.<br><br>Svoj diplomski rad pod nazivom „Učinak indeksa tjelesne mase na ishod postupaka izvantjelesne oplodnje kod žena“ izradila je na Klinici za ginekologiju i porodništvo, Kliničkog bolničkog centra Zagreb.<br><br>Od kolovoza do studenog 2017. volontirala je u Institutu za istraživanje mozga u Zagrebu, stekavši vrijedno iskustvo u području genskog inženjeringa."},{name:"Maja Hanić",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Head of Glycomics CGE Laboratory",hr:"Voditeljica CGE laboratorija glikomike"},img:"hanic",descriptionEn:`Maja joined Genos Ltd as a researcher in 2016, specializing in protein glycosylation in humans and mice, as well as the development and optimization of capillary electrophoresis methods for the analysis of N-glycans. <br><br> In 2022, she was appointed Head of the Laboratory for Capillary Electrophoresis. <br><br> In this role, she oversees research activities and the analysis of the first commercially available glycan-based test for biological age. <br><br> She earned her Master of Pharmacy degree in 2015 and her PhD in Medical Biochemistry in 2024 from the University of Zagreb, Faculty of Pharmacy and Biochemistry. <br><br> Her dissertation focused on "Immunoglobulin G glycosylation in the prediction of therapeutic response and during anti-TNF therapy in Crohn's disease."`,descriptionHr:"Maja se pridružila tvrtki Genos d.o.o. kao istraživačica 2016. godine, specijalizirana za glikozilaciju proteina kod ljudi i miševa, kao i za razvoj i optimizaciju metoda kapilarne elektroforeze za analizu N-glikana.<br><br>Godine 2022. imenovana je voditeljicom Laboratorija za kapilarnu elektroforezu.<br><br>U toj ulozi nadzire istraživačke aktivnosti i analizu prvog komercijalno dostupnog testa na bazi glikana za biološku dob.<br><br>Diplomirala je na Farmaceutsko-biokemijskom fakultetu Sveučilišta u Zagrebu 2015. godine, a doktorirala medicinsku biokemiju 2024. godine na istom fakultetu.<br><br>Njezina disertacija bila je usmjerena na „Glikozilaciju imunoglobulina G u predikciji terapijskog odgovora i tijekom anti-TNF terapije kod Crohnove bolesti.“"},{name:"Jerko Štambuk",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Head of Glycomics MS Laboratory",hr:"Voditelj MS laboratorija glikomike"},img:"stambuk-j",descriptionEn:"Jerko Štambuk has been an esteemed member of the Genos Glycoscience Laboratory. <br><br> Jerko's research focuses on glycan analysis utilizing various platforms, including liquid chromatography and mass spectrometry. <br><br> He actively contributes to the development of high throughput methods for glycan and glycopeptide analysis, as well as the implementation of new technologies in glycomics research. <br><br> His dedication and expertise in this field have led him to be a co-author of over 30 original scientific papers, demonstrating his significant contributions to the scientific community. <br><br> Additionally, Jerko has actively participated in numerous conferences, further showcasing his commitment to staying at the forefront of advancements in glycoscience research. <br><br> Jerko completed his undergraduate studies in Molecular Biology at the University of Zagreb, Faculty of Science, in 2011. <br><br> He continued his academic journey and obtained a PhD in Biology, specializing in Biochemistry and Molecular Biology, from the University of Zagreb in 2017. <br><br> In 2024 Jerko was appointed Head of the MS Laboratory.",descriptionHr:"Jerko Štambuk cijenjeni je član Laboratorija za glikoznanost u tvrtki Genos.<br><br>Njegovo istraživanje usmjereno je na analizu glikana korištenjem različitih platformi, uključujući tekućinsku kromatografiju i masenu spektrometriju.<br><br>Aktivno doprinosi razvoju visokoprotočnih metoda za analizu glikana i glikopeptida, kao i implementaciji novih tehnologija u istraživanju glikomike.<br><br>Njegova predanost i stručnost na ovom području rezultirali su suautorstvom više od 30 izvornih znanstvenih radova, što potvrđuje njegov značajan doprinos znanstvenoj zajednici.<br><br>Osim toga, Jerko je aktivno sudjelovao na brojnim konferencijama, dodatno pokazujući svoju predanost praćenju napretka u istraživanju glikoznanosti.<br><br>Preddiplomski studij molekularne biologije završio je na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu 2011. godine.<br><br>Akademski put nastavio je doktoratom iz biologije, s usmjerenjem na biokemiju i molekularnu biologiju, koji je stekao na Sveučilištu u Zagrebu 2017. godine.<br><br>Godine 2024. Jerko je imenovan voditeljem MS laboratorija."},{name:"Prof. Vlatka Zoldoš",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Head of Epigenetics Laboratory",hr:"Voditeljica epigenetskog laboratorija"},img:"zoldos",descriptionEn:"Vlatka Zoldoš, is a full professor of Genetics and Epigenetics at the University of Zagreb Faculty of Science, Department for Biology, Division of Molecular Biology; she received her doctorate in 2000 at the University of Paris, France, through a cotutelle program with the University of Zagreb.<br><br>She is a principal investigator leading the Laboratory for Epigenetics at Genos, with a primary research focus on the epigenetics of protein glycosylation associated with human diseases.<br><br>Her pioneering work in this field led to several high-impact publications, including the first demonstration of epigenetic regulation of plasma protein and IgG glycosylation.<br><br>She and her team were the first to develop CRISPR/dCas9-based molecular tools for targeted DNA methylation/demethylation and applied them to study the regulation of protein glycosylation.<br><br>She is internationally recognized and has participated in numerous large-scale EU-funded research projects.<br><br>She has also mentored over 20 PhD students.",descriptionHr:"Vlatka Zoldoš redovita je profesorica genetike i epigenetike na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu, na Zavodu za biologiju, Odjelu za molekularnu biologiju; doktorirala je 2000. godine na Sveučilištu u Parizu, Francuska, kroz cotutelle program sa Sveučilištem u Zagrebu.<br><br>Voditeljica je Laboratorija za epigenetiku u Genosu, gdje kao glavna istraživačica vodi istraživanja usmjerena na epigenetiku glikozilacije proteina povezane s ljudskim bolestima.<br><br>Njezina pionirska istraživanja na ovom području rezultirala su nizom značajnih publikacija, uključujući prvo otkriće epigenetske regulacije glikozilacije plazmatskih proteina i IgG-a.<br><br>Ona i njezin tim prvi su razvili molekularne alate temeljene na CRISPR/dCas9 tehnologiji za ciljanje metilacije/demetilacije DNA, koje su primijenili za proučavanje regulacije glikozilacije proteina.<br><br>Međunarodno je priznata znanstvenica i sudjelovala je u brojnim velikim istraživačkim projektima financiranim iz fondova EU-a.<br><br>Dosad je mentorirala više od 20 doktoranada."},{name:"Frano Vučković",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Head of Data Analysis",hr:"Voditelj analize podataka"},img:"vuckovic",descriptionEn:"Frano Vučković is the head of the Data Analysis Team at Genos. <br><br> His work primarily focuses on the development of new models for integrative analysis of glycomics and other -omics data, particularly as part of the MIMOmics and IBD-BIOM projects. <br><br> One of his key research interests involves the development of normalization and batch correction methods for high-throughput glycomics data, aiming to ensure accurate and reliable results. <br><br> Additionally, he is actively involved in studying the regulation of IgG N-glycosylation in autoimmune diseases. <br><br> In 2013, Frano embarked on a research visit to Polyomica Ltd. in the Netherlands, where he honed his skills in modeling experimental variation using advanced statistical approaches, including generalized mixed models and empirical Bayes methods. <br><br> Frano completed his undergraduate studies in Molecular Biology at the University of Zagreb, Faculty of Science in 2012. <br><br> He went on to obtain his doctoral degree in Molecular Biology from the same university in 2016. <br><br> Since 2012, he has been a valued member of Genos Ltd., where he serves as a data analyst and researcher in the Glycoscience Laboratory.",descriptionHr:"Frano Vučković voditelj je Tima za analizu podataka u tvrtki Genos.<br><br>Njegov rad prvenstveno je usmjeren na razvoj novih modela za integrativnu analizu glikomike i drugih -omika podataka, osobito u sklopu projekata MIMOmics i IBD-BIOM.<br><br>Jedno od njegovih ključnih istraživačkih interesa uključuje razvoj metoda za normalizaciju i korekciju serija u visokoprotočnim glikomičkim podacima, s ciljem osiguravanja točnih i pouzdanih rezultata.<br><br>Dodatno, aktivno sudjeluje u proučavanju regulacije N-glikozilacije IgG-a kod autoimunih bolesti.<br><br>Godine 2013. Frano je boravio na istraživačkoj posjeti tvrtki Polyomica Ltd. u Nizozemskoj, gdje je usavršavao vještine modeliranja eksperimentalne varijacije koristeći napredne statističke pristupe, uključujući generalizirane mješovite modele i metode empirijskog Bayesa.<br><br>Preddiplomski studij molekularne biologije završio je na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu 2012. godine.<br><br>Doktorirao je molekularnu biologiju na istom sveučilištu 2016. godine.<br><br>Od 2012. godine cijenjeni je član tvrtke Genos d.o.o., gdje radi kao analitičar podataka i istraživač u Laboratoriju za glikoznanost."},{name:"Nina Šimunić Briški",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Head of Translational Research",hr:"Voditeljica translacijskih istraživanja"},img:"briski",descriptionEn:"Nina Šimunić Briški started working at Genos in 2014, where she worked across several areas, including project management, marketing, and research. <br><br> In the early stages of her PhD, Nina was awarded the IRCRO research grant to investigate the genetic components of soft tissue injuries, specifically within the field of sports genetics. <br><br> This research aimed to uncover the genetic predispositions that contribute to soft tissue injuries in athletes. <br><br> After transitioning into glycobiology, she shifted her focus to studying the impact of the intensity of physical activity and dietary interventions on Immunoglobulin G N-glycosylation. <br><br> This research, which involved different populations, was funded by grants from the Centre of Competence and the Croatian Science Foundation. <br><br> Nina holds an M.Eng. degree in Molecular Biotechnology from the University of Zagreb, Faculty of Food Technology and Biotechnology, which she obtained in 2010. <br><br> During that time, she was awarded two scholarships for her academic excellence—the National Scholarship and the Pliva Ltd. Scholarship. <br><br> During her studies and following her graduation, she worked on two cancer biology research projects in Germany, which further broadened her expertise in molecular biology. <br><br> From 2011 to 2014, Nina worked in the R&D department of the FMCG industry, where she applied her technical knowledge in a practical business setting. <br><br> This experience also allowed her to pursue dual degrees: an M.Sc. in Strategic Management from the Kelley School of Business, Indiana University, USA, and an MBA degree in Marketing and Finance from the Institute of Economics in Zagreb, Croatia. <br><br> In 2024, Nina successfully defended her PhD thesis at the Faculty of Science, University of Zagreb. <br><br> Nina is currently engaged in multiple research projects focusing on exercise and nutrition interventions, healthy aging, and more recently, neuroglycobiology. <br><br> Additionally, she is actively working on establishing new research collaborations.",descriptionHr:"Nina Šimunić Briški započela je rad u tvrtki Genos 2014. godine, gdje je radila na različitim područjima, uključujući upravljanje projektima, marketing i istraživanje.<br><br>U ranim fazama svog doktorata, Nina je dobila IRCRO istraživački grant za proučavanje genetskih čimbenika ozljeda mekih tkiva, posebno unutar područja sportske genetike.<br><br>Ovo je istraživanje imalo za cilj otkriti genetske predispozicije koje doprinose ozljedama mekih tkiva kod sportaša.<br><br>Nakon prelaska u glikobiologiju, svoj je fokus preusmjerila na proučavanje utjecaja intenziteta tjelesne aktivnosti i prehrambenih intervencija na N-glikozilaciju imunoglobulina G.<br><br>Ovo je istraživanje, koje je uključivalo različite populacije, financirano grantovima Centra kompetencija i Hrvatske zaklade za znanost.<br><br>Nina je diplomirala molekularnu biotehnologiju (mag. ing.) na Prehrambeno-biotehnološkom fakultetu Sveučilišta u Zagrebu 2010. godine.<br><br>Tijekom studija dobila je dvije stipendije za izvrsnost — Nacionalnu stipendiju i Plivinu stipendiju.<br><br>Tijekom studija i nakon diplome, radila je na dva istraživačka projekta iz biologije raka u Njemačkoj, što je dodatno proširilo njezino znanje iz molekularne biologije.<br><br>Od 2011. do 2014. radila je u odjelu za istraživanje i razvoj industrije robe široke potrošnje, gdje je primjenjivala svoje tehničko znanje u poslovnom okruženju.<br><br>To joj je također omogućilo stjecanje dvostrukih diploma: magisterija znanosti iz strateškog menadžmenta na Kelley School of Business, Sveučilišta Indiana, SAD, te MBA diplome iz marketinga i financija na Ekonomskom institutu u Zagrebu, Hrvatska.<br><br>Godine 2024. Nina je uspješno obranila doktorsku disertaciju na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu.<br><br>Trenutno sudjeluje u više istraživačkih projekata usmjerenih na intervencije vježbanjem i prehranom, zdravo starenje i, u novije vrijeme, neuroglikobiologiju.<br><br>Dodatno, aktivno radi na uspostavljanju novih istraživačkih suradnji."}]},{group:"Lead researcher",members:[{name:"Anđelo Beletić",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Lead Researcher",hr:"Vodeći istraživač"},img:"beletic",descriptionEn:"Anđelo Beletić holds a Master of Pharmacy-Medical Biochemist degree (2002) from the Faculty of Pharmacy, University of Belgrade, Serbia. <br><br> He obtained his Specialist in Medical Biochemistry title (2012) and a PhD in Medical Sciences-Pharmacy (2014) from the same institution. <br><br> The European Federation of Clinical Chemistry and Laboratory Medicine assigned him a European Specialist of Laboratory Medicine certificate in 2022. <br><br> Following his engagement at the Faculty of Pharmacy, University of Belgrade, Serbia, the University Clinical Center of Serbia, and the Faculty of Veterinary Medicine, University of Zagreb, Croatia, he joined Genos in 2023. <br><br> His professional and scientific expertise covers the fields of Human and Veterinary Laboratory Medicine, proteomic research, and canine vector-borne diseases. <br><br> His publication record contains more than 30 articles. Besides, he serves as an Assistant Editor of Biochemia Medica, the official journal of the Croatian Society of Medical Biochemistry and Laboratory Medicine.",descriptionHr:"Anđelo Beletić magistrirao je farmaciju – medicinsku biokemiju 2002. godine na Farmaceutskom fakultetu Sveučilišta u Beogradu, Srbija.<br><br>Titulu specijalista medicinske biokemije stekao je 2012., a doktorat iz medicinskih znanosti – farmacije 2014. godine na istoj instituciji.<br><br>Europska federacija za kliničku kemiju i laboratorijsku medicinu dodijelila mu je 2022. godine certifikat europskog specijalista laboratorijske medicine.<br><br>Nakon angažmana na Farmaceutskom fakultetu Sveučilišta u Beogradu, Kliničkom centru Srbije i Veterinarskom fakultetu Sveučilišta u Zagrebu, Hrvatskoj, pridružio se Genosu 2023. godine.<br><br>Njegova stručnost i znanstveni interesi obuhvaćaju područja humane i veterinarske laboratorijske medicine, proteomskih istraživanja i bolesti pasa koje prenose vektori.<br><br>Autor je više od 30 znanstvenih radova. Osim toga, obnaša funkciju pomoćnog urednika časopisa *Biochemia Medica*, službenog glasila Hrvatskog društva za medicinsku biokemiju i laboratorijsku medicinu."},{name:"Ivan Gudelj",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Lead Researcher",hr:"Vodeći istraživač"},img:"gudelj",descriptionEn:`Ivan Gudelj actively contributes to the Pain-OMICS project, investigating glycosylation changes in patients with low-back pain, and the Brain Glycome project, which aims to advance methods for analyzing protein glycosylation in the brain. <br><br> With expertise in analytical glycobiology, specifically, UPLC and MALDI-TOF-MS analysis of N-glycans, his research interests encompass the analysis of brain glycosylation across regions and development, as well as the comparison of the brain glycome among different species. <br><br> Ivan obtained his Master of Pharmacy degree from the University of Zagreb, Faculty of Pharmacy and Biochemistry (2013), and a Ph.D. in Chemistry from the Faculty of Science (2017), where his dissertation focused on the "Evolutionary and spatio-temporal comparison of the brain N-glycoms." <br><br> He received notable accolades, including the Rector's award in 2012 and the Dean's award in 2013.`,descriptionHr:"Ivan Gudelj aktivno doprinosi projektu Pain-OMICS, istražujući promjene u glikozilaciji kod pacijenata s bolovima u donjem dijelu leđa, te projektu Brain Glycome, koji ima za cilj unaprijediti metode analize glikozilacije proteina u mozgu.<br><br>Sa stručnosti u analitičkoj glikobiologiji, posebno u UPLC i MALDI-TOF-MS analizi N-glikana, njegovi istraživački interesi obuhvaćaju analizu glikozilacije mozga kroz različite regije i razvojne faze, kao i usporedbe glikomova mozga među različitim vrstama.<br><br>Ivan je diplomirao na Farmaceutsko-biokemijskom fakultetu Sveučilišta u Zagrebu 2013. godine, a doktorirao kemiju na Prirodoslovno-matematičkom fakultetu 2017. godine, s disertacijom na temu „Evolucijska i prostorno-vremenska usporedba N-glikomova mozga“.<br><br>Dobitnik je značajnih priznanja, uključujući Rektorovu nagradu 2012. i Dekanovu nagradu 2013. godine."},{name:"Thomas Klarić",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Lead Researcher",hr:"Vodeći istraživač"},img:"klaric",descriptionEn:"Since 2020, Thomas Klarić has rejoined Genos Ltd., utilizing his extensive expertise in glycan analysis to tackle cutting-edge research questions in the field of neuroglycobiology. <br><br> During his postdoctoral years, Thomas focused on investigating the efficacy of stem cell therapy for stroke treatment using rodent models. <br><br> His dedication and expertise led him to be awarded a prestigious NewFelPro postdoctoral fellowship in 2014 as part of the FP7 Marie Skłodowska-Curie Actions initiative. <br><br> In his fellowship at Genos Ltd., Thomas played a crucial role in the Human Neuroglycome Project, utilizing liquid chromatography and mass spectrometry to examine the spatiotemporal profile of N-glycosylation in the human brain. <br><br> In 2018, he was granted a Fulbright fellowship, allowing him to pursue postdoctoral training at the Yale University School of Medicine. His research at Yale focused on unraveling the mechanisms of transcriptional control during mouse neurodevelopment. <br><br> Thomas graduated from the University of Adelaide in 2005, earning a Bachelor of Biotechnology (Honours) and went on to complete his Ph.D. from the School of Molecular and Biomedical Science at the same institution in 2012.",descriptionHr:"Od 2020. godine Thomas Klarić ponovno je član tima u tvrtki Genos d.o.o., gdje koristi svoje bogato iskustvo u analizi glikana za istraživanje najnovijih znanstvenih pitanja u području neuroglikobiologije.<br><br>Tijekom postdoktorata, Thomas se fokusirao na ispitivanje učinkovitosti terapije matičnim stanicama za liječenje moždanog udara koristeći modele na glodavcima.<br><br>Njegova predanost i stručnost donijele su mu prestižnu postdoktorsku stipendiju NewFelPro 2014. godine, u sklopu inicijative FP7 Marie Skłodowska-Curie Actions.<br><br>U okviru ove stipendije u Genosu, Thomas je imao ključnu ulogu u projektu Human Neuroglycome, gdje je koristio tekućinsku kromatografiju i masenu spektrometriju za ispitivanje prostorno-vremenskog profila N-glikozilacije u ljudskom mozgu.<br><br>Godine 2018. dobio je Fulbrightovu stipendiju, koja mu je omogućila postdoktorsko usavršavanje na Medicinskom fakultetu Sveučilišta Yale. Njegovo istraživanje na Yaleu bilo je usmjereno na razotkrivanje mehanizama transkripcijske kontrole tijekom neurorazvoja miševa.<br><br>Thomas je diplomirao biotehnologiju s pohvalom (Bachelor of Biotechnology, Honours) na Sveučilištu u Adelaideu 2005. godine, a doktorirao je na Školi za molekularne i biomedicinske znanosti istog sveučilišta 2012. godine."},{name:"Jasminka Krištić",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Lead Researcher",hr:"Vodeća istraživačica"},img:"kristic",descriptionEn:"With over a decade of experience, Jasminka has specialized in analytical glycobiology, particularly in UPLC analysis of N-glycans. <br><br> Her research focuses on the analysis of age-related changes in IgG glycosylation and the genetic regulation of protein N-glycosylation. <br><br> In addition to her expertise in glycobiology, she has a strong background in DNA analysis techniques and has worked in DNA laboratories. <br><br> Jasminka's commitment to excellence has been recognized with a best poster award at the prestigious EMBO workshop on Glycobiology in Lisbon in 2014. <br><br> She has also honed her skills through international collaborations, including training and research visits to laboratories in the Netherlands (Nijmegen) and Scotland (Edinburgh) as part of various international projects. <br><br> Jasminka completed her undergraduate studies in Molecular Biology at the University of Zagreb, Faculty of Science in 2011 and earned her PhD in Natural Sciences (Biology) from the University of Zagreb in 2018.",descriptionHr:"S više od deset godina iskustva, Jasminka se specijalizirala za analitičku glikobiologiju, posebno u UPLC analizi N-glikana.<br><br>Njezino istraživanje fokusirano je na analizu promjena u glikozilaciji IgG-a povezanih sa starenjem te na genetsku regulaciju N-glikozilacije proteina.<br><br>Uz stručnost u glikobiologiji, ima i snažnu pozadinu u tehnikama analize DNA te je radila u DNA laboratorijima.<br><br>Jasminkin predan rad prepoznat je nagradom za najbolji poster na prestižnoj EMBO radionici o glikobiologiji u Lisabonu 2014. godine.<br><br>Svoje vještine dodatno je usavršavala kroz međunarodne suradnje, uključujući edukacije i istraživačke boravke u laboratorijima u Nizozemskoj (Nijmegen) i Škotskoj (Edinburgh), u sklopu različitih međunarodnih projekata.<br><br>Jasminka je završila preddiplomski studij molekularne biologije na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu 2011. godine, a doktorirala prirodne znanosti (biologiju) na istom sveučilištu 2018. godine."},{name:"Andrea Skelin",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Lead Researcher",hr:"Vodeća istraživačica"},img:"skelin",descriptionEn:"Dr. Andrea Skelin joined the research team at Genos in October 2014, where she continues to contribute her expertise to various research projects. <br><br> She worked at the Department of Microbiology, Faculty of Agriculture from November 1997 to 2014, achieving the position of assistant professor in the Biotechnical area. <br><br> In 2007, she pursued doctoral training at the University of Ljubljana, Slovenia, and conducted research at the Institute for Soil Ecology, Helmholtz Zentrum Munchen, Germany, in 2009. <br><br> Andrea expanded her knowledge by completing a Food Safety course at Michigan State University, USA, in 2004. <br><br> As a lecturer at the University of Zagreb, Faculty of Agriculture, she coordinates and participates in undergraduate and postgraduate courses. <br><br> She has authored and co-authored 14 scientific papers and has actively engaged in numerous conferences. <br><br> Andrea completed her undergraduate studies in Molecular Biology at the University of Zagreb, Faculty of Science, in 1997, and went on to defend her master's thesis in 2003 and doctoral thesis in 2010 in Biotechnical Sciences from the University of Zagreb.",descriptionHr:"Dr. Andrea Skelin pridružila se istraživačkom timu u tvrtki Genos u listopadu 2014. godine, gdje i dalje doprinosi svojim znanjem različitim istraživačkim projektima.<br><br>Od studenog 1997. do 2014. radila je na Zavodu za mikrobiologiju Agronomskog fakulteta, gdje je stekla zvanje docentice u biotehničkom području.<br><br>Godine 2007. započela je doktorsku izobrazbu na Sveučilištu u Ljubljani, Slovenija, a 2009. provela je istraživanje na Institutu za ekologiju tla, Helmholtz Zentrum München, Njemačka.<br><br>Svoje znanje dodatno je proširila završetkom tečaja o sigurnosti hrane na Državnom sveučilištu Michigan, SAD, 2004. godine.<br><br>Kao predavačica na Agronomskom fakultetu Sveučilišta u Zagrebu, koordinira i sudjeluje u izvođenju kolegija na preddiplomskoj i poslijediplomskoj razini.<br><br>Autorica je i koautorica 14 znanstvenih radova te je aktivno sudjelovala na brojnim konferencijama.<br><br>Preddiplomski studij molekularne biologije završila je na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu 1997. godine, a potom je obranila magistarski rad 2003. i doktorsku disertaciju 2010. godine iz biotehničkih znanosti na Sveučilištu u Zagrebu."},{name:"Tamara Štambuk",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Lead Researcher",hr:"Vodeća istraživačica"},img:"stambuk",descriptionEn:"Tamara is a lead researcher who has made significant contributions to diabetes research. <br><br> After initially joining Genos in 2013 as a young researcher, she collaborated with Professor Lauc's group at the Faculty of Pharmacy and Biochemistry, University of Zagreb. <br><br> Returning to Genos in 2020, Tamara now leads research focused on monitoring glycosylation aberrations in diabetes and exploring the potential use of glycan changes as biomarkers. <br><br> With an MPharm degree from the Faculty of Pharmacy and Biochemistry and a PhD in Biochemistry from the Faculty of Science, both at the University of Zagreb, Tamara's expertise is complemented by her training at the Oxford Centre for Diabetes, Endocrinology, and Metabolism and the Max Planck Institute of Colloids and Interfaces. <br><br> She has received recognition for her work, including the annual award from the Society of University Teachers and Other Scientists. <br><br> Tamara's dedication to scientific advancement is demonstrated through her participation in multiple projects and conferences, contributing to her extensive knowledge in the field.",descriptionHr:"Dr. Andrea Skelin pridružila se istraživačkom timu u tvrtki Genos u listopadu 2014. godine, gdje i dalje doprinosi svojim znanjem različitim istraživačkim projektima.<br><br>Od studenog 1997. do 2014. radila je na Zavodu za mikrobiologiju Agronomskog fakulteta, gdje je stekla zvanje docentice u biotehničkom području.<br><br>Godine 2007. započela je doktorsku izobrazbu na Sveučilištu u Ljubljani, Slovenija, a 2009. provela je istraživanje na Institutu za ekologiju tla, Helmholtz Zentrum München, Njemačka.<br><br>Svoje znanje dodatno je proširila završetkom tečaja o sigurnosti hrane na Državnom sveučilištu Michigan, SAD, 2004. godine.<br><br>Kao predavačica na Agronomskom fakultetu Sveučilišta u Zagrebu, koordinira i sudjeluje u izvođenju kolegija na preddiplomskoj i poslijediplomskoj razini.<br><br>Autorica je i koautorica 14 znanstvenih radova te je aktivno sudjelovala na brojnim konferencijama.<br><br>Preddiplomski studij molekularne biologije završila je na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu 1997. godine, a potom je obranila magistarski rad 2003. i doktorsku disertaciju 2010. godine iz biotehničkih znanosti na Sveučilištu u Zagrebu."}]},{group:"Senior researcher",members:[{name:"Iwona Borošak",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Senior Researcher",hr:"Viša istraživačica"},img:"borosak",descriptionEn:"Iwona Borošak, obtained her master’s degree in Biotechnology from Jagiellonian University in Kraków, Poland. During her master’s she specialized in proteomics and mass spectrometry while focusing her research on the proteomic analysis of Staphylococcus aureus virulence factors. In 2017, she was awarded the prestigious Marie Skłodowska-Curie Fellowship, joining Genos as an Early-Stage Researcher and commencing the interdisciplinary European Industrial Doctorate programme at Leiden University Medical Centre (LUMC) in the Netherlands. During her doctoral studies, she focused on the glycosylation analysis of immune-related molecules, mapping the N-glycosylation of Fc gamma receptor IIIb and analysing subclass-specific IgG N-glycosylation in various pathological conditions. Her research led to several publications in peer-reviewed journals. In 2024, she defended her PhD and currently works as a Senior Researcher at Genos Ltd., where she is advancing her understanding of glycans as potential biomarkers and leveraging high-throughput glycomic and glycoproteomic techniques. Her scientific interests include glycobiology, mass spectrometry, proteomics, protein chemistry, and biomarker discovery.",descriptionHr:"Iwona Borošak magistrirala je biotehnologiju na Jagelonskom sveučilištu u Krakovu, Poljska. Tijekom diplomskog studija specijalizirala se za proteomiku i masenu spektrometriju, a istraživački rad usmjerila je na proteomsku analizu čimbenika virulencije bakterije *Staphylococcus aureus*.<br><br>Godine 2017. dobila je prestižnu Marie Skłodowska-Curie stipendiju, nakon čega se pridružila tvrtki Genos kao istraživačica na početku karijere i započela interdisciplinarni europski industrijski doktorski program na Medicinskom centru Sveučilišta u Leidenu (LUMC) u Nizozemskoj.<br><br>Tijekom doktorskog studija fokusirala se na analizu glikozilacije molekula povezanih s imunosnim sustavom, kartirajući N-glikozilaciju Fc gamma receptora IIIb i analizirajući specifičnu glikozilaciju IgG podklasa u različitim patološkim stanjima. Njezino je istraživanje rezultiralo nizom publikacija u recenziranim znanstvenim časopisima.<br><br>Godine 2024. obranila je doktorsku disertaciju, a trenutno radi kao viša istraživačica u Genosu, gdje produbljuje razumijevanje glikana kao potencijalnih biomarkera i koristi visokoprotočne glikomičke i glikoproteomičke tehnike.<br><br>Njezini znanstveni interesi uključuju glikobiologiju, masenu spektrometriju, proteomiku, kemiju proteina i otkrivanje biomarkera."},{name:"Ana Cindrić",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Senior Researcher",hr:"Viša istraživačica"},img:"cindric",descriptionEn:"Ana Cindrić is a senior researcher at Genos, specializing in the analysis of protein glycosylation, with a focus on utilizing high-throughput methods to study N-glycans. In addition to her research, she is actively involved in scientific writing, student mentorship, and project management. Ana earned her doctoral degree in Biology in 2024 and a Master's degree in Molecular Biology in 2019, both from the University of Zagreb, Faculty of Science. Her research at Genos Ltd. for both her doctoral and master's theses explored IgG glycosylation in Down syndrome. Ana gained valuable experience through traineeships in molecular evolution at the University of Zagreb and Heinrich-Heine University in Düsseldorf, Germany, and spent six months as a research associate at Queen Mary University in London, where she received training in molecular methods and tissue culture techniques, including the establishment and analysis of brain organoids.",descriptionHr:"Ana Cindrić je viša istraživačica u tvrtki Genos, specijalizirana za analizu glikozilacije proteina, s naglaskom na primjenu visokoprotočnih metoda u istraživanju N-glikana. Osim istraživačkog rada, aktivno sudjeluje u znanstvenom pisanju, mentoriranju studenata i upravljanju projektima.<br><br>Ana je doktorirala biologiju 2024. godine, a magisterij iz molekularne biologije stekla je 2019. godine, obje diplome na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu. Istraživanje za svoj diplomski i doktorski rad provodila je u Genosu, s fokusom na glikozilaciju IgG-a kod Downovog sindroma.<br><br>Vrijedno iskustvo stekla je kroz stručne prakse iz molekularne evolucije na Sveučilištu u Zagrebu i Sveučilištu Heinrich-Heine u Düsseldorfu, Njemačka, te kroz šestomjesečni angažman kao istraživačica na Sveučilištu Queen Mary u Londonu, gdje je prošla edukaciju iz molekularnih metoda i tehnika rada s tkivnim kulturama, uključujući uspostavu i analizu moždanih organoida."},{name:"Nika Foglar",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Senior Researcher",hr:"Viša istraživačica"},img:"foglar",descriptionEn:"Nika Foglar joined the Genos team as a researcher in 2024, where she focuses on the epigenetic mechanisms involved in the regulation of gene expression. Her project focuses on the interplay of different epigenetic modifications and long-term increase in DNA methylation for silencing gene expression, through simultaneous manipulation of DNA methylation and histone modifications using the CRISPR/dCas9 system. <br><br> Nika was granted an Erasmus+ scholarship to do her master's thesis research in the Dr. Magdalena Götz lab in Munich, under the mentorship of Dr. Miriam Esgleas. She obtained her master's degree in molecular biology at the University of Zagreb, Faculty of Science, in 2020. In the same year, she started her PhD in the group for Epigenetics led by Professor Vlatka Zoldoš. She expanded the modular CRISPR/dCas9 toolbox with new histone-modifying domains to study how different epigenetic modifications interact and affect the expression of genes involved in epithelial to mesenchymal transition in liver cancer cells. She defended the PhD in 2024 at the Faculty of Science, University of Zagreb.",descriptionHr:"Nika Foglar pridružila se timu Genosa kao istraživačica 2024. godine, gdje se fokusira na epigenetske mehanizme u regulaciji genske ekspresije. Njezin projekt bavi se međudjelovanjem različitih epigenetskih modifikacija i dugoročnim povećanjem metilacije DNA s ciljem utišavanja ekspresije gena, putem simultane manipulacije metilacijom DNA i modifikacijama histona korištenjem CRISPR/dCas9 sustava.<br><br>Nika je dobila Erasmus+ stipendiju za izradu diplomskog rada u laboratoriju dr. Magdalene Götz u Münchenu, pod mentorstvom dr. Miriam Esgleas. Magistrirala je molekularnu biologiju na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu 2020. godine. Iste godine započela je doktorski studij u grupi za epigenetiku koju vodi profesorica Vlatka Zoldoš.<br><br>Tijekom doktorata proširila je modularni CRISPR/dCas9 alat novim domenama za modifikaciju histona kako bi proučila kako različite epigenetske modifikacije međusobno djeluju i utječu na ekspresiju gena uključenih u epitelno-mezenhimalnu tranziciju u stanicama raka jetre. Doktorsku disertaciju obranila je 2024. godine na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu."},{name:"Azra Frkatović-Hodžić",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Senior Researcher",hr:"Viša istraživačica"},img:"frkatovic",descriptionEn:"Azra Frkatović-Hodžić joined Genos in 2018 as an early-stage researcher and became involved in the IMforFUTURE training network. Azra completed her Ph.D. in 2022, which involved using computational approaches to investigate the genetic basis of IgG glycosylation. She now applies her expertise at Genos, primarily conducting genome-wide association studies and analyzing glycan data from diverse cohorts. <br><br> Azra holds a Master's degree in Genetics from the Department of Genetics and Bioengineering at Burch University in Sarajevo, Bosnia and Herzegovina, which she obtained in 2017. Her research during her studies involved genetic markers for oral inflammatory lesions.",descriptionHr:"Azra Frkatović-Hodžić pridružila se tvrtki Genos 2018. godine kao istraživačica na početku karijere i uključila se u obrazovnu mrežu IMforFUTURE. Doktorirala je 2022. godine, a njezin doktorski rad bio je usmjeren na korištenje računalnih pristupa za istraživanje genetske osnove glikozilacije IgG-a. Danas svoju stručnost primjenjuje u Genosu, gdje se prvenstveno bavi analizom podataka glikana iz različitih kohorti te provođenjem genomskih studija asocijacije (GWAS).<br><br>Azra je magistrirala genetiku na Odsjeku za genetiku i bioinženjering na Burch University u Sarajevu, Bosna i Hercegovina, 2017. godine. Tijekom studija bavila se istraživanjem genetskih markera za upalne promjene usne šupljine."},{name:"Tomislav Friganović",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Senior Researcher",hr:"Viši istraživač"},img:"friganovic",descriptionEn:"Tomislav holds a Bachelor’s and a Master’s degree in Chemistry from the Faculty of Science, University of Zagreb, with a specialization in Inorganic and Physical Chemistry. <br><br> He has worked as a research assistant at the Faculty of Pharmacy and Biochemistry, University of Zagreb, and as an expert associate at the Department of Physics, Faculty of Science, University of Zagreb. <br><br> His scientific background primarily includes fluorescence spectroscopy, particularly attenuation corrections and microplate reader applications, as well as glycochemistry, with a focus on studying the thermodynamics of human transferrin glycoforms binding with iron(III) chelates. <br><br> He also has substantial experience in liquid chromatography.",descriptionHr:"Tomislav je diplomirao i magistrirao kemiju na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu, s usmjerenjem na anorgansku i fizikalnu kemiju.<br><br>Radio je kao znanstveni asistent na Farmaceutsko-biokemijskom fakultetu Sveučilišta u Zagrebu te kao stručni suradnik na Fizičkom odsjeku Prirodoslovno-matematičkog fakulteta Sveučilišta u Zagrebu.<br><br>Njegovo znanstveno područje prvenstveno obuhvaća fluorescencijsku spektroskopiju, osobito korekcije atenuacije i primjenu mikroploča, kao i glikokemiju, s fokusom na proučavanje termodinamike vezanja glikoformi humanog transferina s kelatima željeza(III).<br><br>Uz to, ima značajno iskustvo u području tekućinske kromatografije."},{name:"Siniša Habazin",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Senior Researcher",hr:"Viši istraživač"},img:"habazin",descriptionEn:"Siniša obtained an MSc degree in environmental science in 2014 and a PhD degree in biology in 2025 from the University of Zagreb, Faculty of Science, Department of Biology. In 2016, he was a trainee in forensic toxicology at the Forensic Science Centre ‘Ivan Vučetić’, Ministry of the Interior of the Republic of Croatia, gaining hands-on experience in instrumental analytical chemistry, particularly GC-MS and HPLC. In 2017, he passed the state examination for forensic examiners and was employed as a senior technician at the Laboratory for Biomimetic Chemistry, Ruđer Bošković Institute, Zagreb. His current research focuses on mass spectrometry-based glycoanalytics, with particular interest in the glycobiology of unique animal models like the naked mole-rat.",descriptionHr:"Siniša je magistrirao znanosti o okolišu 2014. godine, a doktorirao biologiju 2025. godine na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu, na Odsjeku za biologiju.<br><br>Godine 2016. bio je polaznik stručne prakse iz forenzičke toksikologije u Centru za forenzična ispitivanja, istraživanja i vještačenja „Ivan Vučetić“ pri Ministarstvu unutarnjih poslova Republike Hrvatske, gdje je stekao praktično iskustvo u instrumentalnoj analitičkoj kemiji, posebno u tehnikama GC-MS i HPLC.<br><br>Godine 2017. položio je državni ispit za forenzične vještake te se zaposlio kao viši tehničar u Laboratoriju za biomimetičku kemiju na Institutu Ruđer Bošković u Zagrebu.<br><br>Njegovo trenutno istraživanje usmjereno je na glikoanalitiku temeljenu na masenoj spektrometriji, s posebnim interesom za glikobiologiju jedinstvenih životinjskih modela poput gole krtice (naked mole-rat)."},{name:"Goran Josipović",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Senior Researcher",hr:"Viši istraživač"},img:"josipovic",descriptionEn:`Goran Josipović has been employed in the Genos Glycoscience Research Laboratory since July 2021, where he continues studying the epigenetic regulatory mechanisms of gene expression involved in epithelial-mesenchymal transition and glycosylation. His current project focuses on the targeted manipulation of DNA methylation and histone post-translational marks using CRISPR/dCas9 technology to understand their complex interplay. Additionally, he is investigating the influence of induced post-translational histone marks on the establishment and maintenance of DNA methylation. <br><br> Goran completed his Master’s degree in Molecular Biology at the Faculty of Science, University of Zagreb, in 2016 under the mentorship of Prof. Vlatka Zoldoš. He continued working at the same faculty as a collaborator on the Horizon 2020 project "Systems Medicine Approach to Chronic Inflammatory Disease" and earned his PhD in Biology in May 2021. His doctoral thesis, entitled "Design of CRISPR/dCas9 Modular System Using Orthogonal Cas9 Proteins and Its Application in Epigenetic Manipulation of Gene Loci," involved the development of a modular CRISPR/dCas9 toolbox using two orthologous Cas9 proteins from Streptococcus pyogenes and Staphylococcus aureus, which was published in Nucleic Acids Research. Throughout his career, Goran has received several awards, including the Dean's Award for scientific and professional success and the Young Scientists Award from The Croatian Society of Biochemistry and Molecular Biology (HDBMB) in 2019.`,descriptionHr:'Goran Josipović zaposlen je u Laboratoriju za istraživanje glikoznanosti u tvrtki Genos od srpnja 2021. godine, gdje nastavlja proučavati epigenetske regulatorne mehanizme genske ekspresije povezane s epitelno-mezenhimalnom tranzicijom i glikozilacijom. Njegov trenutni projekt usmjeren je na ciljanu manipulaciju metilacije DNA i posttranslacijskih modifikacija histona primjenom CRISPR/dCas9 tehnologije kako bi se razumjelo njihovo kompleksno međudjelovanje. Osim toga, istražuje utjecaj induciranih posttranslacijskih histonskih modifikacija na uspostavu i održavanje metilacije DNA.<br><br>Goran je završio diplomski studij molekularne biologije na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu 2016. godine pod mentorstvom prof. dr. sc. Vlatke Zoldoš. Nastavio je raditi na istom fakultetu kao suradnik na projektu Horizon 2020 "Sistemski pristup kroničnim upalnim bolestima" te je u svibnju 2021. stekao doktorat iz biologije. Njegova doktorska disertacija, pod nazivom „Dizajn modularnog CRISPR/dCas9 sustava korištenjem ortolognih Cas9 proteina i njegova primjena u epigenetskoj manipulaciji genskih lokusa“, uključivala je razvoj CRISPR/dCas9 alata koristeći dva ortologna Cas9 proteina iz *Streptococcus pyogenes* i *Staphylococcus aureus*, a rezultati su objavljeni u časopisu *Nucleic Acids Research*.<br><br>Tijekom karijere, Goran je dobitnik nekoliko priznanja, uključujući Dekanovu nagradu za znanstveni i stručni uspjeh te Nagradu za mlade znanstvenike Hrvatskog društva za biokemiju i molekularnu biologiju (HDBMB) 2019. godine.'},{name:"Marina Martinić Kavur",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Senior Researcher",hr:"Viša istraživačica"},img:"kavur",descriptionEn:"Marina joined Genos in March 2018 as a senior researcher, focusing on projects related to immunoglobulin glycosylation in health and disease, while also contributing to science communication through social media, traditional news outlets, popular-scientific articles, online and live lectures, and other channels, and playing a key role in the development and commercialization of the first glycan-based test for biological age, bridging the gap between basic science and marketing.<br><br> Marina holds a Bachelor's degree in Biology and a Master's degree in Immunology and Physiology from the University of Zagreb, Faculty of Science, and received academic recognition, including a Dean's award and 2nd place at the national Nesta FameLab competition for young science communicators.<br><br> From 2012 to 2013, Marina worked as a young researcher studying bone morphogenetic protein at the University of Zagreb, School of Medicine, and in 2013, she joined the international Vienna Biocenter PhD Programme in Austria, conducting research at the Institute of Molecular Pathology in Vienna and EMBL Heidelberg in Germany, earning her PhD in Molecular Biology from the University of Vienna in 2018.",descriptionHr:"Marina se pridružila Genosu u ožujku 2018. godine kao viša istraživačica, fokusirajući se na projekte vezane uz glikozilaciju imunoglobulina u zdravlju i bolesti. Osim istraživačkog rada, aktivno sudjeluje u znanstvenoj komunikaciji putem društvenih mreža, tradicionalnih medija, popularno-znanstvenih članaka, online i uživo predavanja te drugih kanala, a imala je ključnu ulogu u razvoju i komercijalizaciji prvog testa biološke dobi temeljenog na glikanima, uspješno povezujući temeljnu znanost i marketing.<br><br>Marina je diplomirala biologiju, a magistrirala imunologiju i fiziologiju na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu. Dobitnica je Dekanove nagrade i osvojila je 2. mjesto na nacionalnom Nesta FameLab natjecanju za mlade znanstvene komunikatore.<br><br>Od 2012. do 2013. radila je kao mlada istraživačica na istraživanju morfogenetskih proteina kostiju na Medicinskom fakultetu Sveučilišta u Zagrebu, a 2013. godine pridružila se međunarodnom doktorskom programu Vienna Biocenter u Austriji, gdje je provodila istraživanja u Institutu za molekularnu patologiju u Beču i EMBL-u u Heidelbergu, Njemačka. Doktorirala je molekularnu biologiju na Sveučilištu u Beču 2018. godine."},{name:"Anika Mijakovac",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Senior Researcher",hr:"Viša istraživačica"},img:"mijakovac",descriptionEn:"Anika Mijakovac is a researcher who joined the Genos team in 2023. She studies the mechanisms that govern glycosylation, with a main focus on immunoglobulin G. Anika works with CRISPR/dCas9-based technology in various cell models. She holds a Bachelor’s degree in Biology, and in 2019, she obtained her Master’s degree in Molecular Biology from the Faculty of Science, University of Zagreb. In the same year, she started her PhD in the Epigenetics group led by Professor Vlatka Zoldoš, where she developed an in vitro expression system based on CRISPR/dCas9 molecular tools to study the regulation of genes involved in IgG glycosylation. During her PhD, she also worked as an assistant and held practical exercises for the Genetics course. Anika mentored several undergraduate and graduate students in laboratory skill training and co-mentored one graduate thesis. She defended her PhD thesis in 2023 at the Faculty of Science, University of Zagreb.",descriptionHr:"Anika Mijakovac istraživačica je koja se pridružila timu Genosa 2023. godine. Proučava mehanizme koji upravljaju glikozilacijom, s posebnim naglaskom na imunoglobulin G. Anika koristi CRISPR/dCas9 tehnologiju u različitim staničnim modelima.<br><br>Diplomirala je biologiju, a 2019. godine stekla je magisterij iz molekularne biologije na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu. Iste godine započela je doktorski studij u grupi za epigenetiku pod vodstvom profesorice Vlatke Zoldoš, gdje je razvila in vitro ekspresijski sustav temeljen na CRISPR/dCas9 molekularnim alatima za proučavanje regulacije gena uključenih u glikozilaciju IgG-a.<br><br>Tijekom doktorata radila je i kao asistentica te vodila praktične vježbe iz kolegija Genetika. Mentorirala je nekoliko studenata na preddiplomskoj i diplomskoj razini u laboratorijskom osposobljavanju te su-mentorirala jedan diplomski rad. Disertaciju je obranila 2023. godine na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu."},{name:"Natali Nakić Bedeković",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Senior Researcher",hr:"Viša istraživačica"},img:"bedekovic",descriptionEn:"Natali completed her Bachelor's and Master's degrees in Chemistry at the University of Zagreb, Faculty of Science, Department of Chemistry in 2015, and worked as a young researcher on the FP7 RegPot project IntegraLife at the University of Zagreb after her studies. In 2020, Natali earned her Ph.D. in Molecular Biology from the Laboratory of Prion Biology at the International School for Advanced Studies (SISSA) in Trieste, Italy.<br><br> Since November 2019, Natali has been a researcher in the Genos Glycoscience Laboratory, where her current research focuses on the analysis of labeled glycans derived from brain organoids using LC-MS and ultra-performance liquid chromatography (UPLC), as well as contributing to the optimization of UPLC methods for analyzing plasma and IgG labeled glycans.",descriptionHr:"Natali je završila preddiplomski i diplomski studij kemije na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu, na Kemijskom odsjeku, 2015. godine. Nakon studija radila je kao mlada istraživačica na projektu FP7 RegPot IntegraLife na Sveučilištu u Zagrebu. Godine 2020. stekla je doktorat iz molekularne biologije u Laboratoriju za biologiju priona na Međunarodnoj školi za napredne studije (SISSA) u Trstu, Italija.<br><br>Od studenoga 2019. Natali je istraživačica u Laboratoriju za glikoznanost tvrtke Genos, gdje se njezino trenutno istraživanje fokusira na analizu označenih glikana dobivenih iz moždanih organoida korištenjem LC-MS i ultra-performansne tekućinske kromatografije (UPLC), kao i na doprinos optimizaciji UPLC metoda za analizu plazmatskih i IgG glikana s oznakama."},{name:"Barbara Radovani",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Senior Researcher",hr:"Viša istraživačica"},img:"radovani",descriptionEn:`Barbara earned her Master's degree in Drug Research and Development from the Department of Biotechnology at the University of Rijeka in 2019. During her studies, she received a scholarship for excellence and was awarded the Rector's Award for the most successful student of the year. After completing her studies, Barbara gained practical experience as a research intern at MetGen Oy in Finland, where she became proficient in SEC-HPLC, UV-VIS spectroscopy, and enzymatic protocols. In 2020, she joined Genos Glycoscience Laboratory, working as a PhD researcher on a project funded by the Croatian Science Foundation titled "Glycosylation in Cardiovascular Diseases." In 2023, Barbara obtained her PhD in Biology, focusing on the analysis of IgG and total plasma protein glycosylation in coronary artery disease. She is currently a postdoctoral researcher at the Faculty of Biotechnology and Drug Development, University of Rijeka, and is undergoing postdoctoral training at the Department of Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg in Germany, where she is conducting in vivo experiments to gain further insights into IgG glycosylation. Throughout her academic and professional career, Barbara has actively participated in numerous national and international conferences, meetings, and workshops. She is also a co-author of several scientific publications.`,descriptionHr:"Barbara je magistrirala istraživanje i razvoj lijekova na Odjelu za biotehnologiju Sveučilišta u Rijeci 2019. godine. Tijekom studija bila je stipendistica za izvrsnost te je dobila Rektorovu nagradu za najuspješniju studenticu godine. Nakon studija stekla je praktično iskustvo kao istraživačka pripravnica u tvrtki MetGen Oy u Finskoj, gdje se usavršila u tehnikama SEC-HPLC, UV-VIS spektroskopije i enzimskim protokolima.<br><br>Godine 2020. pridružila se Laboratoriju za glikoznanost tvrtke Genos kao doktorandica na projektu Hrvatske zaklade za znanost pod nazivom „Glikozilacija u kardiovaskularnim bolestima“. Doktorirala je biologiju 2023. godine, s fokusom na analizu glikozilacije IgG-a i ukupnih plazmatskih proteina u bolesti koronarnih arterija.<br><br>Trenutno radi kao poslijedoktorandica na Fakultetu biotehnologije i razvoja lijekova Sveučilišta u Rijeci te prolazi poslijedoktorsku izobrazbu na Odsjeku za biologiju Sveučilišta Friedrich-Alexander u Erlangenu-Nürnbergu u Njemačkoj, gdje provodi in vivo eksperimente kako bi stekla dublji uvid u glikozilaciju IgG-a.<br><br>Tijekom akademske i profesionalne karijere aktivno je sudjelovala na brojnim nacionalnim i međunarodnim konferencijama, sastancima i radionicama. Također je koautorica nekoliko znanstvenih publikacija."},{name:"Borna Rapčan",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Senior Researcher",hr:"Viši istraživač"},img:"rapcan",descriptionEn:"Borna Rapčan joined Genos in December 2023 as a researcher, focusing on bioinformatics and the study of hormonal influences on glycosylation. He has authored several scientific papers and actively participates in research projects. Borna obtained his Master’s degree in 2019 and is set to complete his PhD in Medical Biochemistry in 2025 from the Faculty of Pharmacy and Biochemistry, University of Zagreb.",descriptionHr:"Borna Rapčan pridružio se Genosu u prosincu 2023. godine kao istraživač, s fokusom na bioinformatiku i proučavanje hormonskih utjecaja na glikozilaciju. Autor je nekoliko znanstvenih radova i aktivno sudjeluje u istraživačkim projektima. Borna je diplomirao 2019. godine, a doktorat iz medicinske biokemije trebao bi steći 2025. godine na Farmaceutsko-biokemijskom fakultetu Sveučilišta u Zagrebu."},{name:"Jelena Šimunović",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Senior Researcher",hr:"Viša istraživačica"},img:"simunovic",descriptionEn:"Since February 2016, Jelena has been employed at the Glycoscience Research Laboratory, Genos Ltd, Zagreb, Croatia. She was involved in the Horizon2020 GlyCoCan project as an early-stage researcher. In 2017 and 2018, she spent time as a guest scientist at the Center of Proteomics and Metabolomics at Leiden University Medical Center in the Netherlands, where she gained expertise in mass spectrometry methods for glycosylation analysis. In 2024, Jelena earned her PhD from the Faculty of Pharmacy and Biochemistry at the University of Zagreb with a dissertation titled “Haptoglobin glycosylation in colorectal cancer.” She is currently part of the MS Laboratory team.",descriptionHr:"Od veljače 2016. Jelena je zaposlena u Laboratoriju za istraživanje glikoznanosti u tvrtki Genos d.o.o., Zagreb, Hrvatska. Sudjelovala je u projektu GlyCoCan u sklopu programa Horizon 2020 kao istraživačica na početku karijere. Tijekom 2017. i 2018. boravila je kao gostujuća znanstvenica u Centru za proteomiku i metabolomiku na Medicinskom centru Sveučilišta u Leidenu, Nizozemska, gdje je stekla stručnost u metodama masene spektrometrije za analizu glikozilacije.<br><br>Godine 2024. stekla je doktorat na Farmaceutsko-biokemijskom fakultetu Sveučilišta u Zagrebu, s disertacijom pod naslovom „Glikozilacija haptoglobina u raku debelog crijeva.“ Trenutno je članica tima MS laboratorija."},{name:"Genadij Razdorov",job:{en:"Senior Researcher",hr:"Viši istraživač"},img:"razdorov",descriptionEn:"Genadij is a dedicated scholar at Genos Glycoscience Laboratory, specializing in the development of innovative mass spectrometry-based methods for glycobiology. His primary research focus lies in high-throughput and clinically applicable glycoanalytics, particularly in the context of blood plasma analysis. <br><br> Genadij earned his Master's degree in Medical Biochemistry from the University of Zagreb, Faculty of Biochemistry and Pharmacy. Following his graduation, he embarked on a successful career as a scholar, gaining extensive expertise in mass spectrometry. He contributed to various research projects, starting with his work at PLIVA, R&D, Analytics, where he focused on identifying protein targets of macrolide anti-inflammatory compounds. He further expanded his knowledge at GSK R&D Zagreb, specializing in the development of LC-SRM-MS methods for quantifying macrolide derivatives in DMPK studies. Genadij also made significant contributions to the field of mass spectrometry-based proteomics, conducting research on bone morphogenetic proteins-related biology at the University of Zagreb, Faculty of Medicine. Additionally, he conducted glycoproteomics studies at the University of Zagreb, Faculty of Biochemistry and Pharmacy. <br><br> With over a decade of experience in mass spectrometry, Genadij has worked with various instrument types, including single quadrupole, ion trap, triple quadrupole, quadrupole time-of-flight, time-of-flight/time-of-flight, and orbitrap instruments. He has continuously sought to enhance his skills and knowledge through training, education, and research collaborations at renowned institutions worldwide. Notable among these are Leiden University Medical Center, the Center for Proteomics and Metabolomics, and the Max Planck Institute of Biochemistry, Department of Proteomics and Signal Transduction. <br><br> Genadij’s profound expertise in mass spectrometry, coupled with his commitment to advancing glycobiology research, greatly contributes to the success of Genos Glycoscience Laboratory. His continuous pursuit of cutting-edge methodologies and his international collaborations ensure that Genos remains at the forefront of glycoanalytics research and development.",descriptionHr:"Genadij je posvećeni znanstvenik u Laboratoriju za glikoznanost tvrtke Genos, specijaliziran za razvoj inovativnih metoda temeljenih na masenoj spektrometriji u području glikobiologije. Njegovo istraživanje primarno je usmjereno na visokoprotočnu i klinički primjenjivu glikoanalitiku, posebno u kontekstu analize krvne plazme.<br><br>Magistarski studij medicinske biokemije završio je na Farmaceutsko-biokemijskom fakultetu Sveučilišta u Zagrebu. Nakon diplome započeo je uspješnu znanstvenu karijeru, stječući opsežno iskustvo u masenoj spektrometriji. Sudjelovao je u brojnim istraživačkim projektima, počevši s radom u PLIVI, u odjelu za istraživanje i razvoj, gdje je istraživao proteinske ciljeve makrolidnih protuupalnih spojeva. Svoje znanje dodatno je proširio u GSK R\\&D Zagreb, specijalizirajući se za razvoj LC-SRM-MS metoda za kvantifikaciju makrolidnih derivata u DMPK studijama.<br><br>Genadij je dao značajan doprinos i u području proteomike temeljene na masenoj spektrometriji, provodeći istraživanja bioloških procesa vezanih uz morfogenetske proteine kostiju na Medicinskom fakultetu Sveučilišta u Zagrebu. Također je provodio glikoproteomička istraživanja na Farmaceutsko-biokemijskom fakultetu Sveučilišta u Zagrebu.<br><br>S više od desetljeća iskustva u masenoj spektrometriji, radio je s različitim vrstama instrumenata, uključujući single quadrupole, ion trap, triple quadrupole, quadrupole time-of-flight, time-of-flight/time-of-flight i orbitrap sustave. Neprestano usavršava svoja znanja i vještine kroz edukacije, obuke i međunarodne istraživačke suradnje s renomiranim institucijama diljem svijeta, među kojima se ističu Medicinski centar Sveučilišta u Leidenu, Centar za proteomiku i metabolomiku, te Max Planck Institut za biokemiju, Odjel za proteomiku i transdukciju signala.<br><br>Genadijeva duboka stručnost u području masene spektrometrije, u kombinaciji s njegovom predanošću napretku istraživanja glikobiologije, značajno doprinosi uspjehu Laboratorija za glikoznanost tvrtke Genos. Njegova stalna težnja za primjenom najnaprednijih metodologija i međunarodne suradnje osiguravaju da Genos ostane predvodnik u području glikoanalitike."},{name:"Vedrana Vičić Bočkor",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Senior Researcher",hr:"Vodeća istraživačica"},img:"bockor",descriptionEn:"Vedrana Vičić Bočkor joined Genos in January 2024. She has extensive knowledge and experience in various fields of molecular biology, including genome and epigenome editing and analyses, lentiviral delivery of transgenes, and molecular cytogenetics. Her research focuses on the epigenetic regulation of transcription factors in the liver and pancreas and their role in disease origin and progression. <br><br> Vedrana completed her undergraduate studies in Molecular Biology at the University of Zagreb, Faculty of Science, in 2006. She obtained her PhD in Biochemistry and Molecular Biology from the same university in 2015, where she continued to work as a postdoctoral researcher and a senior assistant, holding practical courses in Genetics and Molecular Cytogenetics.",descriptionHr:"Vedrana Vičić Bočkor pridružila se tvrtki Genos u siječnju 2024. godine. Posjeduje bogato znanje i iskustvo u različitim područjima molekularne biologije, uključujući uređivanje i analizu genoma i epigenoma, lentivirusnu dostavu transgena te molekularnu citogenetiku. Njezino istraživanje usmjereno je na epigenetsku regulaciju transkripcijskih faktora u jetri i gušterači te njihovu ulogu u nastanku i progresiji bolesti.<br><br>Preddiplomski studij molekularne biologije završila je 2006. godine na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu. Doktorirala je biokemiju i molekularnu biologiju 2015. godine na istom fakultetu, gdje je nastavila raditi kao poslijedoktorandica i viša asistentica, držeći praktične vježbe iz genetike i molekularne citogenetike."},{name:"Olga Zaitseva",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Senior Researcher",hr:"Vodeća istraživačica"},img:"zaitseva",descriptionEn:"Olga joined Genos in 2014 as a postdoctoral researcher, focusing on investigating the relationship between immunoglobulin glycosylation and the immune response. She is actively gaining experience in LC-MS and CE glycan analysis. In addition to her role at Genos, Olga is affiliated with the laboratory of Statistical Functional Genomics at the Institute of Cytology and Genetics and the laboratory of Theoretical and Applied Genomics at Novosibirsk State University. Her research interests span evolutionary biology, human genetics, genetics of complex traits, methods of high-throughput glycan analysis, and next-generation sequencing. Olga holds a Biology degree from the University of Novosibirsk, Faculty of Natural Sciences (2008), and a doctoral degree in Biology (Genetics) from the Institute of Cytology and Genetics (2013). She has a strong research background, having worked as a research assistant at the Institute of Cytology and Genetics in Novosibirsk (2009-2014) and as a part-time teaching assistant for the sub-faculty of Molecular Biology at Novosibirsk State University (2010-2014).",descriptionHr:"Olga se pridružila Genosu 2014. godine kao poslijedoktorandica, fokusirajući se na istraživanje povezanosti između glikozilacije imunoglobulina i imunološkog odgovora. Aktivno stječe iskustvo u LC-MS i CE analizi glikana. Osim rada u Genosu, povezana je s Laboratorijem za statističku funkcionalnu genomiku na Institutu za citologiju i genetiku te s Laboratorijem za teorijsku i primijenjenu genomiku na Državnom sveučilištu u Novosibirsku.<br><br>Njezini istraživački interesi obuhvaćaju evolucijsku biologiju, ljudsku genetiku, genetiku kompleksnih osobina, metode visokoprotočne analize glikana i sekvenciranje nove generacije. Olga je diplomirala biologiju 2008. godine na Fakultetu prirodnih znanosti Sveučilišta u Novosibirsku, a doktorirala biologiju (genetiku) 2013. godine na Institutu za citologiju i genetiku.<br><br>Prije dolaska u Genos, radila je kao znanstvena asistentica na Institutu za citologiju i genetiku u Novosibirsku (2009.–2014.) te kao honorarna asistentica na Katedri za molekularnu biologiju Državnog sveučilišta u Novosibirsku (2010.–2014.)."}]},{group:"PhD Students",members:[{name:"Lara Butumović",job:{en:"Junior Researcher",hr:"Junior istraživač"},img:"butumovic",descriptionEn:"Lara Butumović holds a Master's degree in Food Safety Management and a Bachelor's degree in Biotechnology from the Faculty of Food Technology and Biotechnology, University of Zagreb. <br><br> During her studies, she gained valuable experience working in the Laboratory of Biology and Genetics of Microorganisms, where she completed her master's thesis and developed a passion for experimental research. <br><br> She is currently part of the capillary electrophoresis team at Genos, focusing on analyses related to the glycan-based test for biological age.",descriptionHr:"Lara Butumović magistrirala je upravljanje sigurnošću hrane te završila preddiplomski studij biotehnologije na Prehrambeno-biotehnološkom fakultetu Sveučilišta u Zagrebu.<br><br>Tijekom studija stekla je vrijedno iskustvo radeći u Laboratoriju za biologiju i genetiku mikroorganizama, gdje je izradila svoj diplomski rad i razvila strast prema eksperimentalnom istraživanju.<br><br>Trenutno je članica tima za kapilarnu elektroforezu u Genosu, gdje se bavi analizama povezanim s testom biološke dobi temeljenim na glikanima."},{name:"Helena Deriš",job:{en:"Junior Researcher",hr:"Junior istraživač"},img:"deris",descriptionEn:"Since joining Genos in June 2018 as a Laboratory Analyst, Helena specializes in protein glycosylation analysis using ultra-performance liquid chromatography, particularly focusing on IgG and fibrinogen glycans. She is currently pursuing a Ph.D. at the University of Zagreb, Faculty of Science, Department of Chemistry, expanding her knowledge in the field of glycobiology. <br><br> Helena obtained a degree in Pharmacy - Research and Development of new drugs from the University of Zagreb, Faculty of Pharmacy and Biochemistry in October 2017. Her research during her studies focused on transferrin chemistry and glycosylation, earning recognition with the University of Zagreb Rector's award for her work on the redox potential of holo-transferrin. She gained practical experience through a six-month internship at Roche Diabetes Care's Competitive Intelligence Department in Mannheim, Germany.",descriptionHr:"Helena se pridružila Genosu u lipnju 2018. godine kao analitičarka u laboratoriju, specijalizirana za analizu glikozilacije proteina korištenjem ultra-performansne tekućinske kromatografije, s posebnim fokusom na glikane imunoglobulina G i fibrinogena. Trenutno je na doktorskom studiju na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu, na Kemijskom odsjeku, gdje dodatno produbljuje svoje znanje iz područja glikobiologije.<br><br>Helena je diplomirala farmaciju – istraživanje i razvoj novih lijekova na Farmaceutsko-biokemijskom fakultetu Sveučilišta u Zagrebu u listopadu 2017. godine. Tijekom studija bavila se istraživanjem kemije i glikozilacije transferina, a za rad na redoks potencijalu holo-transferina dobila je Rektorovu nagradu Sveučilišta u Zagrebu.<br><br>Praktično iskustvo stekla je kroz šestomjesečnu stručnu praksu u odjelu za konkurentske analize tvrtke Roche Diabetes Care u Mannheimu, Njemačka."},{name:"Lucija Dončević",job:{en:"Junior Researcher",hr:"Junior istraživač"},img:"doncevic",descriptionEn:"Lucija completed her Bachelor’s degree in Chemistry at the Josip Juraj Strossmayer University of Osijek. Later she obtained her Master’s degree in Analytical Chemistry and Biochemistry from the Faculty of Science, University of Zagreb, where she is currently pursuing her PhD in Analytical Chemistry.<br><br>Her research focuses on the chromatographic separation of glycoproteins. She has a strong background in bacterial and tissue proteome extraction for de novo protein elucidation and specie identification. Lucija has extensive experience in chromatography and mass spectrometry for protein analysis, including the optimization of chromatographic methods for protein and peptide purification and fractionation procedures.",descriptionHr:"Lucija je završila preddiplomski studij kemije na Sveučilištu Josipa Jurja Strossmayera u Osijeku. Kasnije je stekla titulu magistrice analitičke kemije i biokemije na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu, gdje trenutno pohađa doktorski studij iz analitičke kemije.<br><br>Njezino istraživanje usmjereno je na kromatografsku separaciju glikoproteina. Ima snažnu pozadinu u ekstrakciji proteoma bakterija i tkiva za de novo određivanje proteina i identifikaciju vrsta. Lucija posjeduje opsežno iskustvo u kromatografiji i masenoj spektrometriji za analizu proteina, uključujući optimizaciju kromatografskih metoda za pročišćavanje proteina i peptida te postupke frakcioniranja."},{name:"Ivana Duvnjak Orešković",job:{en:"Junior Researcher",hr:"Junior istraživač"},img:"oreskovic",descriptionEn:`Since October 2017, Ivana Duvnjak Orešković has been a valuable member of the Genos team, primarily working in the DNA analysis laboratory. <br><br> In January 2023, she expanded her role by joining the glycomics laboratory at Genos, which specializes in high-throughput glycomics. <br><br> Ivana holds a master's degree in Genetics and Animal Breeding, which she obtained in 2017 from the Faculty of Agriculture. Her master's thesis was titled "Variability of Cattle Mitochondrial DNA". <br><br> She is currently pursuing a Ph.D. at the University of Osijek.`,descriptionHr:"Ivana Duvnjak Orešković članica je tima Genosa od listopada 2017. godine, gdje primarno radi u laboratoriju za analizu DNA.<br><br>U siječnju 2023. proširila je svoj angažman pridruživši se laboratoriju za glikomiku u Genosu, koji je specijaliziran za visokoprotočnu glikomiku.<br><br>Ivana je magistrirala genetiku i oplemenjivanje životinja 2017. godine na Agronomskom fakultetu, a tema njezinog diplomskog rada bila je „Varijabilnost mitohondrijske DNA goveda“.<br><br>Trenutno pohađa doktorski studij na Sveučilištu u Osijeku."},{name:"Matko Fančović",job:{en:"Junior Researcher",hr:"Junior istraživač"},img:"fancovic",descriptionEn:"Matko Fančović is a PhD student at the Faculty of Chemical Engineering and Technology (FKIT) in Zagreb and works as a Research PhD student at Genos. <br><br> Proficient in UHPLC/HPLC and CE, Matko contributes to the development of automated glycosylation analysis processes and plays an important role in the innovative glycan-based test for biological age. With a background in organic molecule synthesis and the development of magnetic particles for medical purposes, he successfully completed his Master’s Degree in Chemical Engineering in 2023. <br><br> He brings not only strong scientific acumen but also programming proficiency, excelling in Python for data analysis and process automation. Furthermore, Matko possesses comprehensive knowledge in polymer characterization techniques such as FTIR, DMA, and TGA. This breadth of expertise equips him to provide valuable insights and contribute effectively to Genos.",descriptionHr:"Matko Fančović doktorand je na Fakultetu kemijskog inženjerstva i tehnologije (FKIT) u Zagrebu i radi kao istraživač-doktorand u tvrtki Genos.<br><br>Vješt u radu s UHPLC/HPLC i kapilarnom elektroforezom (CE), Matko doprinosi razvoju automatiziranih procesa analize glikozilacije te ima važnu ulogu u inovativnom testu biološke dobi temeljenom na glikanima. S iskustvom u sintezi organskih molekula i razvoju magnetskih čestica za medicinsku primjenu, uspješno je završio diplomski studij kemijskog inženjerstva 2023. godine.<br><br>Uz snažnu znanstvenu stručnost, Matko se ističe i programerskim vještinama, posebno u programskom jeziku Python za analizu podataka i automatizaciju procesa. Također posjeduje široko znanje iz tehnika karakterizacije polimera, uključujući FTIR, DMA i TGA. Ova raznolikost znanja i vještina omogućuje mu da daje vrijedan doprinos u radu Genosa."},{name:"Iva Grubeša",job:{en:"Junior Researcher",hr:"Junior istraživač"},img:"grubesa",descriptionEn:"Iva holds a degree in Pharmacy from the Faculty of Pharmacy and Biochemistry at the University of Zagreb. She completed her diploma thesis titled 'Comparison of LC-MS and nano-LC-MS methods for the analysis of N-glycosylation of alpha-1-acid glycoprotein' at the Department of Biochemistry and Molecular Biology. <br><br> As a Junior Researcher, she is a member of the MS team, contributing to projects that investigate the glycosylation of IgG and other representative components of the host’s innate and adaptive immune systems.",descriptionHr:"Iva je diplomirala farmaciju na Farmaceutsko-biokemijskom fakultetu Sveučilišta u Zagrebu. Svoj diplomski rad pod nazivom „Usporedba LC-MS i nano-LC-MS metoda za analizu N-glikozilacije alfa-1-kiselog glikoproteina“ izradila je na Zavodu za biokemiju i molekularnu biologiju.<br><br>Kao mlada istraživačica članica je MS tima, gdje doprinosi projektima koji istražuju glikozilaciju IgG-a i drugih reprezentativnih komponenti urođenog i stečenog imunološkog sustava domaćina."},{name:"Filip Kliček",job:{en:"Junior Researcher",hr:"Junior istraživač"},img:"klicek",descriptionEn:"Filip Kliček is pursuing a PhD with his main focus in the development and optimization of new LC-MS methods for analyzing plasma and IgG glycans in humans and other vertebrates. <br><br> Filip holds a Master's degree in chemistry from the University of Zagreb, which he obtained in 2018. During his time at Genos Ltd., he conducted research for his master's thesis, exploring the impact of salinomycin on the N-glycome of cancer stem cells using liquid chromatography coupled with mass spectrometry.",descriptionHr:"Filip Kliček doktorand je čiji je glavni fokus razvoj i optimizacija novih LC-MS metoda za analizu glikana plazme i IgG-a kod ljudi i drugih kralježnjaka.<br><br>Filip je magistrirao kemiju na Sveučilištu u Zagrebu 2018. godine. Tijekom rada u tvrtki Genos izradio je svoj diplomski rad, u kojem je istraživao utjecaj salinomicina na N-glikom matičnih stanica raka korištenjem tekućinske kromatografije u kombinaciji s masenom spektrometrijom."},{name:"Fran Lukšić",job:{en:"Junior Researcher",hr:"Junior istraživač"},img:"luksic",descriptionEn:"Fran Lukšić joined the Genos team in March 2024, where he continues his research on key transcription factors involved in the development and regulation of pancreatic beta cells. <br><br> Fran obtained his Master’s degree in Molecular Biology from the University of Zagreb, Faculty of Science, in 2021 and started his PhD in the Group for Epigenetics led by Professor Vlatka Zoldoš in the same year.",descriptionHr:"Fran Lukšić pridružio se timu Genosa u ožujku 2024. godine, gdje nastavlja svoje istraživanje ključnih transkripcijskih faktora uključenih u razvoj i regulaciju beta stanica gušterače.<br><br>Fran je diplomirao molekularnu biologiju na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu 2021. godine, a iste je godine započeo doktorski studij u Grupi za epigenetiku pod vodstvom profesorice Vlatke Zoldoš."},{name:"Nikol Mraz",job:{en:"Junior Researcher",hr:"Junior istraživač"},img:"mraz",descriptionEn:`Since June 2022, Nikol has been working as a Laboratory Analyst at Genos Ltd, Glycoscience Research Laboratory in Zagreb, Croatia. Her primary focus is on high-throughput glycomics, where she specializes in the analysis of complex glycan structures. <br><br> Nikol Mraz completed her studies in Laboratory Biomedicine at the University of Ljubljana, Faculty of Pharmacy in September 2021. As part of her academic journey, she conducted research for her Master's Thesis titled "Suitability of selected fluorescent probes for long-term live-cell imaging" at Jožef Stefan Institute in Ljubljana. <br><br> She is currently pursuing a Ph.D. at the Faculty of Science, University of Zagreb, Department of Biology, specializing in glycobiology with a focus on brain glycans.`,descriptionHr:"Od lipnja 2022. godine, Nikol radi kao analitičarka u laboratoriju u tvrtki Genos d.o.o., Laboratoriju za istraživanje glikoznanosti u Zagrebu, Hrvatska. Njezin glavni fokus je visokoprotočna glikomika, gdje se specijalizirala za analizu kompleksnih struktura glikana.<br><br>Nikol Mraz završila je studij laboratorijske biomedicine na Farmaceutskom fakultetu Sveučilišta u Ljubljani u rujnu 2021. godine. Tijekom studija izradila je diplomski rad pod nazivom „Prikladnost odabranih fluorescentnih sondi za dugotrajno snimanje živih stanica“ na Institutu Jožef Stefan u Ljubljani.<br><br>Trenutno pohađa doktorski studij na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu, na Odsjeku za biologiju, s posebnim fokusom na glikobiologiju mozga."},{name:"Kristina Nikolić",job:{en:"Junior Researcher",hr:"Junior istraživač"},img:"nikolic",descriptionEn:"Kristina Nikolić joined the Genos team in May 2025. She has experience in molecular biology, neurobiology, and biochemistry, with a primary research focus on the mechanisms of immunoglobulin G glycosylation.<br><br> Kristina earned her Master's degree in Molecular Biology from the Faculty of Science, University of Zagreb, in 2024. Her Master's thesis research was conducted under the mentorship of Prof. Jasminka Štefulj, PhD, at the Laboratory for Neurochemistry and Molecular Neurobiology, where she investigated gene polymorphisms, expression, and enzyme activity of monoamine oxidase A in the human placenta.",descriptionHr:"Kristina Nikolić pridružila se timu Genosa u svibnju 2025. godine. Ima iskustvo u području molekularne biologije, neurobiologije i biokemije, a njezin primarni istraživački fokus je na mehanizmima glikozilacije imunoglobulina G.<br><br>Kristina je diplomirala molekularnu biologiju na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu 2024. godine. Svoj diplomski rad izradila je pod mentorstvom prof. dr. sc. Jasminke Štefulj u Laboratoriju za neurokemiju i molekularnu neurobiologiju, gdje je istraživala polimorfizme gena, ekspresiju i enzimsku aktivnost monoamin oksidaze A u ljudskoj posteljici."},{name:"Antea Posavec",job:{en:"Junior Researcher",hr:"Junior istraživač"},img:"posavec",descriptionEn:"Antea Posavec joined Genos Ltd. as a Laboratory Analyst in December 2024, shortly after graduating that same year. <br><br> As a current member of the CGE team, she is focusing on the GlycanAge test for biological age determination. <br><br> Antea holds a Master’s degree in Applied Chemistry from the University of Zagreb, Faculty of Chemical Engineering and Technology. <br><br> Throughout her studies, she gained valuable experience in (green) organic synthesis and the structural characterization of organic compounds. <br><br> For her Master’s Thesis, she conducted research at Selvita Ltd., where she worked on optimizing electrochemical organic reactions. <br><br> During this time, she gained hands-on experience with UPLC-MS/UV and further developed her skills in 1D and 2D NMR spectrum analysis.",descriptionHr:"Antea Posavec pridružila se tvrtki Genos d.o.o. u prosincu 2024. godine kao analitičarka u laboratoriju, ubrzo nakon što je iste godine diplomirala.<br><br>Trenutno je članica CGE tima, gdje se fokusira na test GlycanAge za određivanje biološke dobi.<br><br>Antea je magistrirala primijenjenu kemiju na Fakultetu kemijskog inženjerstva i tehnologije Sveučilišta u Zagrebu. Tijekom studija stekla je vrijedno iskustvo u (zelenoj) organskoj sintezi i strukturnoj karakterizaciji organskih spojeva.<br><br>Svoj diplomski rad izradila je u tvrtki Selvita d.o.o., gdje je radila na optimizaciji elektrokemijskih organskih reakcija. U tom je razdoblju stekla praktično iskustvo u radu s UPLC-MS/UV tehnikama te dodatno razvila vještine analize 1D i 2D NMR spektara."},{name:"Ivan Petrić",job:{en:"Junior Researcher",hr:"Junior istraživač"},img:"petric",descriptionEn:`Since February 2023, Ivan Petrić has been working as a laboratory analyst at the Glycobiology Laboratory in Genos Ltd. <br><br> Ivan completed his master's degree in applied chemistry at the University of Zagreb, Faculty of Chemical Engineering and Technology in 2021. <br><br> His master's thesis was titled "Li-polymer batteries: electrochemical properties and degradation".`,descriptionHr:"Od veljače 2023. godine Ivan Petrić radi kao analitičar u Laboratoriju za glikobiologiju u tvrtki Genos d.o.o.<br><br>Ivan je magistrirao primijenjenu kemiju na Fakultetu kemijskog inženjerstva i tehnologije Sveučilišta u Zagrebu 2021. godine.<br><br>Tema njegova diplomskog rada bila je „Li-polimerne baterije: elektrokemijska svojstva i degradacija“."},{name:"Petra Radović",job:{en:"Junior Researcher",hr:"Junior istraživač"},img:"radovic",descriptionEn:"Petra Radović holds a Master’s degree in Biology and Chemistry from the Faculty of Science, University of Zagreb. She conducted her master’s thesis at the Ruđer Bošković Institute, focusing on the expression of genes involved in DNA-protein crosslink repair in zebrafish (Danio rerio) carrying a mutation in the tyrosyl-DNA phosphodiesterase 2b gene. During an Erasmus+ internship at the Jožef Stefan Institute in Ljubljana, she worked in analytical chemistry, focusing on the extraction and analysis of bioactive compounds. She has experience in molecular biology and analytical chemistry, with applications in biotechnology and industrial research.<br><br>She has been employed in Genos as a Junior Researcher from April 2025, working primarily on high-throughput glycomics analyses.",descriptionHr:"Petra Radović magistrirala je biologiju i kemiju na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu. Svoj diplomski rad izradila je na Institutu Ruđer Bošković, fokusirajući se na ekspresiju gena uključenih u popravak DNA-proteinskih međuveza u zebrici (*Danio rerio*) s mutacijom u genu za tirozin-DNA fosfodiesterazu 2b.<br><br>Tijekom Erasmus+ stručne prakse na Institutu Jožef Stefan u Ljubljani radila je u području analitičke kemije, s naglaskom na ekstrakciju i analizu bioaktivnih spojeva. Ima iskustvo u molekularnoj biologiji i analitičkoj kemiji, s primjenama u biotehnologiji i industrijskim istraživanjima.<br><br>Od travnja 2025. zaposlena je u tvrtki Genos kao mlada istraživačica, gdje primarno radi na visokoprotočnim glikomičkim analizama."},{name:"Dora Stergar",job:{en:"Junior Researcher",hr:"Junior istraživač"},img:"stergar",descriptionEn:`Dora Stergar joined Genos in December 2024 as a laboratory analyst in the DNA laboratory, working primarily on DNA analyses in the context of paternity and kinship. <br><br> Dora graduated with a Bachelor's degree in Animal Sciences from the Faculty of Agriculture in Zagreb. <br><br> In 2021, she earned her Master's degree in Animal Genetics and Breeding. Her master's thesis was titled "Darwin's Theory of Evolution and Animal Selection." <br><br> During her studies, she participated in numerous exercises in DNA analysis laboratories and completed her professional practice at the Ruđer Bošković Institute, gaining valuable hands-on experience in scientific research.`,descriptionHr:"Dora Stergar pridružila se tvrtki Genos u prosincu 2024. godine kao analitičarka u laboratoriju za analizu DNA, gdje se primarno bavi DNA analizama u kontekstu utvrđivanja očinstva i srodstva.<br><br>Dora je završila preddiplomski studij animalnih znanosti na Agronomskom fakultetu u Zagrebu.<br><br>Godine 2021. stekla je diplomu magistre genetike i oplemenjivanja životinja, a tema njezinog diplomskog rada bila je „Darwinova teorija evolucije i selekcija životinja“.<br><br>Tijekom studija sudjelovala je u brojnim vježbama u laboratorijima za analizu DNA te je stručnu praksu odradila na Institutu Ruđer Bošković, gdje je stekla vrijedno praktično iskustvo u znanstvenom istraživanju."},{name:"Martina Vinicki",job:{en:"Junior Researcher",hr:"Junior istraživač"},img:"vinicki",descriptionEn:`Martina Vinicki joined Genos Ltd. in 2021 as a Laboratory Analyst, specializing in protein glycosylation using ultra-performance liquid chromatography with a focus on IgG and plasma glycans. <br><br> Martina graduated with a degree in Molecular Biotechnology from the University of Zagreb, Faculty of Food Technology and Biotechnology in 2019 with her master's thesis titled "Biological evaluation of synthesized methoxyflavones." During her academic journey, Martina actively participated in conferences on Food Biotechnology, further enhancing her knowledge and understanding of the subject. <br><br> To expand her practical skills, Martina completed an internship at the Andrija Štampar Teaching Institute of Public Health. During this time, she gained hands-on experience with diagnostic procedures and methods such as PCR, real-time PCR, multiplex PCR, ELISA, Western blot, ELFA, and ITFA, and their applications in the Clinical Microbiology Service. <br><br> Martina Vinicki is currently pursuing a Ph.D. as a researcher in the Initialise project, further expanding her expertise and knowledge in the field.`,descriptionHr:'Martina Vinicki pridružila se Genos Ltd. 2021. godine kao laboratorijska analitičarka, specijalizirana za proteinsku glikozilaciju koristeći ultraperformansnu tečnu kromatografiju s fokusom na IgG i plazma glikane.<br><br> Martina je diplomirala molekularnu biotehnologiju na Sveučilištu u Zagrebu, Fakultetu prehrambene tehnologije i biotehnologije 2019. godine sa završnim radom pod nazivom "Biološka evaluacija sintetiziranih metoksiflavona." Tijekom akademskog puta aktivno je sudjelovala na konferencijama o prehrambenoj biotehnologiji, dodatno produbljujući svoje znanje i razumijevanje tog područja.<br><br> Kako bi proširila svoje praktične vještine, Martina je odradila praksu u Nastavnom zavodu za javno zdravstvo "Andrija Štampar." Tijekom tog razdoblja stekla je praktično iskustvo s dijagnostičkim postupcima i metodama poput PCR, real-time PCR, multiplex PCR, ELISA, Western blot, ELFA i ITFA te njihovim primjenama u Kliničkoj mikrobiološkoj službi.<br><br> Martina Vinicki trenutno radi na doktorskom studiju kao istraživačica u projektu Initialise, dodatno šireći svoju stručnost i znanje u području.'}]},{group:"Administration",members:[{name:"Svjetlana Bušić",job:{en:"Director of EU Funds and Finance",hr:"Direktorica EU fondova i financija"},img:"busic",descriptionEn:"Svjetlana leads and coordinates the Management Board Office at Genos, which includes the Office for National and International Projects, Finance and Accounting, and Human Resources. <br><br> She holds a master's degree from the Faculty of Economics at the University of Zagreb. With a strong educational foundation, she brings her expertise to her current role as the Director of EU Funds and Finance at Genos. <br><br> Svjetlana's professional experience encompasses managing and implementing projects in the field of Research, Development, and Innovation. Notably, she served as the Head of the Monitoring Service for Research, Development, and Innovation at the Croatian Agency for Small Business, Innovation, and Investment, successfully securing grants totaling EUR 128.2 million under the EU funds 2014-2020 program. <br><br> She also held key positions in World Bank projects, overseeing programs such as Proof of Concept (PoC) and Technology and Innovation Infrastructure Development (TEHCRO), with a loan amount of EUR 30 million. <br><br> Furthermore, Svjetlana actively participated in the preparation of National programs to support companies focused on Research, Development, and Innovation.",descriptionHr:"Svjetlana vodi i koordinira Ured Uprave u Genosu, koji uključuje Ured za nacionalne i međunarodne projekte, financije i računovodstvo te ljudske resurse.<br><br> Posjeduje magistarsku diplomu s Ekonomskog fakulteta Sveučilišta u Zagrebu. Sa snažnom obrazovnom podlogom, donosi svoje stručno znanje u svoju trenutnu ulogu direktorice EU fondova i financija u Genosu.<br><br> Svjetlanino profesionalno iskustvo obuhvaća upravljanje i provedbu projekata u području istraživanja, razvoja i inovacija. Posebno je bila voditeljica Službe za monitoring istraživanja, razvoja i inovacija u Hrvatskoj agenciji za malo gospodarstvo, inovacije i investicije, uspješno osiguravši bespovratna sredstva u ukupnom iznosu od 128,2 milijuna eura u okviru programa EU fondova 2014.-2020.<br><br> Također je obnašala ključne pozicije u projektima Svjetske banke, nadzirući programe poput Proof of Concept (PoC) i razvoja tehnološke i inovacijske infrastrukture (TEHCRO), s iznosom zajma od 30 milijuna eura.<br><br> Nadalje, Svjetlana je aktivno sudjelovala u pripremi nacionalnih programa za potporu poduzećima usmjerenima na istraživanje, razvoj i inovacije."},{name:"Vesna Juras",job:{en:"Head of Project Management Office",hr:"Voditeljica Ureda za upravljanje projektima"},img:"juras",descriptionEn:"In June 2020, Vesna joined Genos as the Head of the Project Management Office. With her extensive experience in commercial operations and a proven track record in implementing and supervising EU-funded projects, Vesna brings valuable expertise to our team. <br><br> She has held various positions as a Key Account Manager and Project Manager, successfully overseeing projects in the private and public sectors, particularly in the field of research and development (R&D) and innovation. <br><br> Vesna graduated from the Faculty of Economics & Business at the University of Zagreb, and her dedication to continuous learning has earned her additional certifications, including a Public Procurement Certificate and a Certificate of Internal Auditor of Quality Management Systems ISO 9001.",descriptionHr:"U lipnju 2020. Vesna se pridružila Genosu kao voditeljica Ureda za upravljanje projektima. Sa svojim bogatim iskustvom u komercijalnim poslovima i dokazanim rezultatima u provedbi i nadzoru projekata financiranih iz EU fondova, Vesna donosi vrijednu stručnost našem timu.<br><br> Obnašala je različite funkcije kao Key Account Manager i voditeljica projekata, uspješno nadzirući projekte u privatnom i javnom sektoru, posebno u području istraživanja i razvoja (R\\&D) te inovacija.<br><br> Vesna je diplomirala na Ekonomskom fakultetu Sveučilišta u Zagrebu, a njezina predanost kontinuiranom učenju donijela joj je dodatne certifikate, uključujući Certifikat za javnu nabavu i Certifikat unutarnjeg revizora sustava upravljanja kvalitetom ISO 9001."},{name:"Dijana Peić",job:{en:"Head of Finance and Accounting",hr:"Voditeljica financija i računovodstva"},img:"peic",descriptionEn:"Dijana is the Head of Finance and Accounting and joined Genos in July 2017 as an administrative assistant. <br><br> Dijana graduated in Accounting from the Faculty of Economics in Osijek and completed her studies in Business Administration and Management at the University of Šibenik in 2014. <br><br> From September 2015, she was employed as a Senior Associate in the Municipality of Magadenovac, and from November 2016, she worked as a Project Manager in a private company.",descriptionHr:"Dijana je voditeljica financija i računovodstva te se pridružila Genosu u srpnju 2017. godine kao administrativna asistentica.<br><br> Dijana je diplomirala računovodstvo na Ekonomskom fakultetu u Osijeku, a studij Poslovne administracije i menadžmenta završila je na Sveučilištu u Šibeniku 2014. godine.<br><br> Od rujna 2015. radila je kao viša suradnica u Općini Magadenovac, a od studenog 2016. godine zaposlena je kao voditeljica projekata u privatnoj tvrtki."},{name:"Katarina Marjanović",job:{en:"Financial Project Manager",hr:"Financijska voditeljica projekata"},img:"marjanovic",descriptionEn:"Katarina Marjanović joined the Genos team in September 2023 as a Financial Project Manager with many years of work experience in the field of finance. <br><br> She gained this experience primarily in accounting and public procurement while working for more than 25 years in both the public and private sectors, as well as additional work for NGOs in several countries. <br><br> Katarina based her work experience on her academic title and the fact that she graduated from the Faculty of Economics, University of Sarajevo. <br><br> In accordance with her qualifications, Katarina brings valuable expertise in a wider range of finance to our team and is, among other things, engaged in the implementation and supervision of EU-funded projects.",descriptionHr:"Katarina Marjanović pridružila se timu Genos u rujnu 2023. godine kao financijska voditeljica projekata, donoseći višegodišnje radno iskustvo u području financija.<br><br> Ovo iskustvo stekla je prvenstveno u računovodstvu i javnoj nabavi, radeći više od 25 godina u javnom i privatnom sektoru, kao i dodatno za nevladine organizacije u nekoliko zemalja.<br><br> Katarina je svoje radno iskustvo temeljila na akademskom zvanju, diplomiravši na Ekonomskom fakultetu Sveučilišta u Sarajevu.<br><br> Sukladno svojim kvalifikacijama, Katarina donosi vrijednu stručnost u širem području financija našem timu te je, između ostalog, angažirana na provedbi i nadzoru projekata financiranih iz EU fondova."},{name:"Paula Franceković",job:{en:"Research Manager",hr:"Voditeljica istraživanja"},img:"francekovic",descriptionEn:"Paula holds a Bachelor’s in Nutrition from the Faculty of Food Technology and Biotechnology in Zagreb and a Master’s in Human Nutrition from the Faculty of Science, University of Copenhagen. Her Master's research focused on the nutritional therapies for endothelial glycocalyx regeneration and was published in Nutrients. She spent two years as lead nutritionist at a private health center, while also working with GlycanAge to help clients interpret their glycan results and apply them to improve health. In 2024, she officially joined GlycanAge to support Partner education and guide the clinical use of the test. Most recently, she became part of the Genos team, continuing her work at the intersection of science and practice.",descriptionHr:"Paula je diplomirala nutricionizam na Fakultetu prehrambene tehnologije i biotehnologije u Zagrebu, a magisterij iz ljudske prehrane završila je na Prirodoslovno-matematičkom fakultetu Sveučilišta u Kopenhagenu. Njezino magistarsko istraživanje bilo je usmjereno na prehrambene terapije za regeneraciju endotelijalnog glikokaliksa i objavljeno je u časopisu Nutrients. Dvije godine radila je kao glavna nutricionistica u privatnom zdravstvenom centru, istovremeno surađujući s GlycanAgeom pomažući klijentima u tumačenju njihovih glikanskih rezultata i primjeni istih za poboljšanje zdravlja. Godine 2024. službeno se pridružila GlycanAge timu kako bi podržala edukaciju partnera i usmjeravala kliničku primjenu testa. Nedavno je postala dio Genos tima, nastavljajući svoj rad na spoju znanosti i prakse."},{name:"Ivana Gulišija Radić",job:{en:"Research Manager",hr:"Voditeljica istraživanja"},img:"gulisija",descriptionEn:"In 2023, Ivana Gulišija Radić joined the Genos team, bringing a unique blend of skills from both the business world and human health. Her mission is to harmonize business with science, fostering innovation and contributing to the expansion of knowledge. <br><br> She holds a degree in economics from the University of Split, where she earned the title of Professional Master in Business in 2015. <br><br> In 2021, she successfully obtained a Master of Science degree in Microbiology from the University of New Mexico in the United States. <br><br> During her time in the US, she worked in a microbiology lab at the University of New Mexico as a research assistant and as a teaching assistant for pre-medical students in microbiology and cell biology.",descriptionHr:"Godine 2023. Ivana Gulišija Radić pridružila se timu Genos, donoseći jedinstvenu kombinaciju vještina iz poslovnog svijeta i područja ljudskog zdravlja. Njezina misija je uskladiti poslovanje sa znanošću, poticati inovacije i pridonositi širenju znanja.<br><br> Diplomirala je ekonomiju na Sveučilištu u Splitu, gdje je 2015. stekla naziv Profesionalni magistar poslovne ekonomije.<br><br> Godine 2021. uspješno je završila magistarski studij iz mikrobiologije na Sveučilištu New Mexico u Sjedinjenim Američkim Državama.<br><br> Tijekom boravka u SAD-u radila je u mikrobiološkom laboratoriju Sveučilišta New Mexico kao istraživačka asistentica te kao asistentica u nastavi za premedicinske studente iz mikrobiologije i stanične biologije."},{name:"Dora Lalić",job:{en:"Research Manager",hr:"Voditeljica istraživanja"},img:"lalic",descriptionEn:"Dora earned a Bachelor’s degree in Biology and a Master’s in Molecular Biology from the Faculty of Science, University of Zagreb. Her Master's research focused on the epigenetic manipulation of glycosylation-associated genes in a pancreatic cell model. In 2023, she joined GlycanAge, a spin-off of Genos, before recently becoming part of the Genos team.",descriptionHr:"Dora je diplomirala biologiju te magistrirala molekularnu biologiju na Prirodoslovno-matematičkom fakultetu Sveučilišta u Zagrebu. Njezino magistarsko istraživanje bilo je usmjereno na epigenetsku manipulaciju gena povezanih s glikozilacijom u modelu pankreasnih stanica. Godine 2023. pridružila se GlycanAgeu, spin-off tvrtki Genosa, prije nego što je nedavno postala dio Genos tima."},{name:"Filip Šoštarić",job:{en:"Project Implementation and Public Procurement Specialist",hr:"Stručnjak za provedbu projekata i javnu nabavu"},img:"sostaric",descriptionEn:"Filip joined Genos in autumn 2022 as a Project Implementation and Public Procurement Specialist. <br><br> He gained extensive experience in project implementation, procurement process management, and business plan development at Zagorje Development Agency (2014-2018), where he managed procurement procedures and provided education and training to small and medium-sized entrepreneurs. <br><br> In 2018, Filip transitioned to the Croatian Agency for Small Business, Innovation, and Investment (HAMAG-BICRO) as a Senior Analyst and Deputy Head of the Procurement Verification Department for R&D projects, holding a valid certificate in public procurement. <br><br> Filip graduated with a Master's degree in Accounting and Auditing from the Faculty of Economics in Zagreb in 2014.",descriptionHr:"Filip se pridružio Genosu u jesen 2022. godine kao stručnjak za provedbu projekata i javnu nabavu.<br><br> Stekao je opsežno iskustvo u provedbi projekata, upravljanju postupcima nabave i izradi poslovnih planova u Razvojnoj agenciji Zagorje (2014.-2018.), gdje je upravljao postupcima nabave te pružao edukaciju i obuku malim i srednjim poduzetnicima.<br><br> Godine 2018. prešao je u Hrvatsku agenciju za malo gospodarstvo, inovacije i investicije (HAMAG-BICRO) kao viši analitičar i zamjenik voditelja Službe za provjeru nabave za projekte istraživanja i razvoja, pritom posjedujući važeći certifikat za javnu nabavu.<br><br> Filip je diplomirao i magistrirao računovodstvo i reviziju na Ekonomskom fakultetu u Zagrebu 2014. godine."},{name:"Petra Ružić",job:{en:"Administrative Asisstant",hr:"Administrativna asistentica"},img:"ruzic",descriptionEn:"With a wealth of work experience in administration across various companies, Petra brings valuable expertise to her role as an Administrative Assistant at Genos. <br><br> Her proficiency and skills in administrative tasks contribute to the smooth functioning of our operations and the overall efficiency of our team. <br><br> Petra graduated from the Faculty of Hotel and Tourism Management, earning a Master's degree in Economics in 2009.",descriptionHr:"S bogatim radnim iskustvom u administraciji u različitim tvrtkama, Petra donosi vrijednu stručnost u svojoj ulozi administrativne asistentice u Genosu.<br><br> Njezina stručnost i vještine u administrativnim zadacima pridonose nesmetanom funkcioniranju naših operacija i ukupnoj učinkovitosti tima.<br><br> Petra je diplomirala na Fakultetu za menadžment u hotelijerstvu i turizmu, gdje je 2009. stekla magistarsku diplomu iz ekonomije."},{name:"Snježana Džijan",title:[{hr:"Dr.sc.",en:", PhD"}],job:{en:"Head of DNA Laboratory",hr:"Voditeljica DNA laboratorija"},img:"placeholder-female",descriptionEn:"In January 2013, Snježana Džijan joined the Genos team as a researcher and experienced DNA analyst. <br><br> She is the Head of the DNA Laboratory and a permanent court expert witness for DNA analysis. <br><br> Laboratory analyses are focused on paternity testing, kinship testing, and forensic DNA analysis. <br><br> Snježana completed her Master’s degree at the Faculty of Food Technology and later obtained her PhD at the Faculty of Medicine J. J. Strossmayer University of Osijek. <br><br> She currently works as a Professor of Biochemistry at the Faculty of Dental Medicine and Health in Osijek at the aforementioned university. <br><br> As a Professor, she actively coordinates and participates in undergraduate and postgraduate teaching.",descriptionHr:"U siječnju 2013. Snježana Džijan pridružila se timu Genos kao istraživačica i iskusna analitičarka DNA.<br><br> Ona je voditeljica DNA laboratorija i stalna sudska vještakinja za analizu DNA.<br><br> Laboratorijske analize usmjerene su na testiranje očinstva, određivanje srodstva i forenzičku analizu DNA.<br><br> Snježana je magistrirala na Fakultetu prehrambene tehnologije, a doktorat je stekla na Medicinskom fakultetu Sveučilišta J. J. Strossmayer u Osijeku.<br><br> Trenutno radi kao profesorica biokemije na Fakultetu dentalne medicine i zdravstva u Osijeku pri navedenom sveučilištu.<br><br> Kao profesorica aktivno koordinira i sudjeluje u preddiplomskoj i diplomskoj nastavi."},{name:"Dario Fančović",job:{en:"Branch Manager",hr:"Voditelj poslovnice"},img:"placeholder-male",descriptionEn:"Dario Fančović, a co-founder of Genos, currently holds the positions of Branch Manager in Osijek. With a diploma in Agricultural Engineering (dipl. ing. agr.) and a deep-rooted commitment to Genos since its inception, Dario has been an integral part of the company’s journey. He is known for his effective client communication, ensuring their specific needs are met, and overseeing the collection and distribution of various samples for analysis. Dario also takes care of legal affairs and court-related documentation related to forensic analyses, drawing from his valuable experience as a lay judge to successfully navigate legal proceedings. Dario’s dedication, combined with his practical approach, has been instrumental in fostering a collaborative and client-focused environment at Genos, reinforcing the company’s reputation for excellence in its industry.",descriptionHr:"Dario Fančović, suosnivač Genosa, trenutno obnaša funkciju voditelja poslovnice u Osijeku. Sa diplomom inženjera agronomije (dipl. ing. agr.) i dubokom predanošću Genosu od samih početaka, Dario je neizostavan dio razvoja tvrtke. Poznat je po učinkovitoj komunikaciji s klijentima, osiguravajući da njihove specifične potrebe budu zadovoljene, te nadzire prikupljanje i distribuciju raznih uzoraka za analizu. Također se brine o pravnim poslovima i sudskoj dokumentaciji vezanoj uz forenzičke analize, koristeći svoje vrijedno iskustvo laičkog suca za uspješno vođenje pravnih postupaka. Dariova predanost, u kombinaciji s praktičnim pristupom, bila je ključna u stvaranju suradničkog i klijentima usmjerenog okruženja u Genosu, dodatno jačajući reputaciju tvrtke za izvrsnost u industriji."}]}];var rh=y('<div class="gc-3 gc-sm-6"><button class="team-member"><div><img alt=""></div> <h2><!> <!></h2> <h3> </h3></button></div>'),sh=y('<button class="overlay" aria-label="overlay"></button> <div class="selected-member-dialog"><div class="selected-member-dialog-header"><img class="selected-member-dialog-image" alt=""> <div class="flex-1"><div class="selected-member-dialog-name"> </div> <div class="selected-member-dialog-job"> </div></div> <button class="selected-member-dialog-close"><img src="/images/close.svg" alt=""></button></div> <p class="selected-member-description"><!></p></div>',1),lh=y('<div class="grid grid-large team-members"></div> <!>',1);function uh(o,e){Ke(e,!1);const a=ra(),i=()=>$e(ea,"$language",a);let r=se("");function l(h,j){L(r,Ur[h].members[j])}Ve(()=>c(r),()=>{c(r)?document.documentElement.classList.add("overflow-hidden"):document.documentElement.classList.remove("overflow-hidden")}),ba(),qe();var d=lh(),u=me(d);He(u,5,()=>Ur,xe,(h,j,S)=>{var G=Be(),z=me(G);He(z,1,()=>c(j).members,xe,(M,k,g)=>{var w=rh(),f=n(w),T=n(f),W=n(T);t(T);var X=s(T,2),O=n(X);P(O,()=>i()==="hr",D=>{var _=Ne();A(()=>{var x,b;return m(_,((b=(x=c(k).title)==null?void 0:x[0])==null?void 0:b.hr)||"")}),v(D,_)});var E=s(O),R=s(E);P(R,()=>i()==="en",D=>{var _=Ne();A(()=>{var x,b;return m(_,((b=(x=c(k).title)==null?void 0:x[0])==null?void 0:b.en)||"")}),v(D,_)}),t(X);var U=s(X,2),Q=n(U);t(U),t(f),t(w),A(()=>{B(W,"src",`/team/${c(k).img??""}.jpg`),m(E,` ${c(k).name??""}`),m(Q,i()==="en"?c(k).job.en:c(k).job.hr)}),Pe("click",f,()=>l(S,g)),v(M,w)}),v(h,G)}),t(u);var p=s(u,2);P(p,()=>c(r),h=>{var j=sh(),S=me(j),G=s(S,2),z=n(G),M=n(z),k=s(M,2),g=n(k),w=n(g);t(g);var f=s(g,2),T=n(f);t(f),t(k);var W=s(k,2);t(z);var X=s(z,2),O=n(X);$(O,()=>i()==="en"?c(r).descriptionEn:c(r).descriptionHr),t(X),t(G),A(()=>{B(M,"src",`/team/${c(r).img??""}.jpg`),m(w,c(r).name),m(T,i()==="en"?c(r).job.en:c(r).job.hr)}),Pe("click",S,()=>L(r,"")),Pe("click",W,()=>L(r,"")),v(h,j)}),v(o,d),We()}customElements.define("pb-team",Ge(uh,{},[],[],!1));const ch=[{paper:"Statin effects on immunoglobulin-G glycomic architecture and the link to cardiovascular disease",authors:"Yazdani A",date:2025,doi:"10.21203/rs.3.rs-6112380/v1",journal:"Research Square"},{paper:"Total cell N-glycosylation is altered during differentiation of induced pluripotent stem cells to neural stem cells and is disturbed by trisomy 21",authors:"Cindrić A",date:2025,doi:"10.1016/j.bbadva.2024.100137",journal:"BBA Advances"},{paper:"Phosphorylation of N-glycans in the brain: The case for a non-canonical pathway?",authors:"Sironić L",date:2025,doi:"10.1016/j.bbadva.2024.100134",journal:"BBA Advances"},{paper:"Estimation of human age using N-glycan profiles from bloodstains",authors:"Gudelj I, Keser T, Vučković F, Škaro V, Goreta SŠ, Pavić T, Dumić J, Primorac D, Lauc G, Gornik O.",date:2015,doi:"10.1007/s00414-015-1162-x",journal:"International Journal of Legal Medicine"},{paper:"Inflammatory Bowel Disease Associates with Proinflammatory Potential of the Immunoglobulin G Glycome",authors:"Trbojević Akmačić I, Ventham NT, Theodoratou E, Vučković F, Kennedy NA, Krištić J, Nimmo ER, Kalla R, Drummond H, Štambuk J, Dunlop MG, Novokmet M, Aulchenko Y, Gornik O, Campbell H, Pučić Baković M, Satsangi J, Lauc G;",date:2015,doi:"10.1097/MIB.0000000000000372",journal:"Inflammatory Bowel Disease"},{paper:"Glycosylation Profile of IgG in Moderate Kidney Dysfunction",authors:"Barrios C, Zierer J, Gudelj I, Štambuk J, Ugrina I, Rodríguez E, Soler MJ, Pavić T, Šimurina M, Keser T, Pučić-Baković M, Mangino M, Pascual J, Spector TD, Lauc G, Menni C.",date:2015,doi:"10.1681/ASN.2015010109",journal:"Journal of the American Society of Nephrology"},{paper:"Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome",authors:"Vučković F, Krištić J, Gudelj I, Teruel M, Keser T, Pezer M, Pučić-Baković M, Štambuk J, Trbojević-Akmačić I, Barrios C, Pavić T, Menni C, Wang Y, Zhou Y, Cui L, Song H, Zeng Q, Guo X, Pons-Estel BA, McKeigue P, Leslie Patrick A, Gornik O, Spector TD, Harjaček M, Alarcon-Riquelme M, Molokhia M, Wang W, Lauc G.",date:2015,doi:"10.1002/art.39273",journal:"Arthritis & Rheumatology"},{paper:"Genetic structure and admixture between Bayash Roma from northwestern Croatia and general Croatian population: evidence from Bayesian clustering analysis",authors:"Novokmet N, Galov A, Marjanović D, Škaro V, Projić P, Lauc G, Primorac D, Rudan P.",date:2015,doi:"10.1127/anthranz/2015/0485",journal:"Journal of Biological and Clinical Antropology"},{paper:"Mechanisms of disease: The human N-glycome",authors:"Lauc G, Pezer M, Rudan I, Campbell H.",date:2015,doi:"10.1016/j.bbagen.2015.10.016",journal:"ScienceDirect - Biochimica et Biophysica Acta"},{paper:"High-throughput glycomics: optimization of sample preparation",authors:"Akmačić IT, Ugrina I, Štambuk J, Gudelj I, Vučković F, Lauc G, Pučić-Baković M.",date:2015,doi:"10.1134/S0006297915070123",journal:"Biochemistry (Mosc)"},{paper:"A Monosaccharide Residue Is Sufficient to Maintain Mouse and Human IgG Subclass Activity and Directs IgG Effector Functions to Cellular Fc Receptors",authors:"Kao D, Danzer H, Collin M, Groß A, Eichler J, Stambuk J, Lauc G, Lux A, Nimmerjahn F.",date:2015,doi:"10.1016/j.celrep.2015.11.027",journal:"A cell press"},{paper:"IgG Glycome in Colorectal Cancer",authors:"Vučković F, Theodoratou E, Thaçi K, Timofeeva M, Vojta A, Štambuk J, Pučić-Baković M, Rudd PM, Đerek L, Servis D, Wennerström A, Farrington SM, Perola M, Aulchenko Y, Dunlop MG, Campbell H, Lauc G.",date:2016,doi:"10.1158/1078-0432.CCR-15-1867",journal:"AACR"},{paper:"Using omics in chronic pain conditions to delineate mechanisms and provide new therapeutic strategies",authors:"Freidin MB, Lauc G, Allegri M, Primorac D, Williams FM.",date:2016,doi:"10.2217/pmt.16.2",journal:"Pain management"},{paper:"High-throughput analysis of immunoglobulin G glycosylation",authors:"Trbojević-Akmačić I, Vilaj M, Lauc G.",date:2016,doi:"10.1080/14789450.2016.1174584",journal:"Expert Rev Proteomics"},{paper:"DNA hypomethylation upregulates expression of the MGAT3 gene in HepG2 cells and leads to changes in N-glycosylation of secreted glycoproteins",authors:"Klasić M, Krištić J, Korać P, Horvat T, Markulin D, Vojta A, Reiding KR, Wuhrer M, Lauc G, Zoldoš V.",date:2016,doi:"10.1038/srep24363",journal:"Scientific reports"},{paper:"The Association Between Glycosylation of Immunoglobulin G and Hypertension: A Multiple Ethnic Cross-Sectional Study",authors:"Wang Y, Klarić L, Yu X, Thaqi K, Dong J, Novokmet M, Wilson J, Polasek O, Liu Y, Krištić J, Ge S, Pučić-Baković M, Wu L, Zhou Y, Ugrina I, Song M, Zhang J, Guo X, Zeng Q, Rudan I, Campbell H, Aulchenko Y, Lauc G, Wang W.",date:2016,doi:"10.1097/MD.0000000000003379",journal:"Medicine (Baltimore)"},{paper:"Precision medicine that transcends genomics: Glycans as integrators of genes and environment",authors:"Lauc G.",date:2016,doi:"10.1016/j.bbagen.2016.05.001",journal:"iochim Biophys Acta"},{paper:"The Association Between Low Back Pain and Composition of IgG Glycome",authors:"Wang Y, Klarić L, Yu X, Thaqi K, Dong J, Novokmet M, Wilson J, Polasek O, Liu Y, Krištić J, Ge S, Pučić-Baković M, Wu L, Zhou Y, Ugrina I, Song M, Zhang J, Guo X, Zeng Q, Rudan I, Campbell H, Aulchenko Y, Lauc G, Wang W.",date:2016,doi:"10.1038/srep26815",journal:"Scientific reports"},{paper:"LaCyTools: A Targeted Liquid Chromatography-Mass Spectrometry Data Processing Package for Relative Quantitation of Glycopeptides",authors:"Jansen BC, Falck D, de Haan N, Hipgrave Ederveen AL, Razdorov G, Lauc G, Wuhrer M.",date:2016,doi:"10.1021/acs.jproteome.6b00171",journal:"J Proteome Res"},{paper:"Glycosylation of plasma IgG in colorectal cancer prognosis",authors:"Theodoratou E, Thaçi K, Agakov F, Timofeeva MN, Štambuk J, Pučić-Baković M, Vučković F, Orchard P, Agakova A, Din FV, Brown E, Rudd PM, Farrington SM, Dunlop MG, Campbell H, Lauc G.",date:2016,doi:"10.1038/srep28098",journal:"Scientific reports"},{paper:"Profiling IgG N-glycans as potential biomarker of chronological and biological ages: A community-based study in a Han Chinese population",authors:"Yu X, Wang Y, Kristic J, Dong J, Chu X, Ge S, Wang H, Fang H, Gao Q, Liu D, Zhao Z, Peng H, Pucic Bakovic M, Wu L, Song M, Rudan I, Campbell H, Lauc G, Wang W.",date:2016,doi:"10.1097/MD.0000000000004112",journal:"Medicine (Baltimore)"},{paper:"Changes in total plasma and serum N-glycome composition and patient-controlled analgesia after major abdominal surgery",authors:"Gudelj I, Baciarello M, Ugrina I, De Gregori M, Napolioni V, Ingelmo PM, Bugada D, De Gregori S, Đerek L, Pučić-Baković M, Novokmet M, Gornik O, Saccani Jotti G, Meschi T, Lauc G, Allegri M.",date:2016,doi:"10.1038/srep31234",journal:"Sci Rep"},{paper:"Effects of allergic diseases and age on the composition of serum IgG glycome in children",authors:"Pezer M, Stambuk J, Perica M, Razdorov G, Banic I, Vuckovic F, Gospic AM, Ugrina I, Vecenaj A, Bakovic MP, Lokas SB, Zivkovic J, Plavec D, Devereux G, Turkalj M, Lauc G.",date:2016,doi:"10.1038/srep33198",journal:"Sci Rep"},{paper:"Ubiquitous Importance of Protein Glycosylation",authors:"Krištić J, Lauc G.",date:2017,doi:"10.1007/978-1-4939-6493-2_1",journal:"Methods Mol Biol"},{paper:"Automated Integration of a UPLC Glycomic Profile",authors:"Agakova A, Vučković F, Klarić L, Lauc G, Agakov F.",date:2017,doi:"10.1007/978-1-4939-6493-2_17",journal:"Methods Mol Biol"},{paper:"'Omics' biomarkers associated with chronic low back pain: protocol of a retrospective longitudinal study",authors:"Allegri M, De Gregori M, Minella CE, Klersy C, Wang W, Sim M, Gieger C, Manz J, Pemberton IK, MacDougall J, Williams FM, Van Zundert J, Buyse K, Lauc G, Gudelj I, Primorac D, Skelin A, Aulchenko YS, Karssen LC, Kapural L, Rauck R, Fanelli G;",date:2016,doi:"10.1136/bmjopen-2016-012070",journal:"BMJ Open"},{paper:"Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease",authors:"Ventham NT, Kennedy NA, Adams AT, Kalla R, Heath S, O'Leary KR, Drummond H; IBD BIOM consortium; IBD CHARACTER consortium; Wilson DC, Gut IG, Nimmo ER, Satsangi J.",date:2016,doi:"10.1038/ncomms13507",journal:"Nat Commun"},{paper:"Exploring the molecular basis of age-related disease comorbidities using a multi-omics graphical model",authors:"Zierer J, Pallister T, Tsai PC, Krumsiek J, Bell JT, Lauc G, Spector TD, Menni C, Kastenmüller G.",date:2016,doi:"10.1038/srep37646",journal:"Sci Rep"},{paper:"Comparative Analysis and Validation of Different Steps in Glycomics Studies",authors:"Trbojević-Akmačić I, Ugrina I, Lauc G.",date:2016,doi:"10.1016/bs.mie.2016.09.027",journal:"Methods Enzymol"},{paper:"Estrogens regulate glycosylation of IgG in women and men",authors:"Ercan A, Kohrt WM, Cui J, Deane KD, Pezer M, Yu EW, Hausmann JS, Campbell H, Kaiser UB, Rudd PM, Lauc G, Wilson JF, Finkelstein JS, Nigrovic PA.",date:2017,doi:"10.1172/jci.insight.89703",journal:"JCI Insight"},{paper:"Connecting genetic risk to disease end points through the human blood plasma proteome",authors:"Suhre K, Arnold M, Bhagwat AM, Cotton RJ, Engelke R, Raffler J, Sarwath H, Thareja G, Wahl A, DeLisle RK, Gold L, Pezer M, Lauc G, El-Din Selim MA, Mook-Kanamori DO, Al-Dous EK, Mohamoud YA, Malek J, Strauch K, Grallert H, Peters A, Kastenmüller G, Gieger C, Graumann J.",date:2017,doi:"10.1038/ncomms14357",journal:"Nat Commun"},{paper:"Effects of statins on the immunoglobulin G glycome",authors:"Keser T, Vučković F, Barrios C, Zierer J, Wahl A, Akinkuolie AO, Štambuk J, Nakić N, Pavić T, Periša J, Mora S, Gieger C, Menni C, Spector TD, Gornik O, Lauc G.",date:2017,doi:"10.1016/j.bbagen.2017.02.029",journal:"Biochim Biophys Acta Gen Subj"},{paper:"Micronucleus, cell-free DNA, and plasma glycan composition in the newborns of healthy and diabetic mothers",authors:"Fucic A, Guszak V, Keser T, Wagner J, Juretić E, Plavec D, Stojković R, Gornik O, Lauc G.",date:2017,doi:"10.1016/j.mrgentox.2017.01.002",journal:"Mutat Res Genet Toxicol Environ Mutagen"},{paper:"The N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson's disease",authors:"Russell AC, Šimurina M, Garcia MT, Novokmet M, Wang Y, Rudan I, Campbell H, Lauc G, Thomas MG, Wang W.",date:2017,doi:"10.1093/glycob/cwx022",journal:"Glycobiology"},{paper:"Erratum: Connecting genetic risk to disease end points through the human blood plasma proteome",authors:"Suhre K, Arnold M, Bhagwat AM, Cotton RJ, Engelke R, Raffler J, Sarwath H, Thareja G, Wahl A, DeLisle RK, Gold L, Pezer M, Lauc G, El-Din Selim MA, Mook-Kanamori DO, Al-Dous EK, Mohamoud YA, Malek J, Strauch K, Grallert H, Peters A, Kastenmüller G, Gieger C, Graumann J.",date:2017,doi:"10.1038/ncomms15345",journal:"Nat Commun"},{paper:"Validation of standard operating procedures in a multicenter retrospective study to identify -omics biomarkers for chronic low back pain",authors:"Dagostino C, De Gregori M, Gieger C, Manz J, Gudelj I, Lauc G, Divizia L, Wang W, Sim M, Pemberton IK, MacDougall J, Williams F, Van Zundert J, Primorac D, Aulchenko Y, Kapural L, Allegri M; PainOmics Group.",date:2017,doi:"10.1371/journal.pone.0176372",journal:"PLoS One"},{paper:"Semi-high-throughput isolation and N-glycan analysis of human fibrinogen using monolithic supports bearing monoclonal anti-human fibrinogen antibodies",authors:"Vidic U, Trbojević-Akmačić I, Černigoj U, Albers M, Gašperšič J, Pučić-Baković M, Vidič J, Štrancar A, Lauc G.",date:2017,doi:"10.1002/elps.201700140",journal:"Unknown"},{paper:"The N-Glycosylation of Mouse Immunoglobulin G (IgG)-Fragment Crystallizable Differs Between IgG Subclasses and Strains",authors:"de Haan N, Reiding KR, Krištić J, Hipgrave Ederveen AL, Lauc G, Wuhrer M.",date:2017,doi:"10.3389/fimmu.2017.00608",journal:"Front Immunol"},{paper:"IgG glycan patterns are associated with type 2 diabetes in independent European populations",authors:"Gao Q, Dolikun M, Štambuk J, Wang H, Zhao F, Yiliham N, Wang Y, Trbojević-Akmačić I, Zhang J, Fang H, Sun Y, Peng H, Zhao Z, Liu D, Liu J, Li Q, Sun Q, Wu L, Lauc G, Wang W, Song M.",date:2017,doi:"10.1016/j.bbagen.2017.06.020",journal:"Biochim Biophys Acta Gen Subj"},{paper:"Immunoglobulin G N-Glycans as Potential Postgenomic Biomarkers for Hypertension in the Kazakh Population",authors:"Shen X, Klarić L, Sharapov S, Mangino M, Ning Z, Wu D, Trbojević-Akmačić I, Pučić-Baković M, Rudan I, Polašek O, Hayward C, Spector TD, Wilson JF, Lauc G, Aulchenko YS.",date:2017,doi:"10.1089/omi.2017.0044",journal:"OMICS"},{paper:"Multivariate discovery and replication of five novel loci associated with Immunoglobulin G N-glycosylation",authors:"Keser T, Gornik I, Vučković F, Selak N, Pavić T, Lukić E, Gudelj I, Gašparović H, Biočina B, Tilin T, Wennerström A, Männistö S, Salomaa V, Havulinna A, Wang W, Wilson JF, Chaturvedi N, Perola M, Campbell H, Lauc G, Gornik O.",date:2017,doi:"10.1038/s41467-017-00453-3",journal:"Nat Commun"},{paper:"Increased plasma N-glycome complexity is associated with higher risk of type 2 diabetes",authors:"eser T, Gornik I, Vučković F, Selak N, Pavić T, Lukić E, Gudelj I, Gašparović H, Biočina B, Tilin T, Wennerström A, Männistö S, Salomaa V, Havulinna A, Wang W, Wilson JF, Chaturvedi N, Perola M, Campbell H, Lauc G, Gornik O.",date:2017,doi:"10.1007/s00125-017-4426-9",journal:"Diabetologia"},{paper:"The Effect of Intra-articular Injection of Autologous Microfragmented Fat Tissue on Proteoglycan Synthesis in Patients with Knee Osteoarthritis",authors:"Hudetz D, Borić I, Rod E, Jeleč Ž, Radić A, Vrdoljak T, Skelin A, Lauc G, Trbojević-Akmačić I, Plečko M, Polašek O, Primorac D.",date:2017,doi:"10.3390/genes8100270",journal:"Genes (Basel)"},{paper:" IgG glycosylation and DNA methylation are interconnected with smoking",authors:"Wahl A, Kasela S, Carnero-Montoro E, van Iterson M, Štambuk J, Sharma S, van den Akker E, Klaric L, Benedetti E, Razdorov G, Trbojević-Akmačić I, Vučković F, Ugrina I, Beekman M, Deelen J, van Heemst D, Heijmans BT, B I O S Consortium, Wuhrer M, Plomp R, Keser T, Šimurina M, Pavić T, Gudelj I, Krištić J, Grallert H, Kunze S, Peters A, Bell JT, Spector TD, Milani L, Slagboom PE, Lauc G, Gieger C.",date:2018,doi:"10.1016/j.bbagen.2017.10.012",journal:"Biochim Biophys Acta Gen Subj"},{paper:"The sweet spot for biologics: recent advances in characterization of biotherapeutic glycoproteins",authors:"O'Flaherty R, Trbojević-Akmačić I, Greville G, Rudd PM, Lauc G.",date:2018,doi:"10.1080/14789450.2018.1404907",journal:"Expert Rev Proteomics"},{paper:"Network inference from glycoproteomics data reveals new reactions in the IgG glycosylation pathway",authors:"Benedetti E, Pučić-Baković M, Keser T, Wahl A, Hassinen A, Yang JY, Liu L, Trbojević-Akmačić I, Razdorov G, Štambuk J, Klarić L, Ugrina I, Selman MHJ, Wuhrer M, Rudan I, Polasek O, Hayward C, Grallert H, Strauch K, Peters A, Meitinger T, Gieger C, Vilaj M, Boons GJ, Moremen KW, Ovchinnikova T, Bovin N, Kellokumpu S, Theis FJ, Lauc G, Krumsiek J.",date:2017,doi:"10.1038/s41467-017-01525-0",journal:"Nat Commun"},{paper:"N-Glycan Profile and Kidney Disease in Type 1 Diabetes",authors:"Bermingham ML, Colombo M, McGurnaghan SJ, Blackbourn LAK, Vučković F, Pučić Baković M, Trbojević-Akmačić I, Lauc G, Agakov F, Agakova AS, Hayward C, Klarić L, Palmer CNA, Petrie JR, Chalmers J, Collier A, Green F, Lindsay RS, Macrury S, McKnight JA, Patrick AW, Thekkepat S, Gornik O, McKeigue PM, Colhoun HM; SDRN Type 1 Bioresource Investigators.",date:2018,doi:"10.2337/dc17-1042",journal:"Diabetes Care"},{paper:"Correction to: Increased plasma N-glycome complexity is associated with higher risk of type 2 diabetes",authors:"Keser T, Gornik I, Vučković F, Selak N, Pavić T, Lukić E, Gudelj I, Gašparović H, Biočina B, Tilin T, Wennerström A, Männistö S, Salomaa V, Havulinna A, Wang W, Wilson JF, Chaturvedi N, Perola M, Campbell H, Lauc G, Gornik O.",date:2018,doi:"10.1007/s00125-017-4515-9",journal:"Diabetologia"},{paper:"Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases",authors:"Šimurina M, de Haan N, Vučković F, Kennedy NA, Štambuk J, Falck D, Trbojević-Akmačić I, Clerc F, Razdorov G, Khon A, Latiano A, D'Incà R, Danese S, Targan S, Landers C, Dubinsky M;",date:2018,doi:"10.1053/j.gastro.2018.01.002",journal:"Gastroenterology"},{paper:"Blood plasma/IgG N-glycome biosignatures associated with major depressive disorder symptom severity and the antidepressant response",authors:"Park DI, Štambuk J, Razdorov G, Pučić-Baković M, Martins-de-Souza D, Lauc G, Turck CW.",date:2018,doi:"10.1038/s41598-017-17500-0",journal:"Sci Rep"},{paper:"Deep molecular phenotypes link complex disorders and physiological insult to CpG methylation",authors:"Zaghlool SB, Mook-Kanamori DO, Kader S, Stephan N, Halama A, Engelke R, Sarwath H, Al-Dous EK, Mohamoud YA, Roemisch-Margl W, Adamski J, Kastenmüller G, Friedrich N, Visconti A, Tsai PC, Spector T, Bell JT, Falchi M, Wahl A, Waldenberger M, Peters A, Gieger C, Pezer M, Lauc G, Graumann J, Malek JA, Suhre K.",date:2018,doi:"10.1093/hmg/ddy006",journal:"Hum Mol Genet"},{paper:"N-glycome of the Lysosomal Glycocalyx is Altered in Niemann-Pick Type C Disease (NPC) Model Cells",authors:"Kosicek M, Gudelj I, Horvatic A, Jovic T, Vuckovic F, Lauc G, Hecimovic S.",date:2018,doi:"10.1074/mcp.RA117.000129",journal:"Mol Cell Proteomics"},{paper:"Glycosylation Profile of Immunoglobulin G Is Cross-Sectionally Associated With Cardiovascular Disease Risk Score and Subclinical Atherosclerosis in Two Independent Cohorts",authors:"Menni C, Gudelj I, Macdonald-Dunlop E, Mangino M, Zierer J, Bešić E, Joshi PK, Trbojević-Akmačić I, Chowienczyk PJ, Spector TD, Wilson JF, Lauc G, Valdes AM.",date:2018,doi:"10.1161/CIRCRESAHA.117.312174",journal:"Circ Res"},{paper:"Genome-Wide Association Study on Immunoglobulin G Glycosylation Patterns",authors:"Wahl A, van den Akker E, Klaric L, Štambuk J, Benedetti E, Plomp R, Razdorov G, Trbojević-Akmačić I, Deelen J, van Heemst D, Slagboom PE, Vučković F, Grallert H, Krumsiek J, Strauch K, Peters A, Meitinger T, Hayward C, Wuhrer M, Beekman M, Lauc G, Gieger C.",date:2018,doi:"10.3389/fimmu.2018.00277",journal:"Front Immunol"},{paper:"Low galactosylation of IgG associates with higher risk for future diagnosis of rheumatoid arthritis during 10 years of follow-up",authors:"Krištić J, Zaytseva OO, Ram R, Nguyen Q, Novokmet M, Vučković F, Vilaj M, Trbojević-Akmačić I, Pezer M, Davern KM, Morahan G, Lauc G.",date:2018,doi:"10.1016/j.bbadis.2018.03.018",journal:"Biochim Biophys Acta Mol Basis Dis"},{paper:"Profiling and genetic control of the murine immunoglobulin G glycome",authors:"Krištić J, Zaytseva OO, Ram R, Nguyen Q, Novokmet M, Vučković F, Vilaj M, Trbojević-Akmačić I, Pezer M, Davern KM, Morahan G, Lauc G.",date:2018,doi:"10.1038/s41589-018-0034-3",journal:"Nat Chem Biol"},{paper:"Frontline Science: Plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy",authors:"Vadrevu SK, Trbojevic-Akmacic I, Kossenkov AV, Colomb F, Giron LB, Anzurez A, Lynn K, Mounzer K, Landay AL, Kaplan RC, Papasavvas E, Montaner LJ, Lauc G, Abdel-Mohsen M.",date:2018,doi:"10.1002/JLB.3HI1217-500R",journal:"J Leukoc Biol"},{paper:"Maturity onset diabetes of the young due toHNF1Avariants in Croatia",authors:"Pavić T, Juszczak A, Pape Medvidović E, Burrows C, Šekerija M, Bennett AJ, Ćuća Knežević J, Gloyn AL, Lauc G, McCarthy MI, Gornik O, Owen KR.",date:2018,doi:"10.11613/BM.2018.020703",journal:"Biochem Med (Zagreb)"},{paper:"Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases",authors:"Clerc F, Novokmet M, Dotz V, Reiding KR, de Haan N, Kammeijer GSM, Dalebout H, Bladergroen MR, Vukovic F, Rapp E; IBD-BIOM Consortium; Targan SR, Barron G, Manetti N, Latiano A, McGovern DPB, Annese V, Lauc G, Wuhrer M.",date:2018,doi:"10.1053/j.gastro.2018.05.030",journal:"Gastroenterology"},{paper:"Enabling STD-NMR fragment screening using stabilized native GPCR: A case study of adenosine receptor",authors:"gonet S, Raingeval C, Cecon E, Pučić-Baković M, Lauc G, Cala O, Baranowski M, Perez J, Jockers R, Krimm I, Jawhari A.",date:2018,doi:"10.1038/s41598-018-26113-0",journal:"Sci Rep"},{paper:"The association between subclass-specific IgG Fc N-glycosylation profiles and hypertension in the Uygur, Kazak, Kirgiz, and Tajik populations",authors:"Liu JN, Dolikun M, Štambuk J, Trbojević-Akmačić I, Zhang J, Wang H, Zheng DQ, Zhang XY, Peng HL, Zhao ZY, Liu D, Sun Y, Sun Q, Li QH, Zhang JX, Sun M, Cao WJ, Momčilović A, Razdorov G, Wu LJ, Russell A, Wang YX, Song MS, Lauc G, Wang W.",date:2018,doi:"10.1038/s41371-018-0071-0",journal:"J Hum Hypertens"},{paper:"Plasma N-glycans in colorectal cancer risk",authors:"Doherty M, Theodoratou E, Walsh I, Adamczyk B, Stöckmann H, Agakov F, Timofeeva M, Trbojević-Akmačić I, Vučković F, Duffy F, McManus CA, Farrington SM, Dunlop MG, Perola M, Lauc G, Campbell H, Rudd PM.",date:2018,doi:"10.1038/s41598-018-26805-7",journal:"Sci Rep"},{paper:"Plasma N-glycome composition associates with chronic low back pain",authors:"Trbojević-Akmačić I, Vučković F, Vilaj M, Skelin A, Karssen LC, Krištić J, Jurić J, Momčilović A, Šimunović J, Mangino M, De Gregori M, Marchesini M, Dagostino C, Štambuk J, Novokmet M, Rauck R, Aulchenko YS, Primorac D, Kapural L, Buyse K, Mesotten D, Williams FMK, van Zundert J, Allegri M, Lauc G.",date:2018,doi:"10.1016/j.bbagen.2018.07.003",journal:"Biochim Biophys Acta Gen Subj"},{paper:"Promoter methylation of theMGAT3andBACH2genes correlates with the composition of the immunoglobulin G glycome in inflammatory bowel disease",authors:"Klasić M, Markulin D, Vojta A, Samaržija I, Biruš I, Dobrinić P, Ventham NT, Trbojević-Akmačić I, Šimurina M, Štambuk J, Razdorov G, Kennedy NA, Satsangi J, Dias AM, Pinho S, Annese V, Latiano A, D'Inca R; IBD consortium; Lauc G, Zoldoš V.",date:2018,doi:"10.1186/s13148-018-0507-y",journal:"Clin Epigenetics"},{paper:"Metabolomic and glycomic findings in posttraumatic stress disorder",authors:"Konjevod M, Tudor L, Svob Strac D, Nedic Erjavec G, Barbas C, Zarkovic N, Nikolac Perkovic M, Uzun S, Kozumplik O, Lauc G, Pivac N.",date:2019,doi:"10.1016/j.pnpbp.2018.07.014",journal:"Prog Neuropsychopharmacol Biol Psychiatry"},{paper:"Trace N-glycans including sulphated species may originate from various plasma glycoproteins and not necessarily IgG",authors:"Keser T, Pavić T, Lauc G, Gornik O.",date:2018,doi:"10.1038/s41467-018-05173-w",journal:"Nat Commun"},{paper:"Comparison of 2-Aminobenzamide, Procainamide and Rapi Fluor-MS as Derivatizing Agents for High-Throughput HILIC-UPLC-FLR-MS N-glycan Analysis",authors:"Keser T, Pavić T, Lauc G, Gornik O.",date:2018,doi:"10.3389/fchem.2018.00324",journal:"Front Chem"},{paper:"Immunoglobulin G glycosylation in aging and diseases",authors:"Gudelj I, Lauc G, Pezer M.",date:2018,doi:"10.1016/j.cellimm.2018.07.009",journal:"Cell Immunol"},{paper:"The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia",authors:"Liu D, Chu X, Wang H, Dong J, Ge SQ, Zhao ZY, Peng HL, Sun M, Wu LJ, Song MS, Guo XH, Meng Q, Wang YX, Lauc G, Wang W.",date:2018,doi:"10.1186/s12967-018-1616-2",journal:"J Transl Med"},{paper:"MIgGGly (mouse IgG glycosylation analysis) - a high-throughput method for studying Fc-linked IgG N-glycosylation in mice with nanoUPLC-ESI-MS",authors:"Zaytseva OO, Jansen BC, Hanić M, Mrčela M, Razdorov G, Stojković R, Erhardt J, Brizić I, Jonjić S, Pezer M, Lauc G.",date:2018,doi:"10.1038/s41598-018-31844-1",journal:"Sci Rep"},{paper:"High-throughput Serum N-Glycomics: Method Comparison and Application to Study Rheumatoid Arthritis and Pregnancy-associated Changes",authors:"Reiding KR, Bondt A, Hennig R, Gardner RA, O'Flaherty R, Trbojević-Akmačić I, Shubhakar A, Hazes JMW, Reichl U, Fernandes DL, Pučić-Baković M, Rapp E, Spencer DIR, Dolhain RJEM, Rudd PM, Lauc G, Wuhrer M.",date:2019,doi:"10.1074/mcp.RA117.000454",journal:"Mol Cell Proteomics"},{paper:"Genome-wide meta-analysis of 158,000 individuals of European ancestry identifies three loci associated with chronic back pain",authors:"Suri P, Palmer MR, Tsepilov YA, Freidin MB, Boer CG, Yau MS, Evans DS, Gelemanovic A, Bartz TM, Nethander M, Arbeeva L, Karssen L, Neogi T, Campbell A, Mellstrom D, Ohlsson C, Marshall LM, Orwoll E, Uitterlinden A, Rotter JI, Lauc G, Psaty BM, Karlsson MK, Lane NE, Jarvik GP, Polasek O, Hochberg M, Jordan JM, Van Meurs JBJ, Jackson R, Nielson CM, Mitchell BD, Smith BH, Hayward C, Smith NL, Aulchenko YS, Williams FMK.",date:2018,doi:"10.1371/journal.pgen.1007601",journal:"PLoS Genet"},{paper:"High throughput profiling of whole plasma N-glycans in type II diabetes mellitus patients and healthy individuals: A perspective from a Ghanaian population",authors:"Suri P, Palmer MR, Tsepilov YA, Freidin MB, Boer CG, Yau MS, Evans DS, Gelemanovic A, Bartz TM, Nethander M, Arbeeva L, Karssen L, Neogi T, Campbell A, Mellstrom D, Ohlsson C, Marshall LM, Orwoll E, Uitterlinden A, Rotter JI, Lauc G, Psaty BM, Karlsson MK, Lane NE, Jarvik GP, Polasek O, Hochberg M, Jordan JM, Van Meurs JBJ, Jackson R, Nielson CM, Mitchell BD, Smith BH, Hayward C, Smith NL, Aulchenko YS, Williams FMK.",date:2018,doi:"10.1016/j.abb.2018.10.015",journal:"Arch Biochem Biophys"},{paper:"Increased central adiposity is associated with pro-inflammatory immunoglobulin G N-glycans",authors:"Russell AC, Kepka A, Trbojević-Akmačić I, Ugrina I, Song M, Hui J, Hunter M, Laws SM, Lauc G, Wang W.",date:2019,doi:"10.1016/j.imbio.2018.10.002",journal:"Immunobiology"},{paper:"Plasma Fucosylated Glycans and C-Reactive Protein as Biomarkers of HNF1A-MODY in Young Adult-Onset Nonautoimmune Diabetes",authors:"Juszczak A, Pavić T, Vučković F, Bennett AJ, Shah N, Pape Medvidović E, Groves CJ, Šekerija M, Chandler K, Burrows C, Rojnić Putarek N, Vučić Lovrenčić M, Ćuća Knežević J, James TJ, Gloyn AL, Lauc G, McCarthy MI, Owen KR, Gornik O.",date:2019,doi:"10.2337/dc18-0422",journal:"Diabetes Care"},{paper:"N-glycosylation patterns of plasma proteins and immunoglobulin G in chronic obstructive pulmonary disease",authors:"Pavić T, Dilber D, Kifer D, Selak N, Keser T, Ljubičić Đ, Vukić Dugac A, Lauc G, Rumora L, Gornik O.",date:2018,doi:"10.1186/s12967-018-1695-0",journal:"J Transl Med"},{paper:"Glycosylation of human plasma lipoproteins reveals a high level of diversity, which directly impacts their functional properties",authors:"Sukhorukov V, Gudelj I, Pučić-Baković M, Zakiev E, Orekhov A, Kontush A, Lauc G.",date:2019,doi:"10.1016/j.bbalip.2019.01.005",journal:"Biochim Biophys Acta Mol Cell Biol Lipids"},{paper:"Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis",authors:"Colomb F, Giron LB, Trbojevic-Akmacic I, Lauc G, Abdel-Mohsen M.",date:2019,doi:"10.1007/s11904-019-00433-w",journal:"Curr HIV/AIDS Rep"},{paper:"Molecular Pathways Mediating Immunosuppression in Response to Prolonged Intensive Physical Training, Low-Energy Availability, and Intensive Weight Loss",authors:"Sarin HV, Gudelj I, Honkanen J, Ihalainen JK, Vuorela A, Lee JH, Jin Z, Terwilliger JD, Isola V, Ahtiainen JP, Häkkinen K, Jurić J, Lauc G, Kristiansson K, Hulmi JJ, Perola M.",date:2019,doi:"10.3389/fimmu.2019.00907",journal:"Front Immunol"},{paper:"Defining the genetic control of human blood plasma N-glycome using genome-wide association study",authors:"Sharapov SZ, Tsepilov YA, Klaric L, Mangino M, Thareja G, Shadrina AS, Simurina M, Dagostino C, Dmitrieva J, Vilaj M, Vuckovic F, Pavic T, Stambuk J, Trbojevic-Akmacic I, Kristic J, Simunovic J, Momcilovic A, Campbell H, Doherty M, Dunlop MG, Farrington SM, Pucic-Bakovic M, Gieger C, Allegri M, Louis E, Georges M, Suhre K, Spector T, Williams FMK, Lauc G, Aulchenko YS.",date:2019,doi:"10.1093/hmg/ddz054",journal:"Hum Mol Genet"},{paper:"Altered N-glycosylation profiles as potential biomarkers and drug targets in diabetes",authors:"Rudman N, Gornik O, Lauc G.",date:2019,doi:"10.1002/1873-3468.13495",journal:"FEBS Lett"},{paper:"Fine-Mapping of the Human Blood Plasma N-Glycome onto Its Proteome",authors:"Suhre K, Trbojević-Akmačić I, Ugrina I, Mook-Kanamori DO, Spector T, Graumann J, Lauc G, Falchi M.",date:2019,doi:"10.3390/metabo9070122",journal:"Metabolites"},{paper:"Inflammatory bowel disease - glycomics perspective",authors:"Hanić M, Trbojević-Akmačić I, Lauc G.",date:2019,doi:"10.1016/j.bbagen.2019.07.001",journal:"Biochim Biophys Acta Gen Subj"},{paper:"Next-Generation (Glycomic) Biomarkers for Cardiometabolic Health: A Community-Based Study of Immunoglobulin GN-Glycans in a Chinese Han Population",authors:"Wang H, Li X, Wang X, Liu D, Zhang X, Cao W, Zheng Y, Guo Z, Li D, Xing W, Hou H, Wu L, Song M, Zhong Z, Wang Y, Tan X, Lauc G, Wang W.",date:2019,doi:"10.1089/omi.2019.0099",journal:"OMICS"},{paper:"Glycomics for Type 2 Diabetes Biomarker Discovery: Promise of Immunoglobulin G Subclass-Specific Fragment Crystallizable N-glycosylation in the Uyghur Population",authors:"Liu J, Dolikun M, Štambuk J, Trbojević-Akmačić I, Zhang J, Zhang J, Wang H, Meng X, Razdorov G, Menon D, Zheng D, Wu L, Wang Y, Song M, Lauc G, Wang W.",date:2019,doi:"10.1089/omi.2019.0052",journal:"OMICS"},{paper:"Comprehensive N-glycosylation analysis of immunoglobulin G from dried blood spots",authors:"Simunovic J, Vilaj M, Trbojevic-Akmacic I, Momcilovic A, Vuckovic F, Gudelj I, Juric J, Nakic N, Lauc G, Pezer M.",date:2019,doi:"10.1093/glycob/cwz061",journal:"Glycobiology"},{paper:"Antagonistic and synergistic epigenetic modulation using orthologous CRISPR/dCas9-based modular system",authors:"Josipović G, Tadić V, Klasić M, Zanki V, Bečeheli I, Chung F, Ghantous A, Keser T, Madunić J, Bošković M, Lauc G, Herceg Z, Vojta A, Zoldoš V.",date:2019,doi:"10.1093/nar/gkz709",journal:"Nucleic Acids Res"},{paper:"Decreased Complexity of Serum N-glycan Structures Associates with Successful Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection",authors:"Monaghan TM, Pučić-Baković M, Vučković F, Lee C, Kao D; Human Glycome Project.",date:2019,doi:"10.1053/j.gastro.2019.08.034",journal:"Gastroenterology"},{paper:"N-Glycan Analysis by Ultra-Performance Liquid Chromatography and Capillary Gel Electrophoresis with Fluorescent Labeling",authors:"Vadrevu SK, Trbojevic-Akmacic I, Kossenkov AV, Colomb F, Giron LB, Anzurez A, Lynn K, Mounzer K, Landay AL, Kaplan RC, Papasavvas E, Montaner LJ, Lauc G, Abdel-Mohsen M.",date:2019,doi:"10.1002/cpps.95",journal:"Curr Protoc Protein Sci"},{paper:"Translational glycobiology: from bench to bedside",authors:"Axford J, Alavi A, Cummings R, Lauc G, Opdenakker G, Reis C, Rudd P.",date:2019,doi:"10.1177/0141076819865863",journal:"J R Soc Med"},{paper:"Type 2 Diabetes Mellitus is Associated with the Immunoglobulin G N-Glycome through Putative Proinflammatory Mechanisms in an Australian Population",authors:"Li X, Wang H, Russell A, Cao W, Wang X, Ge S, Zheng Y, Guo Z, Hou H, Song M, Yu X, Wang Y, Hunter M, Roberts P, Lauc G, Wang W.",date:2019,doi:"10.1089/omi.2019.0075",journal:"OMICS"},{paper:"Utilization of N-glycosylation profiles as risk stratification biomarkers for suboptimal health status and metabolic syndrome in a Ghanaian population",authors:"Adua E, Memarian E, Russell A, Trbojević-Akmačić I, Gudelj I, Jurić J, Roberts P, Lauc G, Wang W.",date:2019,doi:"10.2217/bmm-2019-0005",journal:"Biomark Med"},{paper:"Supplementation With the Sialic Acid Precursor N-Acetyl-D-Mannosamine Breaks the Link Between Obesity and Hypertension",authors:"Peng J, Vongpatanasin W, Sacharidou A, Kifer D, Yuhanna IS, Banerjee S, Tanigaki K, Polasek O, Chu H, Sundgren NC, Rohatgi A, Chambliss KL, Lauc G, Mineo C, Shaul PW.",date:2019,doi:"10.1161/CIRCULATIONAHA.119.043490",journal:"Circulation"},{paper:"Why Not Use the Immunoglobulin GN-Glycans as Predictor Variables in Disease Biomarker-Phenotype Association Studies? A Multivariate Analysis",authors:"Russell AC, Kepka A, Trbojević-Akmačić I, Ugrina I, Song M, Hui J, Hunter M, Laws SM, Lauc G, Wang W.",date:2019,doi:"10.1089/omi.2019.0155",journal:"OMICS"},{paper:"Heritability of Human PlasmaN-Glycome",authors:"Zaytseva OO, Freidin MB, Keser T, Štambuk J, Ugrina I, Šimurina M, Vilaj M, Štambuk T, Trbojević-Akmačić I, Pučić-Baković M, Lauc G, Williams FMK, Novokmet M.",date:2020,doi:"10.1021/acs.jproteome.9b00348",journal:"J Proteome Res"},{paper:"N-glycomic Profile in Combat Related Post-Traumatic Stress Disorder",authors:"Tudor L, Nedic Erjavec G, Nikolac Perkovic M, Konjevod M, Svob Strac D, Uzun S, Kozumplik O, Jovanovic T, Lauc G, Pivac N.",date:2019,doi:"0.3390/biom9120834",journal:"Biomolecules"},{paper:"A 24-Month Follow-Up Study of the Effect of Intra-Articular Injection of Autologous Microfragmented Fat Tissue on Proteoglycan Synthesis in Patients with Knee Osteoarthritis",authors:"Borić I, Hudetz D, Rod E, Jeleč Ž, Vrdoljak T, Skelin A, Polašek O, Plečko M, Trbojević-Akmačić I, Lauc G, Primorac D.",date:2019,doi:"10.3390/genes10121051",journal:"Genes (Basel)"},{paper:"Intense Physical Exercise Induces an Anti-inflammatory Change in IgG N-Glycosylation Profile",authors:"Tijardović M, Marijančević D, Bok D, Kifer D, Lauc G, Gornik O, Keser T.",date:2019,doi:"10.3389/fphys.2019.01522",journal:"Front Physiol"},{paper:"Biomarkers of biological age as predictors of COVID-19 disease severity",authors:"Unknown",date:2020,doi:"10.18632/aging.103052",journal:"Aging (Albany NY)"},{paper:"Association of the IgG N-glycome with the course of kidney function in type 2 diabetes",authors:"Singh SS, Heijmans R, Meulen CKE, Lieverse AG, Gornik O, Sijbrands EJG, Lauc G, van Hoek M.",date:2020,doi:"10.1136/bmjdrc-2019-001026",journal:"BMJ Open Diabetes Res Care"},{paper:"Changes in subclass-specific IgG Fc glycosylation associated with the postnatal maturation of the murine immune system",authors:"Barrientos G, Habazin S, Novokmet M, Almousa Y, Lauc G, Conrad ML.",date:2020,doi:"10.1038/s41598-020-71899-7",journal:"Sci Rep"},{paper:"Increased yield of enzymatic synthesis by chromatographic selection of different N-glycoforms of yeast invertase",authors:"Andjelković U, Gudelj I, Klarić T, Hinneburg H, Vinković M, Wittine K, Dovezenski N, Vikić-Topić D, Lauc G, Vujčić Z, Josić D.",date:2020,doi:"10.1002/elps.202000092",journal:"Electrophoresis"},{paper:"Effects of estradiol on biological age measured using the glycan age index",authors:"Jurić J, Kohrt WM, Kifer D, Gavin KM, Pezer M, Nigrovic PA, Lauc G.",date:2020,doi:"10.18632/aging.104060",journal:"Aging (Albany NY)"},{paper:"Fc-Linked IgGN-Glycosylation in FcγR Knock-Out Mice",authors:"Zaytseva OO, Seeling M, Krištić J, Lauc G, Pezer M, Nimmerjahn F.",date:2020,doi:"10.3389/fcell.2020.00067",journal:"Frontiers in Cell and Developmental Biology"},{paper:"N-glycans as functional effectors of genetic and epigenetic disease risk",authors:"Štambuk T, Klasić M, Zoldoš V, Lauc G",date:2020,doi:"10.1016/j.mam.2020.100891",journal:"Molecular Aspects of Medicine"},{paper:"Plasma N-Glycans as Emerging Biomarkers of Cardiometabolic Risk: A Prospective Investigation in the EPIC-Potsdam Cohort Study",authors:"Wittenbecher C, Štambuk T, Kuxhaus O, Rudman N, Vučković F, Štambuk J, Schiborn C, Rahelić D, Dietrich S, Gornik O, Perola M, Boeing H, Schulze MB, Lauc G.",date:2020,doi:"10.2337/dc19-1507",journal:"Diabetes Care"},{paper:"Glycosylation of immunoglobulin G is regulated by a large network of genes pleiotropic with inflammatory diseases",authors:"Klarić L, Tsepilov YA, Stanton CM, Mangino M, Sikka TT, Esko T, Pakhomov E, Salo P, Deelen J, McGurnaghan SJ, Keser T, Vučković F, Ugrina I, Krištić J, Gudelj I, Štambuk J, Plomp R, Pučić-Baković M, Pavić T, Vilaj M, Trbojević-Akmačić I, Drake C, Dobrinić P, Mlinarec J, Jelušić B, Richmond A, Timofeeva M, Grishchenko AK, Dmitrieva J, Bermingham ML, Sharapov SZ, Farrington SM, Theodoratou E, Uh HW, Beekman M, Slagboom EP, Louis E, Georges M, Wuhrer M, Colhoun HM, Dunlop MG, Perola M, Fischer K, Polasek O, Campbell H, Rudan I, Wilson JF, Zoldoš V, Vitart V, Spector T, Aulchenko YS, Lauc G, Hayward C.",date:2020,doi:"10.1126/sciadv.aax0301",journal:"Science Advances"},{paper:"Global variability of the human IgG glycome",authors:"Štambuk J, Nakić N, Vučković F, Pučić-Baković M, Razdorov G, Trbojević-Akmačić I, Novokmet M, Keser T, Vilaj M, Štambuk T, Gudelj I, Šimurina M, Song M, Wang H, Salihović MP, Campbell H, Rudan I, Kolčić I, Eller LA, McKeigue P, Robb ML, Halfvarson J, Kurtoglu M, Annese V, Škarić-Jurić T, Molokhia M, Polašek O, Hayward C, Kibuuka H, Thaqi K, Primorac D, Gieger C, Nitayaphan S, Spector T, Wang Y, Tillin T, Chaturvedi N, Wilson JF, Schanfield M, Filipenko M, Wang W, Lauc G.",date:2020,doi:"10.18632/aging.103884",journal:"Aging"},{paper:"Systematic Evaluation of Normalization Methods for Glycomics Data Based on Performance of Network Inference",authors:"Benedetti E, Gerstner N, Pučić-Baković M, Keser T, Reiding KR, Ruhaak LR, Štambuk T, Selman MHJ, Rudan I, Polašek O, Hayward C, Beekman M, Slagboom E, Wuhrer M, Dunlop MG, Lauc G, Krumsiek J.",date:2020,doi:"10.3390/metabo10070271",journal:"Metabolites"},{paper:"Minimal B Cell Extrinsic IgG Glycan Modifications of Pro- and Anti-Inflammatory IgG Preparationsin vivo",authors:"Schaffert A, Hanić M, Novokmet M, Zaytseva O, Krištić J, Lux A, Nitschke L, Peipp M, Pezer M, Hennig R, Rapp E, Lauc G, Nimmerjahn F.",date:2020,doi:"10.3389/fimmu.2019.03024",journal:"Frontiers in immunology"},{paper:"Dysregulated Antibody, Natural Killer Cell and Immune Mediator Profiles in Autoimmune Thyroid Diseases",authors:"Martin TC, Ilieva KM, Visconti A, Beaumont M, Kiddle SJ, Dobson RJB, Mangino M, Lim EM, Pezer M, Steves CJ, Bell JT, Wilson SG, Lauc G, Roederer M, Walsh JP, Spector TD, Karagiannis SN.",date:2020,doi:"10.3390/cells9030665",journal:"Cells"},{paper:"Decreased Immunoglobulin G Core Fucosylation, A Player in Antibody-dependent Cell-mediated Cytotoxicity, is Associated with Autoimmune Thyroid Diseases",authors:"Martin TC, Šimurina M, Ząbczyńska M, Martinic Kavur M, Rydlewska M, Pezer M, Kozłowska K, Burri A, Vilaj M, Turek-Jabrocka R, Krnjajić-Tadijanović M, Trofimiuk-Müldner M, Ugrina I, Lityńska A, Hubalewska-Dydejczyk A, Trbojevic-Akmacic I, Lim EM, Walsh JP, Pocheć E, Spector TD, Wilson SG, Lauc G.",date:2020,doi:"10.1074/mcp.RA119.001860",journal:"Mollecular & Cellular Proteomics"},{paper:"Pleiotropic ZIP8 A391T implicates abnormal manganese homeostasis in complex human disease",authors:"Sunuwar L, Frkatović A, Sharapov S, Wang Q, Neu HM, Wu X, Haritunians T, Wan F, Michel S, Wu S, Donowitz M, McGovern D, Lauc G, Sears C, Melia J.",date:2020,doi:"10.1172/jci.insight.140978",journal:"JCI Insight"},{paper:"Searching for glycomic biomarkers for predicting resilience and vulnerability in a rat model of posttraumatic stress disorder",authors:"Fazekas CL, Sipos E, Klaric T, Török B, Bellardie M, Erjave GN, Perkovic MN, Lauc G, Pivac N, Zelena D.",date:2020,doi:"10.1080/10253890.2020.1795121",journal:"Unknown"},{paper:"Association of the matrix metalloproteinase 3 (MMP3) single nucleotide polymorphisms with tendinopathies: case-control study in high-level athletes",authors:"Briški N, Vrgoč G, Knjaz D, Janković S, Ivković A, Pećina M, Lauc G",date:2020,doi:"10.1007/s00264-020-04684-w",journal:"Int Orthop"},{paper:"Replication of fifteen loci involved in human plasma protein N-glycosylation in 4,802 samples from four cohorts",authors:"Sharapov SZ, Shadrina AS, Tsepilov YA, Elgaeva EE, Tiys ES, Feoktistova SG, Zaytseva OO, Vuckovic F, Cuadrat R, Jäger S, Wittenbecher C, Karssen LC, Timofeeva M, Tillin T, Trbojević-Akmačić I, Štambuk T, Rudman N, Krištić J, Šimunović J, Momčilović A, Vilaj M, Jurić J, Slana A, Gudelj I, Klarić T, Puljak L, Skelin A, Kadić AJ, Van Zundert J, Chaturvedi N, Campbell H, Dunlop M, Farrington SM, Doherty M, Dagostino C, Gieger C, Allegri M, Williams F, Schulze MB, Lauc G, Aulchenko YS.",date:2020,doi:"10.1093/glycob/cwaa053",journal:"Glycobiology"},{paper:"Evaluation of different PNGase F enzymes in immunoglobulin G and total plasma N-glycans analysis",authors:"Vilaj M, Lauc G, Trbojević-Akmačić I.",date:2020,doi:"10.1093/glycob/cwaa047",journal:"Glycobiology"},{paper:"Fighting COVID-19 with water",authors:"Lauc G, Markotić A, Gornik I, Primorac D.",date:2020,doi:"10.7189/jogh.10.010344",journal:"J Glob Health"},{paper:"Genetic Variants of the MGAT5 Gene Are Functionally Implicated in the Modulation of T Cells Glycosylation and Plasma IgG Glycome Composition in Ulcerative Colitis",authors:"Pereira MS, Durães C, Catarino TA, Costa JL, Cleynen I, Novokmet M, Krištić J, Štambuk J, Conceição-Neto N, Machado JC, Marcos-Pinto R, Magro F, Vermeire S, Lauc G, Lago P, Pinho SS.",date:2020,doi:"10.14309/ctg.0000000000000166",journal:"Clinical and Translational Gastroenterology"},{paper:"Biomarkers of biological age as predictors of COVID-19 disease severity",authors:"Lauc G, Sinclair D.",date:2020,doi:"10.18632/aging.103052",journal:"Aging (Albany NY)"},{paper:"Choosing proper normalization is essential for discovery of sparse glycan biomarkers",authors:"Uh HW, Klarić L, Ugrina I, Lauc G, Smilde AK, Houwing-Duistermaat JJ",date:2020,doi:"10.1039/C9MO00174C",journal:"Molecular Omics"},{paper:"NIST Interlaboratory Study on Glycosylation Analysis of Monoclonal Antibodies: Comparison of Results from Diverse Analytical Methods",authors:"Maria Lorna A De Leoz at al.",date:2020,doi:"10.1074/mcp.RA119.001677",journal:"Molecular & Cellular Proteomics"},{paper:"Glycosylation Alterations in Multiple Sclerosis Show Increased Proinflammatory Potential",authors:"Cvetko A, Kifer D, Gornik O, Klarić L, Visser E, Lauc G, Wilson JF, Štambuk T.",date:2020,doi:"10.3390/biomedicines8100410",journal:"Biomedicines"},{paper:"A strategy to incorporate prior knowledge into correlation network cutoff selection",authors:"Benedetti E, Pučić-Baković M, Keser T, Gerstner N, Büyüközkan M, Štambuk T, Selman MHJ, Rudan I, Polašek O, Hayward C, Al-Amin H, Suhre K, Kastenmüller G, Lauc G, Krumsiek J.",date:2020,doi:"10.1038/s41467-020-18675-3",journal:"Nature Communications"},{paper:"N-glycosylation analysis of mouse immunoglobulin G isolated from dried blood spots",authors:"Patenaude AM, Erhardt J, Hennig R, Rapp E, Lauc G, Pezer M",date:2020,doi:"10.1002/elps.202000249",journal:"Electrophoresis"},{paper:"Composition of the immunoglobulin G glycome associates with the severity of COVID-19",authors:"Petrović T, Alves I, Bugada D, Pascual J, Vučković F, Skelin A, Gaifem J, Villar-Garcia J, Vicente MM, Fernandes Â, Dias AM, Kurolt IC, Markotić A, Primorac D, Soares A, Malheiro L, Trbojević-Akmačić I, Abreu M, Sarmento E Castro R, Bettinelli S, Callegaro A, Arosio M, Sangiorgio L, Lorini LF, Castells X, Horcajada JP, Pinho SS, Allegri M, Barrios C, Lauc G.",date:2020,doi:"10.1093/glycob/cwaa102",journal:"Glycobiology"},{paper:"Glycosylation and Aging",authors:"Cindrić A, Krištić J, Martinić Kavur M, Pezer M.",date:2021,doi:"10.1007/978-3-030-70115-4_17",journal:"The Role of Glycosylation in Health and Disease"},{paper:"Targeting B cells in the pre-phase of systemic autoimmunity globally interferes with autoimmune pathology",authors:"Werner A, Schäfer S, Zaytseva O, Albert H, Lux A, Krištić J, Pezer M, Lauc G, Winkler T, Nimmerjahn F.",date:2021,doi:"10.1016/j.isci.2021.103076",journal:"iScience"},{paper:"Immunoglobulin G glycome composition in transition from premenopause to postmenopause",authors:"Deriš H, Kifer D, Cindrić A, Petrović T, Cvetko A, Trbojević-Akmačić I, Kolčić I, Polašek O, Newson L, Spector T, Menni C, Lauc G.",date:2022,doi:"10.1016/j.isci.2022.103897",journal:"iScience"},{paper:"Post-natal developmental changes in the composition of the rat neocortical N-glycome",authors:"Klarić TS, Salopek M, Micek V, Gornik Kljaić O, Lauc G.",date:2021,doi:"10.1093/glycob/cwaa108",journal:"Glycobiology"},{paper:'Response to "Immunoglobulin G glycome and severity of COVID-19: more likely a quantification of bias than a true association"',authors:"Lauc G.",date:2021,doi:"10.1093/glycob/cwaa116",journal:"Glycobiology"},{paper:"Changes in IgA-targeted microbiota following fecal transplantation for recurrentClostridioides difficileinfection",authors:"Huus KE, Frankowski M, Pučić-Baković M, Vučković F, Lauc G, Mullish BH, Marchesi JR, Monaghan TM, Kao D, Finlay BB.",date:2021,doi:"10.1080/19490976.2020.1862027",journal:"Gut Microbes"},{paper:"High-Throughput and Site-Specific N-Glycosylation Analysis of Human Alpha-1-Acid Glycoprotein Offers a Great Potential for New Biomarker Discovery",authors:"Keser T, Tijardović M, Gornik I, Lukić E, Lauc G, Gornik O, Novokmet M.",date:2021,doi:"10.1074/mcp.RA120.002433",journal:"Mol Cell Proteomics"},{paper:"Site-specific analysis of N-glycans from different sheep prion strains",authors:"Nakić N, Tran TH, Novokmet M, Andreoletti O, Lauc G, Legname G.",date:2021,doi:"10.1371/journal.ppat.1009232",journal:"PLoS Pathog"},{paper:"Multivariate genome-wide analysis of immunoglobulin G N-glycosylation identifies new loci pleiotropic with immune function",authors:"Shadrina AS, Zlobin AS, Zaytseva OO, Klarić L, Sharapov SZ, D Pakhomov E, Perola M, Esko T, Hayward C, Wilson JF, Lauc G, Aulchenko YS, Tsepilov YA.",date:2021,doi:"10.1093/hmg/ddab072",journal:"Hum Mol Genet"},{paper:"Correction: Site-specific analysis of N-glycans from different sheep prion strains",authors:"Nakić N, Tran TH, Novokmet M, Andreoletti O, Lauc G, Legname G.",date:2021,doi:"10.1371/journal.ppat.1009511",journal:"PLoS Pathog"},{paper:"Effects of Environmental Factors on Severity and Mortality of COVID-19",authors:"Kifer D, Bugada D, Villar-Garcia J, Gudelj I, Menni C, Sudre C, Vučković F, Ugrina I, Lorini LF, Posso M, Bettinelli S, Ughi N, Maloberti A, Epis O, Giannattasio C, Rossetti C, Kalogjera L, Peršec J, Ollivere L, Ollivere BJ, Yan H, Cai T, Aithal GP, Steves CJ, Kantele A, Kajova M, Vapalahti O, Sajantila A, Wojtowicz R, Wierzba W, Krol Z, Zaczynski A, Zycinska K, Postula M, Lukšić I, Čivljak R, Markotić A, Brachmann J, Markl A, Mahnkopf C, Murray B, Ourselin S, Valdes AM, Horcajada JP, Castells X, Pascual J, Allegri M, Primorac D, Spector TD, Barrios C, Lauc G.",date:2021,doi:"10.3389/fmed.2020.607786",journal:"Frontiers in Medicine"},{paper:"N-glycosylation profiling of Type 2 diabetes mellitus from baseline to follow-up: an observational study in a Ghanaian population",authors:"Adua E, Memarian E, Afrifa-Yamoah E, Russell A, Trbojević-Akmačić I, Gudelj I, Jurić J, Roberts P, Lauc G, Wang W.",date:2021,doi:"10.2217/bmm-2020-0615",journal:"Biomark Med"},{paper:"Extensive weight loss reduces glycan age by altering IgG N-glycosylation",authors:"Greto VL, Cvetko A, Štambuk T, Dempster NJ, Kifer D, Deriš H, Cindrić A, Vučković F, Falchi M, Gillies RS, Tomlinson JW, Gornik O, Sgromo B, Spector TD, Menni C, Geremia A, Arancibia-Cárcamo CV, Lauc G.",date:2021,doi:"10.1038/s41366-021-00816-3",journal:"Int J Obes (Lond)"},{paper:"Effects of Estradiol on Immunoglobulin G Glycosylation: Mapping of the Downstream Signaling Mechanism",authors:"Mijakovac A, Jurić J, Kohrt WM, Krištić J, Kifer D, Gavin KM, Miškec K, Frkatović A, Vučković F, Pezer M, Vojta A, Nigrović PA, Zoldoš V, Lauc G.",date:2021,doi:"10.3389/fimmu.2021.680227",journal:"Front Immunol"},{paper:"High-throughput rat immunoglobulin G N-glycosylation profiling revealed subclass-specific changes associated with chronic stress",authors:"Habazin S, Mlinarević D, Balog M, Bardak A, Gaspar R, Szűcs KF, Vari SG, Vučković F, Lauc G, Novokmet M, Heffer M.",date:2021,doi:"10.1016/j.jprot.2021.104293",journal:"J Proteomics"},{paper:"The effect of n-3 polyunsaturated fatty acids-enriched hen eggs consumption on IgG and total plasma protein N-glycosylation in healthy individuals and cardiovascular patients",authors:"Stupin A, Cvetko A, Kralik G, Mihalj M, Šušnjara P, Kolobarić N, Breškić Ćurić Ž, Lukinac AM, Kibel A, Selthofer-Relatić K, Jukić I, Stupin M, Kolar L, Kralik Z, Grčević M, Galović O, Mihaljević Z, Matić A, Juranić B, Gornik O, Lauc G, Drenjančević I.",date:2021,doi:"10.1093/glycob/cwab051",journal:"Glycobiology"},{paper:"Robustness and repeatability of GlycoWorks RapiFluor-MS IgG N-glycan profiling in a long-term high-throughput glycomic study",authors:"Deriš H, Cindrić A, Lauber M, Petrović T, Bielik A, Taron CH, van Wingerden M, Lauc G, Trbojević-Akmačić I.",date:2021,doi:"10.1093/glycob/cwab050",journal:"Glycobiology"},{paper:"Glycosylation of IgG Associates with Hypertension and Type 2 Diabetes Mellitus Comorbidity in the Chinese Muslim Ethnic Minorities and the Han Chinese",authors:"Meng X, Song M, Vilaj M, Štambuk J, Dolikun M, Zhang J, Liu D, Wang H, Zhang X, Zhang J, Cao W, Momčilović A, Trbojević-Akmačić I, Li X, Zheng D, Wu L, Guo X, Wang Y, Lauc G, Wang W.",date:2021,doi:"10.3390/jpm11070614",journal:"J Pers Med"},{paper:"N-glycosylation of immunoglobulin G predicts incident hypertension",authors:"Kifer D, Louca P, Cvetko A, Deriš H, Cindrić A, Grallert H, Peters A, Polašek O, Gornik O, Mangino M, Spector TD, Valdes AM, Padmanabhan S, Gieger C, Lauc G, Menni C.",date:2021,doi:"10.1097/HJH.0000000000002963",journal:"J Hypertens"},{paper:"Significant Associations of IgG Glycan Structures With Chronic Graft-Versus-Host Disease Manifestations: Results of the Cross-Sectional NIH Cohort Study",authors:"Prenc E, Pulanic D, Pucic-Bakovic M, Ugrina I, Desnica L, Milosevic M, Pirsl F, Mitchell S, Rose J, Vrhovac R, Nemet D, Lauc G, Pavletic SZ.",date:2021,doi:"10.3389/fimmu.2021.633214",journal:"Front Immunol"},{paper:"Multiomics Profiling Reveals Signatures of Dysmetabolism in Urban Populations in Central India",authors:"Monaghan TM, Biswas RN, Nashine RR, Joshi SS, Mullish BH, Seekatz AM, Blanco JM, McDonald JAK, Marchesi JR, Yau TO, Christodoulou N, Hatziapostolou M, Pucic-Bakovic M, Vuckovic F, Klicek F, Lauc G, Xue N, Dottorini T, Ambalkar S, Satav A, Polytarchou C, Acharjee A, Kashyap RS.",date:2021,doi:"10.3390/microorganisms9071485",journal:"Microorganisms"},{paper:"Rapid COVID-19 Antigen Testing in Croatia: Risk Perception Plays an Important Role in the Epidemic Control",authors:"Primorac D, Perić V, Matišić V, Molnar V, Zadro R, Vince A, Lauc G, Polašek O.",date:2021,doi:"10.3389/fpubh.2021.708907",journal:"Front Public Health"},{paper:"The Importance of Glycosylation in COVID-19 Infection",authors:"Petrović T, Lauc G, Trbojević-Akmačić I.",date:2021,doi:"10.1007/978-3-030-70115-4_12",journal:"Adv Exp Med Biol"},{paper:"Plasma N-glycome shows continuous deterioration as the diagnosis of insulin resistance approaches",authors:"Cvetko A, Mangino M, Tijardović M, Kifer D, Falchi M, Keser T, Perola M, Spector TD, Lauc G, Menni C, Gornik O.",date:2021,doi:"10.1136/bmjdrc-2021-002263",journal:"BMJ Open Diabetes Res Care"},{paper:"SARS-CoV-2 S glycoprotein binding to multiple host receptors enables cell entry and infection",authors:"rbojević-Akmačić I, Petrović T, Lauc G.",date:2021,doi:"10.1007/s10719-021-10021-z",journal:"Glycoconj J"},{paper:"Seminal Plasma Protein N-Glycan Peaks Are Potential Predictors of Semen Pathology and Sperm Chromatin Maturity in Men",authors:"Maric T, Katusic Bojanac A, Matijevic A, Ceppi M, Bruzzone M, Evgeni E, Petrovic T, Wójcik I, Trbojevic-Akmacic I, Lauc G, Jezek D, Fucic A.",date:2021,doi:"10.3390/life11090989",journal:"Life (Basel)"},{paper:"Investigation of the causal relationships between human IgG N-glycosylation and 12 common diseases associated with changes in the IgG N-glycome",authors:"Zaytseva OO, Sharapov SZ, Perola M, Esko T, Landini A, Hayward C, Wilson JF, Lauc G, Aulchenko YS, Klarić L, Tsepilov YA.",date:2021,doi:"10.1093/hmg/ddab335",journal:"Hum Mol Genet"},{paper:"A Multi-Factorial Observational Study on Sequential Fecal Microbiota Transplant in Patients with Medically RefractoryClostridioides difficileInfection",authors:"Monaghan TM, Duggal NA, Rosati E, Griffin R, Hughes J, Roach B, Yang DY, Wang C, Wong K, Saxinger L, Pučić-Baković M, Vučković F, Klicek F, Lauc G, Tighe P, Mullish BH, Blanco JM, McDonald JAK, Marchesi JR, Xue N, Dottorini T, Acharjee A, Franke A, Li Y, Wong GK, Polytarchou C, Yau TO, Christodoulou N, Hatziapostolou M, Wang M, Russell LA, Kao DH.",date:2021,doi:"10.3390/cells10113234",journal:"Cells"},{paper:"Polychromatic Flow Cytometric Analysis of Stromal Vascular Fraction from Lipoaspirate and Microfragmented Counterparts Reveals Sex-Related Immunophenotype Differences",authors:"Zenic L, Polancec D, Hudetz D, Jelec Z, Rod E, Vidovic D, Staresinic M, Sabalic S, Vrdoljak T, Petrovic T, Cukelj F, Molnar V, Cemerin M, Matisic V, Brlek P, Djukic Koroljevic Z, Boric I, Lauc G, Primorac D.",date:2021,doi:"10.3390/genes12121999",journal:"Genes (Basel)"},{paper:"A Transient Expression System with Stably Integrated CRISPR-dCas9 Fusions for Regulation of Genes Involved in Immunoglobulin G Glycosylation",authors:"Mijakovac A, Miškec K, Krištić J, Vičić Bočkor V, Tadić V, Bošković M, Lauc G, Zoldoš V, Vojta A.",date:2022,doi:"10.1089/crispr.2021.0089",journal:"CRISPR J"},{paper:"Fucosylated AGP glycopeptides as biomarkers of HNF1A-Maturity onset diabetes of the young",authors:"Tijardović M, Štambuk T, Juszczak A, Keser T, Gasperikova D, Novokmet M, Tjora E, Pape Medvidović E, Stanik J, Rasmus Njølstad P, Lauc G, Owen KR, Gornik O.",date:2022,doi:"10.1016/j.diabres.2022.109226",journal:"Diabetes Res Clin Pract"},{paper:"Altered IgG glycosylation at COVID-19 diagnosis predicts disease severity",authors:"Vicente MM, Alves I, Gaifem J, Rodrigues CS, Fernandes Â, Dias AM, Štambuk J, Petrović T, Oliveira P, Ferreira-da-Silva F, Soares A, Seixas N, Teixeira T, Malheiro L, Abreu MM, Lauc G, Sarmento E Castro R, Pinho SS.",date:2022,doi:"10.1002/eji.202149491",journal:"Eur J Immunol"},{paper:"Genetic regulation of post-translational modification of two distinct proteins",authors:"Landini A, Trbojević-Akmačić I, Navarro P, Tsepilov YA, Sharapov SZ, Vučković F, Polašek O, Hayward C, Petrović T, Vilaj M, Aulchenko YS, Lauc G, Wilson JF, Klarić L.",date:2022,doi:"10.1038/s41467-022-29189-5",journal:"Nat Commun"},{paper:"The dynamic brain N-glycome",authors:"Klarić TS, Lauc G.",date:2022,doi:"10.1007/s10719-022-10055-x",journal:"Glycoconj J"},{paper:"N-Glycosylation Patterns across the Age-Related Macular Degeneration Spectrum",authors:"Bućan I, Škunca Herman J, Jerončić Tomić I, Gornik O, Vatavuk Z, Bućan K, Lauc G, Polašek O.",date:2022,doi:"10.3390/molecules27061774",journal:"Molecules"},{paper:'Some additional considerations on: "Finding the sweet spot: glycosylation mediated regulation of intestinal inflammation"',authors:"Monaghan TM, Kao D, Lauc G",date:2022,doi:"10.1038/s41385-022-00512-z",journal:"Mucosal immunology"},{paper:"Developments and perspectives in high-throughput protein glycomics: enabling the analysis of thousands of samples",authors:"de Haan N, Pučić-Baković M, Novokmet M, Falck D, Lageveen-Kammeijer G, Razdorov G, Vučković F, Trbojević-Akmačić I, Gornik O, Hanić M, Wuhrer M, Lauc G",date:2022,doi:"10.1093/glycob/cwac026",journal:"Glycobiology"},{paper:"Association Between Human Gut Microbiome and N-Glycan Composition of Total Plasma Proteome",authors:"Petrov VA, Sharapov SZ, Shagam L, Nostaeva AV, Pezer M, Li D, Hanić M, McGovern D, Louis E, Rahmouni S, Lauc G, Georges M, Aulchenko YS.",date:2022,doi:"10.3389/fmicb.2022.811922",journal:"Front Microbiol"},{paper:"Medicinal signaling cells niche in stromal vascular fraction from lipoaspirate and microfragmented counterpart",authors:"Zenić L, Polančec D, Hudetz D, Jeleč Z, Rod E, Vidović D, Starešinić M, Sabalić S, Vrdoljak T, Petrović T, Čukelj F, Molnar V, Čemerin M, Matišić V, Brlek P, Djukić Koroljević Z, Borić I, Lauc G, Primorac D.",date:2022,doi:"10.3325/cmj.2022.63.265",journal:"Croat Med J"},{paper:"Croatian genetic heritage: an updated Y-chromosome story",authors:"Primorac D, Škaro V, Projić P, Missoni S, Horjan Zanki I, Merkaš S, Šarac J, Novokmet N, Ledić A, Makar A, Lauc G, Anđelinović Š, Bašić Ž, Kružić I, Neuberg M, Smolić M, Smolić R, Hrstić I, Trivanović D, Konjhodžić R, Salihefendić L, Babić Jordamović N, Marjanović D.",date:2022,doi:"10.3325/cmj.2022.63.273",journal:"Croat Med J"},{paper:"Genetic and Epigenetic Association of Hepatocyte Nuclear Factor-1α with Glycosylation in Post-Traumatic Stress Disorder",authors:"Tudor L, Konjevod M, Nedic Erjavec G, Nikolac Perkovic M, Uzun S, Kozumplik O, Zoldos V, Lauc G, Svob Strac D, Pivac N.",date:2022,doi:"10.3390/genes13061063",journal:"Genes (Basel)"},{paper:"IgG N-glycome changes during the course of severe COVID-19: An observational study",authors:"Petrović T, Vijay A, Vučković F, Trbojević-Akmačić I, Ollivere BJ, Marjanović D, Bego T, Prnjavorac B, Đerek L, Markotić A, Lukšić I, Jurin I, Valdes AM, Hadžibegović I, Lauc G.",date:2022,doi:"10.1016/j.ebiom.2022.104101",journal:"EBioMedicine"},{paper:"High-Throughput Glycomic Methods",authors:"Trbojević-Akmačić I, Lageveen-Kammeijer GSM, Heijs B, Petrović T, Deriš H, Wuhrer M, Lauc G.",date:2022,doi:"10.1021/acs.chemrev.1c01031",journal:"Chem Rev"},{paper:"Distinct Longitudinal Changes in Immunoglobulin G N-Glycosylation Associate with Therapy Response in Chronic Inflammatory Diseases",authors:"Štambuk J, Vučković F, Habazin S, Hanić M, Novokmet M, Nikolaus S, Tran F, Schreiber S, Franke A, Rosenstiel P, Lauc G, Aden K, Pezer M.",date:2022,doi:"10.3390/ijms23158473",journal:"Int J Mol Sci"},{paper:"Seminal plasma N-glycome as a new biomarker of environmental exposure associated with semen quality",authors:"Marić T, Wójcik I, Katušić Bojanac A, Matijević A, Ceppi M, Bruzzone M, Evgeni E, Petrović T, Trbojević-Akmačić I, Lauc G, Ježek D, Fučić A.",date:2022,doi:"10.1016/j.reprotox.2022.08.005",journal:"Reprod Toxicol"},{paper:"Immunoglobulin G glycans - Biomarkers and molecular effectors of aging",authors:"Krištić J, Lauc G, Pezer M.",date:2022,doi:"10.1016/j.cca.2022.08.006",journal:"Clin Chim Acta"},{paper:"Baseline IgG-Fc N-glycosylation profile is associated with long-term outcome in a cohort of early inflammatory arthritis patients",authors:"Sénard T, Flouri I, Vučković F, Papadaki G, Goutakoli P, Banos A, Pučić-Baković M, Pezer M, Bertsias G, Lauc G, Sidiropoulos P.",date:2022,doi:"10.1186/s13075-022-02897-5",journal:"Arthritis Res Ther"},{paper:"High-Throughput Human Complement C3 N-Glycoprofiling Identifies Markers of Early Onset Type 1 Diabetes Mellitus in Children",authors:"Šoić D, Keser T, Štambuk J, Kifer D, Pociot F, Lauc G, Morahan G, Novokmet M, Gornik O.",date:2022,doi:"10.1016/j.mcpro.2022.100407",journal:"Mol Cell Proteomics"},{paper:"Differences in Immunoglobulin G Glycosylation Between Influenza and COVID-19 Patients",authors:"Kljaković-Gašpić Batinjan M, Petrović T, Vučković F, Hadžibegović I, Radovani B, Jurin I, Đerek L, Huljev E, Markotić A, Lukšić I, Trbojević-Akmačić I, Lauc G, Gudelj I, Čivljak R.",date:2022,doi:"10.1016/j.eng.2022.08.007",journal:"Engineering (Beijing)"},{paper:"Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel disease",authors:"Mishra N, Aden K, Blase JI, Baran N, Bordoni D, Tran F, Conrad C, Avalos D, Jaeckel C, Scherer M, Sørensen SB, Overgaard SH, Schulte B, Nikolaus S, Rey G, Gasparoni G, Lyons PA, Schultze JL, Walter J, Andersen V; SYSCID Consortium; Dermitzakis ET, Schreiber S, Rosenstiel P.",date:2022,doi:"10.1186/s13073-022-01112-z",journal:"Genome Med"},{paper:"Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease",authors:"Birukov A, Plavša B, Eichelmann F, Kuxhaus O, Hoshi RA, Rudman N, Štambuk T, Trbojević-Akmačić I, Schiborn C, Morze J, Mihelčić M, Cindrić A, Liu Y, Demler O, Perola M, Mora S, Schulze MB, Lauc G, Wittenbecher C.",date:2022,doi:"10.2337/dc22-0833",journal:"Diabetes Care"},{paper:"Effects of low-calorie and different weight-maintenance diets on IgG glycome composition",authors:"Deriš H, Tominac P, Vučković F, Briški N, Astrup A, Blaak EE, Lauc G, Gudelj I.",date:2022,doi:"10.3389/fimmu.2022.995186",journal:"Front Immunol"},{paper:"In a pursuit of optimal glycan fluorescent label for negative MS mode for high-throughput N-glycan analysis",authors:"Šoić D, Mlinarić Z, Lauc G, Gornik O, Novokmet M, Keser T.",date:2022,doi:"10.3389/fchem.2022.999770",journal:"Front Chem"},{paper:"High-throughput immunoaffinity enrichment and N-glycan analysis of human plasma haptoglobin",authors:"Šimunović J, Gašperšič J, Černigoj U, Vidič J, Štrancar A, Novokmet M, Razdorov G, Pezer M, Lauc G, Trbojević-Akmačić I.",date:2023,doi:"10.1002/bit.28280",journal:"Biotechnol Bioeng"},{paper:"Susceptibility of Human Plasma N-glycome to Low-Calorie and Different Weight-Maintenance Diets",authors:"Deriš H, Tominac P, Vučković F, Astrup A, Blaak EE, Lauc G, Gudelj I.",date:2022,doi:"10.3390/ijms232415772",journal:"Int J Mol Sci"},{paper:"Heritability of the glycan clock of biological age",authors:"Mijakovac A, Frkatović A, Hanić M, Ivok J, Martinić Kavur M, Pučić-Baković M, Spector T, Zoldoš V, Mangino M, Lauc G.",date:2022,doi:"10.3389/fcell.2022.982609",journal:"Front Cell Dev Biol"},{paper:"Human-specific features and developmental dynamics of the brain N-glycome",authors:"Klarić TS, Gudelj I, Santpere G, Sousa AMM, Novokmet M, Vučković F, Ma S, Bečeheli I, Sherwood CC, Ely JJ, Hof PR, Josić D, Lauc G, Sestan N.",date:2023,doi:"10.1101/2023.01.11.523525",journal:"bioRxiv"},{paper:"Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma",authors:"Visconti A, Rossi N, Deriš H, Lee KA, Hanić M, Trbojević-Akmačić I, Thomas AM, Bolte LA, Björk JR, Hooiveld-Noeken JS, Board R, Harland M, Newton-Bishop J, Harries M, Sacco JJ, Lorigan P, Shaw HM, de Vries EGE, Fehrmann RSN, Weersma RK, Spector TD, Nathan P, Hospers GAP, Sasieni P, Bataille V, Lauc G, Falchi M.",date:2023,doi:"10.1186/s12885-023-10511-3",journal:"BMC Cancer"},{paper:"IgG N-Glycosylation Is Altered in Coronary Artery Disease",authors:"Radovani B, Vučković F, Maggioni AP, Ferrannini E, Lauc G, Gudelj I.",date:2023,doi:"10.3390/biom13020375",journal:"Biomolecules"},{paper:"Mouse milk immunoglobulin G Fc-linked N-glycosylation nano-LC-MS analysis in a model of vancomycin exposure during pregnancy",authors:"Alhasan MM, Habazin S, Kahhaleh FG, Lauc G, Conrad ML, Novokmet M.",date:2023,doi:"10.1007/s00216-023-04635-5",journal:"Anal Bioanal Chem"},{paper:"Comparative analysis of transferrin and IgG N-glycosylation in two human populations",authors:"Trbojević-Akmačić I, Vučković F, Pribić T, Vilaj M, Černigoj U, Vidič J, Šimunović J, Kępka A, Kolčić I, Klarić L, Novokmet M, Pučić-Baković M, Rapp E, Štrancar A, Polašek O, Wilson JF, Lauc G.",date:2023,doi:"10.1038/s42003-023-04685-6",journal:"Commun Biol"},{paper:"The Association of the Polymorphisms in theFUT8-Related Locus with the Plasma Glycosylation in Post-Traumatic Stress Disorder",authors:"Tudor L, Nedic Erjavec G, Nikolac Perkovic M, Konjevod M, Uzun S, Kozumplik O, Mimica N, Lauc G, Svob Strac D, Pivac N.",date:2023,doi:"10.3390/ijms24065706",journal:"Int J Mol Sci"},{paper:"Correction to: Mouse milk immunoglobulin G Fc‑linked N‑glycosylation nano‑LC-MS analysis in a model of vancomycin exposure during pregnancy",authors:"Alhasan MM, Habazin S, Kahhaleh FG, Lauc G, Conrad ML, Novokmet M.",date:2023,doi:"10.1007/s00216-023-04662-2",journal:"Anal Bioanal Chem"},{paper:"Storage stability and HILIC-UHPLC-FLR analysis of immunoglobulin G N-glycome from saliva",authors:"Radovani B, Lauc G, Gudelj I.",date:2023,doi:"10.1007/s00216-023-04682-y",journal:"Anal Bioanal Chem"},{paper:"The N-Glycosylation of Total Plasma Proteins and IgG in Atrial Fibrillation",authors:"Plavša B, Szavits-Nossan J, Blivajs A, Rapčan B, Radovani B, Šesto I, Štambuk K, Mustapić V, Đerek L, Rudan D, Lauc G, Gudelj I.",date:2023,doi:"10.3390/biom13040605",journal:"Biomolecules"},{paper:"IgG glycans in health and disease: Prediction, intervention, prognosis, and therapy",authors:"Shkunnikova S, Mijakovac A, Sironic L, Hanic M, Lauc G, Kavur MM.",date:2023,doi:"10.1016/j.biotechadv.2023.108169",journal:"Biotechnol Adv"},{paper:"Physical Exercise Induces Significant Changes in Immunoglobulin G N-Glycan Composition in a Previously Inactive, Overweight Population",authors:"Šimunić-Briški N, Zekić R, Dukarić V, Očić M, Frkatović-Hodžić A, Deriš H, Lauc G, Knjaz D.",date:2023,doi:"10.3390/biom13050762",journal:"Biomolecules"},{paper:"Potential Clinically Relevant Effects of Sialylation on Human Serum AAG-Drug Interactions Assessed by Isothermal Titration Calorimetry: Insight into Pharmacoglycomics?",authors:"Kerep R, Šeba T, Borko V, Weitner T, Keser T, Lauc G, Gabričević M.",date:2023,doi:"10.3390/ijms24108472",journal:"Int J Mol Sci"},{paper:"Human complement component C3 N-glycome changes in type 1 diabetes complications",authors:"Šoić D, Štambuk J, Tijardović M, Keser T, Lauc G, Bulum T, Lovrenčić MV, Rebrina SV, Tomić M, Novokmet M, Smirčić-Duvnjak L, Gornik O.",date:2023,doi:"10.3389/fendo.2023.1101154",journal:"Front Endocrinol (Lausanne)"},{paper:"Genome-Wide Methylation Profiling in 229 Patients With Crohn's Disease Requiring Intestinal Resection: Epigenetic Analysis of the Trial of Prevention of Post-operative Crohn's Disease (TOPPIC)",authors:"Ventham NT, Kennedy NA, Kalla R, Adams AT, Noble A, Ennis H; TOPPIC Study Group; IBD-BIOM Consortium; Mowat C, Dunlop MG, Satsangi J.",date:2023,doi:"10.1016/j.jcmgh.2023.06.001",journal:"Cell Mol Gastroenterol Hepatol"},{paper:"Not-So-Sweet Dreams: Plasma and IgG N-Glycome in the Severe Form of the Obstructive Sleep Apnea",authors:"Plećaš D, Mraz N, Patanaude AM, Pribić T, Pavlinac Dodig I, Pecotić R, Lauc G, Polašek O, Đogaš Z.",date:2023,doi:"10.3390/biom13060880",journal:"Biomolecules"},{paper:"Anti-TNF Biologicals Enhance the Anti-Inflammatory Properties of IgG N-Glycome in Crohn's Disease",authors:"Hanić M, Vučković F, Deriš H, Bewshea C, Lin S, Goodhand JR, Ahmad T, Trbojević-Akmačić I, Kennedy NA, Lauc G; PANTS Consortium.",date:2023,doi:"10.3390/biom13060954",journal:"Biomolecules"},{paper:"Plasma protein N-glycome composition associates with postprandial lipaemic response",authors:"Louca P, Štambuk T, Frkatović-Hodžić A, Nogal A, Mangino M, Berry SE, Deriš H, Hadjigeorgiou G, Wolf J, Vinicki M, Franks PW, Valdes AM, Spector TD, Lauc G, Menni C.",date:2023,doi:"10.1186/s12916-023-02938-z",journal:"BMC Med"},{paper:"IgG N-glycans are associated with prevalent and incident complications of type 2 diabetes",authors:"Memarian E, Heijmans R, Slieker RC, Sierra A, Gornik O, Beulens JWJ, Hanic M, Elders P, Pascual J, Sijbrands E, Lauc G, Dotz V, Barrios C, 't Hart LM, Wuhrer M, van Hoek M.",date:2023,doi:"10.1002/dmrr.3685",journal:"Diabetes Metab Res Rev"},{paper:"MMP3 single-nucleotide polymorphisms are associated with noncontact ACL injuries in competing high-level athletes",authors:"Simunic-Briski N, Vrgoc G, Knjaz D, Jankovic S, Dembic Z, Lauc G.",date:2023,doi:"10.1002/jor.25663",journal:"J Orthop Res"},{paper:"Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levels",authors:"Aoife Murray,Gillian Gough2,Ana Cindrić3,Frano Vučković3,David Koschut4,Vincenzo Borelli5,Dražen J Petrović6,Ana Bekavac7,Ante Plećaš8,Valentina Hribljan7,Reinhard Brunmeir2,Julija Jurić3,Maja Pučić-Baković3,Anita Slana3,Helena Deriš3,Azra Frkatović3,Jűrgen Groet9,Niamh L O'Brien9,Hong Yu Chen10,Yee Jie Yeap2,Frederic Delom11,Steven Havlicek12,Luke Gammon11,Sarah Hamburg13,Carla Startin14,Hana D'Souza15,Dinko Mitrečić7,Mijana Kero16,Ljubica Odak16,Božo Krušlin17,Željka Krsnik7,Ivica Kostović7,Jia Nee Foo18,Yuin-Han Loh10,Norris Ray Dunn19,Susana de la Luna20,Tim Spector21,Ingeborg Barišić16,Michael S C Thomas15,Andre Strydom22,Claudio Franceschi23,Gordan Lauc24,Jasminka Krištić25,Ivan Alić26,Dean Nižetić27",date:2023,doi:"10.1016/j.ebiom.2023.104692",journal:"EBioMedicine"},{paper:"Salinomycin disturbs Golgi function and specifically affects cells in epithelial-to-mesenchymal transition",authors:"Marjanović M, Mikecin Dražić AM, Mioč M, Paradžik M, Kliček F, Novokmet M, Lauc G, Kralj M.",date:2023,doi:"10.1242/jcs.260934",journal:"J Cell Sci"},{paper:"Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemia",authors:"Darabi M, Lhomme M, Ponnaiah M, Pučić-Baković M, Guillas I, Frisdal E, Bittar R, Croyal M, Matheron-Duriez L, Poupel L, Bonnefont-Rousselot D, Frere C, Varret M, Krempf M, Cariou B, Lauc G, Guerin M, Carrie A, Bruckert E, Giral P, Le Goff W, Kontush A.",date:2023,doi:"10.1016/j.jacl.2023.07.003",journal:"J Clin Lipidol"},{paper:"Reversal of Biological Age in Multiple Rat Organs by Young Porcine Plasma Fraction",authors:"Horvath S, Singh K, Raj K, Khairnar S, Sanghavi A, Shrivastava A, Zoller JA, Li CZ, Herenu CB, Canatelli-Mallat M, Lehmann M, Habazin S, Novokmet M, Vučković F, Woods LCS, Martinez AG, Wang T, Chiavellini P, Levine AJ, Chen H, Brooke RT, Gordevicius J, Lauc G, Goya RG, Katcher HL",date:2023,doi:"10.1101/2023.08.06.552148",journal:"bioRxiv"},{paper:"Long-Term Culturing of FreeStyle 293-F Cells Affects Immunoglobulin G Glycome Composition",authors:"Lukšić F, Mijakovac A, Josipović G, Vičić Bočkor V, Krištić J, Cindrić A, Vinicki M, Rokić F, Vugrek O, Lauc G, Zoldoš V.",date:2023,doi:"10.3390/biom13081245",journal:"Biomolecules"},{paper:"Higher MRI lesion load in multiple sclerosis is related to the N-glycosylation changes of cerebrospinal fluid immunoglobulin G",authors:"Turčić A, Radovani B, Vogrinc Ž, Habek M, Rogić D, Gabelić T, Zaninović L, Lauc G, Gudelj I.",date:2023,doi:"10.1016/j.msard.2023.104921",journal:"Mult Scler Relat Disord"},{paper:"Reversal of biological age in multiple rat organs by young porcine plasma fraction",authors:"Horvath S, Singh K, Raj K, Khairnar SI, Sanghavi A, Shrivastava A, Zoller JA, Li CZ, Herenu CB, Canatelli-Mallat M, Lehmann M, Habazin S, Novokmet M, Vučković F, Solberg Woods LC, Martinez AG, Wang T, Chiavellini P, Levine AJ, Chen H, Brooke RT, Gordevicius J, Lauc G, Goya RG, Katcher HL.",date:2024,doi:"10.1007/s11357-023-00980-6",journal:"Geroscience"},{paper:"Can we suppress chronic systemic inflammation and postpone age-related diseases by targeting the IgG glycome?",authors:"Lauc G.",date:2024,doi:"10.1080/14728222.2023.2277218",journal:"Expert Opinion on Therapeutic Targets"},{paper:"Human-specific features and developmental dynamics of the brain N-glycome",authors:"Klarić TS, Gudelj I, Santpere G, Novokmet M, Vučković F, Ma S, Doll HM, Risgaard R, Bathla S, Karger A, Nairn AC, Luria V, Bečeheli I, Sherwood CC, Ely JJ, Hof PR, Sousa AMM, Josić D, Lauc G, Sestan N.",date:2023,doi:"10.1126/sciadv.adg2615",journal:"Sci Adv"},{paper:"Regular moderate physical exercise decreases Glycan Age index of biological age and reduces inf",authors:"Šimunić-Briški N, Dukarić V, Očić M, Madžar T, Vinicki M, Frkatović-Hodžić A, Knjaz D, Lauc G.",date:2024,doi:"10.1007/s10719-023-10144-5",journal:"Glycoconj J"},{paper:"Mapping of the gene network that regulates glycan clock of ageing",authors:"Frkatović-Hodžić A, Mijakovac A, Miškec K, Nostaeva A, Sharapov SZ, Landini A, Haller T, Akker EVD, Sharma S, Cuadrat RRC, Mangino M, Li Y, Keser T, Rudman N, Štambuk T, Pučić-Baković M, Trbojević-Akmačić I, Gudelj I, Štambuk J, Pribić T, Radovani B, Tominac P, Fischer K, Beekman M, Wuhrer M, Gieger C, Schulze MB, Wittenbecher C, Polasek O, Hayward C, Wilson JF, Spector TD, Köttgen A, Vučković F, Aulchenko YS, Vojta A, Krištić J, Klarić L, Zoldoš V, Lauc G.",date:2024,doi:"10.18632/aging.205106",journal:"Aging (Albany NY)"},{paper:"Correction to: Regular moderate physical exercise decreases Glycan Age index of biological age and reduces inflammatory potential of Immunoglobulin G",authors:"Šimunić-Briški N, Dukarić V, Očić M, Madžar T, Vinicki M, Frkatović-Hodžić A, Knjaz D, Lauc G.",date:2024,doi:"10.1007/s10719-024-10146-x",journal:"Glycoconj J"},{paper:"N-Glycosylation Profiles of Immunoglobulin G and Future Cardiovascular Events",authors:"Hoshi RA, Plavša B, Liu Y, Trbojević-Akmačić I, Glynn RJ, Ridker PM, Cummings RD, Gudelj I, Lauc G, Demler OV, Mora S.",date:2024,href:"https://pubmed.ncbi.nlm.nih.gov/38348651/",journal:"Circ Res"},{paper:"Alterations in plasma protein N-glycosylation after caloric restriction and bariatric surgery",authors:"Štambuk T, Kifer D, Greto VL, Dempster NJ, Cvetko A, Gillies RS, Tomlinson JW, Sgromo B, Mineo C, Shaul PW, Lauc G, Lingvay I, Geremia A, Arancibia-Cárcamo CV.",date:2024,doi:"10.1016/j.soard.2024.01.007",journal:"Surgery for Obesity and Related Diseases"},{paper:"Anastrozole and Tamoxifen Impact on IgG Glycome Composition Dynamics in Luminal A and Luminal B Breast Cancers",authors:"Rapčan B, Fančović M, Pribić T, Kirac I, Gaće M, Vučković F, Lauc G.",date:2024,doi:"10.3390/antib13010009",journal:"Antibodies (Basel)"},{paper:"Influence of Desialylation on the Drug Binding Affinity of Human Alpha-1-Acid Glycoprotein Assessed by Microscale Thermophoresis",authors:"Šeba T, Kerep R, Weitner T, Šoić D, Keser T, Lauc G, Gabričević M.",date:2024,doi:"10.3390/pharmaceutics16020230",journal:"Pharmaceutics"},{paper:"Functional Signature of LRP4 Antibodies in Myasthenia Gravis",authors:"Chuquisana O, Stascheit F, Keller CW, Pučić-Baković M, Patenaude AM, Lauc G, Tzartos S, Wiendl H, Willcox N, Meisel A, Lünemann JD.",date:2024,doi:"10.1212/NXI.0000000000200220",journal:"Neurol Neuroimmunol Neuroinflamm"},{paper:"Machine learning framework to extract the biomarker potential of plasma IgG N-glycans towards disease risk stratification",authors:"Flevaris K, Davies J, Nakai S, Vučković F, Lauc G, Dunlop MG, Kontoravdi C.",date:2024,doi:"10.1016/j.csbj.2024.03.008",journal:"Comput Struct Biotechnol J"},{paper:"Variability of human Alpha-1-acid glycoprotein N-glycome in a Caucasian population",authors:"Vučković F, Novokmet M, Šoić D, Štambuk J, Kolčić I, Polašek O, Lauc G, Gornik O, Keser T.",date:2024,doi:"10.1093/glycob/cwae031",journal:"Glycobiology"},{paper:"IgG sialylation occurs in B cells pre antibody secretion",authors:"Werner A, Hanić M, Zaitseva OO, Lauc G, Lux A, Nitschke L, Nimmerjahn F.",date:2024,doi:"10.3389/fimmu.2024.1402000",journal:"Front Immunol"},{paper:"The role of glycans in personalization of preventive health care",authors:"Lauc G, Primorac D.",date:2024,doi:"10.3325/cmj.2024.65.293",journal:"Croat Med J"},{paper:"Glycan clock of ageing-analytical precision and time-dependent inter- and i-individual variability",authors:"Rapčan B, Song M, Frkatović-Hodžić A, Pribić T, Vuk J, Beletić A, Hanić M, Jurić J, Tominac P, Milas J, Ivić V, Viland S, Bonet S, Šego B, Heffer M, Wang W, Snyder MP, Lauc G.",date:2024,doi:"10.1007/s11357-024-01239-4",journal:"Geroscience"},{paper:"Automated high throughput IgG N-glycosylation sample preparation method development on the Tecan Freedom EVO platform",authors:"Rapčan B, Hanić M, Plavša B, Šimunović J, Štambuk J, Vučković F, Trbojević-Akmačić I, Novokmet M, Lauc G, Razdorov G.",date:2024,doi:"10.11613/BM.2024.020708",journal:"Biochem Med (Zagreb)"},{paper:"Glycoproteins and longevity: an interview with Professor Gordan Lauc",authors:"Gilroy R, Lauc G.",date:2024,doi:"10.1080/14728222.2024.2375809",journal:"Expert Opinion on Therapeutic Targets"},{paper:"A unique serum IgG glycosylation signature predicts development of Crohn's disease and is associated with pathogenic antibodies to mannose glycan",authors:"Gaifem J, Rodrigues CS, Petralia F, Alves I, Leite-Gomes E, Cavadas B, Dias AM, Moreira-Barbosa C, Revés J, Laird RM, Novokmet M, Štambuk J, Habazin S, Turhan B, Gümüş ZH, Ungaro R, Torres J, Lauc G, Colombel JF, Porter CK, Pinho SS.",date:2024,doi:"10.1038/s41590-024-01916-8",journal:"Nat Immunol"},{paper:"A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes",authors:"Halama A, Zaghlool S, Thareja G, Kader S, Al Muftah W, Mook-Kanamori M, Sarwath H, Mohamoud YA, Stephan N, Ameling S, Pucic Baković M, Krumsiek J, Prehn C, Adamski J, Schwenk JM, Friedrich N, Völker U, Wuhrer M, Lauc G, Najafi-Shoushtari SH, Malek JA, Graumann J, Mook-Kanamori D, Schmidt F, Suhre K.",date:2024,doi:"10.1038/s41467-024-51134-x",journal:"Nat Commun"},{paper:"Predicting Biochemical and Physiological Parameters: Deep Learning from IgG Glycome Composition",authors:"Vujić A, Klasić M, Lauc G, Polašek O, Zoldoš V, Vojta A.",date:2024,doi:"10.3390/ijms25189988",journal:"Int J Mol Sci"},{paper:"Effects of testosterone and metformin on the GlycanAge index of biological age and the composition of the IgG glycome",authors:"Vinicki M, Pribić T, Vučković F, Frkatović-Hodžić A, Plaza-Andrades I, Tinahones F, Raffaele J, Fernández-García JC, Lauc G.",date:2024,doi:"10.1007/s11357-024-01349-z",journal:"Geroscience"},{paper:"The importance of IgG glycosylation-What did we learn after analyzing over 100,000 individuals",authors:"Krištić J, Lauc G.",date:2024,doi:"10.1111/imr.13407",journal:"immunol. Rev."},{paper:"High-throughput N-glycan analysis in aging and inflammaging: State of the art and future directions",authors:"Cindrić A, Pribić T, Lauc G.",date:2024,doi:"10.1016/j.smim.2024.101890",journal:"Semin Immunol"},{paper:"Humoral signatures of Caspr2-antibody spectrum disorder track with clinical phenotypes and outcomes",authors:"Terroba-Navajas P, Spatola M, Chuquisana O, Joubert B, de Vries JM, Dik A, Marmolejo L, Jönsson F, Lauc G, Kovac S, Prüss H, Wiendl H, Titulaer MJ, Honnorat J, Lünemann JD.",date:2024,doi:"10.1016/j.medj.2024.09.004",journal:"Med."},{paper:"ABCG1 orchestrates adipose tissue macrophage plasticity and insulin resistance in obesity by rewiring saturated fatty acid pools",authors:"Dahik VD, Kc P, Materne C, Reydellet C, Lhomme M, Cruciani-Guglielmacci C, Denom J, Bun E, Ponnaiah M, Deknuydt F, Frisdal E, Hardy LM, Durand H, Guillas I, Lesnik P, Gudelj I, Lauc G, Guérin M, Kontush A, Soprani A, Magnan C, Diedisheim M, Bluteau O, Venteclef N, Le Goff W.",date:2024,doi:"10.1126/scitranslmed.adi6682",journal:"Sci Transl Med"},{paper:"A 2-year calorie restriction intervention reduces glycomic biological age biomarkers",authors:"Pribić T, Das JK, Đerek L, Belsky DW, Orenduff M, Huffman KM, Kraus WE, Deriš H, Šimunović J, Štambuk T, Hodžić AF, Kraus VB, Das SK, Racette SB, Banskota N, Ferruci L, Pieper C, Lewis NE, Lauc G, Krishnan S",date:2024,doi:"10.1101/2024.12.04.24318451",journal:"medRxiv"},{paper:"Phosphorylation of N-glycans in the brain: The case for a non-canonical pathway?",authors:"Sironić L, Mraz N, Lauc G, Klarić TS.",date:2024,doi:"10.1016/j.bbadva.2024.100134",journal:"BBA Adv"},{paper:"Total cell N-glycosylation is altered during differentiation of induced pluripotent stem cells to neural stem cells and is disturbed by trisomy 21",authors:"Cindrić A, Vučković F, Murray A, Klarić TS, Alić I, Krištić J, Nižetić D, Lauc G.",date:2024,doi:"10.1016/j.bbadva.2024.100137",journal:"BBA Adv"},{paper:"The association between galactosylation of immunoglobulin G and body mass index",authors:" Nikolac Perkovic M, Pucic Bakovic M, Kristic J, Novokmet M, Huffman JE, Vitart V, Hayward C, Rudan I, Wilson JF, Campbell H, Polasek O, Lauc G, Pivac N.",date:2014,doi:"10.1016/j.pnpbp.2013.08.014",journal:"ScienceDirect"},{paper:"Expression of leukocyte adhesion-related glycosyltransferase genes in acute coronary syndrome patients",authors:"Hadžibegović I, Vrselja Z, Lauc G, Curić G. ",date:2014,doi:"10.1007/s00011-014-0735-3",journal:"Springer Nature Link"},{paper:"Epigenetic regulation of glycosylation is the quantum mechanics of biology",authors:"Lauc G, Vojta A, Zoldoš V.",date:2014,doi:"10.1016/j.bbagen.2013.08.017",journal:"ScuenceDirect"},{paper:"The role of glycosylation in IBD",authors:"Theodoratou E, Campbell H, Ventham NT, Kolarich D, Pučić-Baković M, Zoldoš V, Fernandes D, Pemberton IK, Rudan I, Kennedy NA, Wuhrer M, Nimmo E, Annese V, McGovern DP, Satsangi J, Lauc G.",date:2014,doi:"10.1038/nrgastro.2014.78",journal:"Nature reviews"},{paper:"Changes in IgG and total plasma protein glycomes in acute systemic inflammation",authors:"Novokmet M, Lukić E, Vučković F, Ðurić Ž, Keser T, Rajšl K, Remondini D, Castellani G, Gašparović H, Gornik O, Lauc G.",date:2014,doi:"10.1038/srep04347",journal:"Scientific reports"},{paper:"Glycans are a novel biomarker of chronological and biological ages",authors:"Krištić J, Vučković F, Menni C, Klarić L, Keser T, Beceheli I, Pučić-Baković M, Novokmet M, Mangino M, Thaqi K, Rudan P, Novokmet N, Sarac J, Missoni S, Kolčić I, Polašek O, Rudan I, Campbell H, Hayward C, Aulchenko Y, Valdes A, Wilson JF, Gornik O, Primorac D, Zoldoš V, Spector T, Lauc G.",date:2014,doi:"10.1093/gerona/glt190",journal:"The Journals of Gerontology: Series A"},{paper:"Glycans – the third revolution in evolution",authors:"Lauc G, Krištić J, Zoldoš V. Glycans",date:2014,doi:"10.3389/fgene.2014.00145",journal:"Frontiers"},{paper:"Comparative performance of four methods for high-throughput glycosylation analysis of immunoglobulin G in genetic and epidemiological research",authors:"Huffman JE, Pučić-Baković M, Klarić L, Hennig R, Selman MH, Vučković F, Novokmet M, Krištić J, Borowiak M, Muth T, Polašek O, Razdorov G, Gornik O, Plomp R, Theodoratou E, Wright AF, Rudan I, Hayward C, Campbell H, Deelder AM, Reichl U, Aulchenko YS, Rapp E, Wuhrer M, Lauc G.",date:2014,doi:"10.1074/mcp.M113.037465",journal:"MCP"},{paper:"Glycosylation of immunoglobulin g: role of genetic and epigenetic influences",authors:"Menni C, Keser T, Mangino M, Bell JT, Erte I, Akmačić I, Vučković F, Pučić Baković M, Gornik O, McCarthy MI, Zoldoš V, Spector TD, Lauc G, Valdes AM.",date:2013,doi:"10.1371/journal.pone.0082558",journal:"PLOS"},{paper:"High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides",authors:"Baković MP, Selman MH, Hoffmann M, Rudan I, Campbell H, Deelder AM, Lauc G, Wuhrer M.",date:2013,doi:"10.1021/pr300887z",journal:"ACS"},{paper:"Reversibility of Membrane N-Glycome of HeLa Cells upon Treatment with Epigenetic Inhibitors",authors:"Horvat T, Deželjin M, Redžić I, Barišić D, Herak Bosnar M, Lauc G, Zoldoš V.",date:2013,doi:"10.1371/journal.pone.0054672",journal:"PLOS"},{paper:"The association between galactosylation of immunoglobulin G and body mass index.",authors:"Nikolac Perkovic M, Pucic Bakovic M, Kristic J, Novokmet M, Huffman JE, Vitart V, Hayward C, Rudan I, Wilson JF, Campbell H, Polasek O, Lauc G, Pivac N. ",date:2014,doi:"10.1016/j.pnpbp.2013.08.014",journal:"ScienceDirect"},{paper:"Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers",authors:"Lauc G, Huffman JE, Pučić M, Zgaga L, Adamczyk B, Mužinić A, Novokmet M, Polašek O, Gornik O, Krištić J, Keser T, Vitart V, Scheijen B, Uh HW, Molokhia M, Patrick AL, McKeigue P, Kolčić I, Lukić IK, Swann O, van Leeuwen FN, Ruhaak LR, Houwing-Duistermaat JJ, Slagboom PE, Beekman M, de Craen AJ, Deelder AM, Zeng Q, Wang W, Hastie ND, Gyllensten U, Wilson JF, Wuhrer M, Wright AF, Rudd PM, Hayward C, Aulchenko Y, Campbell H, Rudan I.",date:2013,doi:"10.1371/journal.pgen.1003225",journal:"PLOS"},{paper:"Mutations in HNF1A result in marked alterations of plasma glycan profile",authors:"Thanabalasingham G, Huffman JE, Kattla JJ, Novokmet M, Rudan I, Gloyn AL, Hayward C, Adamczyk B, Reynolds RM, Muzinic A, Hassanali N, Pucic M, Bennett AJ, Essafi A, Polasek O, Mughal SA, Redzic I, Primorac D, Zgaga L, Kolcic I, Hansen T, Gasperikova D, Tjora E, Strachan MW, Nielsen T, Stanik J, Klimes I, Pedersen OB, Njølstad PR, Wild SH, Gyllensten U, Gornik O, Wilson JF, Hastie ND, Campbell H, McCarthy MI, Rudd PM, Owen KR, Lauc G, Wright AF.",date:2013,doi:"10.2337/db12-0880",journal:"Diabetes"},{paper:"Prognostic value of cell-free DNA in plasma of out-of-hospital cardiac arrest survivors at ICU admission and 24 hours post-admission",authors:"Gornik I, Wagner J, Gašparović V, Miličić D, Degoricija V, Skorić B, Gornik O, Lauc G.",date:2014,doi:"10.1016/j.resuscitation.2013.10.008",journal:"Resuscitation"},{paper:"Glycosylation of Immunoglobulin G: Role of genetic and epigenetic influences",authors:"Menni C, Keser T, Mangino M, Bell JT, Erte I, Akmačić I, Vučković F, Pučić Baković M, Gornik O, McCarthy MI, Zoldoš V, Spector TD, Lauc G, Valdes AM. ",date:2013,doi:"10.1371/journal.pone.0082558",journal:"PLOS"},{paper:"Genomics and epigenomics of the human glycome",authors:"Zoldoš V, Novokmet M, Bečeheli I, Lauc G. ",date:2013,doi:"10.1007/s10719-012-9397-y",journal:"Springer Nature Link"},{paper:"High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides",authors:"Pučić Baković M, Selman MHJ, Hoffmann M, Rudan I, Campbell H, Deelder AM, Lauc G, Wuhrer M.",date:2013,doi:"10.1021/pr300887z",journal:"ACS"},{paper:"Glycomics meets genomics, epigenomics and other high throughput omics for system biology studies",authors:"Zoldoš V, Horvat T, Lauc G.",date:2013,doi:"10.1016/j.cbpa.2012.12.007",journal:"ScienceDirect"},{paper:"Changes in plasma and IgG N-glycome during childhood and adolescence",authors:"Pucic M, Muzinic A, Novokmet M, Skledar M, Pivac N, Lauc G, Gornik O.",date:2012,doi:"10.1093/glycob/cws062",journal:"Glycobiology"},{paper:"The future of glycoscience.",authors:"Lauc G.",date:2012,doi:"10.1016/j.bbagen.2012.03.001",journal:"ScienceDirect"},{paper:"Changes in plasma and IgG N-glycome during childhood and adolescence",authors:"Pucic M, Muzinic A, Novokmet M, Skledar M, Pivac N, Lauc G, Gornik O.",date:2012,doi:"10.1093/glycob/cws062",journal:"Glycobiology"},{paper:"Association of medication with the human plasma N-glycome",authors:"Saldova R, Huffman JE, Adamczyk B, Mužinić A, Kattla JJ, Pučić M, Novokmet M, Abrahams JL, Hayward C, Rudan I, Wild SH, Wright AF, Polašek O, Lauc G, Campbell H, Wilson JF, Rudd PM.",date:2012,doi:"10.1021/pr2010605",journal:"ACS"},{paper:"The future of glycoscience (editorial)",authors:"Lauc G.",date:2012,doi:"0.1016/j.bbagen.2012.03.001",journal:"ScienceDirect"},{paper:"Heterozygous carriage of a dysfunctional TLR9 allele affects CPG-oligonucleotide responses in B cells",authors:"Knezević J, Pavlinić D, Rose WA 2nd, Leifer CA, Bendelja K, Gabrilovac J, Parcina M, Lauc G, Kubarenko AV, Petricevic B, Vrbanec D, Bulat-Kardum L, Bekeredjian-Ding I, Pavelić J, Dembić Z, Weber AN.",date:2012,doi:"10.1074/jbc.M111.337477",journal:"JBC"},{paper:"Genomics and epigenomics of the human glycome.",authors:"Zoldoš V, Novokmet M, Bečeheli I, Lauc G.",date:2013,doi:"10.1007/s10719-012-9397-y",journal:"Springer Nature Link"},{paper:"Alternative glycosylation modulates function of IgG and other proteins – implications on evolution and disease",authors:"Gornik O, Pavić T, Lauc G.",date:2011,doi:"10.1016/j.bbagen.2011.12.004",journal:"ScienceDirect"},{paper:"Epigenetic silencing of HNF1A by CpG methylation associates with higher branching of N-glycans in human plasma",authors:"Zoldoš V, Horvat T, Novokmet M, Cuenin C, Mužinić A, Pučić M, Huffman JE, Gornik O, Polašek O, Campbell H, Hayward C, Wright AF, Rudan I, Owen K, McCarthy MI, Herceg Z, Lauc G.",date:2012,doi:"10.4161/epi.7.2.18918",journal:"Taylor&Francis online"},{paper:"Epigenetic silencing of HNF1A associates with changes in the composition of the human plasma N-glycome.",authors:"Zoldoš V, Horvat T, Novokmet M, Cuenin C, Mužinić A, Pučić M, Huffman JE, Gornik O, Polašek O, Campbell H, Hayward C, Wright AF, Rudan I, Owen K, McCarthy MI, Herceg Z, Lauc G.",date:2012,doi:"10.4161/epi.7.2.18918",journal:"Taylor&Francis online"},{paper:"Change of transferrin sialylation differs between mild sepsis and severe sepsis and septic shock",authors:"Gornik O, Gornik I, Zagorec-Kolednjak I, Lauc G",date:2011,doi:"10.2169/internalmedicine.50.4704",journal:"Internal Medicine"},{paper:"Glycosylation of human plasma proteins in attention-deficit hyperactivity disorder and autism spectrum disorder",authors:"Pivac N, Knezević A, Gornik O, Pucić M, Igl W, Peeters H, Crepel A, Steyaert J, Novokmet M, Redzić I, Nikolac M, Hercigonja VN, Curković KD, Curković M, Nedić G, Muck-Seler D, Borovecki F, Rudan I, Lauc G.",date:2011,doi:"10.1074/mcp.M110.004200",journal:"MCP"},{paper:"Glycomics meets lipidomics –Associations of N-glycans with classical lipids, glycerophospholipids, and sphingolipids in three",authors:"Maja P B at al.",date:2011,doi:"10.1039/c0mb00095g",journal:"Molecular BioSystem"},{paper:"High throughput isolation and glycosylation analysis of IgG – variability and heritability of the IgG glycome in three isolated human",authors:"Pucić M, Knezević A, Vidic J, Adamczyk B, Novokmet M, Polasek O, Gornik O, Supraha-Goreta S, Wormald MR, Redzić I, Campbell H, Wright A, Hastie ND, Wilson JF, Rudan I, Wuhrer M, Rudd PM, Josić D, Lauc G.",date:2011,doi:"10.1074/mcp.M111.010090",journal:"MCP"},{paper:"The role of epigenetic regulation of membrane glycoconjugates in the attenuation of viral pandemics",authors:"Lauc G, Zoldoš V. ",date:2011,doi:"10.1016/j.mehy.2010.09.033",journal:"ScienceDirect"},{paper:"Does inbreeding affect N-glycosylation of human plasma proteins?",authors:"Polašek O, Leutenegger AL, Gornik O, Zgaga L, Kolcic I, McQuillan R, Wilson JF, Hayward C, Wright AF, Lauc G, Campbell H, Rudan I",date:2011,doi:"10.1007/s00438-011-0620-5",journal:"Springer Nature Link"},{paper:"Polymorphisms in B3GAT1, SLC9A9 and MGAT5 are associated with variation within the human plasma N-glycome of 3533 European adults",authors:"Huffman JE, Knezevic A, Vitart V, Kattla J, Adamczyk B, Novokmet M, Igl W, Pucic M, Zgaga L, Johannson Å, Redzic I, Gornik O, Zemunik T, Polasek O, Kolcic I, Pehlic M, Koeleman CA, Campbell S, Wild SH, Hastie ND, Campbell H, Gyllensten U, Wuhrer M, Wilson JF, Hayward C, Rudan I, Rudd PM, Wright AF, Lauc G.",date:2011,doi:"10.1093/hmg/ddr414",journal:"Oxford academic"},{paper:"Screening novel biomarkers for metabolic syndrome by profiling human plasma N-glycans in Chinese Han and Croatian populations",authors:"Lu JP, Knežević A, Wang YX, Rudan I, Campbell H, Zou ZK, Lan J, Lai QX, Wu JJ, He Y, Song MS, Zhang L, Lauc G, Wang W.",date:2011,doi:"10.1021/pr2004067",journal:"ACS"},{paper:"Evolutional and clinical implications of the epigenetic regulation of protein glycosylation",authors:"Horvat T, Zoldoš V, Lauc G.",date:2011,doi:"10.1007/s13148-011-0039-1",journal:"BMC"},{paper:"High Throughput Plasma N-Glycome Profiling using Multiplexed Labelling and UPLC with Fluorescence Detection",authors:"Knežević A, Bones J, Kračun SK, Gornik O, Rudd PM, Lauc G.",date:2011,doi:"10.1039/c1an15684e",journal:"RSC"},{paper:"Complex genetics of protein glycosylation",authors:"Lauc G, Rudan I, Campbell H, Rudd PM.",date:2010,doi:"10.1039/b910377e",journal:"Molecular BioSystem"},{paper:"Common aberrations from normal human N-glycan plasma profile",authors:"ucic M, Pinto S, Novokmet M, Knezevic A, Gornik O, Polasek O, Vlahovicek K, Wang W, Rudd PM, Wright AF, Campbell H, Rudan I, Lauc G. ",date:2010,doi:"10.1093/glycob/cwq052",journal:"Glycobiology"},{paper:"Protein glycosylation – an evolutionary crossroad between genes and environment",authors:"Lauc G, Zoldoš V.",date:2010,doi:"10.1039/c0mb00067a",journal:"Molecular BioSystem"},{paper:"Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans",authors:"Knezevic A, Gornik O, Polasek O, Pucic M, Redzic I, Novokmet M, Rudd PM, Wright AF, Campbell H, Rudan I, Lauc G.",date:2010,doi:"10.1093/glycob/cwq051",journal:"Glycobiology"},{paper:"Genomics meets glycomics – The first GWAS study of human glycome identifies HNF1a as a master regulator of plasma protein",authors:"Lauc G, Essafi A, Huffman JE, Hayward C, Knežević A, Kattla JJ, Polašek O, Gornik O, Vitart V, Abrahams JL, Pučić M, Novokmet M, Redžić I, Campbell S, Wild SH, Borovečki F, Wang W, Kolčić I, Zgaga L, Gyllensten U, Wilson JF, Wright AF, Hastie ND, Campbell H, Rudd PM, Rudan I.",date:2010,doi:"10.1371/journal.pgen.1001256",journal:"PLOS"},{paper:"Variability, Heritability and Environmental Determinants of Human Plasma N-Glycome",authors:"Knezević A, Polasek O, Gornik O, Rudan I, Campbell H, Hayward C, Wright A, Kolcic I, O'Donoghue N, Bones J, Rudd PM, Lauc G.",date:2009,doi:"10.1021/pr800737u",journal:"ACS"},{paper:"Stability of N-glycan profiles in human plasma",authors:"Gornik O, Wagner J, Pucić M, Knezević A, Redzic I, Lauc G.",date:2009,doi:"10.1093/glycob/cwp134",journal:"Glycobiology"},{paper:"Genome-wide linkage analysis of serum creatinine in three isolated European populations",authors:"Pattaro C, Aulchenko YS, Isaacs A, Vitart V, Hayward C, Franklin CS, Polasek O, Kolcic I, Biloglav Z, Campbell S, Hastie N, Lauc G, Meitinger T, Oostra BA, Gyllensten U, Wilson JF, Pichler I, Hicks AA, Campbell H, Wright AF, Rudan I, van Duijn CM, Riegler P, Marroni F, Pramstaller PP; EUROSPAN Consortium. ",date:2009,doi:"10.1038/ki.2009.135",journal:"Kidney international"}];var dh=y('<a class="publication-year-link"> </a>'),mh=y('<a target="_blank" rel="noreferrer noopener" class="publication-card"><div class="publication-card-paper"> </div> <div class="publication-card-journal"> </div></a>'),ph=y('<a target="_blank" rel="noreferrer noopener" class="publication-card"><div class="publication-card-paper"> </div> <div class="publication-card-journal"> </div></a>'),hh=y('<div class="publications-cards"><h3> </h3> <div class="flex flex-col"></div></div>'),vh=y('<div class="grid grid-small publications"><div class="gc-12 mb-24"><h2> </h2></div> <div class="gc-3 sticky"><p> </p> <div class="sticky-items"></div></div> <div class="gc-9 publications-container"></div></div>');function gh(o,e){Ke(e,!0);const a=ra(),i=()=>$e(ea,"$language",a),r=ch.reduce((g,w)=>{const f=w.date;return g[f]||(g[f]=[]),g[f].push(w),g},{}),l=Object.keys(r).sort((g,w)=>w-g),d=g=>g.split(",")[0];dc(()=>{const g=sessionStorage.getItem("scrollPosition");g&&window.scrollTo(0,parseInt(g,10)),window.addEventListener("beforeunload",()=>{sessionStorage.setItem("scrollPosition",String(window.scrollY))})});var u=vh(),p=n(u),h=n(p),j=n(h);t(h),t(p);var S=s(p,2),G=n(S),z=n(G);t(G);var M=s(G,2);He(M,21,()=>l,xe,(g,w)=>{var f=dh(),T=n(f);t(f),A(()=>{B(f,"href",`/${(i()==="en"?"publications":"publikacije")??""}#${c(w)??""}`),m(T,c(w))}),v(g,f)}),t(M),t(S);var k=s(S,2);He(k,21,()=>l,xe,(g,w)=>{var f=hh(),T=n(f),W=n(T);t(T);var X=s(T,2);He(X,21,()=>r[c(w)],xe,(O,E)=>{var R=Be(),U=me(R);P(U,()=>c(E).doi,Q=>{var D=mh(),_=n(D),x=n(_);t(_);var b=s(_,2),I=n(b);A(()=>m(I,`${c(E).date??""} | ${d(c(E).authors)??""} et al. | ${c(E).journal??""}`)),t(b),t(D),A(()=>{B(D,"href",`https://doi.org/${c(E).doi??""}`),m(x,c(E).paper)}),v(Q,D)},Q=>{var D=Be(),_=me(D);P(_,()=>c(E).href,x=>{var b=ph(),I=n(b),C=n(I);t(I);var H=s(I,2),Y=n(H);A(()=>m(Y,`${c(E).date??""} | ${d(c(E).authors)??""} et al. | ${c(E).journal??""}`)),t(H),t(b),A(()=>{B(b,"href",c(E).href),m(C,c(E).paper)}),v(x,b)},null,!0),v(Q,D)}),v(O,R)}),t(X),t(f),A(()=>{B(f,"id",c(w)),m(W,c(w))}),v(g,f)}),t(k),t(u),A(()=>{m(j,i()==="en"?"Genos has been at the forefront of glycoscience. We have published over 300 articles in the past 15+ years. We continue to advance the field and look forward to further developments in our research field.":"Genos je na čelu glikoznanosti. U proteklih više od 15 godina objavili smo preko 300 znanstvenih radova. Nastavljamo s unaprjeđenjem ovog područja i veselimo se daljnjem razvoju naših istraživanja."),m(z,i()==="en"?"Quick links:":"Izbornik:")}),v(o,u),We()}customElements.define("pb-publications",Ge(gh,{},[],[],!1));const jh=[{group:"Digit",program:"Digit",href:"digit",projects:[{short:"Public consultation (ESMP)",titleEn:"Public Consultation on ESMP Checklists",descriptionEn:"The interested public is invited to participate in a public consultation on draft Environmental and Social Management Plan (ESMP) checklists prepared for two activities: GlycoCardio 2023 and CRISPRdCas9. The purpose of the consultation is to collect comments, suggestions, and opinions in order to improve the quality, clarity, and implementability of the listed documents.",titleHr:"Javno savjetovanje o ESMP kontrolnim listama",descriptionHr:"Zainteresirana javnost poziva se na sudjelovanje u javnom savjetovanju o nacrtima kontrolnih listi Plana upravljanja okolišem i društvom (ESMP) pripremljenih za dvije aktivnosti: GlycoCardio 2023 i CRISPRdCas9. Svrha savjetovanja je prikupljanje komentara, prijedloga i mišljenja radi poboljšanja kvalitete, jasnoće i provedivosti navedenih dokumenata.",startDate:"22/12/2025",projectDurationInDays:"14",pdf:"public-consultation.pdf",projectId:"P180755",callForProposals:"DIGIT.2.2.01",coordinator:"Genos d.o.o.",projectParticipants:2},{short:"Public consultation – Report (ESMP)",titleEn:"Public Consultation – Report",descriptionEn:"Based on the conducted public consultation procedure and the fact that no comments were received, it is determined that the drafts of the subject ESMP checklists remain unchanged.",titleHr:"Javno savjetovanje – izvješće",descriptionHr:"Na temelju provedenog postupka javnog savjetovanja i činjenice da nisu zaprimljeni komentari, utvrđuje se da nacrti predmetnih ESMP checklista ostaju u neizmijenjenom obliku.",startDate:"13/01/2026",projectDurationInDays:"",pdf:"report-on-the-conducted-public-consultation.pdf",projectId:"P180755",callForProposals:"DIGIT.2.2.01",coordinator:"Genos d.o.o.",projectParticipants:2},{short:"GRM (ESMP)",titleEn:"Grievance Redress Mechanism (GRM)",descriptionEn:"A Grievance Redress Mechanism (GRM) is established by publishing the email address grmdigit@genos.hr in accordance with the conducted public consultation and ESMP checklists, to which the interested public, whether groups or individuals, can send complaints, comments, and/or suggestions regarding the implementation of projects under the authority of DIGIT.",titleHr:"GRM mehanizam",descriptionHr:"Uspostavlja se Mehanizam za rješavanje pritužbi (GRM) objavom mail adrese grmdigit@genos.hr sukladno provedenom javnom savjetovanju i ESMP checklistama na koju zainteresirana javnost, bilo grupe ili pojedinci, mogu slati pritužbe, komentare i/ili prijedloge na provedbu projekata u nadležnosti DIGIT-a.",startDate:"13/01/2026",coordinator:"Genos d.o.o.",projectParticipants:2},{short:"EpiGen-toolbox (ESMP)",titleEn:"CRISPR/dCas9 Toolbox for Epigenome and Genome Editing",descriptionEn:"The EpiGen-toolbox project develops a modular CRISPR/dCas9-based platform for precise epigenome and genome editing. The project will deliver a collaborative online platform that enables global access to standardized and customizable epigenome-editing tools for academic and pharmaceutical users. By integrating modular design, biological validation, and digital infrastructure, the project aims to accelerate translational epigenetics research and support applications in drug discovery and biotechnology.",titleHr:"CRISPR/dCas9 alat za uređivanje epigenoma i genoma",descriptionHr:"Projekt EpiGen-toolbox razvija modularni CRISPR/dCas9 alat za precizno uređivanje epigenoma i genoma. Projekt uključuje izgradnju suradničke internetske platforme koja omogućuje globalni pristup standardiziranim i prilagodljivim alatima za epigenetičko uređivanje za akademsku i farmaceutsku zajednicu. Integracijom modularnog dizajna, biološke validacije i digitalne infrastrukture, projekt ima za cilj ubrzati translacijska epigenetička istraživanja te podržati primjene u otkrivanju lijekova i biotehnologiji.",startDate:"01/01/2025",projectDuration:"18",pdf:"epigen-toolbox.pdf",projectId:"P180755",callForProposals:"DIGIT.2.2.01",coordinator:"Genos d.o.o.",projectParticipants:1},{short:"GlycoCardio (ESMP)",titleEn:"IgG Glycome Composition as a Biomarker for Personalised Prevention and Treatment of Cardiovascular Diseases",titleHr:"Sastav IgG glikoma kao biomarker za personaliziranu prevenciju i liječenje kardiovaskularnih bolesti",descriptionEn:"The GlycoCardio PoC project aims to validate IgG glycans as dynamic, modifiable biomarkers for personalised cardiovascular disease (CVD) risk management. Unlike static genetic risk factors, IgG glycans respond to lifestyle and pharmacological interventions. The project will conduct validation studies using large prospective cohorts and real-world intervention data, and develop a dedicated digital application to calculate and present individualised CVD risk scores. The final outcome is a novel GlycoCardio test intended for global commercial deployment via clinical partners.",descriptionHr:"Projekt GlycoCardio PoC ima za cilj validirati IgG glikane kao dinamične i promjenjive biomarkere za personalizirano upravljanje rizikom od kardiovaskularnih bolesti. Za razliku od genetskih čimbenika rizika, IgG glikani reagiraju na promjene načina života i farmakološke intervencije. Projekt uključuje validacijske studije na velikim kohortama i u stvarnim uvjetima te razvoj namjenske digitalne aplikacije za izračun i prikaz individualnog rizika. Krajnji rezultat je novi GlycoCardio test namijenjen komercijalnoj primjeni putem globalne mreže kliničkih partnera.",startDate:"22/12/2025",projectDuration:"18",pdf:"glycocardio.pdf",projectId:"P180755",callForProposals:"DIGIT.2.2.01",programme:"DIGITAL, Innovation and Green Technology Project (DIGIT)",coordinator:"Genos d.o.o.",projectParticipants:2,projectLocation:"Zagreb, Croatia"}]},{group:"Horizon Europe",program:"Horizon Europe",href:"horizon-europe",projects:[{short:"GlycanSwitch",titleEn:"Glycans as Master Switches of B Cell Activity in Autoimmunity",descriptionEn:"Glycosylation is a post-translational modification process that involves the addition of sugar molecules to proteins. In the immune system, glycosylation plays an essential role in regulating the interactions between immune cells and their environment. In the case of antibodies, glycosylation at the fragment antigen-binding (Fab) region affects the antigen-binding affinity of antibodies and may lead to the development and progression of autoimmune diseases. The ERC-funded GlycanSwitch project aims to investigate the cellular mechanisms underlying Fab glycosylation and its effects on the immune system. Researchers will focus on the glycosylation of the B cell receptor and its role in the selection and activation of autoreactive B cells. Project findings will provide the groundwork for targeted therapies against autoimmunity.",titleHr:"Glikani kao glavni prekidači aktivnosti B stanica u autoimunitetu",descriptionHr:"Glikozilacija je proces posttranslacijske modifikacije koji uključuje dodavanje molekula šećera proteinima. U imunološkom sustavu, glikozilacija ima ključnu ulogu u regulaciji interakcija između imunoloških stanica i njihovog okruženja. U slučaju antitijela, glikozilacija na fragmentu koji veže antigen (Fab) utječe na afinitet vezanja antigena i može dovesti do razvoja i progresije autoimunih bolesti. Projekt GlycanSwitch, financiran od strane ERC-a, ima za cilj istražiti stanične mehanizme koji stoje iza Fab glikozilacije i njezin utjecaj na imunološki sustav. Istraživači će se usredotočiti na glikozilaciju B-staničnog receptora i njegovu ulogu u odabiru i aktivaciji autoreaktivnih B stanica. Rezultati projekta pružit će temelje za ciljanje terapija protiv autoimuniteta.",startDate:"01/01/2023",projectDuration:"72",pdf:"1-1.pdf",projectId:"101071386",callForProposals:"ERC-2022-SYG",coordinator:"ACADEMISCH ZIEKENHUIS LEIDEN",projectParticipants:3,projectWebsite:"https://glycanswitch.com/",projectValue:"9,997,500.00€",genosContribution:"2,487,500.50€"},{short:"GeneTiga",titleEn:"Gene-edited T cells combating IgA Nephropathy. A blueprint approach for safe & efficient genome editing of T cells to sustainably combat several immune diseases and cancers related to B-cell pathology",descriptionEn:"There is an unprecedented increase in chronic diseases due to immune imbalance for which there are limited treatment options. The EU-funded geneTIGA is developing a safe and efficient cell therapy based on genome-edited T cells to sustainably combat IgA nephropathy (IgAN), one of the most common causes of endstage renal disease. As an IgA disease, this cell therapy approach can form the blueprint for other IgA diseases including IgA myeloma, IgA related coeliac disease and rheumatoid arthritis, as well as other Ig diseases. Thus, geneTIGA researchers anticipate the delivery of a ‘living drug’ to treat IgAN and other IgA-associated diseases for entry to first-in-human clinical trials.",titleHr:"Genetski modificirane T stanice u borbi protiv IgA nefropatije. Pristup nacrtu za sigurnu i učinkovitu gensku modifikaciju T stanica s ciljem održive borbe protiv više imunoloških bolesti i karcinoma povezanih s patologijom B stanica",descriptionHr:"Zabilježen je neviđeni porast kroničnih bolesti uzrokovanih imunološkom neravnotežom za koje postoje ograničene mogućnosti liječenja. Projekt geneTIGA, financiran od strane EU-a, razvija sigurnu i učinkovitu staničnu terapiju temeljenu na genski modificiranim T stanicama za održivu borbu protiv IgA nefropatije (IgAN), jednog od najčešćih uzroka završnog stadija bubrežne bolesti. Kao IgA bolest, ovaj pristup stanične terapije može poslužiti kao nacrt za liječenje drugih IgA bolesti uključujući IgA mijelom, IgA-povezanu celijakiju i reumatoidni artritis, kao i drugih Ig bolesti. Stoga istraživači projekta geneTIGA očekuju isporuku ‘živog lijeka’ za liječenje IgAN-a i drugih bolesti povezanih s IgA za ulazak u prve kliničke studije na ljudima.",startDate:"01/07/2022",projectDuration:"48",pdf:"1-2.pdf",projectId:"101057438",callForProposals:"HORIZON-HLTH-2021-TOOL-06",coordinator:"CHARITE - UNIVERSITAETSMEDIZIN BERLIN",projectParticipants:12,projectWebsite:"https://www.genetiga-horizon.eu/",projectValue:"6,393,734.00€",genosContribution:"596,875.00€"},{short:"SynHealth",titleEn:"Synergy for Healthy Longevity",descriptionEn:"Traditional healthcare systems focus on treating illness reactively. This puts a strain on resources and budgets. With rising costs and global funding crises, sustainability is at risk. The EU-funded SynHealth project will address these challenges. Specifically, it will leverage glycan biomarkers to revolutionise healthcare. Genos researchers spearheaded glycomics advancements, identifying potential biomarkers. SynHealth aims to harness these discoveries for real-world application in Croatia and Slovenia. Partnerships in the target regions will facilitate innovation and technology transfer. By integrating glycan biomarkers into preventive healthcare, SynHealth paves the way for personalised medicine and efficient resource allocation. Overall, the project aims to translate past breakthroughs into clinical diagnostic tools, heralding a transformative era in healthcare",titleHr:"Sinergija za zdravo starenje",descriptionHr:"Tradicionalni zdravstveni sustavi fokusirani su na reaktivno liječenje bolesti. To opterećuje resurse i proračune. Uz rastuće troškove i globalne financijske krize, održivost je ugrožena. Projekt SynHealth, financiran od strane EU-a, rješavat će ove izazove. Konkretno, iskoristit će glikanske biomarkere kako bi revolucionirao zdravstvenu skrb. Istraživači iz Genosa predvodili su napredak u glikomici, identificirajući potencijalne biomarkere. SynHealth ima za cilj iskoristiti ova otkrića za primjenu u stvarnom svijetu u Hrvatskoj i Sloveniji. Partnerstva u ciljanim regijama olakšat će inovacije i prijenos tehnologije. Integracijom glikanskih biomarkera u preventivnu zdravstvenu skrb, SynHealth otvara put personaliziranoj medicini i učinkovitijoj raspodjeli resursa. Općenito, cilj projekta je pretvoriti dosadašnja otkrića u kliničke dijagnostičke alate, najavljujući transformativnu eru u zdravstvenoj skrbi.",startDate:"01/03/2024",projectDuration:"36",pdf:"1-3.pdf",projectId:"101159018",callForProposals:"HORIZON WIDERA 2023-ACCESS-04",coordinator:"Genos d.o.o.",projectParticipants:7,projectWebsite:"https://synhealth-project.eu/",projectValue:"1,217,125.00€",genosContribution:"488,875.00€"},{short:"INITIALISE",titleEn:"Inflammation in human early life: targeting impacts on life-coursing health",descriptionEn:"Our immune system is educated early on in life through interaction with microbes and environmental factors. This encounter is central, as it influences the development of immune-related diseases later on in childhood or adulthood. However, technical challenges have prohibited the investigation of the process. The EU-funded INITIALISE project aims to shed light on the mechanism of maturation of the immune system, using existing biobanks and cohorts. Researchers will investigate how exposure to different factors impacts immune-related health and drives immune system maturation. Moreover, a clinical study will help determine the outcome of immune system targeting on disease prevention.",titleHr:"Upala u ranom ljudskom životu: ciljanje utjecaja na zdravlje tijekom života",descriptionHr:"Naš imunološki sustav se uči već u ranom životu kroz interakciju s mikrobima i čimbenicima okoliša. Ovo je ključno jer utječe na razvoj bolesti povezanih s imunitetom kasnije u djetinjstvu ili odrasloj dobi. Međutim, tehnički izazovi dosad su onemogućavali istraživanje tog procesa. Projekt INITIALISE, financiran od strane EU-a, ima za cilj rasvijetliti mehanizme sazrijevanja imunološkog sustava korištenjem postojećih biobanki i kohorti. Istraživači će proučavati kako izloženost različitim čimbenicima utječe na zdravlje povezano s imunitetom i potiče sazrijevanje imunološkog sustava. Osim toga, klinička studija pomoći će u određivanju učinka ciljanog djelovanja na imunološki sustav u prevenciji bolesti.",startDate:"01/01/2023",projectDuration:"72",pdf:"1-4.pdf",projectId:"101094099",callForProposals:"HORIZON-HLTH-2022-STAYHLTH-02",coordinator:"TURUN YLIOPISTO",projectParticipants:12,projectWebsite:"https://initialise-project.eu/",projectValue:"7,451,043.75€",genosContribution:"538,750.00€"},{short:"EXPAND-EV",titleEn:"EXPANDing the value of Extracellular Vesicles as carriers of biomarkers and therapy in precision healthcare",descriptionEn:"Extracellular vesicles (EVs) are key players in cell communication, involved in both normal and disease processes. Despite their potential in healthcare (particularly in drug delivery and diagnostics), progress is hindered by limited technological readiness and the absence of standardised guidelines. Current methods for EVs purification are inefficient, which restricts their application in personalised medicine. A breakthrough is needed to fully harness their capabilities in non-invasive diagnostics and targeted therapies. With the support of the Marie Skłodowska-Curie Actions programme, the EXPAND-EV project aims to solve this by developing scalable, cost-effective EV purification systems. These systems will enhance cancer diagnostics for lung, breast and liver malignancies, while at the same time exploring edible plant-based EVs as carriers of therapeutic molecules.",titleHr:"Proširivanje vrijednosti izvanstaničnih vezikula kao nositelja biomarkera i terapije u preciznoj medicini",descriptionHr:"Izvanstanične vezikule (EV) ključni su čimbenici u staničnoj komunikaciji, uključeni u normalne i patološke procese. Unatoč njihovom potencijalu u zdravstvu (posebno u dostavi lijekova i dijagnostici), napredak je ograničen zbog niske tehnološke spremnosti i nedostatka standardiziranih smjernica. Trenutne metode pročišćavanja EV-ova su neučinkovite, što ograničava njihovu primjenu u personaliziranoj medicini. Potreban je proboj kako bi se u potpunosti iskoristile njihove mogućnosti u neinvazivnoj dijagnostici i ciljanim terapijama. Uz potporu programa Marie Skłodowska-Curie Actions, projekt EXPAND-EV ima za cilj razviti skalabilne i isplative sustave za pročišćavanje EV-ova. Ovi sustavi poboljšat će dijagnostiku raka pluća, dojke i jetre, a istovremeno će istražiti jestive biljne EV-ove kao nositelje terapeutskih molekula.",startDate:"01/01/2025",projectDuration:"36",pdf:"1-5.pdf",projectId:"101182851",callForProposals:"HORIZON-MSCA-SE-2023",coordinator:"Hemijski fakultet, Univerzitet u Beogradu",projectParticipants:12,projectValue:"1,357,000.00€",genosContribution:"230,300.00€"},{short:"GLYCOBOOST",titleEn:"Precision control of glycosylation to open a new era of therapeutic antibodies",descriptionEn:"Biologics comprise a $511B market of advanced therapeutics that are used to treat cancer, autoimmune diseases, infectious diseases and beyond. Two thirds of biologics are decorated with sugar molecules attached to the therapeutics, including all antibody therapeutics, called monoclonal antibodies (mAbs). These sugar molecules are known as N-glycans and are vitally important for therapeutic safety and efficacy. To date, the N-glycans are poorly controlled and, as such, display highly heterogeneous patterns on a therapeutic. This complicates large-scale production and regulatory approval of biologics, and significantly limits the possibility of using N-glycans in therapeutic design. GlycoBoost revolutionises mAb design by delivering consistent N-glycans, precisely profiled with advanced analytical techniques. This innovation unlocks the full potential of N-glycans to elevate the effectiveness of mAbs. <br><br>Kyron.bio’s breakthrough technology uses cell engineering to produce therapeutic proteins with uniform and precision-controlled N-glycan patterns. This technology is being used to produce glycoengineered mAbs that are safer and more effective for patients, starting with mAbs used to treat autoimmune diseases where patient resistance to current treatments remains high. <br><br> Through a well-established collaboration between kyron.bio and Genos, one of the world leaders in glycoanalytics on whose SYSCID project this proposal is built, GlycoBoost aims to advance the project to commercialisation through the development of advanced glycoanalytical techniques, preclinical evaluation, pre-industrialisation, bespoke customer PoC’s, partnership-building, and fundraising. GlycoBoost will place Europe at the heart of the glycobiology revolution, leading to the development of safer and more effective treatments for autoimmune diseases and ultimately redefining the landscape of therapeutic drug development.",titleHr:"Precizna kontrola glikozilacije za otvaranje nove ere terapijskih antitijela",descriptionHr:"Biološki lijekovi čine tržište vrijedno 511 milijardi dolara i koriste se za liječenje raka, autoimunih bolesti, zaraznih bolesti i drugih stanja. Dvije trećine bioloških lijekova sadrži molekule šećera vezane za terapijski protein, uključujući sva terapijska antitijela poznata kao monoklonska antitijela (mAb). Te molekule šećera poznate su kao N-glikani i od presudne su važnosti za sigurnost i učinkovitost terapije. Do danas su N-glikani slabo kontrolirani te pokazuju vrlo heterogene obrasce na terapiji, što otežava masovnu proizvodnju i regulatorno odobrenje bioloških lijekova te značajno ograničava mogućnost korištenja N-glikana u dizajnu terapije. GlycoBoost revolucionira dizajn mAb-a isporukom dosljednih N-glikana, precizno profiliranih naprednim analitičkim tehnikama. Ova inovacija otključava puni potencijal N-glikana za povećanje učinkovitosti mAb-a. <br><br>Tehnologija tvrtke Kyron.bio koristi inženjering stanica za proizvodnju terapijskih proteina s ujednačenim i precizno kontroliranim obrascima N-glikana. Ova se tehnologija koristi za proizvodnju gliko-inženjerskih mAb-a koji su sigurniji i učinkovitiji za pacijente, počevši s mAb-ovima za liječenje autoimunih bolesti gdje je otpornost pacijenata na postojeće tretmane još uvijek visoka. <br><br>Kroz već uspostavljenu suradnju između kyron.bio i Genosa, jednog od svjetskih lidera u glikoanalitici, na čijem je projektu SYSCID ova prijava utemeljena, GlycoBoost ima za cilj unaprijediti projekt prema komercijalizaciji razvojem naprednih glikoanalitičkih tehnika, predkliničkom evaluacijom, predindustrijalizacijom, prilagođenim PoC-ovima za klijente, izgradnjom partnerstava i prikupljanjem sredstava. GlycoBoost će Europu postaviti u središte revolucije glikobiologije, što će dovesti do razvoja sigurnijih i učinkovitijih tretmana za autoimune bolesti i u konačnici redefinirati krajolik razvoja terapijskih lijekova.",startDate:"01/04/2025",projectDuration:"30",pdf:"1-6.pdf",projectId:"101214245",callForProposals:"HORIZON-EIC-2024-TRANSITION-0",coordinator:"KYRON.BIO",projectParticipants:10,projectValue:"2,499,549.38€",genosContribution:"792,277.75€"},{short:"GLUCOTYPES",titleEn:"Protein glycosylation and glucose variability patterns for precision nutrition in diabetes",descriptionEn:"GLUCOTYPES-HopOn expands the GLUCOTYPES project by incorporating large-scale glycosylation profiling through the participation of the widening partner, Genos. Specializing in high-throughput glycomics, Genos has contributed glycomic data to over 200,000 samples from population, epidemiological, and clinical studies. With a focus on biomarker discovery and commercialization, Genos brings valuable expertise to the GLUCOTYPES Consortium. Previous research at Genos has shown that glycan biomarkers can predict the development of type 2 diabetes (T2D) independently of traditional risk factors, offering complementary insights. Genos demonstrated that individual differences in plasma protein Nglycome composition can predict T2D up to 10 years before onset with gradual changes in the N-glycome becoming evident years before clinical signs of insulin resistance or T2D appear. <br><br>By analyzing total serum/plasma N-glycans in 11,000 samples available through the GLUCOTYPES project using advanced technologies, Genos will actively support the project's goal of developing personalized dietary strategies to address food-related health conditions (FrHCs) and non-communicable chronic diseases (NCDs). The integration of Genos will follow the project's existing structure, with dedicated subtasks across several work packages, ensuring smooth incorporation of high-throughput glycomics analysis. The GLUCOTYPES-HopOn extension will enhance glycosylation profiling capacity, strengthen commercialization efforts, and boost the impact of the GLUCOTYPES Consortium, potentially opening new research avenues",titleHr:"Glikozilacija proteina i obrasci varijabilnosti glukoze za preciznu prehranu kod dijabetesa",descriptionHr:"GLUCOTYPES-HopOn proširuje projekt GLUCOTYPES uključivanjem opsežnog profiliranja glikozilacije kroz sudjelovanje partnera za širenje, Genosa. Specijaliziran za visokoprotočnu glikomiku, Genos je doprinio glikomičkim podacima za više od 200.000 uzoraka iz populacijskih, epidemioloških i kliničkih studija. S fokusom na otkrivanje i komercijalizaciju biomarkera, Genos donosi vrijednu stručnost u GLUCOTYPES konzorcij. Prethodna istraživanja u Genosu pokazala su da glikanski biomarkeri mogu predvidjeti razvoj dijabetesa tipa 2 (T2D) neovisno o tradicionalnim rizičnim čimbenicima, nudeći komplementarne uvide. Genos je pokazao da individualne razlike u sastavu plazmatskih proteina N-glikoma mogu predvidjeti T2D i do 10 godina prije njegova nastanka, pri čemu postepene promjene u N-glikomu postaju vidljive godinama prije kliničkih znakova inzulinske rezistencije ili T2D. <br><br>Analizom ukupnih serumskih/plazmatskih N-glikana u 11.000 uzoraka dostupnih putem projekta GLUCOTYPES pomoću naprednih tehnologija, Genos će aktivno podržati cilj projekta razvoja personaliziranih prehrambenih strategija za rješavanje zdravstvenih stanja povezanih s hranom (FrHCs) i nezaraznih kroničnih bolesti (NCDs). Integracija Genosa odvijat će se prema postojećoj strukturi projekta, s posvećenim podzadatcima u nekoliko radnih paketa, osiguravajući glatko uključivanje visokoprotočne glikomike. Proširenje GLUCOTYPES-HopOn povećat će kapacitet za profiliranje glikozilacije, ojačati napore za komercijalizaciju i povećati utjecaj GLUCOTYPES konzorcija, potencijalno otvarajući nove istraživačke pravce.",startDate:"01/10/2024",projectDuration:"48",pdf:"1-7.pdf",projectId:"10121705-19",callForProposals:"HORIZON-WIDERA-2023-ACCESS-06",coordinator:"Kobenhavns Universitet",projectParticipants:2,projectWebsite:"https://glucotypes.eu/",projectValue:"593,125.00€",genosContribution:"539,500.00€"},{short:"WORMVACS2.0",titleEn:"Innovations for vaccines against Helminth infections - Glycosylation signatures of immunity",descriptionEn:"The WORMVACS2.0 Hop-on proposal aims to address critical gaps in our understanding of protective immunity against helminth infections, with a particular focus on glycosylation, a complex and common posttranslational modification of proteins. Glycans play essential roles in infectious disease biology, such as mediating host-pathogen interactions, contributing to immune effector functions, and regulating host immune responses. <br><br>Despite the importance of glycosylation in immunity, WORMVACS2.0 currently lacks an in-depth glycosylation analysis of the host’s immune system components - a highly relevant yet underexplored aspect of immunity against helminths that needs to be addressed in support of the development of effective anti-helminth vaccines.<br><br>To address this gap, GENOS, a global leader in high-throughput glycomics, will join the WORMVACS2.0 consortium to perform comprehensive glycosylation analyses on samples from controlled human helminth infection trials, natural infection cohorts, and animal vaccination models. This will include studying the glycosylation patterns of total serum/plasma proteins, immunoglobulins (IgG, IgA, IgM), alpha-1-acid glycoprotein and complement component 3. The project aims to uncover inter-individual differences, track longitudinal changes, and investigate associations between glycosylation patterns and clinical, parasitological, and immunological data.<br><br>The project’s objectives will be achieved through GENOS’ cutting-edge glycoanalytical technologies, which have been successfully applied in largescale studies across various diseases. The findings are expected to enhance the WORMVACS2.0 consortium’s capacity to develop more effective vaccines by incorporating insights into glycosylation and its role in protective immunity, thereby aligning with the work programme’s goals of advancing vaccine research for neglected tropical diseases",titleHr:"Inovacije za cjepiva protiv infekcija helmintima – Glikozilacijski potpis imuniteta",descriptionHr:"Prijedlog WORMVACS2.0 Hop-on ima za cilj popuniti ključne praznine u našem razumijevanju zaštitnog imuniteta protiv infekcija helmintima, s posebnim naglaskom na glikozilaciju, složenu i čestu posttranslacijsku modifikaciju proteina. Glikani imaju ključnu ulogu u biologiji zaraznih bolesti, poput posredovanja u interakcijama domaćin-patogen, doprinošenja efektorskim funkcijama imuniteta i regulacije imunološkog odgovora domaćina. <br><br>Unatoč važnosti glikozilacije u imunitetu, WORMVACS2.0 trenutačno nema detaljnu analizu glikozilacije komponenti imunološkog sustava domaćina – vrlo relevantnog, ali nedovoljno istraženog aspekta imuniteta na helminte koji je potrebno obraditi radi razvoja učinkovitih cjepiva protiv helminta.<br><br>Kako bi se ovaj nedostatak nadoknadio, GENOS, globalni lider u visokoprotočnoj glikomici, pridružit će se konzorciju WORMVACS2.0 kako bi proveo sveobuhvatne analize glikozilacije na uzorcima iz kontroliranih ljudskih ispitivanja infekcija helmintima, kohorti prirodnih infekcija i modela cijepljenja na životinjama. To će uključivati proučavanje glikozilacijskih obrazaca ukupnih proteina seruma/plazme, imunoglobulina (IgG, IgA, IgM), alfa-1-kiselog glikoproteina i komponenti komplementa 3. Projekt ima za cilj otkriti međuljudske razlike, pratiti promjene kroz vrijeme i istražiti povezanosti između glikozilacijskih obrazaca i kliničkih, parazitoloških i imunoloških podataka.<br><br>Ciljevi projekta bit će ostvareni korištenjem najsuvremenijih glikoanalitičkih tehnologija GENOS-a, koje su uspješno primijenjene u velikim studijama raznih bolesti. Očekuje se da će rezultati povećati kapacitet konzorcija WORMVACS2.0 za razvoj učinkovitijih cjepiva uključivanjem uvida u glikozilaciju i njezinu ulogu u zaštitnom imunitetu, čime će se uskladiti s ciljevima programa rada za unapređenje istraživanja cjepiva za zanemarene tropske bolesti.",startDate:"01/09/2023",projectDuration:"60",pdf:"1-8.pdf",projectId:"101217122",callForProposals:"HORIZON-WIDERA-2023-ACCESS-06",coordinator:"ACADEMISCH ZIEKENHUIS LEIDEN",projectParticipants:2,projectWebsite:"https://www.wormvacs.org/",projectValue:"593,587.50€",genosContribution:"539,625.00€"},{short:"AttractAdria",titleEn:"Attractive Research Ecosystem in the Adria Region in the Field of Personalised Preventive Healthcare",descriptionEn:"AttractAdria will create an attractive ecosystem to improve access to excellence at the universities in BiH by raising the research profile of the institution and its staff in the field of personalised healthcare via targeted networking and mentoring and training activities with internationally leading research institutions.<br><br>By networking activities with global leaders, the potential of the BiH universities will be developed to become European-wide known centres with increasing R&I contributions and achievements.<br><br>During the AttractAdria, Ministry of Civil Affairs, Ministry of Science and Higher Education of Kanton Sarajevo, HNK Government and SERDA in BiH and the National Science Foundation in Croatia will pilot some novel measures for R&D.<br><br>The AttractAdria project will help to increase the scientific level, research quality, international visibility, and competitiveness of the BiH universities through targeted activities aimed at career development, transfer of knowledge, institutional development, exchange of best practices and networking.<br><br>Cumulatively, this will improve integration of researchers from Croatia and BiH in the European Research Area and increase their participation in international projects.",titleHr:"Atraktivni istraživački ekosustav u jadranskoj regiji u području personalizirane preventivne zdravstvene skrbi",descriptionHr:"Projekt AttractAdria uspostavit će atraktivan ekosustav za poboljšanje pristupa izvrsnosti na sveučilištima u BiH podizanjem istraživačkog profila institucija i njihovog osoblja u području personalizirane zdravstvene skrbi putem ciljanog umrežavanja, mentorstva i aktivnosti obuke s međunarodno vodećim istraživačkim institucijama.<br><br>Kroz umrežavanje s globalnim liderima, razvit će se potencijal sveučilišta u BiH da postanu europski prepoznatljivi centri s rastućim doprinosom i postignućima u području istraživanja i inovacija.<br><br>Tijekom projekta AttractAdria, Ministarstvo civilnih poslova, Ministarstvo znanosti i visokog obrazovanja Kantona Sarajevo, Vlada HNK i SERDA u BiH te Nacionalna zaklada za znanost u Hrvatskoj pilotirat će neke nove mjere za istraživanje i razvoj.<br><br>Projekt AttractAdria pomoći će u povećanju znanstvene razine, kvalitete istraživanja, međunarodne vidljivosti i konkurentnosti sveučilišta u BiH kroz ciljane aktivnosti usmjerene na razvoj karijere, prijenos znanja, institucionalni razvoj, razmjenu najboljih praksi i umrežavanje.<br><br>Kumulativno, to će poboljšati integraciju istraživača iz Hrvatske i BiH u Europski istraživački prostor i povećati njihovo sudjelovanje u međunarodnim projektima.",startDate:"01/09/2025",projectDuration:"36",pdf:"1-9.pdf",projectId:"101216942",callForProposals:"HORIZON-WIDERA-2024-ERA-02",coordinator:"UNIVERZITET U SARAJEVU (UNSA)",projectParticipants:14,projectValue:"2,192,727.50€",genosContribution:"401,500.00€"}]},{group:"H2020",program:"H2020",href:"h2020",projects:[{short:"3TR",titleEn:"Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions",descriptionEn:"3TR aims to provide fundamental new insights into the mechanisms of response and non-response to treatment. Thereby, we challenge the conventional “single disease”-based approach, in which diseases are classified according to their end-organ involvement rather than the molecular pathways underpinning them. Consequently, we propose a paradigm shift in the way we look at diseases: Promoting a scientific evidence-based rationale for treatment selection, rather than following the traditional trial and error approach, 3TR will have significant implications for future patient management and the assessment of efficacy, safety and quality of future health products. On a more practical level, central work objectives are: establishing a centralised data and sample management platform, performing comprehensive molecular and clinical characterisation of prospective patient cohorts, delivering integrated analysis of all data using advanced bioinformatics/statistical and modelling methods, and identifying sets of predictive biomarkers of response/non-response to therapies.",titleHr:"Identifikacija molekularnih mehanizama neodgovora na liječenje, relapsa i remisije kod autoimunih, upalnih i alergijskih stanja",descriptionHr:"Cilj projekta 3TR je pružiti temeljna nova saznanja o mehanizmima odgovora i neodgovora na liječenje. Time se dovodi u pitanje konvencionalni pristup temeljen na “jednoj bolesti”, u kojem se bolesti klasificiraju prema zahvaćenim organima, a ne prema molekularnim putevima koji ih uzrokuju. Posljedično, predlažemo promjenu paradigme u načinu na koji gledamo na bolesti: promoviranje znanstveno utemeljenog pristupa u odabiru terapije umjesto tradicionalnog pristupa pokušaja i pogreške. 3TR će imati značajne implikacije na buduće upravljanje pacijentima i procjenu učinkovitosti, sigurnosti i kvalitete budućih zdravstvenih proizvoda. Na praktičnijoj razini, središnji ciljevi rada uključuju: uspostavu centralizirane platforme za upravljanje podacima i uzorcima, provođenje sveobuhvatne molekularne i kliničke karakterizacije budućih kohorti pacijenata, isporuku integrirane analize svih podataka pomoću naprednih bioinformatičkih/statističkih i modelirajućih metoda te identifikaciju skupova prediktivnih biomarkera odgovora/neodgovora na terapije.",startDate:"01/09/2019",projectDuration:"84",pdf:"2-1.pdf",projectId:"831434",callForProposals:"H2020-JTI-IMI2-2018-14-two-stage",coordinator:"FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD M.P",projectParticipants:69,projectWebsite:"https://3tr-imi.eu/",projectValue:"40,273,191.50€",genosContribution:"106,501.56€"},{short:"Back-up",titleEn:"Personalised Prognostic Models to Improve Well-being and Return to Work After Neck and Low Back Pain",descriptionEn:"Neck and Low Back Pain is a leading cause for years lived with disability in Europe and worldwide. About 70% of all adults experience this problem at some point in their lives, and both conditions are among the top ten in terms of overall disease burden expressed as disability adjusted life years. Moreover, low back pain is the leading cause work absence in Europe, and it causes an enormous burden on individuals, industry and governments. Most patients (≥85%) seen in primary care with neck or low back problems have non-specific pain i.e., pain that cannot reliably be attributed to a specific disease or pathology. Many patients are therefore left with relatively few treatment options to effectively manage it.<br><br>Current European treatment guidelines recommend a package of care, which includes many different interventions shown to be small to moderately effective, such as self-management education, pain relief, encouragement of physical activity and return to work, a supervised exercise programme and manual therapies. A key aspect to consider is that patients with neck and low back pain are a heterogeneous group where the prognosis and precise mix of factors involved, varies substantially between individuals. This means that a one-size fits-all approach is not recommended, but methods to tailor treatment to the needs of the individual are still relatively under-developed. The Back-UP Project works for a better, personalised, faster and evidence-based management of neck and low back pain, through the development of a technological platform with prognostic models, addressed to patients, clinicians and occupational managers, based on the digital representation of multidimensional clinical information, and in-silico assessments of possible interventions.",titleHr:"Personalizirani prognostički modeli za poboljšanje dobrobiti i povratka na posao nakon bolova u vratu i donjem dijelu leđa",descriptionHr:"Bolovi u vratu i donjem dijelu leđa vodeći su uzrok godina života s invaliditetom u Europi i svijetu. Oko 70% odraslih doživi ovaj problem u nekom trenutku života, a oba su stanja među deset vodećih po ukupnom opterećenju bolestima izraženom kao godine života prilagođene invaliditetu. Štoviše, bol u donjem dijelu leđa glavni je uzrok izostanka s posla u Europi te uzrokuje ogroman teret za pojedince, industriju i vlade. Većina pacijenata (≥85%) koji se javljaju u primarnu zdravstvenu zaštitu s bolovima u vratu ili donjem dijelu leđa ima nespecifične bolove, tj. bolove koji se ne mogu pouzdano povezati s određenom bolešću ili patologijom. Stoga su mnogi pacijenti prepušteni s relativno malo mogućnosti učinkovitog liječenja.<br><br>Trenutne europske smjernice za liječenje preporučuju paket skrbi koji uključuje razne intervencije koje su pokazale malu do umjerenu učinkovitost, poput edukacije za samopomoć, ublažavanja boli, poticanja tjelesne aktivnosti i povratka na posao, nadziranih programa vježbanja i manualnih terapija. Ključno je razumjeti da su pacijenti s bolovima u vratu i donjem dijelu leđa heterogena skupina kod koje se prognoza i točan skup čimbenika znatno razlikuju među pojedincima. To znači da pristup „jedan za sve” nije preporučljiv, ali su metode prilagodbe liječenja potrebama pojedinca još uvijek nedovoljno razvijene. Projekt Back-UP radi na boljem, personaliziranom, bržem i na dokazima utemeljenom upravljanju bolovima u vratu i donjem dijelu leđa, kroz razvoj tehnološke platforme s prognostičkim modelima namijenjene pacijentima, kliničarima i stručnjacima za upravljanje radnim kapacitetom, temeljene na digitalnom prikazu multidimenzionalnih kliničkih informacija i simulacijskim procjenama mogućih intervencija.",startDate:"01/01/2018",projectDuration:"36",pdf:"2-2.pdf",projectId:"777090",callForProposals:"H2020-SC1-2016-2017",coordinator:"INSTITUTO DE BIOMECANICA DE VALENCIA",projectParticipants:13,projectWebsite:"http://backup-project.eu",projectValue:"5,130,140.00€",genosContribution:"554,021.56€"},{short:"IMforFuture",titleEn:"Innovative training in methods for future data",descriptionEn:"IMforFUTURE is an innovative multidisciplinary and intersectoral research training programme which addresses current shortcomings in omics research. We aim to open the new research horizon in integration of genetics, glycomics, and epigenomics datasets into systems biology by developing innovative methods for high throughput omics and for integrative analysis of omics data. We focus on ageing, which is the biggest single risk factor for many diseases. By application of our novel methods to emerging datasets representing inflammation and immunology, IMforFUTURE will contribute to understanding of the underlying biological processes involved in diseases and ageing.",titleHr:"Inovativna obuka u metodama za podatke budućnosti",descriptionHr:"IMforFUTURE je inovativni multidisciplinarni i međusektorski program istraživačke obuke koji rješava trenutne nedostatke u omics istraživanjima. Cilj nam je otvoriti nove istraživačke horizonte u integraciji genetskih, glikomičkih i epigenomskih skupova podataka u sustavsku biologiju razvojem inovativnih metoda za visokoprotočne omics analize i integrativnu analizu omics podataka. Fokusiramo se na starenje, koje je najveći pojedinačni čimbenik rizika za mnoge bolesti. Primjenom naših novih metoda na nove skupove podataka koji predstavljaju upalu i imunologiju, IMforFUTURE će doprinijeti razumijevanju temeljnih bioloških procesa uključenih u bolesti i starenje.",startDate:"01/04/2017",projectDuration:"48",pdf:"2-3.pdf",projectId:"721815",callForProposals:"H2020-MSCA-ITN-2016",coordinator:"University of Leeds",projectParticipants:9,projectValue:"2,757,868.48€",genosContribution:"238,761.00€"},{short:"SYSCID",titleEn:"A Systems medicine approach to chronic inflammatory disease",descriptionEn:"The SYSCID consortium aims to develop a systems medicine approach for predictions in chronic inflammatory diseases (CID). The overall goal is to create a prediction framework for disease outcome to guide therapy decisions on an individual patient level enabling the choice of the right therapy at the right time. Furthermore, the SYSCID consortium targets new therapy approaches by “reprogramming” disease through epigenome editing.",titleHr:"Pristup sustavske medicine kroničnim upalnim bolestima",descriptionHr:"Konzorcij SYSCID ima za cilj razviti pristup sustavske medicine za predviđanja kod kroničnih upalnih bolesti (CID). Ukupni cilj je stvoriti okvir za predviđanje ishoda bolesti kako bi se vodile terapijske odluke na razini pojedinog pacijenta, omogućujući izbor prave terapije u pravom trenutku. Nadalje, konzorcij SYSCID usmjeren je na nove terapijske pristupe kroz “reprogramiranje” bolesti pomoću uređivanja epigenoma.",startDate:"01/01/2017",projectDuration:"63",pdf:"2-4.pdf",projectId:"733100",callForProposals:"H2020-SC1-2016-2017",coordinator:"Kiel University with University Hospital Schleswig Holstein",projectParticipants:16,projectWebsite:"https://www.syscid.eu/",projectValue:"14,456,236.25€",genosContribution:"746,743.15€"},{short:"GlyCoCan",titleEn:"Glycosylation in colorectal cancer",descriptionEn:"Colorectal cancer (CRC) is a major worldwide cancer burden with about 1.4 million cases in 2012 and an annual mortality of approximately 700,000. Early detection is crucial as treatment is most efficient in early stages where population based screenings could substantially reduce incidence and mortality.Current screening techniques are invasive or lack sensitivity and specificity. Moreover, the molecular mechanisms leading to the formation of different antigens suggested as CRC biomarkers and potential therapeutic targets are poorly understood, especially with regard to carbohydrate-based molecules, such as glycans. Enhancing our understanding of the structure-function relationship of glycosylation in CRC could lead to the discovery of improved diagnostic and prognostic biomarkers and pave the way for nov-el therapeutic targets. <br><br>Building on an established network of analysts with many years of experience in (glyco)proteomics and biomarker research, in collaboration with colleagues in the field of glycobiology and glyco-immunology, GlyCoCan will develop new methods, and use current state of the art methods, to investigate the role of glycosylation in many different aspects of CRC. <br><br>The GlyCoCan multidisciplinary network will principally be a training programme with a substantial industrial focus on technology transfer and teaching of internationally adopted biopharma regulations (GMP, ISO9001, ICH guidelines). The underlying specific research objectives will be addressed within individual ESR projects, giving rise to a generation of ESRs whose main focus is investigating and tackling the challenges of the role of glycosylation within CRC and other diseases. The network will address the currently unmet need for glycosylation researchers with an inter-disciplinary perspective to fully exploit the immense potential of the young scientific field of glyco-oncology and to set them on a path to successful and productive careers in academic and industrial collaborations.",titleHr:"Glikozilacija kod raka debelog crijeva",descriptionHr:"Rak debelog crijeva (CRC) predstavlja značajan globalni zdravstveni problem s oko 1,4 milijuna slučajeva u 2012. godini i godišnjom smrtnošću od približno 700.000. Rano otkrivanje ključno je jer je liječenje najučinkovitije u ranim fazama, gdje bi populacijski programi probira mogli značajno smanjiti učestalost i smrtnost. Trenutne metode probira su invazivne ili im nedostaje osjetljivost i specifičnost. Štoviše, molekularni mehanizmi koji dovode do stvaranja različitih antigena predloženih kao biomarkeri CRC-a i potencijalne terapijske mete slabo su shvaćeni, osobito u pogledu molekula na bazi ugljikohidrata, poput glikana. Unaprjeđenje razumijevanja odnosa struktura-funkcija glikozilacije kod CRC-a moglo bi dovesti do otkrića poboljšanih dijagnostičkih i prognostičkih biomarkera te otvoriti put za nove terapijske mete. <br><br>Oslanjajući se na uspostavljenu mrežu analitičara s dugogodišnjim iskustvom u (gliko)proteomici i istraživanju biomarkera, u suradnji s kolegama iz područja glikobiologije i gliko-imunologije, GlyCoCan će razviti nove metode i koristiti najmodernije postojeće metode kako bi istražio ulogu glikozilacije u različitim aspektima CRC-a. <br><br>Multidisciplinarna mreža GlyCoCan bit će prvenstveno program obuke sa značajnim industrijskim fokusom na prijenos tehnologije i podučavanje međunarodno prihvaćenih biopharma regulativa (GMP, ISO9001, ICH smjernice). Temeljni specifični istraživački ciljevi bit će obrađeni unutar pojedinačnih ESR projekata, dajući novu generaciju ESR-ova čiji je glavni fokus istraživanje i suočavanje s izazovima uloge glikozilacije u CRC-u i drugim bolestima. Mreža će odgovoriti na trenutno nezadovoljenu potrebu za istraživačima glikozilacije s interdisciplinarnom perspektivom kako bi se u potpunosti iskoristio ogroman potencijal mladog znanstvenog područja gliko-onkologije i usmjerilo ih prema uspješnim i produktivnim karijerama u akademskoj i industrijskoj suradnji.",startDate:"01/09/2015",projectDuration:"48",pdf:"2-5.pdf",projectId:"676421",callForProposals:"H2020-MSCA-ITN-2015",coordinator:"ACADEMISCH ZIEKENHUIS LEIDEN",projectParticipants:17,projectWebsite:"https://glycocan.eu/",projectValue:"3,297,697.30€",genosContribution:"371,641.50€"}]},{group:"ESIF",program:"ESIF",href:"esif",projects:[{short:"LIMS",titleEn:"Implementation of Laboratory Information Management System",descriptionEn:"To address identified shortcomings and improve business process management, Genos d.o.o. plans to acquire an ERP system that will cover the following nine business processes: procurement, sales, BI reporting, project management, asset management, human resources, warehouse management, risk management and planning, and logistics.<br><br>Laboratory operations will be enhanced by introducing a Laboratory Information Management System (LIMS). LIMS is an IT solution that enables centralized laboratory management. For Genos, this means a central data repository with automated data storage, processing, and integration. Beyond storage, managing this data is of utmost importance. Data related to cohorts, patients, batches, and samples; processes, experiments, measurements, methods, instruments, analysts, and analytics must be integrated, indexed, searchable, appropriately displayed, and available for data mining, editing, and deletion.<br><br>The system should be modern, with a flexible user interface, compatible with all modern platforms (Windows, Mac, Android), highly configurable by the end user, and must allow data entry, search, editing, and deletion. It should also have integrated suitable viewers for all data types. The interface should be extendable via Python scripts.<br><br>This project will introduce two information systems that will support all business processes within the company, both of which are available on the market.",titleHr:"Implementacija sustava za upravljanje laboratorijskim informacijama",descriptionHr:"Kako bi se riješili identificirani nedostaci i poboljšalo upravljanje poslovnim procesima, Genos d.o.o. planira nabaviti ERP sustav koji će obuhvatiti sljedećih devet poslovnih procesa: nabavu, prodaju, BI izvještavanje, upravljanje projektima, upravljanje imovinom, ljudske resurse, upravljanje skladištem, upravljanje rizicima i planiranjem te logistiku.<br><br>Rad laboratorija unaprijedit će se uvođenjem sustava za upravljanje laboratorijskim informacijama (LIMS). LIMS je IT rješenje koje omogućuje centralizirano upravljanje laboratorijem. Za Genos to znači središnje skladište podataka s automatiziranim pohranjivanjem, obradom i integracijom podataka. Osim pohrane, upravljanje tim podacima je od iznimne važnosti. Podaci vezani uz kohorte, pacijente, serije i uzorke; procese, eksperimente, mjerenja, metode, instrumente, analitičare i analize moraju biti integrirani, indeksirani, pretraživi, prikazani na odgovarajući način i dostupni za rudarenje podataka, uređivanje i brisanje.<br><br>Sustav treba biti moderan, s fleksibilnim korisničkim sučeljem, kompatibilan sa svim suvremenim platformama (Windows, Mac, Android), visoko konfigurabilan od strane krajnjeg korisnika, te mora omogućiti unos, pretraživanje, uređivanje i brisanje podataka. Također treba imati integrirane prikazivače prikladne za sve vrste podataka. Sučelje treba biti proširivo putem Python skripti.<br><br>Ovim projektom uvest će se dva informacijska sustava koja će podržavati sve poslovne procese unutar tvrtke, a oba su dostupna na tržištu.",startDate:"01/09/2019",projectDuration:"19",pdf:"3-1.pdf",projectId:"KK.03.2.1.19.0146",contactPerson:"glauc@genos.hr",projectValue:"1,207,731.25 HRK",euCoFinancingAmount:"628,020.25 HRK"},{short:"NovaGenGliko",titleEn:"Increasing the Development of New Products and Services Arising from Research and Development Activities",descriptionEn:"Through the New Generation of High-Throughput GlycoServices (NovaGenGliko) project, GENOS will expand the range of its services, which is crucial for further development and market expansion. The ability to quickly adapt to client requirements, a broad spectrum of automated high-throughput analyses supported by new analytical methods, and the capability to analyze various biological samples will collectively contribute to market growth. Most importantly, this will enable GENOS to maintain a high market share.<br><br>High-throughput services will contribute to the optimization of glycoanalysis and significantly reduce the cost of individual analyses.<br><br>In addition to new technological services, the project brings a significant expansion of GENOS's production capacities, which will support the development of the next generation of drugs and biomarkers. At the same time, it will open the doors for the advancement of personalized analysis concepts.",titleHr:"Povećanje razvoja novih proizvoda i usluga proizašlih iz aktivnosti istraživanja i razvoja",descriptionHr:"Kroz projekt Nova generacija visokoprotočnih GlikoServisa (NovaGenGliko), GENOS će proširiti spektar svojih usluga, što je ključno za daljnji razvoj i širenje na tržištu. Sposobnost brze prilagodbe zahtjevima klijenata, širok raspon automatiziranih visokoprotočnih analiza potpomognutih novim analitičkim metodama te mogućnost analize različitih bioloških uzoraka zajednički će pridonijeti rastu tržišta. Najvažnije je da će to omogućiti GENOS-u da zadrži visoki tržišni udio.<br><br>Visokoprotočne usluge doprinijet će optimizaciji glikoanalize i značajno smanjiti trošak pojedinačnih analiza.<br><br>Uz nove tehnološke usluge, projekt donosi i značajno proširenje proizvodnih kapaciteta GENOS-a, što će podržati razvoj sljedeće generacije lijekova i biomarkera. Istodobno, otvorit će se vrata za napredak koncepata personalizirane analize.",startDate:"03/10/2016",projectDuration:"53",pdf:"3-2.pdf",projectId:"KK.01.2.1.01.0003",contactPerson:"glauc@genos.hr",projectValue:"24,022,928.63 HRK",euCoFinancingAmount:"17,927,218.21 HRK"},{short:"CardioMetabolic",titleEn:"Increasing the Development of New Products and Services Arising from Research and Development Activities - Phase II",descriptionEn:"The Development of a Personalized Diagnostic Tool for the Prevention and Treatment of Cardiometabolic Diseases (CardioMetabolic) project is being implemented by Genos in collaboration with partners, including three businesses and three research and knowledge dissemination organizations, with the support of EU and Croatian government grants.<br><br>The project aims to develop a set of innovative products that will contribute to reducing the incidence of diabetes and cardiovascular diseases in the global population. This will be achieved through tools for:<ul><li>Timely risk prediction of disease development</li><li>Enhancing therapy effectiveness for individuals already diagnosed with one or more cardiometabolic diseases</li><li>Developing mechanisms for predicting complications in patients with diagnosed cardiometabolic diseases</li></ul>",titleHr:"Povećanje razvoja novih proizvoda i usluga proizašlih iz aktivnosti istraživanja i razvoja – Faza II",descriptionHr:"Projekt Razvoj personaliziranog dijagnostičkog alata za prevenciju i liječenje kardiometaboličkih bolesti (CardioMetabolic) provodi Genos u suradnji s partnerima, uključujući tri poduzeća i tri organizacije za istraživanje i prijenos znanja, uz potporu sredstava EU-a i hrvatske vlade.<br><br>Cilj projekta je razviti skup inovativnih proizvoda koji će pridonijeti smanjenju učestalosti dijabetesa i kardiovaskularnih bolesti u globalnoj populaciji. To će se postići alatima za:<ul><li>Pravovremeno predviđanje rizika od razvoja bolesti</li><li>Povećanje učinkovitosti terapije za osobe koje su već dijagnosticirane s jednom ili više kardiometaboličkih bolesti</li><li>Razvoj mehanizama za predviđanje komplikacija kod pacijenata s dijagnosticiranim kardiometaboličkim bolestima</li></ul>",startDate:"01/08/2020",projectDuration:"40",pdf:"3-3.pdf",projectId:"KK.01.2.1.02.0321",contactPerson:"glauc@genos.hr",projectValue:"38,208,971.04 HRK",euCoFinancingAmount:"26,537,841.28 HRK"},{short:"Clinical and Molecular Phenotyping of Osteoarthritis",titleEn:"Increasing the Development of New Products and Services Arising from Research and Development Activities - Phase II",descriptionEn:"Osteoarthritis is a complex and heterogeneous disease that affects millions of people worldwide, yet current diagnostic and treatment approaches remain limited. This project aims to revolutionize the way osteoarthritis is diagnosed and treated by integrating clinical and molecular phenotyping into a personalized healthcare approach.<br><br>Through advanced molecular analysis, the project seeks to identify specific biomarkers that can provide deeper insights into disease progression and patient response to treatment. By leveraging state-of-the-art technologies and data-driven methodologies, this research will pave the way for targeted therapies, improved early detection, and more effective disease management strategies.<br><br>The project is conducted in collaboration with leading research institutions and industry partners, ensuring a multidisciplinary approach that combines scientific innovation with real-world clinical applications. The ultimate goal is to enhance patient outcomes by enabling personalized treatment plans tailored to individual disease profiles.",titleHr:"Povećanje razvoja novih proizvoda i usluga proizašlih iz aktivnosti istraživanja i razvoja – Faza II",descriptionHr:"Osteoartritis je složena i heterogena bolest koja pogađa milijune ljudi diljem svijeta, no trenutačne dijagnostičke i terapijske metode ostaju ograničene. Ovaj projekt ima za cilj revolucionirati način dijagnosticiranja i liječenja osteoartritisa integracijom kliničkog i molekularnog fenotipiziranja u personalizirani pristup zdravstvenoj skrbi.<br><br>Putem napredne molekularne analize, projekt nastoji identificirati specifične biomarkere koji mogu pružiti dublji uvid u napredovanje bolesti i odgovor pacijenata na terapiju. Korištenjem najnaprednijih tehnologija i metoda temeljenih na podacima, ovo istraživanje otvorit će put ciljanim terapijama, poboljšanom ranom otkrivanju bolesti i učinkovitijim strategijama upravljanja bolešću.<br><br>Projekt se provodi u suradnji s vodećim istraživačkim institucijama i industrijskim partnerima, osiguravajući multidisciplinarni pristup koji kombinira znanstvene inovacije s kliničkom primjenom u stvarnom svijetu. Krajnji cilj je poboljšati ishode za pacijente omogućavanjem personaliziranih terapijskih planova prilagođenih individualnim profilima bolesti.",startDate:"17/02/2020",projectDuration:"46",pdf:"3-4.pdf",projectId:"KK.01.2.1.02.0173",contactPerson:"glauc@genos.hr",projectValue:"41,486,649.38 HRK"},{short:"ZCI",titleEn:"Cutting-edge research in centers of excellence",descriptionEn:'The Center of Excellence for Personalized Health Care is an interdisciplinary hub advancing biotechnological and biomedical sciences. The Center aims to transfer knowledge from biotechnology into fundamental and applied biomedical research, bringing together teams from various institutions to address health challenges through personalized medicine.<br><br>A major focus is the analysis of glycan biomarkers to assess the effects of functional foods on healthy individuals and patients. This innovative approach to health and nutrition aims to impact the global scientific community and improve regional and national economic competitiveness.<br><br>The Center comprises two primary scientific units:<br><br><ol class="ordered-list"><li>Glycoscience Research Unit</li>Led by Prof. Dr. Gordan Lauc, this unit investigates how glycosylation patterns influence inflammatory and autoimmune diseases, diabetes, and neurological conditions. Key research areas include:<ul class="unordered-list"><li>Development of  glycoproteomics technologies</li><li>Statistical and bioinformatic methods for data analysis</li><li>Investigating glycosylation in immunology and plasma proteins</li><li>Exploring glycosylation’s role in diseases and pharmacoglycomics</li></ul><br>The unit participates in large European projects, collaborating with leading international researchers, securing significant funding from the European Commission’s Framework Program for Research and Development.<br><br><li>Functional Food Research Unit</li>Led by Prof. Dr. Ines Drenjančević, this unit focuses on the development, production, and medical testing of functional foods to promote health and prevent disease. The goal is to create personalized, evidence-based food products that aid in disease prevention, particularly for metabolic and cardiovascular health.<br><br>The Center works closely with academic institutions and industry partners to foster collaborations leading to groundbreaking discoveries in personalized healthcare. Through its research and innovation, the Center enhances both scientific knowledge and regional economic and scientific competitiveness globally.<br><br>The Center of Excellence for Personalized Health Care represents a leap forward in personalized medicine, offering new insights into how glycan biomarkers and functional foods can improve human health. It bridges cutting-edge scientific research and practical healthcare solutions.</ol>',titleHr:"Istraživanja na vrhunskoj razini u centrima izvrsnosti",descriptionHr:'Centar izvrsnosti za personaliziranu zdravstvenu skrb predstavlja interdisciplinarno središte za napredak u biotehnološkim i biomedicinskim znanostima. Cilj Centra je prijenos znanja iz biotehnologije u temeljna i primijenjena biomedicinska istraživanja, okupljajući timove iz različitih institucija kako bi se zajednički suočili sa zdravstvenim izazovima putem personalizirane medicine.<br><br>Glavni fokus je analiza glikanskih biomarkera kako bi se procijenio učinak funkcionalne hrane na zdrave osobe i pacijente. Ovaj inovativni pristup zdravlju i prehrani ima za cilj utjecati na globalnu znanstvenu zajednicu i poboljšati regionalnu i nacionalnu gospodarsku konkurentnost.<br><br>Centar se sastoji od dvije osnovne znanstvene jedinice:<br><br><ol class="ordered-list"><li>Jedinica za istraživanje glikoznanosti</li>Na čelu s prof. dr. Gordanom Laucom, ova jedinica istražuje kako obrasci glikozilacije utječu na upalne i autoimune bolesti, dijabetes i neurološka stanja. Ključna istraživačka područja uključuju:<ul class="unordered-list"><li>Razvoj glikoproteomskih tehnologija</li><li>Statističke i bioinformatičke metode za analizu podataka</li><li>Istraživanje glikozilacije u imunologiji i plazmatskim proteinima</li><li>Istraživanje uloge glikozilacije u bolestima i farmakoglikomici</li></ul><br>Jedinica sudjeluje u velikim europskim projektima, surađuje s vodećim međunarodnim istraživačima i osigurava značajna sredstva iz Okvirnog programa Europske komisije za istraživanje i razvoj.<br><br><li>Jedinica za istraživanje funkcionalne hrane</li>Na čelu s prof. dr. Ines Drenjančević, ova jedinica usmjerena je na razvoj, proizvodnju i medicinsko testiranje funkcionalne hrane za promicanje zdravlja i prevenciju bolesti. Cilj je stvoriti personalizirane, na dokazima utemeljene prehrambene proizvode koji pomažu u prevenciji bolesti, posebno onih povezanih s metaboličkim i kardiovaskularnim zdravljem.<br><br>Centar blisko surađuje s akademskim institucijama i industrijskim partnerima kako bi potaknuo suradnje koje vode do revolucionarnih otkrića u području personalizirane zdravstvene skrbi. Kroz svoja istraživanja i inovacije, Centar doprinosi razvoju znanstvenih spoznaja i povećava regionalnu te globalnu gospodarsku i znanstvenu konkurentnost.<br><br>Centar izvrsnosti za personaliziranu zdravstvenu skrb predstavlja značajan iskorak u personaliziranoj medicini, nudeći nova saznanja o tome kako glikanski biomarkeri i funkcionalna hrana mogu poboljšati ljudsko zdravlje. On spaja vrhunska znanstvena istraživanja i praktična rješenja u zdravstvenoj skrbi.</ol>',startDate:"01/06/2017",projectDuration:"79",pdf:"3-5.pdf",projectId:"KK.01.2.1.02.0321",projectValue:"41,486,649.38 HRK",euCoFinancingAmount:"26,537,841.28 HRK",projectWebsite:"zcipersonhealth.unios.hr"},{short:"CEKOM",titleEn:"Support for developing competence centers",descriptionEn:`The Center of Competence in Molecular Diagnostics (CEKOM) project, led by Genos d.o.o., aims to strengthen the synergy between public and private institutions in Croatia, consolidating its position in the global market. Through collaboration with companies such as Biognost, Exaltum Ultra, and Consortium, a comprehensive value chain has been established, covering everything from product development and production to analysis and the application of IT technologies in data analysis and process automation.<br><br>The project also involves multiple prominent academic and research institutions, including:<ul class="unordered-list"><li>Clinic for Infective Diseases Dr. Fran Mihaljević, Zagreb</li><li>Children’s Hospital Srebrnjak, Zagreb</li><li>University of Split, Faculty of Medicine</li><li>University of Zagreb, Faculty of Pharmacy and Biochemistry</li><li>University of Zagreb, Faculty of Science</li><li>University of Zagreb, Kinesiological Faculty</li><li>Institute Ruđer Bošković, Zagreb</li><li>Biognost d.o.o.</li><li>Exaltum Ultra d.o.o.</li><li>Consortium d.o.o.</li></ul><br><b>Project Goals & Results:</b><br><br><ol class="ordered-list"><li>Primary Goals:</li><ul class="unordered-list"><li>Maintain Genos' leadership in high-throughput glycomics on a global scale.</li><li>Achieve a leading position in the global market for molecular diagnostics.</li></ul><br><li>Project Results:</li><ul class="unordered-list"><li>Development of 9 products ready for global market launch (TRL 8 and CE mark).</li><li>Introduction of 2 new services and improvement of one existing service.</li><li>Development of 3 biomarkers and 1 genomic panel.</li><li>Filing of 9 stamps and 2 patent applications.</li><li>Creation of 31 new job positions.</li></ul></ol><br>This project will significantly enhance Croatia’s position in molecular diagnostics and biotechnology, leading to international recognition and increased competitiveness in the healthcare sector.`,titleHr:"Podrška razvoju centara kompetencija",descriptionHr:'Projekt Centar kompetencija za molekularnu dijagnostiku (CEKOM), kojim upravlja Genos d.o.o., ima za cilj jačanje sinergije između javnih i privatnih institucija u Hrvatskoj, učvršćujući njezinu poziciju na globalnom tržištu. Kroz suradnju s tvrtkama poput Biognost, Exaltum Ultra i Consortium, uspostavljen je sveobuhvatan lanac vrijednosti koji obuhvaća sve od razvoja i proizvodnje proizvoda do analize i primjene IT tehnologija u analizi podataka i automatizaciji procesa.<br><br>Projekt uključuje i niz istaknutih akademskih i istraživačkih institucija, uključujući:<ul class="unordered-list"><li>Klinika za infektivne bolesti Dr. Fran Mihaljević, Zagreb</li><li>Dječja bolnica Srebrnjak, Zagreb</li><li>Medicinski fakultet Sveučilišta u Splitu</li><li>Farmaceutsko-biokemijski fakultet Sveučilišta u Zagrebu</li><li>Prirodoslovno-matematički fakultet Sveučilišta u Zagrebu</li><li>Kineziološki fakultet Sveučilišta u Zagrebu</li><li>Institut Ruđer Bošković, Zagreb</li><li>Biognost d.o.o.</li><li>Exaltum Ultra d.o.o.</li><li>Consortium d.o.o.</li></ul><br><b>Ciljevi i rezultati projekta:</b><br><br><ol class="ordered-list"><li>Primarni ciljevi:</li><ul class="unordered-list"><li>Očuvanje liderske pozicije Genosa u visokoprotočnoj glikomici na globalnoj razini.</li><li>Postizanje vodeće pozicije na globalnom tržištu molekularne dijagnostike.</li></ul><br><li>Rezultati projekta:</li><ul class="unordered-list"><li>Razvoj 9 proizvoda spremnih za plasman na globalno tržište (TRL 8 i CE oznaka).</li><li>Uvođenje 2 nove usluge i unapređenje jedne postojeće usluge.</li><li>Razvoj 3 biomarkera i jednog genomski panela.</li><li>Prijava 9 žigova i 2 patentne prijave.</li><li>Otvaranje 31 novog radnog mjesta.</li></ul></ol><br>Ovaj projekt će značajno unaprijediti poziciju Hrvatske u području molekularne dijagnostike i biotehnologije, dovesti do međunarodnog priznanja i povećati konkurentnost u zdravstvenom sektoru.',startDate:"01/04/2018",projectDuration:"69",pdf:"3-6.pdf",projectId:"KK.01.2.2.03.0006",projectValue:"9,370,377.00€",projectWebsite:"cekom.hr"}]},{group:"NPOO",program:"NPOO",href:"npoo",projects:[{shortEn:"Development of Personalized Tests for Determining Biological Age of the Brain and Early Detection of Dementia",shortHr:"Razvoj personaliziranih testova za određivanje biološke dobi mozga i rano otkrivanje demencije",titleEn:"Targeted Scientific Research",descriptionEn:"This project focuses on developing personalized tests to assess the biological age of the brain and enable early detection of dementia. It aims to create innovative diagnostic tools that can help identify early biomarkers of dementia, improving patient outcomes through early intervention. The project involves a partnership between various institutions, with Genos as one of the key project partners, contributing to the research and development of personalized health solutions.",titleHr:"Ciljana znanstvena istraživanja",descriptionHr:"Ovaj projekt usmjeren je na razvoj personaliziranih testova za procjenu biološke starosti mozga i omogućavanje ranog otkrivanja demencije. Cilj je stvoriti inovativne dijagnostičke alate koji mogu pomoći u identifikaciji ranih biomarkera demencije, čime se poboljšavaju ishodi za pacijente kroz ranu intervenciju. Projekt uključuje partnerstvo između različitih institucija, a Genos je jedan od ključnih projektnih partnera koji doprinosi istraživanju i razvoju personaliziranih zdravstvenih rješenja.",startDate:"01/01/2024",projectDuration:"30",pdf:"5-1.pdf",projectId:"NPOO.C3.2.R3-I1.04.0089",projectValue:"1,591,504.70€"},{shortEn:"Biochemical and Genetic Mechanisms in the Development of Anterior Cruciate Ligament Injuries: A New Concept for Injury Prevention",shortHr:"Biokemijski i genetski mehanizmi u razvoju ozljeda prednjeg križnog ligamenta: novi koncept prevencije ozljeda",titleEn:"Targeted Scientific Research",descriptionEn:'This project focuses on investigating the biochemical and genetic mechanisms underlying anterior cruciate ligament (ACL) injuries, aiming to develop new methods for their prevention. ACL injuries are a significant concern in both sports and general health, often leading to long-term complications such as joint instability and increased risk of osteoarthritis. By examining the genetic and biochemical factors that contribute to ACL injuries, this research seeks to identify high-risk individuals and develop personalized approaches for injury prevention.<br><br>Through an interdisciplinary approach, the project will explore the molecular and genetic profiles of individuals susceptible to ACL injuries. By understanding these factors, the project aims to establish a preventive framework that can guide interventions in individuals at higher risk, ultimately reducing the incidence of ACL injuries.<br><br>Objectives:<ol class="ordered-list"><li>To identify biochemical markers associated with ACL injury susceptibility.</li><li>To investigate the genetic predisposition to ACL injuries.</li><li>To develop a novel prevention strategy based on genetic and biochemical insights.</li></ol><br>Expected Outcomes:<ul class="unordered-list"><li>Identification of key genetic and biochemical markers linked to ACL injuries.</li><li>Development of innovative strategies and interventions for preventing ACL injuries, particularly for individuals with a genetic predisposition.</li><li>Contribution to improved rehabilitation methods for individuals recovering from ACL injuries.</li></ul><br>The research will contribute to a deeper understanding of ACL injuries and has the potential to revolutionize preventive care in sports medicine and orthopedics.',titleHr:"Ciljana znanstvena istraživanja",descriptionHr:'Ovaj projekt fokusiran je na istraživanje biokemijskih i genetskih mehanizama koji stoje u pozadini ozljeda prednjeg križnog ligamenta (ACL), s ciljem razvoja novih metoda njihove prevencije. ACL ozljede predstavljaju značajan problem u sportu i općem zdravlju, često dovodeći do dugoročnih komplikacija poput nestabilnosti zgloba i povećanog rizika od osteoartritisa. Istraživanjem genetskih i biokemijskih čimbenika koji doprinose ozljedama ACL-a, projekt nastoji identificirati osobe s visokim rizikom i razviti personalizirane pristupe za prevenciju ozljeda.<br><br>Kroz interdisciplinarni pristup, projekt će istražiti molekularne i genetske profile osoba sklonih ozljedama ACL-a. Razumijevanjem tih čimbenika, cilj je uspostaviti preventivni okvir koji će usmjeravati intervencije kod osoba s većim rizikom, čime bi se u konačnici smanjila učestalost ACL ozljeda.<br><br>Ciljevi:<ol class="ordered-list"><li>Identificirati biokemijske markere povezane s osjetljivošću na ozljede ACL-a.</li><li>Istražiti genetsku predispoziciju za ACL ozljede.</li><li>Razviti novu strategiju prevencije temeljenu na genetskim i biokemijskim uvidima.</li></ol><br>Očekivani rezultati:<ul class="unordered-list"><li>Identifikacija ključnih genetskih i biokemijskih markera povezanih s ACL ozljedama.</li><li>Razvoj inovativnih strategija i intervencija za prevenciju ACL ozljeda, osobito kod osoba s genetskom predispozicijom.</li><li>Doprinos poboljšanju metoda rehabilitacije za osobe koje se oporavljaju od ACL ozljeda.</li></ul><br>Istraživanje će doprinijeti dubljem razumijevanju ACL ozljeda i ima potencijal revolucionirati preventivnu skrb u sportskoj medicini i ortopediji.',startDate:"17/12/2023",projectDuration:"30",pdf:"5-2.pdf",projectId:"NPOO.C3.2.R3-I1.04.0284",projectValue:"847,918.79€"},{short:"MetaAge",titleEn:"Commercialization of the Biological Test for Metabolic Age",descriptionEn:'The MetaAge project focuses on the commercialization of a biological test designed to assess metabolic age. This innovative test is based on analyzing specific biomarkers to determine how the body’s metabolism has aged compared to its chronological age. The project aims to bring this test to market, enabling individuals to gain valuable insights into their metabolic health and to take action in improving their overall well-being. By applying cutting-edge technologies in biological testing, the MetaAge test will provide an essential tool for preventive healthcare and personalized wellness. This initiative is supported by the "Commercialization of Innovations" call, aiming to foster the transfer of research innovations to real-world applications.',titleHr:"Komercijalizacija biološkog testa za metaboličku dob",descriptionHr:'Projekt MetaAge usmjeren je na komercijalizaciju biološkog testa osmišljenog za procjenu metaboličke dobi. Ovaj inovativni test temelji se na analizi specifičnih biomarkera kako bi se utvrdilo koliko je metabolizam tijela ostario u odnosu na kronološku dob. Cilj projekta je plasirati test na tržište, omogućujući pojedincima da dobiju vrijedne uvide u svoje metaboličko zdravlje i poduzmu korake za poboljšanje općeg blagostanja. Primjenom najsuvremenijih tehnologija u biološkom testiranju, test MetaAge postat će ključni alat za preventivnu zdravstvenu skrb i personalizirano zdravlje. Ova inicijativa podržana je kroz poziv "Komercijalizacija inovacija", s ciljem poticanja prijenosa istraživačkih inovacija u stvarnu primjenu.',startDate:"01/01/2023",projectDuration:"24",pdf:"5-3.pdf",projectId:"NPOO.C1.1.2.R2-I5.01.0170",projectValue:"849,835.00€"}]},{group:"FP7",program:"FP7",href:"fp7",projects:[{short:"HTPGlycomet",titleEn:"High-Throughput Glycoprotein Analysis Methods",descriptionEn:"The main aim of the HTP-GlycoMet proposal is to develop technologies, which will enable high-throughput analysis of glycosylation of individual proteins from body fluids and cell membranes and apply them to understand some key processes in immunity and infections. Glycan analysis is extremely demanding from both technological and conceptual aspect and (beside one study performed by partners in this proposal) large-scale studies of glycosylation of individual proteins were not attempted previously. However, we are confident that by successfully combining complementary expertise in the (i) production of specialised monolithic chromatographic tools for high-throughput fractionation of complex biological fluids (BIA-SEP), (ii) purification of proteins from body fluids and membrane proteins (UNI-RI), (iii) high-throughput glycomic analysis by use of chromatography (Genos) and multiplexed capillary gel electrophoresis (MPI) and (iv) expertise in the field of viral immunology (MEDRI) we can achieve significant progress in this direction. All our partners are recognized leaders who already made significant progress beyond the state of the art in their respective fields. Through HTP-GlycoMet project we will organise secondments on all levels (MER, ER, ESR) to capitalize on synergistic effects of this interdisciplinary and transnational collaboration. In addition to the generation of new knowledge and the development of new innovative technologies, we will also achieve significant transfer of knowhow between academic and industrial partners. Our SME partners also expect to develop new lines of products and services through the HTP-GlycoMet programme, but also through future collaboration with HTP-GlycoMet partners beyond the lifetime of this project.",titleHr:"Metode za visokoprotočnu analizu glikoproteina",descriptionHr:"Glavni cilj prijedloga HTP-GlycoMet je razviti tehnologije koje će omogućiti visokoprotočnu analizu glikozilacije pojedinačnih proteina iz tjelesnih tekućina i staničnih membrana te ih primijeniti za razumijevanje ključnih procesa u imunitetu i infekcijama. Analiza glikana iznimno je zahtjevna i s tehnološkog i konceptualnog aspekta i (osim jedne studije provedene od strane partnera u ovom prijedlogu) dosad nisu pokušavane velike studije glikozilacije pojedinačnih proteina. Međutim, uvjereni smo da uspješnim kombiniranjem komplementarne ekspertize u (i) proizvodnji specijaliziranih monolitnih kromatografskih alata za visokoprotočnu frakcionaciju složenih bioloških tekućina (BIA-SEP), (ii) pročišćavanju proteina iz tjelesnih tekućina i membranskih proteina (UNI-RI), (iii) visokoprotočnoj glikomičkoj analizi korištenjem kromatografije (Genos) i multipleksne kapilarne gel elektroforeze (MPI) te (iv) stručnosti u području virusne imunologije (MEDRI) možemo postići značajan napredak u ovom smjeru. Svi naši partneri priznati su lideri koji su već postigli značajan napredak iznad trenutno dostupnih rješenja u svojim područjima. Kroz projekt HTP-GlycoMet organizirat ćemo razmjene na svim razinama (MER, ER, ESR) kako bismo iskoristili sinergijske učinke ove interdisciplinarne i transnacionalne suradnje. Osim stvaranja novog znanja i razvoja novih inovativnih tehnologija, postići ćemo i značajan prijenos znanja između akademskih i industrijskih partnera. Naši MSP partneri također očekuju razvoj novih linija proizvoda i usluga kroz HTP-GlycoMet program, kao i kroz buduću suradnju s partnerima HTP-GlycoMet-a nakon završetka ovog projekta.",startDate:"01/10/2012",projectDuration:"48",pdf:"6-1.pdf",projectId:"324400",coordinator:"SVEUČILISTE U RIJECI",projectValue:"1,900,000.00€",projectWebsite:"cordis.europa.eu/project/id/324400"},{short:"Pain-omics",titleEn:"Multidimensional Omics Approach to Stratification of Patients with Lower Back Pain",descriptionEn:"The PAIN-OMICS project is a large collaborative research program funded by the European Union under the FP7-HEALTH-2012 initiative. The primary objective of the project is to improve the stratification of patients with lower back pain (LBP) using a multidimensional omics approach. This innovative project combines a variety of omics technologies, such as genomics, proteomics, metabolomics, and transcriptomics, to identify novel biomarkers and mechanisms associated with the condition.<br><br>The project aims to improve the understanding of the molecular and cellular pathways that contribute to LBP, which is a major health concern globally. By identifying distinct patient subgroups based on their molecular profiles, the project seeks to enable more personalized treatment strategies and better management of LBP. The research is expected to provide valuable insights into the development of targeted therapies for LBP, leading to improved outcomes for patients suffering from this widespread condition.<br><br>PAIN-OMICS is designed to integrate cutting-edge scientific research with clinical practice, offering the potential to revolutionize the way lower back pain is diagnosed and treated, ultimately improving quality of life for patients.",titleHr:"Višedimenzionalni omics pristup stratifikaciji pacijenata s bolovima u donjem dijelu leđa",descriptionHr:"Projekt PAIN-OMICS veliki je suradnički istraživački program financiran od strane Europske unije u okviru inicijative FP7-HEALTH-2012. Primarni cilj projekta je unaprijediti stratifikaciju pacijenata s bolovima u donjem dijelu leđa (LBP) korištenjem višedimenzionalnog omics pristupa. Ovaj inovativni projekt kombinira različite omics tehnologije poput genomike, proteomike, metabolomike i transkriptomike kako bi identificirao nove biomarkere i mehanizme povezane s tim stanjem.<br><br>Cilj projekta je poboljšati razumijevanje molekularnih i staničnih puteva koji doprinose LBP-u, što predstavlja značajan globalni zdravstveni problem. Identificiranjem različitih podskupina pacijenata temeljenih na njihovim molekularnim profilima, projekt nastoji omogućiti personaliziranije strategije liječenja i bolji način upravljanja LBP-om. Očekuje se da će istraživanje pružiti vrijedne uvide u razvoj ciljanih terapija za LBP, što će dovesti do boljih rezultata za pacijente koji pate od ovog raširenog stanja.<br><br>PAIN-OMICS je osmišljen kako bi integrirao vrhunska znanstvena istraživanja s kliničkom praksom, nudeći potencijal za revoluciju u načinu dijagnosticiranja i liječenja bolova u donjem dijelu leđa te u konačnici poboljšanje kvalitete života pacijenata.",startDate:"02/09/2013",projectDuration:"60",pdf:"6-2.pdf",projectId:"602736",projectValue:"7,800,000.00€",additionalInformation:["svkatarina.hr/istrazivanje-razvoj/pain-omics","cordis.europa.eu/project/id/602736"]},{short:"IBD-BIOM",titleEn:"IBD-BIOM (Diagnostic and prognostic biomarkers for inflammatory bowel disease)",descriptionEn:"Inflammatory bowel diseases affect 0.8% of the Europeans, and are associated with high morbidity, definite mortality and an increasing economic burden.<br><br>IBD-BIOM is a European FP7 collaborative scientific research programme for the discovery of diagnostic and prognostic biomarkers for inflammatory bowel disease (IBD). The IBD-BIOM consortium partners are a multidisciplinary team of leading academic and industrial researchers in IBD, genomics, glycomics, activomics, bioanalytical services and diagnostic kits.<br><br>Current diagnostic tools and therapeutics for IBD are unsatisfactory. Development of biomarkers allowing insights into pathogenesis, prognosis and targeted therapy is a major unmet need. This programme addresses that need. IBD-BIOM is a multidisciplinary consortium of leading academic and industrial SME researchers in inflammatory bowel disease, genomics, glycomics, glycoproteomics and activomics.<br><br>Recent genome-wide association studies performed by IBD-BIOM partners have identified nearly 100 genes associated with IBD, but clinical application of these is so far limited. IBD-BIOM will capitalise on its existing high quality clinical, genetic, biochemical and immunological data and biological samples on over 6000 very well characterised IBD patients and controls by exploiting novel technological approaches made available through the expertise and global leading position of IBD-BIOM partners. These comprise cutting edge epigenetic, glycomic, glycoproteomic and activomic approaches which were all previously reported to be associated with inflammation and disturbances to the immune system.<br><br>The inclusion of these complementary analyses in the diagnostics of IBD should also facilitate elucidation of pathways through which environmental exposures influence IBD risk and progression. A complex systems biology approach will be used to integrate, interrogate and understand this multidimensional dataset to identify novel early diagnostic and prognostic biomarkers and new targets for therapeutic intervention. The track record of achievement of IBD-BIOM partners coupled to the central and leading positions of the research-intensive SME partners in IBD-BIOM is a strong indication that the ambitions work programme will be achieved and a framework to facilitate swift conversion of research discoveries into commercial products.",titleHr:"IBD-BIOM (Dijagnostički i prognostički biomarkeri za upalne bolesti crijeva)",descriptionHr:"Upalne bolesti crijeva pogađaju 0,8% Europljana i povezane su s visokom razinom morbiditeta, značajnom smrtnošću i rastućim ekonomskim opterećenjem.<br><br>IBD-BIOM je europski znanstvenoistraživački program suradnje u okviru FP7 za otkrivanje dijagnostičkih i prognostičkih biomarkera za upalne bolesti crijeva (IBD). Partneri konzorcija IBD-BIOM čine multidisciplinarni tim vodećih akademskih i industrijskih istraživača u području IBD-a, genomike, glikomike, aktivomike, bioanalitičkih usluga i dijagnostičkih setova.<br><br>Trenutni dijagnostički alati i terapije za IBD nisu zadovoljavajući. Razvoj biomarkera koji omogućuju uvid u patogenezu, prognozu i ciljanu terapiju predstavlja veliku neispunjenu potrebu. Ovaj program adresira tu potrebu. IBD-BIOM je multidisciplinarni konzorcij vodećih akademskih i industrijskih MSP istraživača u području upalnih bolesti crijeva, genomike, glikomike, glikoproteomike i aktivomike.<br><br>Nedavne studije asocijacija cijelog genoma provedene od strane partnera IBD-BIOM identificirale su gotovo 100 gena povezanih s IBD-om, ali njihova klinička primjena za sada je ograničena. IBD-BIOM će iskoristiti postojeće visokokvalitetne kliničke, genetske, biokemijske i imunološke podatke te biološke uzorke više od 6000 vrlo dobro okarakteriziranih pacijenata s IBD-om i kontrola, koristeći pritom nove tehnološke pristupe dostupne zahvaljujući stručnosti i globalnom vodećem položaju partnera IBD-BIOM-a. To uključuje vrhunske epigenetske, glikomičke, glikoproteomičke i aktivomičke metode koje su prethodno povezane s upalom i poremećajima imunološkog sustava.<br><br>Uključivanje ovih komplementarnih analiza u dijagnostiku IBD-a također bi trebalo olakšati razjašnjavanje puteva putem kojih okolišni čimbenici utječu na rizik i progresiju bolesti. Koristit će se složen pristup sustavske biologije za integraciju, analizu i razumijevanje ovog višedimenzionalnog skupa podataka s ciljem identifikacije novih ranih dijagnostičkih i prognostičkih biomarkera te novih ciljeva za terapijske intervencije. Dosadašnja postignuća partnera IBD-BIOM-a, uz njihovu središnju i vodeću poziciju među istraživački orijentiranim MSP-ovima, snažno ukazuju na uspješnu realizaciju ambicioznog radnog programa te uspostavu okvira za brzu komercijalizaciju istraživačkih otkrića.",startDate:"01/10/2012",projectDuration:"48",pdf:"6-3.pdf",projectId:"305479",projectValue:"8,550,991.99€",additionalInformation:"cordis.europa.eu/project/id/305479",coordinator:"THE UNIVERSITY OF EDINBURGH"},{short:"MIMOmics",titleEn:"Methods for Integrated Analysis of Multi-Omics Data Sets",descriptionEn:"MIMOmics is based on our involvement in studies participating in EU funded projects, i.e. GEHA, IDEAL, Mark-Age, ENGAGE and EuroSpan. In these consortia the primary goal is to identify molecular profiles that monitor and explain complex traits with novel findings so far. Support for methodological development is missing. The state-of-the-art methodology does not match by far the complexity of the biological problem. Complex data are being analysed in a rather simple way which misses the opportunity to uncover combinations of predictive profiles among the omics data.<br><br>The objectives of MIMOmics are: to develop a statistical framework of methods for all analysis steps needed for identifying and interpreting omics-based biomarkers; and to integrate data derived from multiple omics platforms across several study designs and populations. Specific steps include: experimental design; pipelines for data gathering; cleaning of noisy spectra; predictive modeling of biomarkers; meta analysis; and causality assessment. To enhance our understanding, systems approaches will be considered for pathways and structural modelling of biological networks. The major challenge in the joint analysis of omics datasets will be to develop methods that deal with the high dimensionality, noisy spectral data, heterogeneity, and structure of these datasets.<br><br>To perform these tasks successfully we bring together established EU academic and industrial researchers in metabolomics, glycomics, biostatistics, bioinformatics, scientific computing and epidemiology, with complementary expertise. A key feature of our project is the validation of novel methodology by performing a proof of principle (Metabolic Health) . Special effort will be made for rapid uptake of methods by communication with associated consortia and development of user-friendly software.",titleHr:"Metode za integriranu analizu višestrukih omics skupova podataka",descriptionHr:"Projekt MIMOmics temelji se na našem sudjelovanju u studijama unutar EU projekata kao što su GEHA, IDEAL, Mark-Age, ENGAGE i EuroSpan. Primarni cilj u tim konzorcijima je identificirati molekularne profile koji prate i objašnjavaju složene osobine, s dosadašnjim značajnim otkrićima. Međutim, nedostaje podrška za razvoj metodologije. Trenutna metodologija ni približno ne odgovara složenosti biološkog problema. Složeni podaci analiziraju se prilično jednostavno, čime se propušta prilika za otkrivanje kombinacija prediktivnih profila među omics podacima.<br><br>Ciljevi projekta MIMOmics su: razviti statistički okvir metoda za sve korake analize potrebne za identifikaciju i tumačenje biomarkera temeljenih na omics podacima; te integrirati podatke dobivene s više omics platformi u različitim dizajnima studija i populacijama. Specifični koraci uključuju: eksperimentalni dizajn; sustave za prikupljanje podataka; čišćenje šumovitih spektara; prediktivno modeliranje biomarkera; metaanalizu; i procjenu uzročnosti. Kako bi se produbilo razumijevanje, razmatrat će se sustavni pristupi za putove i strukturno modeliranje bioloških mreža. Glavni izazov u zajedničkoj analizi omics skupova podataka bit će razvoj metoda koje se nose s visokom dimenzionalnošću, šumovitim spektralnim podacima, heterogenošću i strukturom tih skupova podataka.<br><br>Za uspješnu provedbu ovih zadataka okupljamo priznate akademske i industrijske EU istraživače u području metabolomike, glikomike, biostatistike, bioinformatike, znanstvenog računalstva i epidemiologije, s komplementarnim stručnostima. Ključna značajka našeg projekta je validacija nove metodologije kroz izvedbu dokaza koncepta (Metaboličko zdravlje). Poseban naglasak bit će stavljen na brzu primjenu metoda kroz komunikaciju s povezanim konzorcijima i razvoj korisnički prihvatljivog softvera.",startDate:"01/10/2012",projectDuration:"60",pdf:"6-4.pdf",projectId:"305280",projectValue:"7,883,081.13€",additionalInformation:"cordis.europa.eu/project/id/305280",coordinator:"ACADEMISCH ZIEKENHUIS LEIDEN"},{short:"HighGlycan",titleEn:"Methods for High-Throughput Analysis of Protein Glycosylation",descriptionEn:"Glycosylation is a post-translational modification that enriches protein complexity and function. Dysregulation of glycosylation is associated with a wide range of diseases, including cancer, diabetes, as well as congenital, cardiovascular, immunological and infectious disorders. A number of studies identified potentially important glycan disease biomarkers. With regard to biotechnology, proper glycosylation of biologicals is important, as deviations in glycosylation are known to be associated with adverse drug reactions and reduced therapeutic efficacy. However, glycomics is significantly lagging behind genomics and proteomics, mainly due to the absence of high-throughput analytical methods which can reliably quantify a multitude of glycan structures in complex biological samples.<br><br>We are confident that by coordinated efforts of leading European scientists in glycan analysis using HPLC, MS and CGE-LIF technologies this project will make a decisive step forward by developing real high-throughput tools for glycosylation analysis. By teaming up with leading European researchers in the field of genome wide association studies this project will perform validation of all methods on extremely well characterized set of samples resulting from the FP6 EuroSpan project. The addition of the newly generated glycome data to the pre-existing information about these individuals will enable development of methods for the systems biology approach analysis of the glycome which will integrate glycomic, genomic and environmental data about thousands of individuals. The same methods will also be adapted for quality control and monitoring in the production of biopharmaceuticals.<br><br>Strong participation of SMEs in the project and close contacts with large industrial partners will ensure that research accomplishments achieved by collaboration between academic and industrial scientists are swiftly transformed into innovative products and services for the benefit of European industry.",titleHr:"Metode za visokoprotočnu analizu glikozilacije proteina",descriptionHr:"Glikozilacija je posttranslacijska modifikacija koja povećava složenost i funkcionalnost proteina. Poremećaji u glikozilaciji povezani su s nizom bolesti, uključujući rak, dijabetes, kao i kongenitalne, kardiovaskularne, imunološke i infektivne poremećaje. Brojne studije identificirale su potencijalno važne glikanske biomarkere bolesti. U kontekstu biotehnologije, ispravna glikozilacija bioloških lijekova iznimno je važna jer su odstupanja u glikozilaciji povezana s nuspojavama i smanjenom terapijskom učinkovitošću. Međutim, glikomika značajno zaostaje za genomikom i proteomikom, uglavnom zbog nedostatka visokoprotočnih analitičkih metoda koje pouzdano kvantificiraju velik broj glikanskih struktura u složenim biološkim uzorcima.<br><br>Uvjereni smo da će koordinirani napori vodećih europskih znanstvenika u analizi glikana korištenjem HPLC, MS i CGE-LIF tehnologija omogućiti odlučujući iskorak kroz razvoj pravih visokoprotočnih alata za analizu glikozilacije. U suradnji s vodećim europskim istraživačima u području asocijacijskih studija cijelog genoma, projekt će validirati sve metode na iznimno dobro okarakteriziranom skupu uzoraka iz projekta FP6 EuroSpan. Dodavanje novo generiranih podataka o glikomima postojećim informacijama o tim pojedincima omogućit će razvoj metoda za sustavsku biološku analizu glikoma koja će integrirati glikomičke, genomske i okolišne podatke o tisućama pojedinaca. Iste metode bit će prilagođene i za kontrolu kvalitete i nadzor u proizvodnji biofarmaceutika.<br><br>Snažna uključenost malih i srednjih poduzeća u projekt i bliski kontakti s velikim industrijskim partnerima osigurat će da se istraživačka postignuća, ostvarena suradnjom akademske i industrijske zajednice, brzo pretvore u inovativne proizvode i usluge na korist europske industrije.",startDate:"01/11/2011",projectDuration:"60",pdf:"6-5.pdf",projectId:"278535",projectValue:"7,799,296.87€",additionalInformation:"cordis.europa.eu/project/id/278535",coordinator:"ACADEMISCH ZIEKENHUIS LEIDEN"},{short:"GlycoBioM",titleEn:"Tools for the Detection of Novel Glyco-biomarkers",descriptionEn:"Glycosylation is a post-translational modification that enriches protein complexity and function. Dysregulation of glycosylation is associated with a wide range of diseases, including cancer, diabetes, as well as congenital, cardiovascular, immunological and infectious disorders. A number of studies identified potentially important glycan disease biomarkers. With regard to biotechnology, proper glycosylation of biologicals is important, as deviations in glycosylation are known to be associated with adverse drug reactions and reduced therapeutic efficacy. However, glycomics is significantly lagging behind genomics and proteomics, mainly due to the absence of high-throughput analytical methods which can reliably quantify a multitude of glycan structures in complex biological samples.<br><br>We are confident that by coordinated efforts of leading European scientists in glycan analysis using HPLC, MS and CGE-LIF technologies this project will make a decisive step forward by developing real high-throughput tools for glycosylation analysis. By teaming up with leading European researchers in the field of genome wide association studies this project will perform validation of all methods on extremely well characterized set of samples resulting from the FP6 EuroSpan project. The addition of the newly generated glycome data to the pre-existing information about these individuals will enable development of methods for the systems biology approach analysis of the glycome which will integrate glycomic, genomic and environmental data about thousands of individuals. The same methods will also be adapted for quality control and monitoring in the production of biopharmaceuticals.<br><br>Strong participation of SMEs in the project and close contacts with large industrial partners will ensure that research accomplishments achieved by collaboration between academic and industrial scientists are swiftly transformed into innovative products and services for the benefit of European industry.",titleHr:"Alati za otkrivanje novih gliko-biomarkera",descriptionHr:"Glikozilacija je posttranslacijska modifikacija koja povećava složenost i funkcionalnost proteina. Poremećaji u glikozilaciji povezani su s nizom bolesti, uključujući rak, dijabetes, kao i kongenitalne, kardiovaskularne, imunološke i infektivne poremećaje. Brojne studije identificirale su potencijalno važne glikanske biomarkere bolesti. U kontekstu biotehnologije, pravilna glikozilacija bioloških lijekova iznimno je važna jer su odstupanja u glikozilaciji povezana s nuspojavama i smanjenom terapijskom učinkovitošću. Međutim, glikomika značajno zaostaje za genomikom i proteomikom, ponajprije zbog nedostatka visokoprotočnih analitičkih metoda koje pouzdano kvantificiraju velik broj glikanskih struktura u složenim biološkim uzorcima.<br><br>Uvjereni smo da će koordiniranim naporima vodećih europskih znanstvenika u analizi glikana korištenjem HPLC, MS i CGE-LIF tehnologija ovaj projekt omogućiti odlučujući napredak razvojem pravih visokoprotočnih alata za analizu glikozilacije. U suradnji s vodećim europskim istraživačima u području asocijacijskih studija cijelog genoma, projekt će provesti validaciju svih metoda na iznimno dobro okarakteriziranom skupu uzoraka iz projekta FP6 EuroSpan. Dodavanje novo generiranih glikomskih podataka postojećim informacijama o tim pojedincima omogućit će razvoj metoda za sustavsku biološku analizu glikoma, koja će integrirati glikomičke, genomske i okolišne podatke o tisućama pojedinaca. Iste će se metode također prilagoditi za kontrolu kvalitete i nadzor u proizvodnji biofarmaceutika.<br><br>Snažno sudjelovanje malih i srednjih poduzeća u projektu i bliski kontakti s velikim industrijskim partnerima osigurat će da se znanstvena postignuća ostvarena suradnjom akademskih i industrijskih istraživača brzo pretoče u inovativne proizvode i usluge za dobrobit europske industrije.",startDate:"01/01/2011",projectDuration:"60",pdf:"6-6.pdf",projectId:"259869",projectValue:"6,806,915.80€",additionalInformation:"cordis.europa.eu/project/id/259869",coordinator:"THE UNIVERSITY OF MANCHESTER"}]},{group:{hr:"HRZZ",en:"CSF"},program:"CSF",href:"csf",projects:[{short:"GlycoCOVID",titleEn:"Support for developing competence centers",descriptionEn:'The GlycoCOVID project focuses on investigating glycans, which are complex oligosaccharides attached to proteins and lipids, as biomarkers and functional effectors in severe COVID-19 cases. The project aims to evaluate the role of glycans in COVID-19 severity by analyzing total plasma glycans and IgG glycans in multiple longitudinal samples of approximately 1000 mild and severe COVID cases. The main objectives are:<br><br><ol class="ordered-list"><li>To evaluate host protein glycosylation as a predictor of COVID-19 severity.</li><li>To evaluate biological age as a predictor of COVID-19 severity.</li><li>To evaluate changes in total protein and IgG glycosylation as predictors of severe COVID-19.</li></ol><br>The project is supported by the Croatian Science Foundation as part of a thematic call focusing on infectious diseases caused by coronaviruses and the social and educational aspects of the pandemic.',titleHr:"Podrška razvoju centara kompetencija",descriptionHr:'Projekt GlycoCOVID fokusiran je na istraživanje glikana, složenih oligosaharida vezanih uz proteine i lipide, kao biomarkera i funkcionalnih efektora kod težih slučajeva bolesti COVID-19. Cilj projekta je evaluirati ulogu glikana u težini bolesti COVID-19 analizom ukupnih plazmatskih glikana i IgG glikana u višestrukim longitudinalnim uzorcima otprilike 1000 blagih i teških slučajeva COVID-a. Glavni ciljevi su:<br><br><ol class="ordered-list"><li>Procijeniti glikozilaciju proteina domaćina kao prediktor težine bolesti COVID-19.</li><li>Procijeniti biološku dob kao prediktor težine bolesti COVID-19.</li><li>Procijeniti promjene u glikozilaciji ukupnih proteina i IgG-a kao prediktore teških oblika COVID-19.</li></ol><br>Projekt je podržan od strane Hrvatske zaklade za znanost u sklopu tematskog poziva usmjerenog na zarazne bolesti uzrokovane koronavirusima te na društvene i obrazovne aspekte pandemije.',startDate:"08/07/2020",projectDuration:"18",pdf:"4-1.pdf",projectId:"IP-CORONA-04-2052",projectValue:"1,500,500.00 HRK",contactPerson:"glauc@genos.hr"},{short:"GlycoDown",titleEn:"Protein Glycosylation in Aging-Related Diseases Through the Study of Down Syndrome as an Accelerated Aging Condition",descriptionEn:"The GlycoDown project focuses on studying protein glycosylation in individuals with Down Syndrome (DS) to understand aging-related diseases, especially Alzheimer's Disease (AD). It aims to identify glycan biomarkers of accelerated aging in DS and investigate their role in systemic inflammation and other comorbidities like autoimmune diseases. By analyzing IgG glycosylation in 300 DS individuals from three European populations, the project will explore how specific chromosome 21 gene products impact glycosylation profiles and identify glycan biomarkers predictive of AD and other diseases. The project leverages iPSCs and derived cell types to further understand how T21 influences glycosylation.",titleHr:"Glikozilacija proteina kod bolesti povezanih sa starenjem kroz proučavanje Downovog sindroma kao stanja ubrzanog starenja",descriptionHr:"Projekt GlycoDown usmjeren je na proučavanje glikozilacije proteina kod osoba s Downovim sindromom (DS) kako bi se bolje razumjele bolesti povezane sa starenjem, posebice Alzheimerova bolest (AD). Cilj mu je identificirati glikanske biomarkere ubrzanog starenja kod DS-a i istražiti njihovu ulogu u sustavnoj upali i drugim komorbiditetima poput autoimunih bolesti. Analizom IgG glikozilacije kod 300 osoba s DS-om iz tri europske populacije, projekt će istražiti kako specifični geni s kromosoma 21 utječu na glikozilacijske profile i identificirati glikanske biomarkere prediktivne za AD i druge bolesti. Projekt koristi iPSC stanice i izvedene stanične tipove za dodatno razumijevanje utjecaja T21 na glikozilaciju.",startDate:"01/10/2019",projectDuration:"43",pdf:"4-2.pdf",projectId:"PZS-2019-02-4277",projectValue:"2,200,000.00 HRK",contactPerson:"glauc@genos.hr"}]},{group:{hr:"Ostali",en:"Miscellaneous"},href:"miscellaneous",programs:[{program:"IRCRO",href:"ircro",projects:[{short:"GENPrevent",titleEn:"Research on Genetic Predispositions and Development of a Test for the Prevention of Sports Injuries",descriptionEn:"Modern sports genomics studies the connection between genotype and physical activity, performance, endurance, and susceptibility to exercise-induced injuries. Soft tissue and musculoskeletal injuries, such as Achilles tendon injuries in the heel and anterior cruciate ligament (ACL) injuries in the knee, are two of the most common sports injuries, both in recreational athletes and professional sportspeople. Recent studies show that physically active individuals who engage in sports and have suffered Achilles tendon injuries often share certain genetic characteristics.<br><br>The goal of the project is to investigate genetic predispositions to sports injuries and develop the GENPrevent test, which would identify these predispositions. Based on this information, a program for customized exercise would be created to prevent sports injuries. The project will result in the introduction of a new DNA test in the Genos DNA laboratory portfolio, which will provide top athletes and recreational athletes with information about their injury susceptibility. Based on their genetic predispositions, and in consultation with specialists, a personalized exercise plan will be created to reduce the likelihood of sports injuries and the consequences of long-term rehabilitation and absence from the sports field, which is especially important for professional athletes.<br><br>Ligament and tendon injuries in recreational athletes often mean a complete cessation of recreational sports, which increases the likelihood of adopting an unhealthy lifestyle, weight gain, and potential development of cardiovascular diseases or diabetes. To make the product more accessible to a wider population and not just professional athletes, a sample collection kit is also planned, which can be ordered by mail or purchased at pharmacies.",titleHr:"Istraživanje genetskih predispozicija i razvoj testa za prevenciju sportskih ozljeda",descriptionHr:"Moderna sportska genomika proučava povezanost između genotipa i tjelesne aktivnosti, izvedbe, izdržljivosti te sklonosti ozljedama uzrokovanim fizičkim naporom. Ozljede mekih tkiva i mišićno-koštanog sustava, poput ozljeda Ahilove tetive u peti i ozljeda prednjeg križnog ligamenta (ACL) u koljenu, jedne su od najčešćih sportskih ozljeda, kako kod rekreativaca, tako i kod profesionalnih sportaša. Nedavne studije pokazuju da fizički aktivne osobe koje se bave sportom i pretrpe ozljede Ahilove tetive često dijele određene genetske karakteristike.<br><br>Cilj projekta je istražiti genetske predispozicije za sportske ozljede i razviti test GENPrevent koji bi identificirao te predispozicije. Na temelju tih informacija izradit će se program prilagođene tjelesne aktivnosti za prevenciju sportskih ozljeda. Projekt će rezultirati uvođenjem novog DNA testa u portfelj Genos DNA laboratorija, koji će vrhunskim i rekreativnim sportašima pružiti informacije o njihovoj sklonosti ozljedama. Na temelju genetskih predispozicija i u konzultaciji sa stručnjacima, izradit će se personalizirani plan vježbanja kako bi se smanjila vjerojatnost sportskih ozljeda i posljedice dugotrajne rehabilitacije te izostanka s terena, što je posebno važno za profesionalne sportaše.<br><br>Ozljede ligamenata i tetiva kod rekreativaca često znače potpuno odustajanje od rekreativnog bavljenja sportom, što povećava vjerojatnost usvajanja nezdravog načina života, debljanja i mogućeg razvoja kardiovaskularnih bolesti ili dijabetesa. Kako bi proizvod bio dostupniji široj populaciji, a ne samo profesionalnim sportašima, planiran je i komplet za uzimanje uzoraka koji se može naručiti poštom ili kupiti u ljekarnama.",startDate:"01/01/2016",projectDuration:"24",pdf:"7-1.pdf",projectLead:"Nina Šimunić Briški",projectValue:"831,800.00 HRK"},{shortEn:"Development of Molecular Diagnostics Methods",descriptionEn:"The Development of Molecular Diagnostics Methods project aimed to enhance molecular diagnostic techniques through the identification of genetic and molecular markers. Co-funded by the Business Innovation Center of Croatia (BICRO) under the IRCRO program, the project focused on improving diagnostic accuracy and efficiency, with potential applications in personalized medicine and early disease detection. Led by Dr. Vedrana Škaro and conducted in collaboration with the University of Split School of Medicine, the project contributed to the advancement of molecular diagnostics in Croatia.",shortHr:"Razvoj metoda molekularne dijagnostike",descriptionHr:"Projekt Razvoj metoda molekularne dijagnostike imao je za cilj unaprijediti tehnike molekularne dijagnostike kroz identifikaciju genetskih i molekularnih markera. Suﬁnanciran od strane Poslovno-inovacijskog centra Hrvatske (BICRO) u okviru programa IRCRO, projekt je bio usmjeren na poboljšanje točnosti i učinkovitosti dijagnostike, s potencijalnim primjenama u personaliziranoj medicini i ranom otkrivanju bolesti. Projekt je vodila dr. Vedrana Škaro u suradnji s Medicinskim fakultetom Sveučilišta u Splitu te je dao doprinos razvoju molekularne dijagnostike u Hrvatskoj.",startDate:"28/03/2011",projectDuration:"15",pdf:"7-2.pdf",projectLead:"Vedrana Škaro",jobTitle:{hr:"Dr.Sc.",en:", PhD"},projectValue:"831,800.00 HRK"}]},{program:"PoC Private",href:"pocprivate",projects:[{shortEn:"Glycans as a Measure of General Health and Aging",descriptionEn:'This project aimed to explore glycans as biomarkers for assessing overall health and biological aging. Glycans, complex sugar molecules attached to proteins and lipids, play a crucial role in various biological processes, including immune response, inflammation, and aging.<br><br>By leveraging innovative glycomic analysis techniques, the project sought to validate glycans as reliable indicators of physiological aging and health status. The research findings could contribute to the development of novel diagnostic tools for personalized healthcare, enabling early detection of age-related health risks and improved preventive strategies.<br><br>The project was co-funded by BICRO under the "Proof of Concept for Entrepreneurs" program, supporting the commercialization potential of glycan-based health assessments.',shortHr:"Glikani kao pokazatelj općeg zdravlja i starenja",descriptionHr:"Cilj ovog projekta bio je istražiti glikane kao biomarkere za procjenu općeg zdravlja i biološkog starenja. Glikani, složene molekule šećera vezane uz proteine i lipide, imaju ključnu ulogu u brojnim biološkim procesima, uključujući imunološki odgovor, upalu i starenje.<br><br>Korištenjem inovativnih tehnika glikomičke analize, projekt je nastojao potvrditi glikane kao pouzdane pokazatelje fiziološkog starenja i zdravstvenog stanja. Rezultati istraživanja mogli bi doprinijeti razvoju novih dijagnostičkih alata za personaliziranu zdravstvenu skrb, omogućujući rano otkrivanje zdravstvenih rizika povezanih sa starenjem i poboljšane preventivne strategije.<br><br>Projekt je suﬁnanciran od strane BICRO-a u sklopu programa „Potvrda inovativnog koncepta za poduzetnike“, podržavajući komercijalizacijski potencijal zdravstvenih procjena temeljenih na glikanima.",startDate:"01/01/2014",projectDuration:"12",pdf:"8-1.pdf",projectLead:"Mislav Novokmet",jobTitle:{hr:"Dr.Sc.",en:", PhD"},projectValue:"699,795.23 HRK"},{shortEn:"Analysis of Antenary Fucose as Routine Diagnostics for HNF1A-MODY",descriptionEn:"The project focuses on analyzing antennary fucose as a potential routine diagnostic tool for HNF1A-MODY, a genetic form of diabetes. By examining specific glycosylation patterns, such as the presence of antennary fucose on plasma proteins, the project aims to develop a reliable diagnostic method for identifying this condition.<br><br>The project is co-financed by BICRO (the Croatian Agency for SMEs, Innovation, and Investments) as part of the Innovative Concept Verification Program.<br><br>The goal of the project is to validate the feasibility of using antennary fucose as a diagnostic marker, ultimately contributing to more accessible and accurate diagnostics for patients with HNF1A-MODY.",shortHr:"Analiza antenarnog fukoza za rutinsku dijagnostiku HNF1A-MODY dijabetesa",descriptionHr:"Projekt se fokusira na analizu antenarnog fukoza kao potencijalnog rutinskog dijagnostičkog alata za HNF1A-MODY, genetski oblik dijabetesa. Ispitivanjem specifičnih obrazaca glikozilacije, poput prisutnosti antenarnog fukoza na plazmatskim proteinima, cilj je razviti pouzdanu dijagnostičku metodu za prepoznavanje ovog stanja.<br><br>Projekt je sufinanciran od strane BICRO-a (Hrvatska agencija za malo gospodarstvo, inovacije i investicije) u sklopu Programa provjere inovativnog koncepta.<br><br>Cilj projekta je potvrditi izvedivost korištenja antenarnog fukoza kao dijagnostičkog markera te time doprinijeti pristupačnijoj i preciznijoj dijagnostici za pacijente s HNF1A-MODY dijabetesom.",startDate:"01/06/2011",projectDuration:"6",pdf:"8-2.pdf",projectLead:"Ana Knežević",jobTitle:{hr:"Dr.Sc.",en:", PhD"},projectValue:"707,331.00 HRK"}]},{program:"Poduzetnički Impuls 2013",href:"poduzetnicki-impuls2013",projects:[{shortEn:"Antenary Fucosylation of Plasma Proteins as a Biomarker for HNF1A-MODY",descriptionEn:"This project aimed to explore antenary fucosylation of plasma proteins as a potential biomarker for HNF1A-MODY (Maturity-Onset Diabetes of the Young, type HNF1A). HNF1A-MODY is a rare, monogenic form of diabetes caused by mutations in the HNF1A gene, leading to impaired insulin secretion. Early and accurate diagnosis is crucial, as individuals with this form of diabetes often respond well to sulfonylurea treatment, reducing their dependence on insulin therapy.<br><br>By investigating specific glycosylation changes, particularly antennary fucosylation, the project sought to develop a novel biomarker that could aid in the early detection and differentiation of HNF1A-MODY from other types of diabetes. The research focused on analyzing plasma protein glycosylation patterns in affected individuals to identify distinct glycan signatures associated with the condition.<br><br>The project was co-funded by the Ministry of Entrepreneurship and Crafts through the Entrepreneurial Impulse 2013 program, supporting innovative research with potential applications in personalized medicine and diagnostic advancements.",shortHr:"Antenerna fukozilacija plazmatskih proteina kao biomarker za HNF1A-MODY",descriptionHr:"Cilj ovog projekta bio je istražiti antenernu fukozilaciju plazmatskih proteina kao mogući biomarker za HNF1A-MODY (mladenački dijabetes s početkom u odrasloj dobi, tip HNF1A). HNF1A-MODY je rijedak, monogenski oblik dijabetesa uzrokovan mutacijama u HNF1A genu, što dovodi do smanjene sekrecije inzulina. Rana i točna dijagnoza ključna je jer osobe s ovim oblikom dijabetesa često dobro reagiraju na terapiju sulfonilurejom, čime se smanjuje potreba za terapijom inzulinom.<br><br>Istraživanjem specifičnih promjena u glikozilaciji, posebno antenerne fukozilacije, projekt je nastojao razviti novi biomarker koji bi mogao pomoći u ranom otkrivanju i razlikovanju HNF1A-MODY dijabetesa od drugih tipova dijabetesa. Istraživanje se fokusiralo na analizu obrazaca glikozilacije plazmatskih proteina kod pogođenih osoba radi identifikacije karakterističnih glikanskih potpisa povezanih s ovim stanjem.<br><br>Projekt je sufinanciran od strane Ministarstva poduzetništva i obrta kroz program Poduzetnički impuls 2013, s ciljem potpore inovativnim istraživanjima s potencijalnim primjenama u personaliziranoj medicini i razvoju dijagnostike.",startDate:"04/07/2013",projectDuration:"12",pdf:"9-1.pdf",projectValue:"375,000.00 HRK"}]},{program:"3C",href:"3c",projects:[{shortEn:"High-Throughput Plasma Glycan Analysis",descriptionEn:"The project aimed to develop and optimize high-throughput analytical methods for plasma glycan profiling. By leveraging advanced glycomics technologies, the research focused on improving the efficiency and accuracy of glycan analysis, enabling large-scale studies on the role of glycans in health and disease. The findings contributed to the broader application of glycomics in biomarker discovery and personalized medicine.",shortHr:"Visokoprotočna analiza glikana u plazmi",descriptionHr:"Projekt je imao za cilj razvoj i optimizaciju visokoprotočnih analitičkih metoda za profiliranje glikana u plazmi. Korištenjem naprednih glikomičkih tehnologija, istraživanje se fokusiralo na poboljšanje učinkovitosti i točnosti analize glikana, omogućujući provedbu velikih studija o ulozi glikana u zdravlju i bolesti. Rezultati su pridonijeli široj primjeni glikomike u otkrivanju biomarkera i personaliziranoj medicini.",startDate:"01/12/2010",projectDuration:"6",pdf:"10-1.pdf",projectLead:"Ana Knežević",jobTitle:{hr:"Dr.Sc.",en:", PhD"},projectValue:"445,700.00 HRK"}]},{program:"NSF",href:"nsf",projects:[{shortEn:"Analysis of N-Linked Glycans in Human Plasma",descriptionEn:"The project focused on the comprehensive analysis of N-linked glycans in human plasma to better understand their role in health and disease. By employing advanced glycomics techniques, researchers aimed to identify glycan biomarkers that could contribute to improved diagnostics and personalized medicine. The study provided valuable insights into the structural complexity of glycans and their potential as indicators of various physiological and pathological conditions.",shortHr:"Analiza N-vezanih glikana u ljudskoj plazmi",descriptionHr:"Projekt se fokusirao na sveobuhvatnu analizu N-vezanih glikana u ljudskoj plazmi s ciljem boljeg razumijevanja njihove uloge u zdravlju i bolesti. Primjenom naprednih glikomičkih tehnika, istraživači su nastojali identificirati glikanske biomarkere koji bi mogli doprinijeti poboljšanju dijagnostike i personalizirane medicine. Studija je pružila vrijedne uvide u strukturnu složenost glikana i njihov potencijal kao pokazatelja različitih fizioloških i patoloških stanja.",startDate:"01/06/2010",projectDuration:"36",pdf:"11-1.pdf",projectLead:"Igor Rudan",jobTitle:{hr:"Dr.Sc.",en:", PhD"}}]},{program:"HIT",href:"hit",projects:[{shortEn:"Application of DNA Analysis in the Development of Traceability Systems in Livestock and Meat Processing Production",descriptionEn:"The project focused on applying DNA analysis to develop advanced traceability systems for the livestock and meat processing industries. By implementing genetic identification methods, the project aimed to enhance food safety, quality control, and regulatory compliance. The outcomes provided a reliable framework for tracking the origin of meat products, ensuring authenticity, and reducing the risk of fraud in the supply chain.",shortHr:"Primjena DNA analize u razvoju sustava sljedivosti u stočarskoj i mesoprerađivačkoj proizvodnji",descriptionHr:"Projekt se fokusirao na primjenu DNA analize za razvoj naprednih sustava sljedivosti u stočarskoj i mesoprerađivačkoj industriji. Uvođenjem metoda genetske identifikacije, cilj je bio poboljšati sigurnost hrane, kontrolu kvalitete i usklađenost s propisima. Rezultati su omogućili pouzdan okvir za praćenje podrijetla mesnih proizvoda, osiguranje autentičnosti i smanjenje rizika od prijevara u opskrbnom lancu.",startDate:"26/03/2010",projectDuration:"36",pdf:"12-1.pdf",projectLead:"Damir Marjanović",jobTitle:{hr:"Dr.Sc.",en:", PhD"},projectValue:"1,810,000.00 HRK"}]},{program:"MZO",href:"mzo",projects:[{shortEn:"Development of a System for DNA Analysis of Archaeological Bone Samples",descriptionEn:"The project, funded by the Ministry of Science, Education, and Sports, focused on developing methodologies for extracting and analyzing DNA from archaeological bone samples. By refining DNA isolation and sequencing techniques, the project aimed to improve genetic research on ancient human and animal remains. The results contributed to the fields of archaeology, anthropology, and forensic science by enabling more accurate reconstructions of historical populations and their genetic heritage.",shortHr:"Razvoj sustava za DNA analizu arheoloških uzoraka kostiju",descriptionHr:"Projekt, financiran od strane Ministarstva znanosti, obrazovanja i športa, bio je usmjeren na razvoj metodologija za ekstrakciju i analizu DNA iz arheoloških uzoraka kostiju. Unapređivanjem tehnika izolacije i sekvenciranja DNA, projekt je imao za cilj poboljšati genetska istraživanja drevnih ljudskih i životinjskih ostataka. Rezultati su doprinijeli područjima arheologije, antropologije i forenzike omogućujući točniju rekonstrukciju povijesnih populacija i njihovog genetskog nasljeđa.",startDate:"02/01/2007",projectDuration:"35",pdf:"13-1.pdf",projectLead:"Damir Marjanović",jobTitle:{hr:"Dr.Sc.",en:", PhD"},projectValue:"233,315.36 HRK"}]}]}];var kh=y("<a><!></a>"),fh=y('<p class="project-text clamp"><!></p>'),bh=y('<p style="margin-bottom: 1rem;"><!></p>'),yh=y("<tr><td><!></td><td> </td></tr>"),zh=y("<tr><td><!></td><td> <!></td></tr>"),Sh=y("<tr><td><!></td><td> </td></tr>"),Mh=y("<tr><td><!></td><td> </td></tr>"),wh=y("<tr><td><!></td><td> </td></tr>"),Ah=y("<tr><td><!></td><td> </td></tr>"),Gh=y("<tr><td><!></td><td> </td></tr>"),Dh=y("<tr><td><!></td><td> </td></tr>"),Ih=y("<tr><td><!></td><td> </td></tr>"),Ph=y("<tr><td><!></td><td> </td></tr>"),Ch=y('<div class="project-details"><!> <table><tbody><!><!><!><!><!><!><!><!><!><!></tbody></table></div>'),Th=y('<a target="_blank" class="button-filled open-pdf">Open as PDF</a>'),Nh=y('<a target="_blank" class="button-filled open-pdf">Otvori kao PDF</a>'),Lh=y('<div class="project-card-container"><div class="project-card"><h4 class="project-title"><!></h4> <!> <button class="details-toggle"><!></button> <!> <!></div></div>'),_h=y('<p class="project-text clamp"><!></p>'),Eh=y('<p style="margin-bottom: 1rem;"><!></p>'),Hh=y("<tr><td><!></td><td> </td></tr>"),xh=y(" <!>",1),Oh=y(" <!>",1),Rh=y("<tr><td><!></td><td><!></td></tr>"),Fh=y("<tr><td><!></td><td> </td></tr>"),Bh=y("<tr><td><!></td><td> </td></tr>"),Vh=y("<tr><td><!></td><td> </td></tr>"),Jh=y("<tr><td><!></td><td> </td></tr>"),Kh=y("<tr><td><!></td><td> </td></tr>"),Wh=y("<tr><td><!></td><td><!> <!></td></tr>"),Zh=y("<tr><td><!></td><td> </td></tr>"),Uh=y("<tr><td><!></td><td> </td></tr>"),Yh=y("<tr><td><!></td><td> </td></tr>"),$h=y('<div class="project-details"><!> <table><tbody><!><!><!><!><!><!><!><!><!><!><!></tbody></table></div>'),qh=y('<a target="_blank" class="button-filled open-pdf">Open as PDF</a>'),Xh=y('<a target="_blank" class="button-filled open-pdf">Otvori kao PDF</a>'),Qh=y('<div class="project-card-container"><div class="project-card"><h4 class="project-title"><!></h4> <!> <button class="details-toggle"><!></button> <!> <!></div></div>'),ev=y('<div class="program-container"><h3 class="program-title" style="margin-top: 1.5rem"> </h3> <!></div>'),av=y('<div class="projects-cards"><h3 class="program-title"><!></h3> <!></div>'),iv=y('<div class="grid grid-small projects"><div class="gc-12 mb-24"><h2> </h2></div> <div class="gc-3 sticky"><p> </p> <div class="sticky-items"></div></div> <div class="gc-9 programs"></div></div>');function ov(o,e){Ke(e,!1);const a=ra(),i=()=>$e(ea,"$language",a),r=()=>$e(d,"$sortedProjects",a),l=w=>{const[f,T,W]=w.split("/").map(Number);return new Date(W,T-1,f)},d=fc([],()=>jh.map(w=>{let f={...w};return f.projects?f.projects=[...f.projects].sort((T,W)=>l(W.startDate)-l(T.startDate)):f.programs&&(f.programs=f.programs.map(T=>({...T,projects:[...T.projects].sort((W,X)=>l(X.startDate)-l(W.startDate))}))),f}));let u=se("");qe();var p=iv(),h=n(p),j=n(h),S=n(j);t(j),t(h);var G=s(h,2),z=n(G),M=n(z);t(z);var k=s(z,2);He(k,5,r,xe,(w,f)=>{var T=kh(),W=n(T);P(W,()=>c(f).group.en||c(f).group.hr,X=>{var O=Ne();A(()=>m(O,`${(i()==="en"?c(f).group.en:c(f).group.hr)??""}
            ${(i()==="en"?"projects":"projekti")??""}`)),v(X,O)},X=>{var O=Ne();A(()=>m(O,`${c(f).group??""} ${(i()==="en"?"projects":"projekti")??""}`)),v(X,O)}),t(T),A(()=>B(T,"href",`/${(i()==="en"?"projects":"projekti")??""}#${c(f).href??""}`)),v(w,T)}),t(k),t(G);var g=s(G,2);He(g,5,r,xe,(w,f)=>{var T=av(),W=n(T),X=n(W);P(X,()=>c(f).group.en||c(f).group.hr,E=>{var R=Ne();A(()=>m(R,`${(i()==="en"?c(f).group.en:c(f).group.hr)??""}
            ${(i()==="en"?"projects":"projekti")??""}`)),v(E,R)},E=>{var R=Ne();A(()=>m(R,`${c(f).group??""} ${(i()==="en"?"projects":"projekti")??""}`)),v(E,R)}),t(W);var O=s(W,2);P(O,()=>c(f).projects,E=>{var R=Be(),U=me(R);He(U,1,()=>c(f).projects,xe,(Q,D)=>{var _=Lh(),x=n(_),b=n(x),I=n(b);P(I,()=>c(D).shortEn&&c(D).shortHr,Z=>{var F=Be(),ke=me(F);P(ke,()=>i()==="en",oe=>{var le=Ne();A(()=>m(le,c(D).shortEn)),v(oe,le)},oe=>{var le=Ne();A(()=>m(le,c(D).shortHr)),v(oe,le)}),v(Z,F)},Z=>{var F=Ne();A(()=>m(F,c(D).short)),v(Z,F)}),t(b);var C=s(b,2);P(C,()=>c(D).titleEn&&c(D).titleHr,Z=>{var F=fh(),ke=n(F);P(ke,()=>i()==="en",oe=>{var le=Ne();A(()=>m(le,`${c(D).titleEn??""}.`)),v(oe,le)},oe=>{var le=Ne();A(()=>m(le,`${c(D).titleHr??""}.`)),v(oe,le)}),t(F),v(Z,F)});var H=s(C,2),Y=n(H);P(Y,()=>i()==="en",Z=>{var F=Ne();A(()=>m(F,c(u)===c(D)?"Less details":"More details")),v(Z,F)},Z=>{var F=Ne();A(()=>m(F,c(u)===c(D)?"Manje detalja":"Više detalja")),v(Z,F)}),t(H);var ie=s(H,2);P(ie,()=>c(u)===c(D),Z=>{var F=Ch(),ke=n(F);P(ke,()=>c(u).descriptionEn||c(u).descriptionHr,ye=>{var q=bh(),te=n(q);P(te,()=>i()==="en",ze=>{var ce=Be(),fe=me(ce);$(fe,()=>c(u).descriptionEn),v(ze,ce)},ze=>{var ce=Be(),fe=me(ce);$(fe,()=>c(u).descriptionHr),v(ze,ce)}),t(q),v(ye,q)});var oe=s(ke,2),le=n(oe),Oe=n(le);P(Oe,()=>c(u).startDate,ye=>{var q=yh(),te=n(q),ze=n(te);$(ze,()=>i()==="en"?"Start Date:":"Datum početka:"),t(te);var ce=s(te),fe=n(ce);t(ce),t(q),A(()=>m(fe,c(u).startDate)),v(ye,q)});var Fe=s(Oe);P(Fe,()=>c(u).projectDuration,ye=>{var q=zh(),te=n(q),ze=n(te);$(ze,()=>i()==="en"?"Project Duration:":"Trajanje projekta:"),t(te);var ce=s(te),fe=n(ce),Fa=s(fe);$(Fa,()=>i()==="en"?"months":"mjeseci"),t(ce),t(q),A(()=>m(fe,`${c(u).projectDuration??""} `)),v(ye,q)});var aa=s(Fe);P(aa,()=>c(u).projectId,ye=>{var q=Sh(),te=n(q),ze=n(te);$(ze,()=>i()==="en"?"Project ID:":"ID projekta:"),t(te);var ce=s(te),fe=n(ce);t(ce),t(q),A(()=>m(fe,c(u).projectId)),v(ye,q)});var ma=s(aa);P(ma,()=>c(u).callForProposals,ye=>{var q=Mh(),te=n(q),ze=n(te);$(ze,()=>i()==="en"?"Call For Proposals:":"Poziv:"),t(te);var ce=s(te),fe=n(ce);t(ce),t(q),A(()=>m(fe,c(u).callForProposals)),v(ye,q)});var Ce=s(ma);P(Ce,()=>c(u).coordinator,ye=>{var q=wh(),te=n(q),ze=n(te);$(ze,()=>i()==="en"?"Coordinator:":"Koordinator:"),t(te);var ce=s(te),fe=n(ce);t(ce),t(q),A(()=>m(fe,c(u).coordinator)),v(ye,q)});var ve=s(Ce);P(ve,()=>c(u).projectParticipants,ye=>{var q=Ah(),te=n(q),ze=n(te);$(ze,()=>i()==="en"?"Project Participants:":"Sudionici projekta:"),t(te);var ce=s(te),fe=n(ce);t(ce),t(q),A(()=>m(fe,c(u).projectParticipants)),v(ye,q)});var Je=s(ve);P(Je,()=>c(u).projectValue,ye=>{var q=Gh(),te=n(q),ze=n(te);$(ze,()=>i()==="en"?"Project Value:":"Vrijednost projekta:"),t(te);var ce=s(te),fe=n(ce);t(ce),t(q),A(()=>m(fe,c(u).projectValue)),v(ye,q)});var Te=s(Je);P(Te,()=>c(u).genosContribution,ye=>{var q=Dh(),te=n(q),ze=n(te);$(ze,()=>i()==="en"?"Genos Grant Amount:":"Iznos Genosove potpore:"),t(te);var ce=s(te),fe=n(ce);t(ce),t(q),A(()=>m(fe,c(u).genosContribution)),v(ye,q)});var Me=s(Te);P(Me,()=>c(u).euCoFinancingAmount,ye=>{var q=Ih(),te=n(q),ze=n(te);$(ze,()=>i()==="en"?"Eu Co-finacing Amount:":"Iznos EU sufinanciranja:"),t(te);var ce=s(te),fe=n(ce);t(ce),t(q),A(()=>m(fe,c(u).euCoFinancingAmount)),v(ye,q)});var sa=s(Me);P(sa,()=>c(u).contactPerson,ye=>{var q=Ph(),te=n(q),ze=n(te);$(ze,()=>i()==="en"?"Contact Person:":"Kontakt osoba:"),t(te);var ce=s(te),fe=n(ce);t(ce),t(q),A(()=>m(fe,c(u).contactPerson)),v(ye,q)}),t(le),t(oe),t(F),Oa(3,F,()=>li),v(Z,F)});var K=s(ie,2);P(K,()=>c(D).pdf,Z=>{var F=Be(),ke=me(F);P(ke,()=>i()==="en",oe=>{var le=Th();A(()=>B(le,"href",`/pdfs/en/${c(D).pdf??""}`)),v(oe,le)},oe=>{var le=Nh();A(()=>B(le,"href",`/pdfs/hr/${c(D).pdf??""}`)),v(oe,le)}),v(Z,F)}),t(x),t(_),Pe("click",H,()=>L(u,c(u)===c(D)?"":c(D))),v(Q,_)}),v(E,R)},E=>{var R=Be(),U=me(R);P(U,()=>c(f),Q=>{var D=Be(),_=me(D);He(_,1,()=>c(f).programs,xe,(x,b)=>{var I=ev(),C=n(I),H=n(C);t(C);var Y=s(C,2);He(Y,1,()=>c(b).projects,xe,(ie,K)=>{var Z=Qh(),F=n(Z),ke=n(F),oe=n(ke);P(oe,()=>c(K).shortEn&&c(K).shortHr,Ce=>{var ve=Be(),Je=me(ve);P(Je,()=>i()==="en",Te=>{var Me=Ne();A(()=>m(Me,c(K).shortEn)),v(Te,Me)},Te=>{var Me=Ne();A(()=>m(Me,c(K).shortHr)),v(Te,Me)}),v(Ce,ve)},Ce=>{var ve=Ne();A(()=>m(ve,c(K).short)),v(Ce,ve)}),t(ke);var le=s(ke,2);P(le,()=>c(K).titleEn&&c(K).titleHr,Ce=>{var ve=_h(),Je=n(ve);P(Je,()=>i()==="en",Te=>{var Me=Ne();A(()=>m(Me,`${c(K).titleEn??""}.`)),v(Te,Me)},Te=>{var Me=Ne();A(()=>m(Me,`${c(K).titleHr??""}.`)),v(Te,Me)}),t(ve),v(Ce,ve)});var Oe=s(le,2),Fe=n(Oe);P(Fe,()=>i()==="en",Ce=>{var ve=Ne();A(()=>m(ve,c(u)===c(K)?"Less details":"More details")),v(Ce,ve)},Ce=>{var ve=Ne();A(()=>m(ve,c(u)===c(K)?"Manje detalja":"Više detalja")),v(Ce,ve)}),t(Oe);var aa=s(Oe,2);P(aa,()=>c(u)===c(K),Ce=>{var ve=$h(),Je=n(ve);P(Je,()=>c(u).descriptionEn||c(u).descriptionHr,we=>{var ee=Eh(),ae=n(ee);P(ae,()=>i()==="en",Ae=>{var ue=Be(),Se=me(ue);$(Se,()=>c(u).descriptionEn),v(Ae,ue)},Ae=>{var ue=Be(),Se=me(ue);$(Se,()=>c(u).descriptionHr),v(Ae,ue)}),t(ee),v(we,ee)});var Te=s(Je,2),Me=n(Te),sa=n(Me);P(sa,()=>c(u).startDate,we=>{var ee=Hh(),ae=n(ee),Ae=n(ae);$(Ae,()=>i()==="en"?"Start Date:":"Datum početka:"),t(ae);var ue=s(ae),Se=n(ue);t(ue),t(ee),A(()=>m(Se,c(u).startDate)),v(we,ee)});var ye=s(sa);P(ye,()=>c(u).projectDuration||c(u).projectDurationInDays,we=>{var ee=Rh(),ae=n(ee),Ae=n(ae);$(Ae,()=>i()==="en"?"Project Duration:":"Trajanje projekta:"),t(ae);var ue=s(ae),Se=n(ue);P(Se,()=>c(u).projectDurationInDays,ka=>{var ya=xh(),ia=me(ya),pa=s(ia);$(pa,()=>i()==="en"?"days":"dana"),A(()=>m(ia,`${c(u).projectDurationInDays??""} `)),v(ka,ya)},ka=>{var ya=Oh(),ia=me(ya),pa=s(ia);$(pa,()=>i()==="en"?"months":"mjeseci"),A(()=>m(ia,`${c(u).projectDuration??""} `)),v(ka,ya)}),t(ue),t(ee),v(we,ee)});var q=s(ye);P(q,()=>c(u).projectId,we=>{var ee=Fh(),ae=n(ee),Ae=n(ae);$(Ae,()=>i()==="en"?"Project ID:":"ID projekta:"),t(ae);var ue=s(ae),Se=n(ue);t(ue),t(ee),A(()=>m(Se,c(u).projectId)),v(we,ee)});var te=s(q);P(te,()=>c(u).callForProposals,we=>{var ee=Bh(),ae=n(ee),Ae=n(ae);$(Ae,()=>i()==="en"?"Call For Proposals:":"Poziv:"),t(ae);var ue=s(ae),Se=n(ue);t(ue),t(ee),A(()=>m(Se,c(u).callForProposals)),v(we,ee)});var ze=s(te);P(ze,()=>c(u).coordinator,we=>{var ee=Vh(),ae=n(ee),Ae=n(ae);$(Ae,()=>i()==="en"?"Coordinator:":"Koordinator:"),t(ae);var ue=s(ae),Se=n(ue);t(ue),t(ee),A(()=>m(Se,c(u).coordinator)),v(we,ee)});var ce=s(ze);P(ce,()=>c(u).projectParticipants,we=>{var ee=Jh(),ae=n(ee),Ae=n(ae);$(Ae,()=>i()==="en"?"Project Participants:":"Sudionici projekta:"),t(ae);var ue=s(ae),Se=n(ue);t(ue),t(ee),A(()=>m(Se,c(u).projectParticipants)),v(we,ee)});var fe=s(ce);P(fe,()=>c(u).projectValue,we=>{var ee=Kh(),ae=n(ee),Ae=n(ae);$(Ae,()=>i()==="en"?"Project Value:":"Vrijednost projekta:"),t(ae);var ue=s(ae),Se=n(ue);t(ue),t(ee),A(()=>m(Se,c(u).projectValue)),v(we,ee)});var Fa=s(fe);P(Fa,()=>c(u).projectLead,we=>{var ee=Wh(),ae=n(ee),Ae=n(ae);$(Ae,()=>i()==="en"?"Project lead":"Voditelj projekta:"),t(ae);var ue=s(ae),Se=n(ue);P(Se,()=>i()==="hr",ia=>{var pa=Ne();A(()=>{var Ia;return m(pa,(Ia=c(u).jobTitle)==null?void 0:Ia.hr)}),v(ia,pa)});var ka=s(Se),ya=s(ka);P(ya,()=>i()==="en",ia=>{var pa=Ne();A(()=>{var Ia;return m(pa,(Ia=c(u).jobTitle)==null?void 0:Ia.en)}),v(ia,pa)}),t(ue),t(ee),A(()=>m(ka,` ${c(u).projectLead??""}`)),v(we,ee)});var Ba=s(Fa);P(Ba,()=>c(u).genosContribution,we=>{var ee=Zh(),ae=n(ee),Ae=n(ae);$(Ae,()=>i()==="en"?"Genos Grant Amount:":"Iznos Genosove potpore:"),t(ae);var ue=s(ae),Se=n(ue);t(ue),t(ee),A(()=>m(Se,c(u).genosContribution)),v(we,ee)});var Va=s(Ba);P(Va,()=>c(u).euCoFinancingAmount,we=>{var ee=Uh(),ae=n(ee),Ae=n(ae);$(Ae,()=>i()==="en"?"Eu Co-finacing Amount:":"Iznos EU sufinanciranja:"),t(ae);var ue=s(ae),Se=n(ue);t(ue),t(ee),A(()=>m(Se,c(u).euCoFinancingAmount)),v(we,ee)});var Oi=s(Va);P(Oi,()=>c(u).contactPerson,we=>{var ee=Yh(),ae=n(ee),Ae=n(ae);$(Ae,()=>i()==="en"?"Contact Person:":"Kontakt osoba:"),t(ae);var ue=s(ae),Se=n(ue);t(ue),t(ee),A(()=>m(Se,c(u).contactPerson)),v(we,ee)}),t(Me),t(Te),t(ve),Oa(3,ve,()=>li),v(Ce,ve)});var ma=s(aa,2);P(ma,()=>c(K).pdf,Ce=>{var ve=Be(),Je=me(ve);P(Je,()=>i()==="en",Te=>{var Me=qh();A(()=>B(Me,"href",`/pdfs/en/${c(K).pdf??""}`)),v(Te,Me)},Te=>{var Me=Xh();A(()=>B(Me,"href",`/pdfs/hr/${c(K).pdf??""}`)),v(Te,Me)}),v(Ce,ve)}),t(F),t(Z),Pe("click",Oe,()=>L(u,c(u)===c(K)?"":c(K))),v(ie,Z)}),t(I),A(()=>{B(C,"id",c(b).href),m(H,`${c(b).program??""}
                ${(i()==="en"?"projects":"projekti")??""}`)}),v(x,I)}),v(Q,D)},null,!0),v(E,R)}),t(T),A(()=>B(W,"id",c(f).href)),v(w,T)}),t(g),t(p),A(()=>{m(S,i()==="en"?"With over 40 larger and smaller collaborative projects conducted with scientific teams from different research institutions from around the world, we have the expertise to design studies and bring them to a successful conclusion.":"S više od 40 većih i manjih suradničkih projekata provedenih sa znanstvenim timovima iz različitih istraživačkih institucija diljem svijeta, posjedujemo stručnost za osmišljavanje studija i njihovo uspješno provođenje."),m(M,i()==="en"?"Quick links:":"Izbornik:")}),v(o,p),We()}customElements.define("pb-projects",Ge(ov,{},[],[],!1));var tv=y('<img class="intro-bg">');function nv(o,e){Ke(e,!1);let a=J(e,"src",12),i=J(e,"alt",12,"");var r=tv();return A(()=>{B(r,"src",a()),B(r,"alt",i())}),v(o,r),We({get src(){return a()},set src(l){a(l),V()},get alt(){return i()},set alt(l){i(l),V()}})}customElements.define("pb-intro",Ge(nv,{src:{},alt:{}},[],[],!1));const rv="AIzaSyCv9dQEwPOLoV_Cdn8NKLhNqA9bYb9Umew";var sv=y('<div id="map" class="svelte-1ogzh53"></div>');const lv={hash:"svelte-1ogzh53",code:`
    #map.svelte-1ogzh53 {
        width: 100%;
        height: 500px
    }
`};function uv(o,e){Ke(e,!1),es(o,lv);const a=se(),i=se();let r,l=se(10),d=J(e,"lat",12),u=J(e,"lng",12),p=J(e,"mapzoom",12);Da(()=>{new Promise((S,G)=>{if(window.google&&window.google.maps)S();else{const z=document.createElement("script");z.src=`https://maps.googleapis.com/maps/api/js?key=${rv}`,z.async=!0,z.onload=S,z.onerror=G,document.head.appendChild(z)}}).then(()=>{r=new window.google.maps.Map(document.getElementById("map"),{center:{lat:c(a),lng:c(i)},zoom:+p()||c(l)}),new window.google.maps.Marker({map:r,position:{lat:c(a),lng:c(i)}})})}),Ve(()=>(c(a),pe(d())),()=>{L(a,parseFloat(d())||c(a)||37.7749)}),Ve(()=>(c(i),pe(u())),()=>{L(i,parseFloat(u())||c(i)||-122.4194)}),Ve(()=>(c(l),pe(p())),()=>{L(l,parseInt(p())||c(l))}),ba(),qe();var h=sv();return v(o,h),We({get lat(){return d()},set lat(j){d(j),V()},get lng(){return u()},set lng(j){u(j),V()},get mapzoom(){return p()},set mapzoom(j){p(j),V()}})}customElements.define("pb-google-map",Ge(uv,{lat:{},lng:{},mapzoom:{}},[],[],!1));function cv(o,e){Ke(e,!1);let a=J(e,"data",12),i=[],r=[],l=se(0),d;const u=[];mr.set({title:a().title,...a().meta}),a().renderLayout||u.push("standalone");function p(k){i.forEach(g=>{!g.el||!g.className||(k>g.height?g.el.classList.add(g.className):g.el.classList.contains(g.className)&&g.el.classList.remove(g.className))})}async function h(){for(;!window.Swiper;)await new Promise(g=>setTimeout(g,50));let k=0;for(;!window.swipers&&k<100;)await new Promise(g=>setTimeout(g,50)),k+=1;if(!(!window.swipers||!Object.keys(window.swipers).length))for(const g in window.swipers){const{swiper:w,id:f}=window.swipers[g];let T=document.getElementById(f),W=0;for(;!T&&W<100;)await new Promise(X=>setTimeout(X,50)),T=document.getElementById(f);T&&(window.swiperInstances||(window.swiperInstances={}),window.swiperInstances[g]||(window.swiperInstances[g]=w(T)))}}function j(k){{if(window.swipers&&(window.swipers={}),window.swiperInstances&&Object.keys(window.swiperInstances).length&&(window.swiperInstances={}),a().scripts){const g=document.createElement("script");g.innerHTML=a().scripts,document.body.appendChild(g)}h().catch()}r=[],document.querySelectorAll("[data-pblink]").forEach(g=>{const w=g.classList.contains("active"),f=g.getAttribute("href");w&&f!==k.url.pathname?g.classList.remove("active"):!w&&f===k.url.pathname&&g.classList.add("active")}),document.querySelectorAll("[data-pbanchor]").forEach(g=>{g.addEventListener("click",w=>{w.preventDefault();const f=document.querySelector(g.getAttribute("href"));f&&(f==null||f.scrollIntoView({behavior:g.getAttribute("animation")}))})}),mr.set({title:a().title,...a().meta}),i=[],document.querySelectorAll("[data-scroll-tracker-class]").forEach(g=>{const w=g.getAttribute("data-scroll-tracker-class"),f=parseInt(g.getAttribute("data-scroll-tracker-height"),10)||100;i.push({el:g,className:w,height:f})}),document.querySelectorAll("[data-scroll-to-selector]").forEach(g=>{const w=g.getAttribute("data-scroll-to-selector");g.addEventListener("click",()=>{const f=document.querySelector(w);f&&f.scrollIntoView({behavior:g.getAttribute("data-scroll-to-behavior")||"smooth"})})}),document.querySelectorAll("[data-toggle-class-class]").forEach(g=>{const w=g.getAttribute("data-toggle-class-class");g.addEventListener("click",()=>{g.classList.contains(w)?g.classList.remove(w):g.classList.add(w)})}),r=[...document.querySelectorAll("[data-is-in-view-classes-to-add], [data-is-in-view-classes-to-remove]")].map(g=>{var T,W;const w=((T=g.getAttribute("data-is-in-view-classes-to-add"))==null?void 0:T.split(","))||[],f=((W=g.getAttribute("data-is-in-view-classes-to-remove"))==null?void 0:W.split(","))||[];return{el:g,classesToAdd:w,classesToRemove:f}})}function S(){d=$r.subscribe(k=>{j(k)})}function G(){for(let k=r.length-1;k>=0;(k-=1)+1){const{el:g,classesToAdd:w,classesToRemove:f}=r[k],T=g.getBoundingClientRect();T.top>=0&&T.left>=0&&T.bottom<=window.innerHeight&&T.right<=window.innerWidth&&(w!=null&&w.length&&g.classList.add(...w),f!=null&&f.length&&g.classList.remove(...f),r.splice(k,1))}}Da(()=>{S()}),jc(()=>{d&&d()}),Ve(()=>c(l),()=>{p(c(l))}),ba(),qe();var z=Be();Pe("scroll",$t,G,void 0,!0),Pe("resize",$t,G,void 0,!0),Pe("load",$t,G);var M=me(z);return $(M,()=>a().content),hc(mc.body,(k,g)=>yc(k,g),()=>u),bc("y",()=>c(l),k=>L(l,k)),v(o,z),We({get data(){return a()},set data(k){a(k),V()}})}Ge(cv,{data:{}},[],[],!0);export{cv as component};
